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Embryology is a branch of science concerned with the morphological aspects of 
organismal development. The genomic and molecular revolution of the second half 
of the 20th century, together with the classic descriptive aspects of this science have 
allowed greater integration in our understanding of many developmental events. 
Through such integration, modern embryology seeks to provide practical knowledge 
that can be applied to assisted reproduction, stem cell therapy, birth defects, fetal 
surgery and other fields. This book focuses on human embryology and aims to provide 
an up-to-date source of information on a variety of selected topics. The book consists 
of nine chapters organized into three sections, namely: 1) gametes and infertility, 2) 
implantation, placentation and early development, and 3) perspectives in embryology. 
The contents of this book should be of interest to biology and medical students, clinical 
embryologists, laboratory researchers, obstetricians and urologists, developmental 
biologists, molecular geneticists and anyone who wishes to know more about recent 
advances in human development.
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Preface 
Embryology is a branch of science concerned with the morphological aspects of 
organismal development. The genomic and molecular revolution of the second half of 
the 20th century, together with the classic descriptive aspects of this science have 
allowed greater integration in our understanding of many developmental events. 
Current studies in embryology and developmental biology are not restricted to gamete 
formation, fertilization (in vivo or in vitro), zygote formation, early growth or the 
development of living organisms, but also involve investigation of the genetic control 
of these processes and of development itself (so called morphogenesis). Modern 
embryology seeks to provide practical knowledge that can be applied to assisted 
reproduction, stem cell therapy, birth defects, fetal surgery and other fields. 
This book focuses on human embryology and aims to provide an up-to-date source of 
information on a variety of selected topics. The book consists of nine chapters 
organized into three sections, namely: 1) gametes and infertility, 2) implantation, 
placentation and early development, and 3) perspectives in embryology.  
1. Gametes and Infertility
Development begins with fertilization. However, the success of fertilization depends 
on the ability of the gametes involved. The molecular alterations that occur in oocytes 
during female reproductive aging represent a controversial area of clinical interest 
since these changes can markedly affect human female fecundity by 40 years of age or 
less. This topic is discussed in chapter 1 by Drs. Imai, Qin, Yamakawa, Miyado, 
Umezawa and Takahashi, who review their studies and recent knowledge on female 
reproductive aging, as well as the possibility of preventing age-associated infertility.  
Infertility affects approximately 15% of all couples trying to conceive. The important 
subject of male fertility and the biology of male gametes are dealt with in chapters two 
and three. Reduced semen quality contributes to ~50% of the cases of male infertility, 
while there is no clear explanation for infertility in the remaining 50% of cases. In 
chapter 2, Dr. Bungum discusses the techniques for assessing the intactness of sperm 
DNA since recent molecular studies have shown that factors such as breaks in sperm 
DNA can contribute to male infertility. In chapter 3, Drs. Arrotéia, Garcia, Barbieri, 
Justino and Pereira discuss sperm epididymal maturation, i.e., the process by which 
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spermatozoa acquire their post-testicular ability to fertilize. The embryology, 
structure, function and role of the epididymis in fertilization and in male infertility are 
also emphasized. 
2. Implantation, Placentation and Early Development 
Fertilization is followed by pre-implantational events that lead to formation of the 
blastocyst which is subsequently implanted in the endometrium. The onset of 
endometrial receptivity to the blastocyst, trophoblast invasion and placental 
development involves the expression of specific genes in particular cell types. As 
discussed by Dr. Tapia in chapter 4, this expression is temporally regulated, with some 
genes being turned on or showing enhanced expression while others are down-
regulated or completely switched off. Likewise, when implantation has occurred, 
another set of genes facilitates the continuing trophoblast invasion and placentation.  
In chapter 5, Drs. Gridelet, Gaspard, Polese, Ruggeri, Ravet, Munaut, Geenen, Foidart, 
Lédée and Perrier d’Hauterive point out that implantation of the blastocyst and 
placentation remain the black boxes of fertility since only 20-25% of embryos 
transferred to the uterus after in vitro fertilization result in a birth. As pointed out by 
these authors, successful implantation requires that a good quality oocyte meet a 
normal sperm, leading to the development of a functionally normal blastocyst able to 
interact with the maternal endometrium.  
Placental macrophages play a central role in the establishment and maintenance of 
pregnancy through their ability to produce a variety of endogenous mediators 
involved in pregnancy, as well as in parturition, lactation, local immune reactions and 
maternal-fetal tolerance. In chapter 6, Drs. Pinhal-Enfield, Vasan and Leibovich show 
that the study of placental macrophages can provide insights into normal embryonic 
development and the possible causes of embryo loss. 
DNA methylation during early embryonic development has received considerable 
attention. In chapter 7, Drs. Pan, Smith and Zakar describe the influence of DNA 
methylation in cell-lineage determination, genomic imprinting and the genesis of germ 
cells, as well as its role in a group of diseases related to the Developmental Origins of 
Health and Disease (DOHaD). 
3. Perspectives in Embryology 
Stem cells are undifferentiated cells that can proliferate and give rise to various types 
of differentiating cell lines. Stem cells were discovered through a combination of 
studies involving early embryonic development, genetics, cell surface immunology 
and tissue culture. The ability of these cells to differentiate into various cell types has 
created numerous perspectives for their use in many fields. However, the presence of 
these cells raises important questions. For example, if stem cells occur in humans then 
why does the human body not regenerate completely? And what about stem cell 
therapy? Chapter 8 by Drs. Amat, Becerra, Medina, Quesada and Marí-Beffa provides 
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an introduction to the concept, nature and diversity of stem cells. The authors 
summarize current research in this field and describe the potential applications of 
stem cells in a variety of areas. 
The final chapter (9) by Dr. Beloussov provides a useful summary of what we still do 
not know and do not understand about organism development.  This chapter clearly 
shows that there are more black boxes or “dark areas” in our understanding than one 
might initially suppose based on the numerous advances in embryology in recent 
years. One avenue for future progress suggested by Dr. Beloussov is the application of 
a self-organizational theory for developmental events, an approach that is generally 
not addressed in conventional text-books of embryology. 
The contents of this book should be of interest to biology and medical students, 
clinical embryologists, laboratory researchers, obstetricians and urologists, 
developmental biologists, molecular geneticists and anyone who wishes to know 
more about contemporary topics of human development. I hope that this book will 
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Aging is a multifunctional disorder that leads to cell death, tumors and the other diseases. 
Accumulation of improper molecular information during aging results in loss of functions 
in cells and tissues. The ovary is one of the first organs to age; women lose their fertility in 
their middle age (around 35 years old) and their fecundity expires soon thereafter (at more 
than 40 years old) (Baird et al. 2005; Alviggi et al. 2009). Although the exact mechanism 
underlying female reproductive aging remains unclear, common features among species, 
including loss of the ovarian follicle pool, disability of chromosome segregation leading to 
aneuploidy, and increasing mitochondrial dysfunctions, have been reported (Djahanbakhch 
et al. 2007). These changes are largely associated with the unique mechanism of oogenesis. 
Oocytes that mitotically proliferate during fetal development are stored in the ovaries 
without further proliferation and are repeatedly ovulated after they enter meiosis. 
Accordingly, oocytes that are stored for a longer duration gradually lose their functions 
because the ovarian microenvironment changes with aging. 
Ovulation is known to produce reactive oxygen species (ROS) in the ovaries. Although ROS 
are toxic and sometimes lethal for any cell types, they are even necessary for proper 
ovulation because direct administration of ROS scavengers, N-acetylcysteine and 
dibutylhydroxytoluene, into mouse bursa blocked ovulation and hydrogen peroxide-
assisted ovulation by functioning like luteinizing hormone (LH) (Shkolnik et al. 2011). 
Nevertheless, repeated exposure of stored oocytes to ROS at each ovulation results in loss of 
the integrity of these stored oocytes (Chao et al. 2005; Miyamoto et al. 2010). Oxidative stress 
is well known to damage macromolecules and cellular components, e.g., mitochondrial 
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desensitization, mitochondrial DNA mutation, irregular DNA methylation, and improper 
chromosome segregation. In addition, these changes affect the hormonal regulation; losing 
ovarian endocrine cells by both ovulation and oxidative damages alters the hormonal 
feedback system in the pituitary-gonad axis.  
From a clinical viewpoint, age-associated infertility is not a small part in all the infertile 
patients. However, lack of knowledge regarding the aging mechanism hampers clinical 
approaches for treatment of aged women. Here we review recent findings on female 
reproductive aging and propose possible treatment options for age-associated infertility.  
2. The prenatal and postnatal pathways of oogenesis 
The debate on the duration of oogenesis in the whole life of females had been sealed for 
decades. However, recent reports on postnatal oogenesis and germline stem cells have 
resumed this debate. Herein we describe the prenatal and postnatal pathways of oogenesis 
from the viewpoint of reproductive aging. 
2.1 The prenatal pathway of oogenesis 
In the early stage of embryogenesis, primordial germ cells (PGCs) – from which oocytes 
originate – migrate from the dorsal yolk sac into the genital ridge where gonads would be 
formed (De Felici & Siracusa 1985). In mice, the germ cells originated from the proximal 
epiblast of the egg cylinder at embryonic day 5.5 to 6 in response to Bmp4 and Bmp8b 
signaling (Ying et al. 2001). In humans, this process occurs during the first month of 
gestation (Djahanbakhch et al. 2007). Then, the cells undergo mitosis; however the number of 
PGCs is highly limited at this time point. The PGCs proliferate rapidly, and approximately 7 
× 106 oogonia are eventually formed at 6–8 weeks of gestation in humans. During this 
process, transforming growth factor- (TGF- family members, including activins, BMPs, 
and TGF-1, support the proliferation of PGCs (Godin & Wylie 1991; Richards et al. 1999; 
Farini et al. 2005; Childs et al. 2010). Activins and their receptors are highly expressed in 
human oogonia at later stages of gestation and activin A supports the proliferation of 
oogonia in vitro (Martins da Silva et al. 2004). The oogonia then enter meiosis at 11–12 weeks 
of gestation in humans (Gondos et al. 1986).  
After oogonia are enclosed by the granulosa cells and primordial follicles are formed, a 
number of oocytes are destined to die without contributing to reproduction during meiotic 
prophase I (Hussein 2005; Ghafari et al. 2007). More than one-third of all pachytene oocytes 
are proapoptotic, and a high frequency of atresia is observed between midterm and birth in 
the human ovaries (Speed 1988; De Pol et al. 1997). The large-scale loss of the ovarian follicle 
pool has been estimated to be more than 80% in humans (Martins da Silva et al. 2004).  
Several paracrine factors that affect oocyte survival have been reported (Fig. 1). For example, 
growth factors including KIT ligand, leukocyte inhibitory factor (LIF), BMP-4, SDF-1, and 
basic FGF have been shown to be able to sustain the survival and proliferation of PGCs in 
the absence of somatic cell support (Farini et al. 2005). In addition, SCF, insulin-like growth 
factor I (IGF-I), and LIF have been found to assist the survival of germ cells in mice (Morita 
et al. 1999; Gu et al. 2009). In contrast, tumor necrosis factor- (TNF-) promotes apoptosis at 
the neonatal stage in rats (Marcinkiewicz et al. 2002; Morrison & Marcinkiewicz 2002). In 
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addition, intracellular factors determine the fate of oocytes. Members of the B cell 
lymphoma/leukemia (BCL) protein family, including BCL-2 and BAX, have been suggested 
to be involved in this process (Felici et al. 1999); BCL-2 is expressed in oocytes undergoing 
meiosis, and its expression is stable during meiotic prophase I, whereas upregulation of 
BAX is observed in oocytes undergoing apoptosis. Genetic inactivation (knockout) of BAX 
in mice resulted in higher number of germ cells in peri-natal ovaries compared with wild-
type or heterozygous mice (Alton & Taketo 2007). Moreover, NANOS3 and DND1 protect 
PGCs from apoptosis (Tsuda et al. 2003; Youngren et al. 2005). Although the biological basis 
of the oocyte selection has not been completely understood, prenatal loss of oocytes may 
occur because of exclusion of accumulated mutations in mitochondria, clearance of lethal 
errors arising during the mitosis or meiotic prophase, or increased survival of some oocytes 
within a particular sibling “nest“ (Ghafari et al. 2007). An imbalance between cell death and 
survival signaling would result in an abnormal number of follicles that would be stored in 
the ovaries at this stage; higher frequency of oocyte death that is a result of atresia 
eventually leads to irreversible premature ovarian failure (Krysko et al. 2008). Therefore, the 
number of oocytes that are stored prenatally must be extremely important for the 
subsequent reproductive period. 
 
Fig. 1. Determinants of the maximum number of oocytes in the entire life of an organism. 
Several growth factors, including activins, BMPs, SCF, IGF-1, and LIF, promote proliferation 
of PGCs and oocyte growth, whereas TNF- induces oocyte death. The number of follicles 
at this stage is determined by the balance between survival and death signaling. In addition, 
the intracellular balance between BCL-2 and BAX determines oocyte survival and death. 
NANOS3 is another anti-apoptotic molecule found in PGCs.  
2.2 The postnatal pathway of oogenesis 
Can oocytes be newly produced in adult ovaries? This ancient question arises with the 
observation of adult mice whose ovaries contain mitotically active germ cells (Johnson et al. 
2004). This finding led to the hypothesis that oocytes can be generated from sources other 
than those prenatally stored in the ovaries. A possible origin of postnatal oocytes has been 
reported to be a specific set of bone marrow cells or peripheral blood cells expressing 
germline markers (Johnson et al. 2005). Johnson et al. reported that both bone marrow and 
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addition, intracellular factors determine the fate of oocytes. Members of the B cell 
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number of oocytes that are stored prenatally must be extremely important for the 
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Fig. 1. Determinants of the maximum number of oocytes in the entire life of an organism. 
Several growth factors, including activins, BMPs, SCF, IGF-1, and LIF, promote proliferation 
of PGCs and oocyte growth, whereas TNF- induces oocyte death. The number of follicles 
at this stage is determined by the balance between survival and death signaling. In addition, 
the intracellular balance between BCL-2 and BAX determines oocyte survival and death. 
NANOS3 is another anti-apoptotic molecule found in PGCs.  
2.2 The postnatal pathway of oogenesis 
Can oocytes be newly produced in adult ovaries? This ancient question arises with the 
observation of adult mice whose ovaries contain mitotically active germ cells (Johnson et al. 
2004). This finding led to the hypothesis that oocytes can be generated from sources other 
than those prenatally stored in the ovaries. A possible origin of postnatal oocytes has been 
reported to be a specific set of bone marrow cells or peripheral blood cells expressing 
germline markers (Johnson et al. 2005). Johnson et al. reported that both bone marrow and 
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peripheral blood transplantations restored oocytes in mice that lost all oocytes by 
chemotherapy. However, another study claimed that fresh mature oocytes could not be 
obtained when wild-type and GFP-transgenic mice were parabiotically jointed to establish 
blood crossover (Eggan et al. 2006). Later, this report was supported when transplanted 
bone marrow cells could be transformed only into immature oocytes (Lee et al. 2007; Tilly et 
al. 2009). Moreover, other reports emphasized the possibility that putative germline stem 
cells exist inside and outside the ovaries in some species. In pigs, fetal skin cells have been 
reported to contribute to the generation of oocytes (Dyce et al. 2006). The ovarian surface 
epithelium (OSE) cells are another candidate for the origin of oocyte in adult human and rat 
ovaries (Bukovsky et al. 2008; Parte et al. 2011), although the candidate cells in OSE may 
originate from bone marrow cells. In addition, a pancreatic stem cell line seems to 
differentiate into oocyte-like cells in rats (Danner et al. 2007). Unfortunately, none of these 
germline stem cells have contributed to the production of the next generation. Furthermore, 
the molecular mechanisms underlying postnatal oogenesis of putative germline stem cells 
continue to be a black box. Even so, these cells might be useful for clinical applications if a 
specific condition in which mature fertile oocytes are postnatally generated is elucidated. 
Although these findings are fascinating, the following questions are arising. 
1. Can the germline stem cells participate in oogenesis over the entire life of females? 2. Do 
other germline stem cells exist? 3. Is there a specific condition in which the germline stem 
cells participate in oogenesis? 4. How many oocytes are generated in the ovaries through 
postnatal oogenesis? 5. Are the factors that assist postnatal oogenesis the same as those that 
assist in prenatal oogenesis? 6. What is the exact role of postnatal oogenesis? Unfortunately, 
we still have to wait many years to obtain sufficient data to answer these questions. 
3. Modification of oocyte quantities and qualities during aging 
The common physiology of the ovaries during aging among species includes loss of the 
ovarian follicle pool, chromosomal abnormalities and cytoplasmic abnormalities (Fig. 2). All 
these changes may be inevitable and are associated with declining oocyte quality. Here 
recent findings regarding the alterations in oocyte quantities and qualities are discussed.  
 
Fig. 2. Common features of female reproductive aging in mammals. Loss of the ovarian follicle 
pool is caused partly by characteristic oogenesis and partly by ovulation, thereby leading to 
hormonal imbalance. Chromosomal aberrancy and cytoplasmic abnormalities are possibly 
induced by longer exposures of stored oocytes to oxidative stress. Recently, these 
abnormalities have been shown to be reversible by calorie restriction (Selesniemi et al. 2011). 
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3.1 Age-associated decrease of the ovarian follicle pool 
After puberty, the number of oocytes steadily decreases due to repeated ovulation. A lot of 
oocytes are consumed in 1 estrous cycle, but only a few oocytes are eventually ovulated. In 
humans, only 400 oocytes are dedicated for ovulation throughout the lifespan. During 
aging, the ovarian follicle pool declines continuously, and this is partly because of atresia. 
Resting follicles in humans enter atresia through a necrotic process during the initial 
recruitment phase of folliculogenesis because the ooplasm in those follicles contains 
increasing numbers of multivesicular bodies and lipid droplets, dilation of the smooth 
endoplasmic reticulum and the Golgi apparatus, and irregular mitochondria with changed 
matrix densities (de Bruin et al. 2002; de Bruin et al. 2004). The atresia of ovarian follicles 
during aging may be induced by dysfunctions of proteosomes and the endoplasmic 
reticulum (Matsumine et al. 2008). 
Although most primordial follicles that are initiated to grow are destined to cell death, the 
recruitment of follicles from the resting ovarian follicle pool is the sole method to salvage 
the follicles. FSH is a strong trophic factor that supports both the cyclic recruitment of antral 
follicles and the growth of follicular somatic cells (Chun et al. 1996).  
3.2 Age-associated aberrancies of oocyte chromosomes 
The most deleterious damage in oocytes is often observed in chromosomes. The relationship 
between maternal age and the increased incidence of oocyte aneuploidies has been studied 
in several epidemiological studies (Hassold & Jacobs 1984; McFadden & Friedman 1997; 
Pellestor et al. 2003). In women in their early 20’s, the risk of trisomy in a clinically 
recognized pregnancy is only approximately 2%, whereas it increases up to 35% in women 
in their 40’s (Hassold & Chiu 1985). Supportively, more than half of oocytes from patients of 
advanced age exhibit aneuploidy (Kuliev & Verlinsky 2004; Pellestor et al. 2005). This 
abnormality is believed to occur because of chromosomal nondisjunction during either 
meiosis I or II (Nicolaidis & Petersen 1998; Hassold et al. 2007). The incidence of aneuploidy 
is not random; abnormalities of chromosomes 16 and 22 originate more frequently in 
meiosis II than in meiosis I, and those of chromosomes 13, 18, and 21 occur more frequently 
in meiosis I than in meiosis II (Kuliev et al. 2005). In addition to this nondisjunction theory, 
the premature separation of chromatids during meiosis is suggested to be responsible for 
aneuploidy; the age-associated degradation of cohesins or the other molecules sustaining 
chromatids during metaphase I may contribute to the age-related increase in aneuploidy 
(Watanabe & Nurse 1999).  
3.3 Age-associated decline of mitochondrial activities 
The mitochondria alter their organization, shape, and size, depending on various signals 
(Bereiter-Hahn & Voth 1994). Mitochondrial turnover is the most important process to 
maintain a healthy state of the mitochondria. During this process, they undergo biogenesis 
and degradation (Seo et al. 2010). Mitochondrial biogenesis is enhanced in muscle cells 
under certain physiological conditions such as myogenesis, exercise, cold exposure, 
hypoxia, and calorie restriction (CR) (Freyssenet et al. 1996; Nisoli et al. 2003; Kraft et al. 2006; 
Civitarese et al. 2007; Zhu et al. 2010). Damaged or incompetent mitochondria are removed 
by macroautophagy (Wang & Klionsky 2011).  
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Although whether mitochondrial dynamics are important for the maintenance of oocyte 
integrity during aging remains unclear, the copy number of the mitochondria is one of the 
factors that affect the developmental capacity of oocytes after implantation in mice (Wai et 
al. 2010). In addition, mouse oocytes with artificial mitochondrial damages lost their ability 
to be matured in vitro (Takeuchi et al. 2005). Thus, the oocyte quality is largely dependent on 
mitochondrial health. 
Progressive and accumulative damages to mitochondrial DNA (mtDNA) have been 
postulated to be responsible for the aging process. In aged human fibroblasts, point 
mutations are likely to occur at specific positions in the replication-controlling region 
(Michikawa et al. 1999). Although these specific mutations have never been reported in aged 
human oocytes, several mutations in mtDNA were responsible for the decreased ability of 
oocytes to develop (Barritt et al. 2000). In the report, ooplasmic transfer from young oocytes 
to aged oocytes improved the quality of aged oocytes, indicating that the decreased 
mitochondrial activities in aged oocytes were complemented. 
4. Molecular events during aging 
Oocyte quality declines during aging in a complicated process involving several events  
(Fig. 3). Oxidative stress affects both the size of the ovarian follicle pool and oocyte quality. 
The reduced follicle pool accelerates hormonal dysregulation. This, in turn, promotes the 
decrease in the size of the ovarian follicle pool and oocyte quality. In this section, the recent 
findings regarding the molecular events that occur during reproductive aging are discussed. 
 
Fig. 3. A negative loop leading to the age-associated decline of oocyte quality. Because of 
repeated ovulation and the loss of antioxidants including SOD, catalase, glutathione S-
transferases (GSTs) etc., excess oxidative stress accelerates the decrease of both oocyte quality 
and the size of the follicle pool. The decreased follicle pool results in the insufficient secretion 
of ovarian estrogens and inhibins and the rise of FSH. These changes accelerate the decrease of 
the follicle pool and directly affect oocyte quality. Both oxidative stress and aberrant hormones 
induce the molecular alterations (GSTT1, p-p38 etc.) in oocytes and granulosa cells. 
 
Molecular Alterations During Female Reproductive Aging: Can Aged Oocytes Remind Youth? 
 
9 
4.1 Serum hormone levels 
Full competence of oocytes to develop to term is acquired depending on the proper timing 
of hormonal activation. The decrease in follicle numbers because of aging ensures 
aberrant hormonal regulation as a result of incomplete feedback mechanisms. This 
hormonal dysregulation will, in turn, accelerate the loss of follicles at the advanced age 
(McTavish et al. 2007). 
The most well-known hormones that affect aging are FSH and LH. Under the normal 
conditions, relatively high levels of FSH promote the synthesis of estradiol, inhibin A, and 
inhibin B in granulosa cells (Tonetta & diZerega 1989). On the other hand, LH regulates the 
production of androgens in theca cells of small antral follicles and promotes the conversion 
of androgens to estradiol by aromatization (Erickson et al. 1985). These factors, in turn, 
decrease the serum levels of FSH and LH. With luteal regression, the downregulation of 
estradiol and inhibin A in luteinized granulosa cells allows the rise of FSH again at the onset 
of the subsequent menstrual cycle (Broekmans et al. 2009). Therefore, the negative feedback 
system between the pituitary and the ovary enables follicles to grow properly. 
The dysfunction of the hypothalamic GnRH pulse generators results in an abnormal release 
of FSH and LH from the pituitary around menopause (Wise et al. 1996). However, the factor 
that is critical to induce improper hormonal regulation is the loss of the follicle pool (Fig. 3). 
Decreasing numbers of follicles in the ovaries result in decreasing concentrations of 
circulating estrogens and inhibins during aging (Broekmans et al. 2009). Accordingly, the 
serum concentration of FSH is elevated because of aging (Klein et al. 1996). The hormonal 
changes, especially the decrease in the levels of inhibins, are highly associated with oocyte 
quality (Chang et al. 2002).  
Anti-Mullerian inhibitory hormone (AMH) is expressed in granulosa cells of nonatretic 
preantral and small antral follicles (Baarends et al. 1995). AMH has been postulated to 
regulate the entry of primordial follicles into the growing pool (Durlinger et al. 2002). As the 
number of antral follicles decreases with age, the serum amount of AMH diminishes (van 
Rooij et al. 2004).  
Because these changes are largely associated with the unique features of oogenesis, age-
associated hormonal changes are inevitable. Abnormal levels of hormones can be a risk 
factor for certain diseases other than infertility. For example, elevated FSH levels stimulate 
TNF- synthesis directly from bone marrow granulocytes and macrophages and promote 
osteoporosis in mice (Iqbal et al. 2006; Sun et al. 2006). In addition, the single nucleotide 
polymorphism (SNP) rs6166 of the FSHR gene significantly influences bone mineral density 
in postmenopausal women (Rendina et al. 2010).  
4.2 Oxidative stress and cellular scavengers 
Oxidative stress is generally accepted as the major cause of aging. The major source of ROS 
is believed to be the mitochondria, because ROS are generated as byproducts of electron 
transport during respiration. Although about 1 – 2 % of oxygen in the heart is converted into 
ROS under physiological conditions, ROS generation increases under pathological 
conditions (O'Rourke et al. 2005; Valko et al. 2007). ROS are removed rapidly through 
multiple pathways to protect cells and tissues in normal young individuals.  
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A similar system must be present in the ovaries. Free radical activities in human follicular 
fluid have been shown to be increased during aging (Wiener-Megnazi et al. 2004). However, 
the levels of free radical scavengers, including SOD1, SOD2, and catalase, were significantly 
decreased in the granulosa cells from older women compared with those in the granulosa 
cells from younger women (Tatone et al. 2006). In addition, oxidative damages measured by 
the expression of 8-hydroxydeoxyguanosine were observed in oocytes after ovulation (Chao 
et al. 2005; Miyamoto et al. 2010). Although the ovarian levels of oxidative stress during 
aging remain unclear, excess ROS induced by ovulation may affect the quality of oocytes 
that are stored in the ovaries (Fig. 3). In fact, ovulation induced ROS generation in the 
ovaries, resulting in oxidative damage of genomic DNA and mitochondrial DNA mutations 
(Agarwal et al. 2005; Chao et al. 2005). 
Glutathione (GSH) – a direct ROS scavenger – protects cells from deleterious attacks of ROS. 
Accordingly, it is highly correlated with oocyte quality in terms of viability (Zuelke et al. 
2003; Luberda 2005). However, whether the level of GSH in oocytes from aged females is 
decreased compared with that from young females is unclear.  
GSTs are well-known detoxification factors that excrete genotoxins by conjugation of GSH 
directly to the genotoxins (Sheehan et al. 2001). In addition to this characteristic, some GSTs 
have been shown to play important roles in ROS scavenging by affecting JNK stress 
signaling (Adler et al. 1999; Cheng et al. 2001). As expected from the known functions, GST 
activities in aged oocytes were lower than those in young oocytes (Tarin et al. 2004). We 
previously reported that GSTT1 was upregulated in aged granulosa cells, although the other 
isoforms of GSTs were downregulated (Ito et al. 2008). GSTT1 is known to have bilateral 
features in that it removes toxins and oxidative stress from cells and tissues and it produces 
harmful formaldehyde using halogenated substrates (Sherratt et al. 1998; Landi 2000). 
Although it remains uncertain whether GSTT1 is positively or negatively involved in 
reproductive aging, GSTT1-depleted granulosa cells exhibit mitochondrial 
hyperpolarization, suggesting that GSTT1 plays a role in controlling mitochondrial activities 
(Ito et al., 2011). 
4.3 Genes-related to apoptosis during reproductive aging 
BCL family members are closely related to apoptosis in ovarian cells as well as in other cell 
types (Tilly et al. 1997). Overexpression of BCL-2 in mouse ovaries leads to decreased 
follicular apoptosis (Hsu et al. 1996). A prominent decrease of BCL-2 was also observed in 
eggs aged in vitro (Gordo et al. 2002). In addition, the upregulation of BIM in cumulus cells 
seems to accelerate oocyte aging (Wu et al. 2011). More impressively, ovarian functions in 
mice with genetically engineered BAX were prolonged (Perez et al. 1999). Supporting this 
report, damaged oocytes in mice exhibited higher expression level of BAX (Kujjo et al. 2010). 
Hence, BAX may be a therapeutic target for oocyte rejuvenation. 
4.4 Cellular signaling involved in oocyte survival and death 
The crosstalk of the signal kinases is important for oocyte survival. For the survival of 
primordial follicles, 3-phosphoinositide-dependent protein kinase-1 (PDK1) in oocytes 
preserves the lifespan by maintaining the ovarian follicle pool (Reddy et al. 2009). PDK1 and 
PTEN have been reported to be critical regulators in the phosphatidylinositol 3-kinase (PI3K) 
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signaling pathway (Iwanami et al. 2009). Therefore, the loss of PTEN results in the activation 
and depletion of the primordial follicle pool in early adulthood (Reddy et al. 2008). 
Higher levels of M-phase promoting factors and mitogen-activated protein kinases 
(MAPKs) have been observed in ovulated oocytes from aged mice (Tarin et al. 2004). 
Although how these signaling molecules are involved in oocyte activities remains uncertain, 
JNK, but not p38 MAPK, was found to participate in oocyte fragmentation and 
parthenogenetic activation in aged oocytes (Petrova et al. 2009). 
In our previous report, p38 MAPK in human granulosa cells showed a unique pattern of 
activation and localization during aging (Ito et al. 2010). Because p38 has been shown to 
translocate between the nucleus and cytoplasm upon stimulation (Gong et al. 2010), the 
changes in the subcellular localization of active p38 during aging reflect the 
microenvironmental status around oocytes and granulosa cells. The nuclear localization of 
p38 in young granulosa cells may be due to the proper transactivation of genes in response 
to hormones. On the other hand, the cytoplasmic localization of p38 in aged granulosa cells 
may be resulted from exposure to oxidative stress. Although it is unclear whether or not 
such kind of age-associated changes occurs in oocytes, regulation of activation and 
localization of p38 may contribute to oocyte juvenescence. 
5. Is it possible to rescue age-related infertility? 
5.1 Anti-aging effects of calorie restriction 
Although aged oocytes adapt to the stressful environment and endure multiple disorders 
that occur inside and outside oocytes, they eventually lose their ability to develop to term. Is 
it possible to rejuvenate aged oocytes? Although oocyte rejuvenation should be considerably 
attractive for treatment of age-related infertility, it has not succeeded so far. However, it 
may be possible to prolong ovarian functions (or to delay ovarian aging). Physical 
juvenescence can be achieved with several methods, including calorie restriction (CR), 
moderate fitness and nutritional supply (Prokopov & Reinmuth 2010). These treatments are 
believed to maximize mitochondrial performance and lower the incidence of mitochondrial 
dysfunction (Lopez-Lluch et al. 2006; McKiernan et al. 2007).  
CR has been suggested to elongate the lifespan of many organisms (Wolf 2006). CR 
influences energy metabolism, oxidative damage, inflammation, and insulin sensitivity. CR 
is reported to activate SIRT1, a key factor that regulates longevity (Allard et al. 2009). An 
important role of SIRT1 may be refreshment of damaged mitochondria by inducing 
macroautophagy (Kume et al. 2010). Therefore, CR enhances cellular homeostasis. Apart 
from the beneficial effects of CR on longevity, it was believed to be the cost for reproductive 
capacities (Holliday 1989). Harsh CR (30% or more) is unable to maintain stored oocytes 
enough for their subsequent development, whereas milder CR (20%) resulted in the loss of 
the negative effects on fecundity (Rocha et al. 2007). Recently, CR has been shown to be 
beneficial for maintaining the integrity of oocyte chromosomes in mice (Selesniemi et al. 
2011). These effects were mimicked by the genetic loss of the metabolic regulator, 
peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1). Our 
preliminary data also reveal that CR (approximately 15% reduction of body mass after one 
year of treatment) did not reduce fertility in mice. Rather, the CR-treated mice bore more 
offspring. These data indicate that CR supports the oocyte quality in aged females.  
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Although the hypothesis that physical juvenescence correlates with the maintenance of 
oocyte integrity must be explored further, other treatments that lead to anti-aging may 
support oocyte integrity during aging. 
5.2 Nutritional supports of fertility 
Since CR has been demonstrated to be beneficial for the juvenescence of cells and tissues 
including germ cells, as described above, the daily nutritional intake must be crucial for 
cellular juvenescence. One of the most successful nutrients that affect anti-aging may be 
polyphenols. For example, turmeric-derived tetrahydrocurcumin and green tea polyphenols 
promote longevity of mice (Kitani et al. 2007). Of those polyphenols, resveratrol has been a 
potent therapeutic target for age-related diseases. Resveratrol is found in eucalyptus, 
peanuts, and grapevines (Soleas et al. 1997), and its functional properties are versatile 
probably because of its divergent targets. It has beneficial effects in terms of prevention of 
various cancers, cardiovascular diseases, neurodegenerative diseases, and diabetes in 
animal models (Vang et al. 2011), because of its antioxidant and anti-inflammatory 
properties (Schmitt et al. 2010). Moreover, resveratrol has been demonstrated to prolong 
lifespan in short-lived vertebrates (Valenzano et al. 2006), because it greatly enhances the 
activity of SIRT1 (Howitz et al. 2003; Knutson & Leeuwenburgh 2008). In addition to its anti-
aging properties, resveratrol has been reported to function as estrogen through direct 
association with estrogen-responsive element (ERE) (Klinge et al. 2003). Although the 
beneficial effects of resveratrol in humans remain to be determined, it is expected to be a 
mimetic of CR and have the potential to preserve oocyte quality in aged females. 
Supportively, resveratrol assisted the increase of the ovarian follicle pool in both neonatal 
and aged rat ovaries (Kong et al. 2011). Genistein, one of isoflavones, also seems to increase 
the ovarian follicle pool by inhibiting atresia in aged rats (Chen et al. 2010).  
Royal jelly (RJ) was reported to contribute to the prolongation of longevity in mice (Inoue et 
al. 2003). RJ reduced the damages of DNA by acting as an antioxidant. Similar to resveratrol, 
RJ contains an estrogen-like component that associates with the ERE (Mishima et al. 2005). 
Traditionally, it has been used to treat menopausal symptoms, although the detailed 
mechanism by which RJ treats menopausal disorders is yet to be determined. RJ seems to 
rebalance the hormonal concentration in the blood; it decreased the FSH concentrations and 
increased the estrogen concentrations in aged mice (Fig. 4). These changes, in turn, increased 
the number of ovulated oocytes. This may improve the oocyte quality in aged body, 
although further investigation is required.  
Recently, a probiotic strain, LKM512, present in yogurt was shown to prolong the 
longevity of mice (Matsumoto et al. 2011). LKM512 has been suggested to act on the 
polyamines circulating bodies and result in the unexpected prolongation of longevity. 
Although whether these beneficial effects on longevity can sustain the maintenance of 
oocyte quality remains unclear, some of these nutritional elements may alleviate female 
reproductive aging. 
The exact mechanism by which some anti-aging treatments improve female reproductive 
capacity remains unknown. However, hormonal regulation in aged females becomes similar to 
that in young females with anti-aging treatments, and this is probably due to the prevention of 
follicle loss or the enhancement of hormonal secretion from aged ovaries (Fig. 5).  
 




Fig. 4. Effects of RJ on female reproductive capacities. The administration of RJ in drinking 
water to aged female mice (60 weeks old) for 2 months markedly decreased the serum 
concentrations of FSH (a). RJ slightly increased the number of ovulated oocytes (b).  
 
Fig. 5. Age-dependent hormonal regulation in the ovaries. In young females, the negative 
feedback system in the pituitary-gonadal axis is active, and the amount of FSH and LH is 
regulated by estrogens (E2) and inhibins secreted from the ovaries. However, inadequate 
amounts of E2 and inhibins synthesized from aged ovaries cannot decrease the serum levels 
of FSH and LH. These changes can be treated by anti-aging therapies, such as the 
supplemental administration of RJ that may prevent the waste of follicles during ovulation 
or enhance the synthesis of ovarian hormones. 
5.3 Other compounds that affect oocyte aging 
Because oxidative stress promotes reproductive aging, antioxidants can be effective in 
regaining reproductive juvenescence. In fact, oral administration of vitamins C and E could 
prevent age-related ovarian disorders in mice (Tarin et al. 1998a; Tarin et al. 2002). In 
addition, some antioxidants are used to treat infertility (Visioli & Hagen 2011).  
L-cystine, a component of GSH, and -mercaptoethanol decreases oocyte quality to develop 
to the blastocyst stage, whereas dithiothreitol (DTT) enhances the fertilization rate and the 
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developmental capacity of oocytes (Tarin et al. 1998b). Moreover, DTT supports embryonic 
integrity regarding cell number in inner cell mass cells (Rausell et al. 2007). Therefore, 
reagents that assist redox may be effective in enhancing oocyte quality. However, all these 
compounds were tested in oocytes that were aged in vitro, and thus, their reported effects 
may not be observed in oocytes from aged females.  
On the other hand, nitric oxide (NO) seems to be a strong candidate for the treatment of the 
declining oocyte quality in aged females, because the exposure of aged oocytes to  
NO decreased the loss of cortical granules and the frequency of spindle abnormalities (Goud 
et al. 2005). 
6. Future perspectives to achieve the juvenescence of female fertility 
The impact of reproduction on the maternal longevity has been postulated by numerous 
epidemiological and historical studies (Westendorp & Kirkwood 1998; Le Bourg 2007; 
Mitteldorf 2010), and the tradeoff between fertility and longevity may occur through genetic 
or metabolic factors. However, some studies reported a positive correlation between 
maternal age at reproduction and female longevity (Muller et al. 2002; Helle et al. 2005). 
Although the outcomes of those surveys varied, maternal age at the time of the first 
childbirth seems to be positively correlated with female longevity.  
Therefore, the most important factor affecting their fecundity must be physical 
juvenescence. Because the quality of oocytes from women who successfully give birth at 
advanced ages is somehow integral, physical juvenescence can increase oocyte quality 
(chromosomes and cytoplasm), although it may be difficult to increase the number of 
follicles stored in aged ovaries. Regarding longevity, fitness, or CR is successful in several 
species, including humans (Lahdenpera et al. 2004). In addition, some nutritional 
supplements could assist the longevity of animals, as described above. Although it remains 
uncertain whether or not those supplements can improve the integrity of oocytes even after 
aging, these kinds of treatment may help age-associated infertility in the future.  
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Role of Sperm DNA Integrity in Fertility 
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1. Introduction 
The traditional semen analysis is a cornerstone in diagnosis and treatment of male fertility 
(World Health Organisation (WHO), 1999, 2010). The sperm parameters concentration, 
motility and morphology are, however, claimed to be poor predictors of a male´s fertility 
status, this in natural conception (Bonde et al., 1998; Guzick et al., 2001) as well as in assisted 
reproductive techniques (ART) (Wolf et al., 1996).  
As a consequence of the limited predictive role of the traditional semen analysis there have 
for long been searched for better parameters, For the last decade an increased focus on 
sperm DNA is seen.  
Infertile men are shown to have significantly more sperm DNA damage compared to fertile 
men (Evenson et al., 1999; Gandini et al., 2000; Irvine et al., 2000; Larson et al., 2000; Spanò  
et al., 2000; Carrell and Liu 2001; Hammadeh et al., 2001; Zini et al., 2001a; Zini et al., 2002) 
and time to spontaneous pregnancy is proved to be longer in couples where the male 
partner have an increased amount of sperm with DNA damage (Evenson et al., 1999; Spanò  
et al., 2000). Methods assessing sperm DNA integrity have shown a better predictivity of 
both in vivo and in vitro fertility than the WHO sperm parameters (Bungum et al., 2007).  
Moreover, studies have shown that sperm DNA integrity assessment can be applied in ART 
in order to find the most effective treatment in a given couple (Bungum et al., 2004, 2007; 
Boe-Hansen et al., 2006). 
Semen quality is known to be influenced by a variety of lifestyle, environmental, and 
occupational factors. Although still much is unknown, the origins of sperm DNA damage 
are believed to be multi-factorial where defects during spermatogenesis, abortive apoptosis  
and oxidative stress may be possible causes of a defective sperm DNA (reviewed in 
(Erenpreiss et al., 2006a)). 
During the last decades a variety of techniques to assess sperm DNA integrity have been 
developed.  In the context of fertility the COMET, TUNEL, and Sperm Chromatin Structure 
assays (SCSA) as well as the sperm chromatin dispersion (SCD) test are the most frequently 
used  (reviewed in (Erenpreiss et al., 2006a)). So far, SCSA is the test that is found to have 
the most stable threshold values in regard to fertility and therefore of best clinical value 
(Bungum et al., 2007) . 
Accordingly, this chapter will first of all refer to available SCSA data in regard to fertility.  
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1. Introduction 
The traditional semen analysis is a cornerstone in diagnosis and treatment of male fertility 
(World Health Organisation (WHO), 1999, 2010). The sperm parameters concentration, 
motility and morphology are, however, claimed to be poor predictors of a male´s fertility 
status, this in natural conception (Bonde et al., 1998; Guzick et al., 2001) as well as in assisted 
reproductive techniques (ART) (Wolf et al., 1996).  
As a consequence of the limited predictive role of the traditional semen analysis there have 
for long been searched for better parameters, For the last decade an increased focus on 
sperm DNA is seen.  
Infertile men are shown to have significantly more sperm DNA damage compared to fertile 
men (Evenson et al., 1999; Gandini et al., 2000; Irvine et al., 2000; Larson et al., 2000; Spanò  
et al., 2000; Carrell and Liu 2001; Hammadeh et al., 2001; Zini et al., 2001a; Zini et al., 2002) 
and time to spontaneous pregnancy is proved to be longer in couples where the male 
partner have an increased amount of sperm with DNA damage (Evenson et al., 1999; Spanò  
et al., 2000). Methods assessing sperm DNA integrity have shown a better predictivity of 
both in vivo and in vitro fertility than the WHO sperm parameters (Bungum et al., 2007).  
Moreover, studies have shown that sperm DNA integrity assessment can be applied in ART 
in order to find the most effective treatment in a given couple (Bungum et al., 2004, 2007; 
Boe-Hansen et al., 2006). 
Semen quality is known to be influenced by a variety of lifestyle, environmental, and 
occupational factors. Although still much is unknown, the origins of sperm DNA damage 
are believed to be multi-factorial where defects during spermatogenesis, abortive apoptosis  
and oxidative stress may be possible causes of a defective sperm DNA (reviewed in 
(Erenpreiss et al., 2006a)). 
During the last decades a variety of techniques to assess sperm DNA integrity have been 
developed.  In the context of fertility the COMET, TUNEL, and Sperm Chromatin Structure 
assays (SCSA) as well as the sperm chromatin dispersion (SCD) test are the most frequently 
used  (reviewed in (Erenpreiss et al., 2006a)). So far, SCSA is the test that is found to have 
the most stable threshold values in regard to fertility and therefore of best clinical value 
(Bungum et al., 2007) . 
Accordingly, this chapter will first of all refer to available SCSA data in regard to fertility.  
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2. Male infertility 
Infertility is a health problem affecting approximately 15% of all couples trying to conceive. 
It is now evident that in at least 50% of all cases, reduced semen quality is a factor 
contributing to the problem of the couple. In 20% of the couples, the main cause is solely 
male related, and in another 27%, both partners contribute to the problem (WHO 2000).  
Male infertility can be the result of congenital and acquired urogenital abnormalities, 
infections of the genital tract, varicocele, endocrine disturbances, genetic or immunological 
factors (WHO, 2000). However, in at least 50% of the infertile men, no explanation to their 
reduced semen quality can be found (Seli and Sakkas, 2005; Matzuk and Lamb, 2008; 
O’Flynn O’Brien et al., 2010).  
Recent studies have shown that also sperm factors at a molecular level can cause infertility. 
One example of this is DNA breaks (Evenson et al., 2002; Sharma et al., 2004; Lewis and 
Aitken, 2005; Lewis 2007; Aitken, 2006; Erenpreiss et al., 2006a; Evenson and Wixon, 2006; 
Muratori et al., 2006; Collins et al., 2008; Lewis and Agbaje, 2008; Lewis et al., 2008; Bungum 
et al., 2007; Zini and Sigman, 2009; Aitken and De Iuliis, 2010; Sakkas and Alvarez, 2010).  
2.1 Diagnosis and treatment of male infertility 
Traditionally, diagnosis of male infertility is based on the conventional sperm analysis 
where World Health Organisation (WHO) has set criteria for normality in regard to semen 
volume, sperm concentration, motility and morphology (WHO, 2010). The traditional semen 
analysis has, however, been criticized (Bonde et al., 1998; Giwercman et al., 1999; Auger et 
al., 2001; Guzick et al., 2001; Nallella et al., 2006; Swan 2006), in particular because of lack of 
power in regard to predict fertility. Human semen is a highly fluctuable fluid and all WHO 
parameters vary significantly between individuals, seasons, countries and regions and even 
between consecutive samples from one individual (Chia et al., 1998; WHO 1999; Auger et 
al., 2000; Jorgensen et al., 2001; Chen et al., 2003; Jorgensen et al., 2006). The traditional 
analysis is performed by light microscopy of 1-200 spermatozoa and this means a high grade 
of intra- and interlaboratory variation (Neuwinger et al., 1990; Cooper et al., 1992) and a 
considerable overlap in all three parameters; sperm concentration, motility and morphology 
between fertile and infertile is shown (Bonde et al., 1998; Guzick et al., 2001). One of the 
reasons behind the low status as fertility predictor may be that the WHO analysis only takes 
few sperm characteristics into consideration.  Generally overlooked has been the fact that 
sperm carry DNA and that the DNA can be of a different quality. Such parameters 
describing sperm nuclear potential are not routinely assessed.  However, there are ongoing 
debates whether sperm DNA integrity assessment should be introduced as a routine test in 
all or selected groups of infertile men (Evenson et al., 2000; Giwercman et al., 2010; ASRM, 
2008, Makhlouf and Niederberger, 2006; Erenpreiss et al., 2006; Zini and Sigman, 2009). 
Until the 1990s, the majority of cases of severe male factor subfertility were virtually 
untreatable, however,  the introduction of ICSI revolutionized the treatment of male 
infertility (Palermo et al., 1992). However, ICSI is a subject of an ongoing debate regarding 
its indications and safety (Govaerts et al., 1996; Griffin et al., 2003; Kurinczuk 2003; Verpoest 
and Tournaye 2006; Varghese et al., 2007). One of the causes to this is that ICSI must be seen 
as a symptomatic treatment, not taking the underlying causes of infertility into account.  
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3. Sperm DNA structure 
With a volume 40 times less than that of a somatic cell nucleus the genetic material of a 
spermatozoon is more compact packaged than in the nucleus of a somatic cell (Ward et al., 
1991). During spermiogenesis histones are replaced by the more basic and small protamines 
(Fuentes-Mascorro et al. 2000). Each unit of mammalian sperm chromatin is a toroid 
containing 50–60 kb of DNA and individual toroids represent DNA loop-domains highly 
condensed by protamines and fixed at the nuclear matrix. The toroids are bound by 
disulfide crosslinks, formed by oxidation of sulfhydryl groups of cysteine present in the 
protamines and each chromosome represents a garland of toroids (Fuentes-Mascorro et al., 
2000; Ward et al., 1993). While in most other species the protamines comprise as much as 
95%, human protamines comprise 85% of the spermatozoal nucleoproteins. (Fuentes-
Mascorro et al., 2000).  This may explain why human sperm chromatin is less compacted 
and more frequently contains DNA breaks (Bench et al., 1993) compared to other species.  
4. Sperm DNA damage 
Human sperm DNA is often not so well packaged as meant to be (Sakkas et al., 1999a) and is 
therefore susceptible to DNA damage (Irvine et al., 2000). Whilst the mature sperm is a 
repair-deficient cell (Sega et al., 1978), oocytes and embryos are, to a certain degree, able to  
repair DNA damage (Matsuda and Tobari 1988; Ahmadi and Ng 1999b). 
Sperm possess a variety of abnormalities at the nuclear level and that these anomalies can 
have an impact on fertility (Evenson et al., 1980; Hewitson 1999; Huszar 1999). The most 
common types of DNA damage include chemical modification of a base, inter- and intra-
strand crosslinks, and single or double DNA strand breaks (Marchetti and Wyrobek 2005). 
The origin of human sperm DNA damage is involving both testicular and post-testicular 
mechanisms. Testicular mechanisms include a) alterations in chromatin modelling during 
the process of spermiogenesis, and b) abortive apoptosis, whereas post-testicular factors are 
mostly related to the action of c) reactive oxygen species (ROS), and d) activation of caspases 
and endonucleases( Reviewed in (Aitken and De Iuliis, 2010 and Sakkas and Alvarez, 2010)).  
Oxidative stress during sperm transport through the male reproductive tract is likely the 
most frequent cause of sperm DNA damage (Aitken and De Iuliis, 2010; Sakkas and 
Alvarez, 2010). Under normal conditions ROS are necessary for the functioning of sperm 
(reviewed by Aitken 2006), however, oxidative stress resulting from an over production or 
reduced antioxidant protection are thought to cause DNA damage (Aitken et al. 1998).  
The risk of having ROS induced DNA damaged sperm increases by advanced age, 
abstinence time, influence of cancer treatment, varicocele and obesity (reviewed in 
Erenpreiss et al., 2006a; Aitken and De Iulius 2007). Moreover, several studies have reported 
a negative effect of cigarette smoking on sperm DNA, but data are not conclusive (Robbins 
et al., 1997; Sun et al., 1997; Rubes et al., 1998; Potts et al., 1999; Saleh et al., 2002b; Sepaniak 
et al., 2006).  Other sources of ROS include organophosphorous pesticides (Sanchez-Pena et 
al., 2004) and other types of air pollution (Rubes et al., 1998; Selevan et al., 2000; Evenson 
and Wixon 2005). These agents possess estrogenic properties that are capable of inducing 
ROS production (Sanchez-Pena et al., 2004; Baker and Aitken 2005; Bennetts et al., 2008).  
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5. Sperm DNA integrity testing 
Several tests developed to assess sperm DNA damage are available. The most frequently 
used is the Sperm Chromatin Structure assay (SCSA), the single-cell gel electrophoresis 
assay (COMET assay) in its alkaline, neutral, 2-tailed versions (Singh et al., 1997; Lewis and 
Agbaje, 2008; Enciso et al., 2009), the terminal deoxynucleotidyl transferase dUTP nick-end 
labeling (TUNEL) assay (Gorczyka et al., 1993) and the sperm chromatin dispersion (SCD) 
test (Fernandez et al., 2003). Although these tests correlate to each other (Aravindan et al. 
1997;  Zini et al. 2001; Perera et al. 2002; Erenpreiss et al. 2004, Donelly et al., 2000) and all 
measure single and double strand breaks, the methodologies are based on different 
principles and different aspects of sperm DNA damage (Makhlouf and Niederberger, 2006). 
5.1 Sperm Chromatin Structure Assay (SCSA) 
The SCSA® is a flow-cytrometic test based on the fact that damaged sperm chromatin 
denatures when exposed to a low pH-buffer, whereas normal chromatin remains stable 
(Evenson et al., 1980). The SCSA measures the denaturation of sperm DNA stained with 
acridine orange, which differentially stains double- and single stranded DNA. Five to ten 
thousand cells are analysed. Thereafter, the flow cytometric data is further analyzed using 
dedicated software (SCSASoft; SCSA Diagnostics, Brookings, SD, USA). Data appears in 
histo- and cytograms and results given as DAN fragmentation index (DFI) and High DNA 
stainability (HDS). It  is still unclear which mechanisms and types of DNA damage that are 
lying behind DFI and HDS, however, it is believed that DFI are related to the percentage of 
sperm with both single strand breaks (SSB) and double strand breaks (DSB) or problems in 
the histone to protamine exchange. HDS is thought to represent immature sperm. The clear 
advantage of SCSA is the objectivity of the test as well as the high reproducibility 
(Giwercman et al., 2003) when ran after the standardised protocol (Evenson et al., 2002). 
Moreover, the clear cut-off levels in relation to fertility is maybe the most obvious benefit 
compared to other sperm DNA integrity tests (Bungum et al., 2007). A disadvantage is that 
an expensive flow cytometer is required to run the analysis. Moreover, the test irreversibly 
damage spermatozoa; after analysis they cannot be used for fertilisation purposes.  
5.2 COMET assay 
The COMET assay (Singh et al., 1997)  is a single cell gel electrophoresis of immobilised 
sperm, which involves their encapsulation in agarose, lysis and electrophoresis. When the 
electric field is applied the negatively charged DNA will be drawn towards the positively 
charged anode. While undamaged DNA are too large and will remain in nucleus, the 
smaller broken DNA fragments move in a given period of time. The amount of DNA that 
leaves the nucleus is a measure of the DNA damage in the cell. The sperm are stained with a 
DNA-binding dye and the intensity of the fluorescence is measured by image analysis. The 
overall structure resembles a COMET with a circular head corresponding to the undamaged 
DNA that remains in the nucleus and a tail of damaged DNA. COMET assay can be ran 
under neutral or alkaline conditions. Under neutral conditions (pH 8–9), mainly DSB are 
detected (Collins et al. 2004). Under alkaline conditions, DSB and SSB (at pH 12.3) and 
additionally alkali labile sites (at pH≥13) can be visualised resulting in increased DNA 
migration in the electrophoretic field (Fairbairn et al., 1994). In COMET assay, normally only 
around 100 cells are analysed. 
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5.3 TUNEL assay 
The terminal deoxynucleotidyl transferase (TdT)-mediated 2´-deoxyuridine 5´-triphosphate-
nick end labelling (TUNEL) assay can be applied for both light microscopy and flow 
cytometry. The assay uses TdT to label the 3’-OH ends of double-stranded DNA breaks, but 
also works on the single strand 3’-OH (Gorczyka et al., 1993). The assay detects the DNA 
breaks directly, without any initial step of denaturation as in SCSA or by introducing acid or 
alkaline pH as in COMET assay. Whilst TUNEL assay based on light microscopy normally 
assess 2-500 cells the flow cytometry TUNEL assess 5-10 000 cells. 
5.4 Sperm Chromatin Dispersion (SCD) test 
The Sperm chromatin dispersion (SCD) test is a relatively simple test that can be applied 
either by fluorescence microscopy or by bright field microscopy. The test is based on the 
principle that sperm with fragmented DNA fails to produce the characteristic halo of 
dispersed DNA loops that are observed on sperm with non-fragmented DNA, when mixed 
with aqueous agarose following acid denaturation and removal of chromatin nuclear 
proteins (Fernandez et al., 2003). In the SCD test normally 500 spermatozoa are analysed.  
6. Intra-individual variation of DFI  
The WHO semen analysis is a golden standard in diagnosis of male infertility, this despite 
an intra-individual variation reported to be as high as up to 54% (Keel 2006). The first SCSA 
studies demonstrated that sperm chromatin parameters varied less within a man (Evenson 
et al., 1991; Spanò et al., 1998). In a study of 45 men who delivered monthly semen samples 
Evenson reported an average within-donor CV of the SCSA-parameter DFI around 23% 
(Evenson et al., 1991). These results were confirmed by another SCSA study of 277 men 
whose semen was measured two times during a period of six months (Spanò et al., 1998).  
Also Smit and co-workers in 100 men from an outpatient andrology clinic demonstrated a 
lower biological variation of sperm DNA fragmentation than the classical WHO sperm 
parameters (Smit et al., 2007). However, conflicting results were obtained in 282 patients 
undergoing ART with repeated (between 2 and 5) SCSA measurements. In this study, CV of 
DFI was as high as 29% (Erenpreiss et al., 2006b). In a more recent study these results were 
reproduced by Olechuk et al., (2011) who also found the mean CV for DFI to be around 30%. 
In this study 85% of the men that repeated their SCSA analysis remained in the same DFI 
category (DFI <30% or DFI >30%) from sample one to sample two. 
7. Sperm chromatin damage and male infertility 
It is evident that infertile men possess more sperm with DNA damage than fertile men 
(Evenson et al., 1999; Gandini et al., 2000; Host et al., 2000b; Irvine et al., 2000; Larson et al., 
2000; Spanò  et al., 2000; Carrell and Liu 2001; Hammadeh et al., 2001; Zini et al., 2001a; 
Sakkas et al., 2002; Saleh et al., 2002b; Zini et al., 2002; Erenpreisa et al., 2003; Muratori et al., 
2003; Saleh et al., 2003a). However, very few infertile men are offered a sperm DNA 
integrity analysis during their fertility work-up, and are therefore not aware of the problem. 
This despite the fact that in 10-25% of men diagnosed with unexplained infertility sperm 
DNA damage can, at least partly explain their childlessness (Bungum et al., 2007; Erenpreiss 
et al.,2008; Smit et al., 2010; Giwercman et al., 2010).  
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2000; Spanò  et al., 2000; Carrell and Liu 2001; Hammadeh et al., 2001; Zini et al., 2001a; 
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8. Predictive role of DFI in spontaneous pregnancy  
Only few studies have studied the role of sperm DNA integrity in relation to fertility in an 
unselected population. The US Georgetown study included 165 couples (Evenson et al., 
1991) and the Danish first pregnancy planners study (Spanò  et al., 2000) included 215 
couples who tried to obtain pregnancy. Both studies analysed sperm DNA damage by the 
use of SCSA and demonstrated that the chance of spontaneous pregnancy, measured by the 
time-to-pregnancy (TTP), decreased when DFI, exceeded 20–30% and became infinite when 
DFI was more than 30%.  
These results have been confirmed in a more recent SCSA case-control study of 127 men 
from infertile couples where female factors were excluded and 137 men with proven 
fertility.  The risk of being infertile was increased when DFI rised above 20% in men with 
normal standard semen parameters (OR 5.1), whereas if one of the WHO parameters were 
abnormal, the OR for infertility was increased already at DFI above 10% (OR 16) 
(Giwercman et al., 2010). This above mentioned study demonstrated that SCSA can be used 
in prediction of the chance of spontaneous pregnancy, independently of the standard sperm 
parameters but also that combining WHO parameters with DFI can be beneficial. 
Giwercman and co-workers claimed that since a DFI >20% was found in 40% of men with 
otherwise normal standard sperm parameters, in almost half of the cases of unexplained 
infertility, sperm DNA defects are a contributing factor to the problem. 
9. Predictive role of DFI in intrauterine insemination (IUI) 
Several reports have studied DFI in prediction of fertility following intrauterine 
insemination (IUI). The first report used the TUNEL assay on prepared semen for sperm 
DNA integrity analysis (Duran et al., 2002). In 154 couples they found lack of pregnancy 
when DFI was above 12%. Other smaller SCSA studies have confirmed this (Saleh et al., 
2003; Boe-Hanssen el al., 2006). In 2007, our group published a study based on 387 IUI cycles 
where DFI was assessed by SCSA (Bungum et al., 2007). DFI was shown to be a predictor of 
fertility independent of other sperm parameters. In men having a DFI level below 30% the 
proportion of children born per cycle was 19.0%. This was in contrast to those having a DFI 
value above 30% who only had a take-home-baby rate of 1.5 %. The chance of IUI pregnancy 
started to decrease already when the DFI value exceeded the 20%-level, but became close to 
zero when exceeding 30%.   
10. Predictive role of DFI in IVF and ICSI 
More contrasting data exist regarding role of sperm DNA damage in relation to fertilisation, 
embryo development and pregnancy outcome in IVF and ICSI. 
10.1 IVF and ICSI pregnancy 
The first SCSA studies based on a relatively limited number of couples indicated that DFI 
above 27% could be used as a cut-off value for infertility (Larsson et al., 2000; Larsson-Cook 
et al., 2003). However, in 2004 three independent SCSA reports demonstrated that one 
through the use of IVF and ICSI were able to compensate for poor sperm chromatin quality 
(Bungum et al., 2004; Virro et al., 2004; Gandini et al., 2004). Then in 2007 data based on 388 
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IVF and 223 ICSI cycles were published (Bungum et al., 2007). We observed no statistically 
significant differences between the outcomes of ICSI and ICSI when a DFI level of 30% was 
used.. However, in the DFI >30% group, the results of ICSI were significantly better than 
those of IVF.  When comparing ICSI to IVF the odds ratios (ORs) for biochemical pregnancy, 
clinical pregnancy and delivery were 3.0 (95% CI: 1.4–6.2), 2.3 (5% CI: 1.1–4.6) and 2.2 (95% 
CI: 1.0–4.5), respectively. Also smaller reports using TUNEL or COMET assays shows that 
sperm DNA damage is more predictive in IVF than in ICSI (Hammadeh et al., 1998; Host et 
al., 2000; Simon et al., 2011). In contrast, one single SCSA study has reported that DFI 
threshold did not predict IVF outcome (Payne et al., 2005). However in this study the 
authors did not discriminate between IVF and ICSI. 
10.2 Fertilisation and embryo development  
In a mouse model Ahmadi and Ng demonstrated that spermatozoa with DNA damage were 
able to fertilise oocytes (Ahmadi and Ng 1999a). They also reported sperm DNA damage to 
be related to poor embryo development (Ahmadi and Ng 1999b), although the oocyte, to a 
certain degree, was able to repair the sperm DNA damage. The human data from ART 
populations regarding fertilisation and embryo development in relation to DNA damage is, 
however, conflicting.  
In our large study of 611 IVF and ICSI couples we compared fertilisation rates between 
those having a DFI>30% and those having a DFI≤30%, however, no statistically significant 
differences were seen, neither for IVF nor for ICSI patients (Bungum et al., 2007). Our 
findings are in accordance with most other reports using the SCSA analysis (Larson et al., 
2000; Larson-Cook et al., 2003; Gandini et al., 2004; Virro et al., 2004; Li et al., 2006) as well as 
other sperm DNA integrity testing methods (Sakkas et al., 1996; Hammadeh et al., 2001; 
Tomlinson et al., 2001; Morris et al., 2002; Tomsu et al., 2002; Henkel et al., 2004; Lewis et al., 
2004; Huang et al., 2005; Nasr-Esfahani et al., 2005). In contrast, a negative correlation 
between sperm DNA fragmentation and IVF and ICSI fertilisation rates were reported by 
others (Sun et al., 1997; Lopes et al., 1998a; Saleh et al., 2003a; Payne et al., 2005). A Danish 
study (Host et al., 2000a) assessed sperm DNA breaks with the TUNEL- assay in infertile 
couples and found negative correlations between the proportion of spermatozoa with DNA 
damage and fertilisation in all groups except for those treated with ICSI.  
In our ART-study from 2007 (Bungum et al., 2007), embryo development was compared 
between those having a SCSA-DFI>30% and those having a DFI≤30%, however, no 
statistically significant differences between the groups were seen. Several other authors have 
reported identical results (Larson et al., 2000; Larson-Cook et al., 2003; Gandini et al., 2004; 
Boe-Hansen et al., 2006). This, however, is contrasted by the findings of others (Sun et al., 
1997; Morris et al., 2002; Saleh et al., 2003a), who showed that DFI levels were negatively 
correlated with embryo quality after IVF and ICSI. Seli et al. (2004) and Virro et al. (2004) 
reported that men with a high DFI had higher risk of low blastocyst formation rate 
compared to those with a low DFI.  
10.3 DFI and risk of pregnancy loss  
Traditionally, pregnancy loss has been explained by either genetic, structural, infective, 
endocrine or unexplained causes (reviewed in (Rai and Regan 2006)).  However, recently 
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IVF and 223 ICSI cycles were published (Bungum et al., 2007). We observed no statistically 
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certain degree, was able to repair the sperm DNA damage. The human data from ART 
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also sperm DNA damage has been associated to recurrent pregnancy loss (Evenson et al., 
1999; Carrell et al., 2003). In a population of first pregnancy planners Evenson et al. (1999) 
reported a miscarriage rate higher in fertile couples where the partner had a high SCSA-DFI 
compared to those with a low DFI. Also Carrell et al. (2003) by using the TUNEL assay on 
sperm from 24 couples with unexplained recurrent pregnancy loss showed that pregnancy 
loss was associated with DNA damage. As control group they used donors of known 
fertility and unscreened men from the general population.  
Several studies have reported an increased risk of pregnancy loss after IVF and ICSI (Check 
et al., 2005; Zini et al. 2005; Lin et al., 2008), however data are conflicting (Bungum et al., 
2007). In a recent meta-analysis Zini and co-workers (Zini et al., 2008) collected data from 11 
studies involving 1549 IVF/ICSI treatments and 640 pregnancies. They demonstrated a 
combined odds ratio (OR) of 2.48 (95% CI; 1.52, 4.04, p<0.0001). The conclusions from this 
analysis should, however, be interpreted with care since different types of sperm DNA 
integrity tests and different sperm sources were included. We have demonstrated that 
washed semen is not predictive for the outcome of ART (Bungum et al., 2008). Further large-
scale studies should be performed to get firm conclusions.  
11. Prevention or treatment of sperm DNA damage 
A more precise diagnosing would enable clinicians to better counsel the infertile couple and 
may also result in improvement and further development of cause-related therapy, which is 
very little used in today’s clinical practice (Skakkebaek et al., 1994). The effects of therapy 
based on antioxidants on sperm DNA quality has been evaluated, however, the studies have 
been small and conflicting (Greco et al., 2005a; Greco et al., 2005b; Silver et al., 2005; Song et 
al., 2006; Menezo et al., 2007; Kefer et al., 2009) and so far no standardized, clinically well-
proven treatment of sperm oxidative stress and DNA damage are established.   
Data on how to best advise couples in what they self can do to prevent against sperm DNA 
damage are lacking. Several life-style factors are suggested to negatively influence sperm 
DNA, however, data are conflicting. Examples are smoking and obesity (Reviewed in 
(DuPlessis et al., 2010 and Agarwal et al., 2008)). Interestingly, the first published 
intervention study in severe obese men demonstrated improvement in WHO parameters 
but not in sperm DNA integrity after weight reduction (Hakonsen et al., 2011).  
12. Conclusion and future perspectives 
Sperm DNA damage is a frequent problem in infertile men. Although not yet routine, sperm 
DNA integrity is a good tool in investigation and treatment of infertility. Sperm DNA 
integrity is a marker of male fertility, alone or in combination with the WHO semen 
parameters, this in natural conception as well as in ART.   
The role of DFI as a predictor of fertilisation, embryo development and pregnancy in IVF 
and ICSI is still discussed. Although not conclusive, also a relation between sperm DNA 
damage and risk of pregnancy loss have been suggested.  
Among the different sperm DNA integrity assays available SCSA is currently the only 
method that has provided clear and stable clinical cut-off levels and therefore can be 
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recommended for a clinical sperm DNA damage evaluation. The normality ranges and 
thresholds for male fertility potential of the other assays still need to be clarified.  
It seems clear that ART, especially ICSI, are able to overcome the natural barriers of sperm 
DNA damage levels not compatible with fertilisation under natural circumstances. The 
consequences of this for the progeny are still not clear, however, it is also reason to concern 
regarding possible consequences of achieving a pregnancy using spermatozoa possessing 
DNA damage. So far no proven treatment of sperm DNA damage is available. Adequately 
powered, placebo-controlled trials of antioxidants in the prevention of sperm oxidative 
stress should be performed.  
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1. Introduction 
The epididymis, located between the efferent ducts and the vas deferens, is a male accessory 
organ characterized by a single coiled tubule duct with an estimated length of 5–7 m in men 
(Sullivan, 2004; O’Hara et al., 2011).  
The anatomic segments of the epididymis include the initial segment, the caput, the corpus 
and the cauda. Each region consists of a lumen and a polarized epithelium composed mostly 
of principal and basal cells (Lasserre et al., 2001; Dacheux et al., 2005). Although these four 
anatomical regions of the epididymis are easily identified in most adult male mammals 
(Yanagimachi et al., 1985; Smithwick & Young, 2001), histological and ultrastructural 
segmentation of this organ varies among the different phylogenies of mammals. The rat 
epididymis is most commonly adopted as an experimental model of study (Figure 1). 
Several descriptive anatomical and histological studies of the epididymis appeared at the 
beginning of the twentieth century. The authors hypothesized that the epididymal 
secretions played a role in the maintenance of sperm vitality, sperm motility (Benoit, 1926) 
and the capacity to become fertile (Young, 1929a, 1929b, 1931). Relatively little research was 
done on the excurrent duct system during the ensuing three decades. However, in 1967, 
Marie-Claire Orgebin-Crist demonstrated that the key event in sperm maturation was not 
the passage of time but the exposure of the sperm to the luminal environment of the 
epididymis (Bedford, 1967; Orgebin-Crist, 1967). 
The epididymal duct is now recognized as a channel that transports, concentrates and stores 
the spermatozoa. It is also known that the spermatozoa leaving the testis are immovable, 
immature and unable to fertilize an oocyte (Yanagimachi, 1994; Flesch & Gadella, 2000), and 
that under androgen control, the epididymal epithelium secretes proteins within the 
intraluminal compartment that create a very complex environment surrounding the 
spermatozoa (Hermo et al., 1994, 2004; Sullivan, 2004). This luminal compartment stores the 
spermatozoa until ejaculation and specifically prepares the sperm for fertilization by 
providing the essentials in terms of temperature, oxygen tension, pH and an available 
energy substrate (Dacheux et al., 2005). The epididymal duct produces the morphological, 
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biochemical, physiological and functional changes to the structures of the spermatozoa 
through a process known as epididymal maturation, which converts the spermatozoa into 
fertilization-competent cells (Toshimori, 2003; Gatti et al., 2004; Flesch & Gadella, 2000). 
 
Fig. 1. The regionalization of the epididymis. The illustrations compare the mouse and 
human epididymides. A) Mouse epididymis (A1: proximal caput, A2: mid-caput). B) 
Human epididymis (A1: anterior caput, A2: posterior caput, B1: anterior corpus, B2: mid-
corpus, B3: posterior corpus, C1: anterior cauda, C2: posterior cauda). 
Since 1966, more than 12,000 research articles have been published on the epididymis. These 
articles, while addressing the various aspects of the epididymis from several points of view, 
all agree that the epididymis is crucial for the preparation of the spermatozoa prior to 
fertilization. It is well known that the proteins and small molecules secreted by the 
epididymal epithelium into the lumen interact with the transiting spermatozoa and directly 
or indirectly affect the spermatozoa surface; these proteins and small molecules function as 
signaling molecules to induce activity in the other epididymal proteins (Gatti et al., 2004). A 
significant number of these molecules will be taken up by the spermatozoa. Several of the 
acrosome molecules, which were previously formed during spermiogenesis and are 
involved in the acrosome reaction or in the sperm-zona pellucida interaction and sperm-egg 
fusion, will be gradually rearranged and compartmentalized in a stage-specific manner 
during sperm maturation (França et al., 2005).  
Through research, we have learned a substantial amount about the function and the 
biochemical properties of the epididymal structure. However, there are still gaps in nearly 
all aspects of the research.  Studying the complexity of the cellular properties, the spatial 
and temporal organization of protein syntheses and secretion and the dynamic interactions 
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between the epithelial cells and the contents of the luminal compartment remains 
challenging but important. A more complete understanding of this organ will allow for the 
development of male contraceptive agents (Turner et al., 2006).  Additionally, up to 40% of 
infertile men exhibit idiopathic infertility that may reflect sperm maturational disorders 
(Cornwall, 2009).  
A greater understanding of the function and biochemical properties of the epididymis may 
lead to the development of therapeutic agents to treat certain types of infertility. This 
chapter provides an overview of the human epididymal embryology, malformation, 
structure and function. 
2. The prenatal development of the epididymis 
In mammals, the genetic sex of the embryo is determined mainly by the presence or absence 
of a single gene on the Y chromosome, the SRY, which is required to initiate male-specific 
pathways and to repress female-specific pathways of development (Moore & Persaud, 
2003). At the onset of sex differentiation, the reproductive primordial organs are 
indistinguishable in male and female embryos. The gonads (testicles or ovaries), the genital 
ducts (Wolffian or Müllerian) and the urogenital sinus of both sexes emerge from the 
morphologically undifferentiated primordia. We can then assume that the genes involved in 
the establishment of these primordia are the same for both sexes. During development, the 
first morphological sex difference appear in the gonads of male embryos, followed by the 
genital ducts, and finally, they appear in the urogenital sinus (Larios & Mendoza, 2001).  
In humans, the genital ducts arise from the intermediate mesoderm. Shortly after the 
formation of the Wolffian ducts, the adjacent Müllerian ducts are formed. In males, sexual 
differentiation develops through regression of the Müllerian ducts and the development of 
the Wolffian ducts into multiple reproductive organs, such as the epididymis, the vas 
deferens ducts and the the seminal vesicles. In females, the Wolffian ducts regress and the 
Müllerian ducts differentiate to form the uterus, the fallopian tubes, and the proximal 
vagina (Hannema & Hughes, 2007; Kobayashi & Behringer, 2003).  
The development of sexual differentiation involves genetic processes that are primarily 
controlled by the sexual chromosomes (França et al., 2005). 
In the male tract, Müllerian duct regression, which depends on the testicular Sertoli cells, is 
mediated by the Y chromosome genes and is triggered by a mechanism that is not well 
understood. The Sertoli cells produce and secrete an anti-Müllerian substance, a non-
steroidal hormone. Under the control of human chorionic gonadotrophin (hCG), a placental 
gonadotrophin, the Leydig cells then differentiate and produce the androgens that will 
positively regulate the ipsilateral Wolffian duct in a paracrine way. These hormonal 
combinations induce the cranial Wolffian duct to become highly convoluted and to 
differentiate into the epididymis.  
The major morphogenic event during Wolffian duct/epididymal duct development is the 
elongation and coiling of the duct (Hannema & Hughes, 2007). The process of elongation is 
likely a product of potential mechanisms such as cell proliferation coupled with directed cell 
rearrangements, along with the interactions between the Wolffian duct ephitelium and the 
surrounding mesenchyme cells (Hinton et al., 2011).  
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The Wolffian ducts also induce the formation of the mesonephric tubules in the 
mesonephric mesenchyme, which extend to the epithelial cells of the gonad and 
subsequently differentiate into efferent ductules. These ductules open into the epididymis 
(Figure 2). Distal to the epididymis, the Wolffian ducts acquire a thicker investment of 
smooth muscle and become the ductus deferens (Moore & Persaud, 2003; Hannema & 
Hughes, 2007). 
 
Fig. 2. The intra-uterine development of the epididymis. A) A sagittal section of a mouse 
embryo showing the relative locations of the developing urogenital structures. B) The 
testicular production and secretion of testosterone positively regulates the Wolffian ducts. 
The ducts then induce the formation of the mesonephric tubules in the mesonephric 
mesenchyme that extend to the epithelial cells of the gonad. C) The cords arising from the 
apical mesonephric tubules form the efferent ducts and fuse with the adjacent ducts to form 
the rete testis. The coiling of the initial segment of the efferent duct is not shown here, but it 
proceeds independently of the coiling of the main epididymal duct shown in D, E and F. D) 
The coiling shifts from the proximal to the distal duct in a temporal fashion. E) The initial 
stages of coiling are planar, meaning that the coiling is at the two-dimensional level.  F) The 
three-dimensional coiling proceeds in a caput-to-cauda direction and is completed in the 
early postnatal period.  
3. The postnatal development of the epididymis 
While cell proliferation in the Wolffian duct appears to be dependent on the presence of 
androgens and mesenchymal factors during prenatal development, lumicrine factors 
produced by the testicles play an additional role during postnatal development (Hinton et 
al., 2011). Lumicrine factors are molecules (such as androgens, growth factors and enzymes) 
whose effect on the secretory activity of the epithelial cells of the epididymis and in the 
epididymis spermatozoa directly participates in the process of epididymal maturation (Lan 
et al., 1998; Robaire et al., 2006). In general, the postnatal development of the mammalian 
epididymis can be divided into three periods that take place across two developmental 
phases (Figure 3). 
 




Fig. 3. A schematic diagram that describes the differentiation of the mouse epididymal 
epithelium from birth until adulthood. A to F indicate the different types of cells in the 
epithelium of the epididymis. 
3.1 The first phase: From birth to early infancy 
By birth, the presumptive areas of the initial segment, caput and corpus have experienced 
considerable coiling compared with the epididymal cauda (Figure 4). Within the first few 
days after birth, the individual conjunctive septum initiates the anatomical segmentation of 
epididymis, along with the considerable growth of the duct. The epithelium is still 
undifferentiated and characterized by columnar cells. The histological changes do not begin 
until the first stages of early infancy with the appearance of halo cells (Robaire et al., 2000, 
2006) (Figure 3). The first phase begins, then, with the undifferentiated period and ends with 
the first event of the differentiation period, which is defined by the appearance of halo cells. 
3.2 The second phase: From early infancy to adulthood 
The epididymal epithelium differentiates into the pseudostratified epithelium, which 
contains principal, basal, apical, narrow and clear cells (Figure 3). Epithelial cell 
differentiation is completed during puberty when the highest rate of cell division and 
epididymal expansion occurs. This period of expansion describes the continued growth of 
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the duct and the appearance of spermatozoa in the epididymal lumen. The establishment of 
the regionalized protein secretion takes place progressively coupled to the consolidation of 
an anatomical epididymal segmentation (Figure 4). The differentiation and regionalization 
are related to the different stages of testicular maturation, the steroidogenic activity of the 
Leydig cells, the androgen dependence of the epididymis itself and the lumicrine factors (De 
Miguel et al., 1998; Robaire et al., 2000; Dacheux et al., 2005; Cornwall, 2009; Robaire et al., 
2006). Then the second phase starts after halo cell differentiation and ends in puberty.  
 
Fig. 4. Photomicrographs of a mouse epididymis. A) At birth, the undifferentiated period 
shows a poorly coiling duct and little regionalization. B) A well-formed adult epididymis in 
expansion with a completely coiled and regionalized duct. Scale bar: A) 100µm. B) 1100µm. 
4. Structural features 
In the testes, the seminiferous tubules converge to form the rete testis, which in turn gives 
rise to the efferent ducts. The number of tubules contained in the efferent ducts varies 
depending on the species and on how the tubules converge to form the single coiled duct 
of the epididymis. The epididymal tubular lumen is continuous with the lumina of the 
efferent ducts and comes to an end in the vas deferens, which has a thick layer of muscle. 
The urethra is the final extension of the vas deferens and communicates with the outside 
of the body. 
4.1 Macroscopic features 
The mammalian epididymis is an elongated coiled duct suspended within the 
mesorchium and firmly or loosely bound to the testicular tunica albuginea. The gross 
aspect of the epididymis allows the identification of the different segments (Figure 1), 
which are comprised of the proximal region (the initial segment and the caput), the 
corpus and the distal cauda (Robaire et al., 2006; Turner, 2008). In all mammalian species, 
each region of the epididymis is further organized into lobules that are separated by the 
connective tissue septa. These septa not only serve as internal support for the organ but 
are also thought to provide a functional separation between the lobules that allows for the 
selective expression of genes and proteins within the individual lobules (Kirchhoff, 1999; 
Cornwall, 2009). 
4.2 Microscopic features 
The epididymis also contains region-specific and cell-specific functions specifically located 
within the epithelium of a given segment. The highly specific regionalization of the  
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epithelium and the luminal protein secretion within the three main epididymal segments 
can be further subdivided into several regions (França et al., 2005; Robaire et al., 2006; 
Turner, 2008). In general, the five physiological regions are distinguished as follows: (i) the 
proximal caput or the initial segment, (ii) the middle caput, (iii) the distal caput and the 
proximal corpus, (iv) the distal corpus and (v) the cauda (Dacheux et al., 2005; Turner, 2008). 
Note that the proposed physiological regions are slightly different from the anatomical 
regions (Figure 1).  
The differential response of the segments to androgen withdrawal, stress and aging 
indicates that each region represents discrete regulatory units (Jervis & Robaire, 2001). 
The epididymis is more than a uniform channel that transports and stores spermatozoa. 
The maturation and storage of the spermatozoa depends upon the epithelial tight and 
adhering junctions. They are important in maintaining the integrity of the epididymal 
epithelium and in the formation of the blood epididymal barrier. Tight junctions between 
the adjacent epididymal epithelial cells form the blood-epididymal barrier and restrict the 
passage of a number of ions, solutes, and macromolecules through the epididymal 
ephitelium. This barrier also serves as an extension of the blood-testis barrier. The 
spermatozoa are immunogenic and contain proteins on their surfaces that would be 
recognized as nonself if they leave the epididymis (Robaire & Hermo, 1988; Dacheux  
et al., 2005). 
Histological characteristics allow for the easy identification of the anterior and posterior 
extremities of the mammalian epididymis. The thickness of the epididymal epithelium 
varies with the thickest portion in the proximal caput and the thinnest in the caudal region 
(Figure 5). Conversely, the luminal diameter and the thickness of the peritubular smooth 
muscle increases from the proximal to the distal regions (Lasserre et al., 2001; Toshimori, 
2003). Few sperm are found in the initial segment, but a large mass of sperm aggregates are 
located in the cauda (Yanagimachi et al., 1985; Cornwall, 2009). In all of these segments, the 
epididymal duct is lined with an epithelium composed of principal and basal cells. Other 
cells, such as apical, narrow, clear and halo cells, are also present in this duct in a segment-
specific manner (Figure 6). 
 
Fig. 5. Photomicrographs showing the histological regionalization of the A) initial segment 
and caput separated by the connective tissue septa, B) the corpus and C) the cauda of the 
mouse epididymis. The thickness of the epididymal epithelium varies from the thickest 
portion in the proximal caput to the thinnest in the caudal region. Conversely, the luminal 
diameter and the thickness of the peritubular smooth muscle increases from the proximal to 
the distal regions. Scale bar: 50µm. 
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the duct and the appearance of spermatozoa in the epididymal lumen. The establishment of 
the regionalized protein secretion takes place progressively coupled to the consolidation of 
an anatomical epididymal segmentation (Figure 4). The differentiation and regionalization 
are related to the different stages of testicular maturation, the steroidogenic activity of the 
Leydig cells, the androgen dependence of the epididymis itself and the lumicrine factors (De 
Miguel et al., 1998; Robaire et al., 2000; Dacheux et al., 2005; Cornwall, 2009; Robaire et al., 
2006). Then the second phase starts after halo cell differentiation and ends in puberty.  
 
Fig. 4. Photomicrographs of a mouse epididymis. A) At birth, the undifferentiated period 
shows a poorly coiling duct and little regionalization. B) A well-formed adult epididymis in 
expansion with a completely coiled and regionalized duct. Scale bar: A) 100µm. B) 1100µm. 
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Fig. 6. A schematic cross section of epididymis showing the organization of the major cell 
types in the epithelium of the epididymal duct as observed through a light microscope. A 
generic epididymal compartment with the relative position and distribution of all cell types 
found throughout the epithelium is illustrated. The thinnest coat of organized smooth 
muscle is in the interstitial tissue surrounding the duct and is characteristic of the anterior 
regions of the epididymis. Note the spermatozoa in the center of the epididymal lumen. 
4.2.1 Principal cells 
Principal cells (Figure 3B) are the most abundant and extensively studied cell type found in 
the epididymal epithelium. Principal cells constitute approximately 80% of the total 
epithelial cell population in the initial segment. The number of principal cells gradually 
decreases to 65% of the total epithelial cell population in the cauda epididymis (Robaire & 
Hermo, 1988). These columnar cells present prominent stereocilia and extend into the 
lumen. Ultrastructurally, the supranuclear region of this cell type contains large stacks of 
Golgi saccules, mitochondria, multivesicular bodies and apical dilated membranous 
elements, while the infranuclear region is densely packed with rough endoplasmic 
reticulum (Robaire et al., 2000, Dacheux et al., 2005). Principal cells are responsible for the 
bulk of the proteins that are secreted into the lumen and are directly involved in the control 
of luminal protein concentrations. They frequently exhibit blebs of cytoplasm emanating 
from their apical cell surface. These cells also form tight junctions with one another, and as 
such, form the blood-epididymis barrier (Robaire et al., 2006; Cornwall, 2009). 
4.2.2 Basal cells 
Basal cells (Figure 3C) are the second most abundant cell type found in the epididymal 
epithelium, constituting 15-20% of the total epithelial cell population of the epididymis. 
They are triangular and flat cells and they reside in the base of the epithelium. Basal cells 
cannot access the luminal compartment. They have elongated or round shaped nuclei, and 
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they are in close association with the overlying principal cells or other basal cells through 
the presence of cytoplasmatic extensions (Robaire et al., 2000; Cornwall, 2009). Because of 
this contact with the basement membrane, basal cells form an extensive cellular sheet 
surrounding the epididymal epithelium (Robaire et al., 2006; Cornwall, 2009). Although 
basal cells are extratubular in origin, some findings have suggested that the cells may have a 
role within the processes of the epithelial immune system and in the regulation of 
electrolytes by principal cells. However, the exact functions of these cells are not yet clear 
(Robaire et al., 2006).  
4.2.3 Apical cells 
Apical cells (Figure 3D) comprise approximately 10% of the total epithelial population in the 
initial segment but only approximately 1% of the total epithelial population in the cauda of the 
epididymis (Adamali & Hermo, 1996). They are clearly defined by the many mitochondria in 
the apical cytoplasm, the few microvilli at the luminal border and a nucleus that is located in 
the upper half of the cell cytoplasm (Adamali & Hermo, 1996; Robaire et al., 2006). These cells 
are related to sperm quiescence and to the regulation of the pH in the lumen through the 
production of enzymes of the carbonic anhydrase family (Hermo et al., 2005). 
4.2.4 Narrow cells 
Narrow cells (Figure 3E) are the slender elongated cells. They increase from 3% of the total 
epithelial population in the initial segment to 6% of the total epithelial population in the 
corpus. These cells presents numerous C-shaped vesicles and mitochondria with a small 
flattened nucleus located in the upper half of the cell cytoplasm. The structural features of 
both apical and narrow cells suggest that these cells are involved in the process of 
intracellular transport between the lumen and the epithelial cells, in the degradation of 
specific proteins and carbohydrates within their lysosomes and in protecting spermatozoa 
from a changing environment of harmful electrophiles (Adamali & Hermo, 1996; Robaire et 
al., 2006). They also differ dramatically from the neighboring principal cells and display 
region-specific expression of proteins, such as the glutathione S-transferases and lysosomal 
enzymes (Adamali & Hermo, 1996). 
4.2.5 Clear cells 
Clear cells (Figure 3F), along with halo cells, constitute fewer than 5% of the total epithelial cell 
population. Clear cells are equally distributed through the caput, the corpus and the cauda 
segments. The dark-stained nucleus of these cells is surrounded by the pale-staining 
cytoplasm. They are also present in all levels of the epididymal epithelium. Clear cells are also 
endocytic cells and may be responsible for the clearance of proteins from the epididymal 
lumen. They normally take up the contents of the cytoplasmic droplets released by the 
spermatozoa as they transit through the duct (Hermo et al., 1994, 2005; Robaire et al., 2006). 
4.2.6 Halo cells 
Halo cells (Figure 3A) are usually located in the base of the ephitelium where it does not 
touch the basement membrane. These cells contain variable numbers of dense core granules. 
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They develop in the immune system from a combination of B and T lymphocytes and 
monocytes (Dacheux et al., 2005; Robaire et al., 2006).  
4.2.7 Cell interactions in the epididymal duct 
The cell types described above are active in the processes of epididymal function, such as 
protein secretion and absorption (principal cells); endocytosis (clear and apical cells); the 
secretory activities responsible for the acidification of the luminal fluid (clear cells and 
narrow cells); immune defense; phagocytosis (halo cells); and the production of antioxidants 
(basal cells) (Robaire et al., 2000; França et al., 2005). It is important to understand that each 
cell type may express different proteins within the distinct epididymal regions. This 
indicates that the cells perform different functions according to their location, and that the 
specificity of epididymal secretions is progressively established with age (Robaire et al., 
2000, 2006). This information confirms the high degree of regionalization involved in the 
activity of the epididymis. This epididymal regionalization, which is attributed to the 
diverse patterns of gene expression, is critical to the formation and maintenance of the 
functions of the epididymal duct (Suzuki et al., 2004). 
5. The maintenance of the epididymis  
In mammals, the development and maintenance of a fully differentiated epididymal 
epithelium is dependent on a combination of factors that provide an ideal site where  
the spermatozoa undergo a series of morphological, biochemical and physiological 
changes. During this process of epididymal maturation, the spermatozoa move along  
the ducts in a fluid that dynamically evolves through the processes of absorption and 
secretion by the epithelial cells, androgens, as well as through lumicrine factors from the 
testis (Cornwall, 2009).  
5.1 Hormones 
Androgens play a crucial role in the development of the male reproductive organs, such as 
the testis, the epididymis, the vas deferens, the seminal vesicle, the prostate and the penis. 
The role of androgens is an important topic in the study of puberty, male fertility and male 
sexual function. The effects of androgen withdrawal have been well established through the 
experimental model of orchiectomy. A decrease in the weight of the epididymis has been 
commonly observed in animals that have had their testicles removed. In these cases, 
androgen replacement, even at supraphysiological levels, only partially restored the weight 
of the epididymis. The removal of the testicles caused the loss of androgens, but it is clear 
that this approach affected estrogen levels and other testicular factors that may affect the 
maintenance of epididymis (Robaire et al., 2000).  
5.1.1 Androgen: Testosterone and dihydrotestosterone 
The formation and function of the epididymis is androgen-dependent. The principal 
androgen, testosterone (T), is essential for the development of the internal sex organs and is 
derived from the Wolffian duct system, which consists of the epididymis, the vas deferens, 
and the seminal vesicle (Umar et al., 2003). Dihydrotestosterone (DHT), the 5α-reduced form 
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of T, is involved in the development of the prostate and the external genitalia. Although T is 
the predominantly active androgen during the first phase of the postnatal development of 
the epididymis, it is the effects of DHT that are important in the epididymal fluid of the 
mature epididymis. DHT can be produced locally in the epididymis by principal cells and is 
primarily found in the initial segment of the duct (Dacheux et al., 2005; França et al., 2005; 
Robaire & Henderson, 2006).  
The actions of both T and DHT are initiated through the intracellular receptor known as the 
androgen receptor (AR). DHT is the more potent androgen of the two. The AR is found in all 
male reproductive organs and can be stimulated by either T or its more potent metabolite, 
DHT. The binding of either T or DHT to the AR may regulate distinct androgenic effects in 
target tissues. Clinical syndromes, such as androgen insensitivity (AIS), illustrate the 
differential actions of T and DHT (Umar et al., 2003). AR expression in the developing male 
genital tract occurs in a strict temporal pattern. It is first detected in the mesenchymal cells, 
then in the epithelial cells and then in both the epithelial and stromal compartments of the 
epididymis (Umar et al., 2003; O’Hara et al., 2011). 
The initiation of androgen-dependent differentiation of the Wolffian duct system into 
epididymis occurs before epithelial cells express a detectable level of the AR protein. In this 
phase of development, the mesenchymal cells are important androgen targets that elicit 
androgenic effects in the epithelial cells via paracrine factors and mesenchymal-epithelial 
interactions (Umar et al., 2003). Genetic mutations in the AR or treatment with AR 
antagonists during the male embryonic stage results in the regression of the Wolffian ducts 
and an absence of the epididymis in adult males (O’Hara et al., 2011). 
During postnatal development, the luminal secretion of androgens is essential for the 
maintenance of epithelial cell identity (O´Hara et al., 2011), and for the normal development 
and function of the stromal cells (Nitta et al., 1993; Robaire et al., 2000; Hess et al., 2001; 
O’Hara et al., 2011). Both the regionalized differentiation of the epididymis and the variation 
in the luminal fluid composition take place under the control of androgens (Toshimori, 
2003). The production and secretion of at least half of the epididymal proteins, including 
those later incorporated by the spermatozoa in transit, are under androgenic control. 
Androgenic control may act positively or negatively, depending on the varying levels of 
sensitivity (Tezon et al., 1985; Ellerman et al., 1998; Robaire et al., 2000, Dachuex et al. 2005; 
Robaire & Henderson, 2006). 
5.1.2 Estrogen 
In addition to testosterone and other androgenic-derived metabolites, estrogen has been 
reported to target epididymal epithelial cells (Hess et al., 2001, 2011). The presence of two 
estrogen receptors (ESR) types in the head of the epididymis, as well as in other regions of 
the epididymis, has been well documented. Their expression appears to be isotype-,  
species-, and cell-specific (Hess et al., 2001, 2011). Recent studies have shown that the 
luminal fluid reabsorption that occurs in the efferent ductules and in the initial segment of 
the epididymis is regulated by estrogen. The estrogen present in the epididymis also 
regulates the transport of fluid through the duct and is responsible for increasing the 
concentration of sperm as they enter the caput of the epididymis (França et al., 2005; Hess et 
al., 2011). Estrogen assists in the maintenance of a differentiated epithelial morphology, 
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species-, and cell-specific (Hess et al., 2001, 2011). Recent studies have shown that the 
luminal fluid reabsorption that occurs in the efferent ductules and in the initial segment of 
the epididymis is regulated by estrogen. The estrogen present in the epididymis also 
regulates the transport of fluid through the duct and is responsible for increasing the 
concentration of sperm as they enter the caput of the epididymis (França et al., 2005; Hess et 
al., 2011). Estrogen assists in the maintenance of a differentiated epithelial morphology, 
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which means that it is absolutely necessary for the process of enhancing fertility in the male 
(Kobayashi & Behringer, 2003). 
5.2 Lumicrine factors 
Lumicrine factors are molecules produced by an upstream set of cells through a luminal or 
ductal system in the testes that actively participates through paracrine signaling to the 
cellular mechanisms of development and maintenance of the epididymis (Lan et al., 1998). 
In the absence of lumicrine factors, the segments of the epididymal duct regress to a 
transcriptionally undifferentiated state, which is consistent with a less differentiated 
histology. The absence of testicular molecules could also stimulate an individual’s gene 
expression in some epididymal segments while suppressing it in others (Turner et al., 2007). 
Androgen replacement in the experimental models of castrated subjects has shown that 
apoptotic cell death in the epididymis can be prevented, but the initial segment is dependent 
on the luminal components coming from the testis and not just on the androgens alone 
(Robaire et al., 2000). The direct influence of lumicrine factors, in addition to the secretion of 
androgens by the testicular Leydig cells, is of extreme importance for both cell signaling and 
the maintenance of the male reproductive tract epithelia. Lumicrine factors regulate the 
secretion of the molecule-specific androgen-region substances present in the epididymal 
fluid, which support a peculiar microenvironment that is necessary for the survival and 
functionality of sperm (Turner et al., 2007; von Horsten et al., 2007). 
5.3 Additional molecules 
Other substances for which the receptors for or the substance itself have been found in the 
epididymis include prolactin, retinoic acid, and vitamin D, whose active metabolite is 
synthesized primarily in the cauda epididymis (Robaire et al., 2000). In a complementary 
way, another regulator of epididymal function is vitamin E, which plays an important role 
in maintaining the viability and the functional and structural appearances of the epithelial 
cells of the epididymal duct (França et al., 2005).  
6. Biological function in adulthood 
The epididymal functions of transporting, concentrating, maturing, and storing 
spermatozoa are important processes for male fertility, and their absence or depletion might 
be a significant factor in male infertility (Turner, 2008). In order to fulfill so many functions, 
the epididymis is dependent on the establishment of a peculiar microenvironment, which is 
formed by the highly regionalized secretion of proteins, glycoproteins and other molecules 
from the testis. Although the composition of the epididymal luminal fluid of several species 
is known to be the epididymal site where spermatozoa mature and are stored, the manner in 
which the epididymis contributes to the formation of this specialized milieu is not fully 
understood (Robaire et al., 2006). Our understanding of the mechanisms behind the 
regulation of the functions of the epididymal epithelium, and their effects on the 
spermatozoa, is still fairly limited. The major function of the adult epididymis is to provide 
the ideal conditions that ensure the progress of the spermatozoa along the duct as they are 
exposed to a continually changing environment that supports the development and 
maintenance of fertilization.  
 






Fig. 7. A schematic illustration representing the distinct changes in the sperm surface 
throughout the stages of sperm maturation and epididymal cellular distribution 
throughout the epididymal epithelium. Histological characteristics allow for the 
identification of the anterior and posterior extremities of the epididymis. The epididymal 
epithelium varies from its thickest section in the proximal caput to its thinnest section in 
the caudal region. The relative position and distribution of the main cell types are 
illustrated in each macroscopic structural region of the epididymis demonstrating that 
principal and basal cells are the two most abundant cell types throughout the entire 
epididymis. Detailed illustrations in the upper portion of the figure show the maturation 
of the spermatozoa, along with the incorporation of the molecules along the passage 
through the duct. Some molecules are bound, and later, may or may not disappear. Other 
molecules are incorporated into the cellular membrane of the plasma of the spermatozoa or 
associate with the surface receptors and ions channels that are activated. Note the 
molecules that are also incorporated into the acrosomal vesicle. Some of these molecules 
will persist until the capacitation reaction in the reproductive female tract.  
These molecules are indispensable to the specific recognition processes of the egg-
spermatozoa interaction.  
 
Embryology – Updates and Highlights on Classic Topics 
 
52
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6.1 The epididymal maturation of the spermatozoa 
Sperm maturation involves morphological and biochemical changes in the sperm surface in 
response to the epididymal secretions of enzymes, proteins and glycoproteins, which are 
essential in the process of fertilization (Orgebin-Crist, 1967; Robaire et al., 2000, 2006). The 
knowledge of the interactions between the luminal fluid microenvironment and the 
dynamics of the epididymal epithelium is indispensable to an understanding of the process 
of the development and maturation of the spermatozoa in the adult epididymis. 
In the process of sperm maturation, molecules are secreted into the luminal fluid by 
different regions of the epididymis. These molecules interact sequentially with the surface 
of the spermatozoa or the acrosome, and alter their molecular function (Orgebin-Crist, 
1967; Robaire et al., 2000, 2006; Gatti et al., 2004; Dacheux et al., 2005; Sullivan et al., 2005) 
(Figure 7). In this process, some proteins bind to the sperm and presumably affect sperm 
function directly (Ellerman et al., 1998; Von Horsten et al., 2007). Some proteins will later 
bind to the zona pellucida (Ellerman et al., 1998) or the plasma membrane of the oocyte 
(Cohen et al., 1996; Flesch & Gadella, 2000). Other proteins remain in the lumen 
throughout the length of the tubule (Dacheux et al., 2005; Fouchécourt et al., 2002). Several 
of the epididymal proteins that remain in the lumen are either closely bound to each other 
or they may be integrated into the membrane of the spermatozoa because of their 
hydrophobic properties (as GPI-anchored proteins) or because of the proteolysis of their 
carboxy-terminal region (Gatti et al., 2004).  
Other proteins are present in the epididymal lumen for only a short time, suggesting that 
their continued presence may be detrimental to sperm maturation and/or epididymal cell 
functions. Selective mechanisms are in place for their removal (von Horsten et al., 2007). 
These short-acting proteins that are loosely bound probably prevent direct interactions with 
the sperm surface by masking the sites that will be activated during fertilization.  
In addition, there are a number of proteins that can be transferred from the epididymal 
epithelium to the spermatozoa by a very specific and not fully elucidated mechanism 
mediated by the epididymosomes. Almost all of these proteins are rapidly absorbed or 
degraded in the first segment of the epididymis. Some of these molecules or aggregates 
become outer membrane components of the sperm, while others become integral membrane 
proteins. CRISPs (Cysteine-Rich Secretory Proteins, originally named DE) are epididymal 
proteins in rats and mice that do not require stable or long-term bounds with the sperm to 
perform their functions. CRISPs adhere to the sperm surface as epididymosomes during 
epididymal maturation and are subsequently lost during epididymal transit (Ellerman et al., 
1998; Cohen et al., 2011). 
Some molecules secreted by the epididymis do not interact directly with the surface of the 
sperm. Instead, the molecules interact with the sperm acrosome. The sperm acrosome is a 
highly specialized organelle overlying the anterior part of the sperm nucleus. The acrosome 
contains a number of hydrolytic enzymes that are believed to be required for fertilization 
(Yoshinaga & Toshimori, 2003).  
The SP-10 and the acrin family (1 and 2) are examples of molecules undergoing intense 
regulation of the distribution in the movement into and out of the acrosome. These 
molecules induce changes in the acrosomal proteins of the spermatozoa by maturation-
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dependent modifications attributed to glycosylation/deglycosylation and/or proteolytic 
processing during epididymal maturation (Yoshinaga & Toshimori, 2003). The acrosomal 
human SP-10 protein decreases from 45 kDa to 18-25 kDa as a result of the proteolytic 
process when the spermatozoa pass into the caput epididymis. Acrin 1 and acrin 2 move 
from one acrosomal domain to another, which results in a compartmentalization of these 
molecules during epididymal maturation. Intra-acrosomal proteins initially generated in the 
testis can change their location and their size simultaneously during epididymal maturation 
(Yoshinaga & Toshimori, 2003). 
There is a range of others proteins that are known to dwell in the epididymal fluid, such as 
lactoferrin, clusterin, cholesterol transfer protein, glutathione-peroxidase, albuminoidal 
proteins, prostaglandin, prostaglandin D2 synthase, hexosaminidase and procathepsin D 
(Fouchecort et al., 2000; Suzuki et al., 2004). It is generally known that these epididymal-
secreted proteins exhibit either transport and binding functions or enzymatic activity. They 
contribute to the fertilization capacity of the spermatozoa by facilitating the exchange of 
proteins or lipids between the spermatozoa and the surrounding fluid (Dacheux et al., 2005) 
during epididymal maturation. The proteolysis of the pre-existing proteins, and even the 
metabolic activity of the spermatozoa, also contributes to the protein profile of the 
epididymal fluid (Dacheux et al., 2005). 
Most of the molecules found in the epididymal luminal fluid participate in the maturation of 
the spermatozoa by responding to one of the various mechanisms previously described. 
Although the many of the molecular mechanisms that induce sperm maturation have not 
been definitively identified, it has been established that the regionalized epididymal fluid 
microenvironments promote numerous changes in the spermatozoa along the entire length 
of the epididymal tubule (von Horsten et al., 2007). 
6.2 The epididymis and the protection of the mature spermatozoa  
In humans, the spermatozoa take approximately ten days to travel from the initial segment 
to the cauda region of the epididymis (Toshimori, 2003). Once they are fully mature, the 
spermatozoa may be stored in the terminal region of the cauda epididymis for days or 
weeks, depending on the species, until ejaculation occurs (Yanagimachi, 1994). The 
mechanisms of sperm survival in the distal epididymis are poorly understood. The 
spermatozoa are at risk during transit and during the period of storage within the 
epididymis. The predominance of polyunsaturated fatty acids (PUFA) in the plasma 
membrane of the spermatozoa renders them highly susceptible to lipid peroxidation 
because of attacks by reactive oxygen species (ROS). The development of enzymatic and 
non-enzymatic strategies for protecting the spermatozoa during this extremely vulnerable 
period is another role attributed to the secretory activity of the epididymal epithelium. Some 
of the proteins released by the epididymal epithelium into the lumen seem to be involved in 
the protection of the spermatozoa from both oxidation reactions and/or bacterial attacks 
(Robaire et al., 2000; Gatti et al., 2004; Robaire et al., 2006). 
A system for the regulated storage of spermatozoa in the distal region of the organ was 
developed in mammals, ensuring that the stored cells are quiescent and unreactive (Gatti et 
al., 2004). The exact mechanism of this physiological phenomenon, known as sperm 
quiescence, is not clearly understood. One hypothesis is that remaining in a quiescent state 
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protects the sperm from the drastic change in ionic composition of the medium in the cauda 
epididymis. Other factors, such as the inorganic and organic constituents of the luminal 
fluid, are of secondary importance and might assist in inducing sperm quiescence (Gatti et 
al., 2004).  
Finally, there are a number of epididymal sperm-coating proteins that exert their effects on 
the male gamete in the female, and not in the male tract. These proteins produced by the 
epididymis and bind the luminal sperm, but they become functional in the female oviduct. 
Some of these molecules are considered to be decapacitating factors and might bind to the 
spermatozoa surface to prevent premature sperm activation (Kobayashi & Behringer, 2003). 
6.3 Postepididymal events 
After undergoing epididymal maturation, the mature spermatozoa are stored in the cauda 
epididymal segment until ejaculation. Once in the female reproductive tract, the mature 
spermatozoa must be capacitated. Capacitation is a complex maturational phenomenon that 
renders spermatozoa capable of binding and fusing with the oocyte, which is a requirement 
for mammalian fertilization. Capacitation encompasses plasma membrane reorganization, 
ion permeability regulation, cholesterol loss and changes in the phosphorylation state of 
many proteins (Visconti et al., 2011). 
To acquire the potential for fusion with the oocyte, the capacitated spermatozoa initially 
interact in a species-specific manner with the zona pellucida, an extracellular coat that 
surrounds the mammalian egg. This process, called primary binding, is mediated by the 
zona pellucida glycoconjugates that recognize the sperm receptors located on the surface of 
the male gamete. These receptors are incorporated into the spermatozoa surface during 
epididymal maturation (Bedford, 2008; Robaire et al., 2006). The bound spermatozoa 
undergo the acrosome reaction and initiate penetration into the zona pellucida. Sperm 
penetration involves both the digestion of the zona pellucida and vigorous sperm motion. 
The sperm is also kept bound to the matrix via sperm receptors, an interaction that is called 
secondary binding (Flesch & Gadella, 2000). Numerous candidates have been postulated as 
possible sperm receptors for primary and secondary binding, such as human P34H, an 
epididymal sperm protein secreted predominantly by principal cells in the proximal-distal 
segment of the corpus epididymis (Boué & Sullivan, 1996). 
Acrosome-mediated spermatozoa that have penetrated the zona pellucida enter the 
perivitelline space, bind and fuse to the egg plasma membrane and release the genetic 
material that will initiate zygote development. Protein complexes with both binding and 
fusion functions are present in both the egg and the spermatozoa and interact with their 
counterparts on the surface of the other gamete. Recent studies have demonstrated that the 
capacitated spermatozoa contain multiprotein complexes that are present on the sperm 
surface during capacitation. These complexes display an affinity for the zona pellucida in 
the event of fertilization (Toshimori, 2003). Several proteins of epididymal origin have also 
been proposed as participants in the sperm-egg membrane fusion process. In general, fusion 
proteins may have sequences of hydrophobic residues. They are mostly comprised of an 
alpha-helical structure and are known as fusion molecules. In a similar manner, the extern 
proteins that are bound to the sperm surface reveal new functional peptide domains that 
may trigger the sperm-egg interactions such as protein fertilin β (also known as ADAM2) 
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that initially covers the entire testicular sperm head, is degraded by two successive 
cleavages during caput transit and is further restricted to the post-acrosomal domain of the 
spermatozoa (Toshimori, 2003). 
7. The aging process of the epididymis  
During aging, the male reproductive tract is characterized by testicular dysfunction 
resulting in the atrophy of the seminiferous epithelium and the Leydig cells. However, in 
rats, the average epididymal weight is not significantly affected by aging (3 months to 24 
months). Aging affects the epididymis in a segment- and cell-dependent manner. Basal cells 
are primarily affected in the initial segment, clear cells are most modified in the caput 
segment and principal cells are most damaged in the corpus. In the proximal cauda 
segment, aging more dramatically affects the appearance of cells. In this segment, clear cells 
become enlarged and are filled with dense lysosomes, and some principal cells contain large 
vacuoles (Robaire et al., 2006). 
Gene expression significantly decreases with age in the initial segment, the corpus and the 
cauda of the epididymis. The decrease in total epididymal gene expression from aging can 
be clearly observed in the corpus and the cauda, where expression of 83% and 62% of genes 
is respectively reduced to approximately 50%. This is in contrast to the initial segment, in 
which only 31% of the genes had a decrease in expression of at least 50%. The caput of the 
epididymis was the only segment in which the expression of large proportions of genes did 
not drastically change with age (less than 33%) (Robaire et al., 2006). 
The function of the epididymis is highly dependent on the presence of androgens, 
particularly 5α-reduced androgens. Rat models have shown that the ability of  
the epididymis to produce 5α-reduced androgens becomes compromised with age. 
However the ability of the organ to respond to androgens is not compromised (Smithwick 
& Young, 2001).  
Finally, the blood-epididymis barrier may be compromised in structure and function with 
age, resulting in the appearance of, and an increase in the number of, 
monocytes/macrophages mainly in the initial segment. Several kinematic parameters 
associated with sperm motility in the cauda of the epididymis may also be decreased. An 
increased incidence in the rates of pre-implantation loss, lower fetal weight and higher post-
natal deaths was observed in the offspring of young female rats mated with older male rats 
(Robaire et al., 2000, 2006). Whether these effects are due to deficient epididymal maturation 
or due to a testicular dysfunction requires further study. Dysregulated intracellular 
trafficking, decreased protein degradation and oxidative stress are a few of the possible 
hypotheses that may explain the molecular mechanisms behind these changes (Robaire et 
al., 2000, 2006). 
Many social factors have contributed to the increase in the number of men over the age of 35 
who wish to become parents over the past several years. In 1970, fewer than 15% of all men 
fathering children were over the age of 35, but recent percentages have risen to almost 25%. 
Reproductive function gradually declines with advanced paternal age from multifactorial 
causes. Pattern quality parameters for fertility significantly decrease from 30-year-old men 
to 50-year-old men as follows: sperm motility (262 ± 116 ppm to 110 ± 152 ppm), the volume 
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surrounds the mammalian egg. This process, called primary binding, is mediated by the 
zona pellucida glycoconjugates that recognize the sperm receptors located on the surface of 
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that initially covers the entire testicular sperm head, is degraded by two successive 
cleavages during caput transit and is further restricted to the post-acrosomal domain of the 
spermatozoa (Toshimori, 2003). 
7. The aging process of the epididymis  
During aging, the male reproductive tract is characterized by testicular dysfunction 
resulting in the atrophy of the seminiferous epithelium and the Leydig cells. However, in 
rats, the average epididymal weight is not significantly affected by aging (3 months to 24 
months). Aging affects the epididymis in a segment- and cell-dependent manner. Basal cells 
are primarily affected in the initial segment, clear cells are most modified in the caput 
segment and principal cells are most damaged in the corpus. In the proximal cauda 
segment, aging more dramatically affects the appearance of cells. In this segment, clear cells 
become enlarged and are filled with dense lysosomes, and some principal cells contain large 
vacuoles (Robaire et al., 2006). 
Gene expression significantly decreases with age in the initial segment, the corpus and the 
cauda of the epididymis. The decrease in total epididymal gene expression from aging can 
be clearly observed in the corpus and the cauda, where expression of 83% and 62% of genes 
is respectively reduced to approximately 50%. This is in contrast to the initial segment, in 
which only 31% of the genes had a decrease in expression of at least 50%. The caput of the 
epididymis was the only segment in which the expression of large proportions of genes did 
not drastically change with age (less than 33%) (Robaire et al., 2006). 
The function of the epididymis is highly dependent on the presence of androgens, 
particularly 5α-reduced androgens. Rat models have shown that the ability of  
the epididymis to produce 5α-reduced androgens becomes compromised with age. 
However the ability of the organ to respond to androgens is not compromised (Smithwick 
& Young, 2001).  
Finally, the blood-epididymis barrier may be compromised in structure and function with 
age, resulting in the appearance of, and an increase in the number of, 
monocytes/macrophages mainly in the initial segment. Several kinematic parameters 
associated with sperm motility in the cauda of the epididymis may also be decreased. An 
increased incidence in the rates of pre-implantation loss, lower fetal weight and higher post-
natal deaths was observed in the offspring of young female rats mated with older male rats 
(Robaire et al., 2000, 2006). Whether these effects are due to deficient epididymal maturation 
or due to a testicular dysfunction requires further study. Dysregulated intracellular 
trafficking, decreased protein degradation and oxidative stress are a few of the possible 
hypotheses that may explain the molecular mechanisms behind these changes (Robaire et 
al., 2000, 2006). 
Many social factors have contributed to the increase in the number of men over the age of 35 
who wish to become parents over the past several years. In 1970, fewer than 15% of all men 
fathering children were over the age of 35, but recent percentages have risen to almost 25%. 
Reproductive function gradually declines with advanced paternal age from multifactorial 
causes. Pattern quality parameters for fertility significantly decrease from 30-year-old men 
to 50-year-old men as follows: sperm motility (262 ± 116 ppm to 110 ± 152 ppm), the volume 
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of semen (3.7 ± 8.5 mL to 2.1 ± 1.5 mL) and the concentration of spermatozoa (76 ± 55 
million/mL to 59 ± 57 million/mL), respectively. Most evidence suggests that increased 
aging has negative effects on male fertility and some genetic risk for offspring, but the age at 
which the risk develops and the magnitude of the risk are poorly defined, as is the role of 
the epididymis in this process (Stewart & Kim, 2011). 
8. Epididymis and infertility  
Approximately 13-15% of couples will encounter fertility problems during their 
reproductive life. Factors involving males are responsible for infertility in approximately 
20% of couples and are contributory in another 30–40% of couples. This means that factors 
involving males and infertility are implicated in more than 50% of the difficulties couples 
encounter when attempting pregnancy (Hamada et al., 2011). Diagnostic tools and therapies 
to treat female infertility are relatively well developed. However, many of the causes of 
male infertility are considered idiopathic (Sullivan, 2004). 
The spermogram accurately assesses male fertility through an evaluation of semen quality, 
sperm concentration, motility and morphology (Hamada et al., 2011). The normal 
spermogram values were based on multi-centered population studies on fertile men. 
However, several men presenting normal spermogram values are diagnosed as 
idiopathically infertile. These men may present with post-testicular defects that result in the 
ejaculation of spermatozoa with a normal morphology but with a sub-optimal fertilization 
capacity (Sullivan, 2004). The epididymis could be particularly involved in a number of the 
pathophysiologies affecting sperm maturation in some of these cases of male infertility 
(Sullivan, 2004; Hamada et al., 2011). 
8.1 The epididymis, xenobiotics and endocrine disruptors  
Xenobiotics are substances that are foreign to an organism. Some of these substances can 
produce adverse effects or damage under specific conditions of use, such as when these 
substances are present in much higher concentrations than are usual. Through the influence 
of lifestyle, environmental factors or prenatal exposures to compounds, xenobiotics can act 
as endocrine disruptors that reduce testosterone synthesis and androgenic signaling 
(Smithwick & Young, 2001; Marty et al., 2003). As previously described, the epididymis 
depends on androgens for both the development and maintenance of the organ. The 
epididymis is therefore a potential target for the toxic effects of xenobiotics, which may then 
influence male fertility. Experimental models that block the action of androgen produce side 
effects equivalent to a chemical orchiectomy. The formation of DHT was blocked in the 
epididymis by inhibiting the expression of genes involved in signal transduction, such as 
fatty acid and lipid metabolism and the regulation of ion and fluid transport. This inhibition 
affected sperm quality but did not result in the complete obstruction of fertility. The 
blocking of the actions of estrogen resulted in a dramatic reduction in the fluid uptake 
capacity of the epididymal tissue and caused infertility (Robaire et al., 2000). 
Epididymal histopathological studies and sperm function tests have not been standard in 
the fields of drug development or in the assessment of toxicants. The effects of xenobiotics 
on the epididymis may often have been overlooked (Robaire et al., 2000). In addition to the 
damaging potential of xenobiotic substances, there are concerns about the effects of new 
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anti-neoplastic drugs and herbal products, chemicals and plastics (cyclophosphamide, 
bisphenol A, phthalates sulfonates, and plasticizer), cleaning agents (alkylphenols) and 
pesticides/fungicides (mainly organochlorine compounds). 
8.2 Epididymal abnormalities in cryptorchidism 
Epididymal anomalies have been more commonly associated with undescended, rather than 
descended, testes. Testicular maldescent, then, is commonly associated with epididymal 
anomalies. However, most epididymal abnormalities are not likely to have contributed to 
testicular maldescent (Elder, 1992; Han & Kang, 2002). Cryptorchidism is a disease in which 
the testes and the epididymis are retained in the inguinal tract and the seminiferous tubules 
become atrophic as a result of the increase in temperature, which does not favor 
spermatogenesis (Garcia et al., 2011). The incidence of cryptorchidism is 1-4% in human 
male neonates (Toppari et al., 2001). The cause of cryptorchidism is multifactorial, although 
possible causes and risk factors, such as endocrine disorders, anatomical abnormalities and 
environmental and genetic factors, can explain the etiology of this phenomenon (Nieschalag 
et al., 2000).  
The damage caused by cryptorchidism is reflected in a reduced diameter of the duct and a 
reduction in the length of the epithelium within the duct, along with the absence of 
spermatozoa in the lumen of the duct itself (Arrotéia et al., 2005; Garcia et al., 2011) (Figure 8).  
 
Fig. 8. Photomicrographs of a mouse epididymal caput. A: control photomicrograph of an 
adult epididymis; B: the epididymis of a cryptorchidic mouse. Sperm is absent because of 
the failure of production in the cryptorchidical testis. Scale bar: 50µm 
Alterations in temperature also affect the ionic and protein composition of the cauda fluid, 
which effects the cauda epithelium by eliminating the special ability of the cauda to store 
and prolong the life of spermatozoa through the promotion of rapid epididymal transport 
(Nieschalag et al., 2000). In a series of studies on the epididymides of cryptorchidic animals 
and on primary epithelial cell cultures, it was shown that some epididymal gene products 
are exquisitely sensitive to small changes in temperature (Kirchhoff et al., 2000). Although 
there is no information on whether epididymal function (and hence sperm maturation) is 
irreversibly compromised in adult men who were submitted to orchidopexy as children, 
experimental results in mice indicate that gross and histological alterations caused by 
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epididymis is therefore a potential target for the toxic effects of xenobiotics, which may then 
influence male fertility. Experimental models that block the action of androgen produce side 
effects equivalent to a chemical orchiectomy. The formation of DHT was blocked in the 
epididymis by inhibiting the expression of genes involved in signal transduction, such as 
fatty acid and lipid metabolism and the regulation of ion and fluid transport. This inhibition 
affected sperm quality but did not result in the complete obstruction of fertility. The 
blocking of the actions of estrogen resulted in a dramatic reduction in the fluid uptake 
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Epididymal histopathological studies and sperm function tests have not been standard in 
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anti-neoplastic drugs and herbal products, chemicals and plastics (cyclophosphamide, 
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pesticides/fungicides (mainly organochlorine compounds). 
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Epididymal anomalies have been more commonly associated with undescended, rather than 
descended, testes. Testicular maldescent, then, is commonly associated with epididymal 
anomalies. However, most epididymal abnormalities are not likely to have contributed to 
testicular maldescent (Elder, 1992; Han & Kang, 2002). Cryptorchidism is a disease in which 
the testes and the epididymis are retained in the inguinal tract and the seminiferous tubules 
become atrophic as a result of the increase in temperature, which does not favor 
spermatogenesis (Garcia et al., 2011). The incidence of cryptorchidism is 1-4% in human 
male neonates (Toppari et al., 2001). The cause of cryptorchidism is multifactorial, although 
possible causes and risk factors, such as endocrine disorders, anatomical abnormalities and 
environmental and genetic factors, can explain the etiology of this phenomenon (Nieschalag 
et al., 2000).  
The damage caused by cryptorchidism is reflected in a reduced diameter of the duct and a 
reduction in the length of the epithelium within the duct, along with the absence of 
spermatozoa in the lumen of the duct itself (Arrotéia et al., 2005; Garcia et al., 2011) (Figure 8).  
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adult epididymis; B: the epididymis of a cryptorchidic mouse. Sperm is absent because of 
the failure of production in the cryptorchidical testis. Scale bar: 50µm 
Alterations in temperature also affect the ionic and protein composition of the cauda fluid, 
which effects the cauda epithelium by eliminating the special ability of the cauda to store 
and prolong the life of spermatozoa through the promotion of rapid epididymal transport 
(Nieschalag et al., 2000). In a series of studies on the epididymides of cryptorchidic animals 
and on primary epithelial cell cultures, it was shown that some epididymal gene products 
are exquisitely sensitive to small changes in temperature (Kirchhoff et al., 2000). Although 
there is no information on whether epididymal function (and hence sperm maturation) is 
irreversibly compromised in adult men who were submitted to orchidopexy as children, 
experimental results in mice indicate that gross and histological alterations caused by 
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cryptorchidism can be restored by orchidopexy (Arrotéia et al., 2005; Garcia et al., 2011). 
However, the decrease in the transit time of the spermatozoa in the epididymis (i.e., 
acceleration of sperm passage through the epididymal duct) and the reduction of fertility, 
fecundity and potency observed in cryptorchidic mice were not fully restored following 
orchidopexy (Garcia et al., 2011). 
8.3 The expresssion of epididymal proteins and infertility 
The fate of the proteins involved in spermatozoa maturation may interfere with successful 
fertilization. The proteins secreted along the epididymis under androgenic control vary 
from one segment to the other and modify the maturing male gamete in a sequential 
manner (Sullivan, 2004). The presence or absence of given molecules on the spermatozoa 
has often been correlated to certain traits of the sperm, such as the recognition and binding 
to the zona pellucida or oocyte membrane, or to the movement of the spermatozoa 
(Dacheux et al., 2005).  
During the passage through the epididymal duct, molecules are incorporated into the 
development of the spermatozoa. Some molecules are more relevant than others in the 
maturation process and these or other molecules may play a relevant role in the acrosomal 
process later on. In the case of the protein P34H, which is related to male idiopathic 
infertility, the spermatozoa maturation process is a key event in the process of fertilization. 
Men diagnosed with idiopathic male infertility have an unexplained reduction in semen 
quality. These patients have no abnormal findings on physical examination and no 
laboratory abnormalities associated endocrine function. P34H is a 34 kDa human 
epididymal sperm protein synthesized and secreted predominantly by principal cells. P34H 
is physiologically undetectable on the spermatozoa in the caput of the epididymis and 
progressively accumulates on the sperm surface covering the acrosomal cap from the corpus 
to the distal cauda of the epididymis. This protein remains inactive in capacitated 
spermatozoa but apparently is lost during the acrosome reaction (Boué & Sullivan, 1996). 
This suggests that P34H is a human epididymal protein involved in the sperm interaction 
with the zona pellucida. P34H is associated with the spermatozoa of semen samples 
obtained from fertile donors, but it is undetectable in approximately 40% of the semen 
samples obtained from men presenting with idiopathic infertility. Spermatozoa with 
undetectable levels of P34H were related to the inability to bind to the zona pellucida 
through in vitro assays. These cases of infertility could be attributed to the inefficient 
epididymal maturation of male gametes that are then unable to fertilize. The human P34H 
protein and other epididymal molecules could be considered as markers for epididymal 
function in sperm maturation and can be used as a diagnostic tool to identify cases of 
infertility in men that have not been diagnosed through the classic methods of semen 
analysis (Boué & Sullivan, 1996).  
Another possible protein interaction that may affect fertility is a protein complex recognized 
by the monoclonal antibody (mAb) TRA 54 (a high molecular mass albumin-containing 
protein complex) located in the acrosome of the spermatozoa that binds to the spermatozoa 
membrane during passage through the epididymal lumen. Experiments using in vitro 
fertilization have demonstrated that the addition of mAb TRA 54 to the fertilization medium 
significantly decreases the fertilization rate (Arrotéia et al., submitted for publication). 
 
The Epididymis: Embryology, Structure, Function and Its Role in Fertilization and Infertility 
 
61 
Similarly, the mAb 4A8 inhibited sperm penetration into the zona pellucida (Batova et al., 
1998). Although the mAb used in these studies have the potential to recognize specific 
molecules that are directly involved in the formation of functional spermatozoa and form 
the molecular basis of gamete interaction in mammals, the recognition epitopes of these 
mAb are still not fully characterized (Arrotéia et al., 2004). 
In addition to the causes indicated above, any disruption of the epididymal 
microenvironment through congenital abnormalities, intrinsic alterations in pH, protein 
composition and concentration, temperature, and other factors may lead to male post-
testicular infertility. The study of the fate of molecules involved in sperm maturation and 
sperm-oocyte recognition represents a key to the etiology of the idiopathic male infertility.  
9. Conclusion 
The mammalian epididymis promotes the modifications of the spermatozoa that are 
necessary for the spermatozoa to become fertilization-competent cells and to be stored 
safely in the male reproductive tract. Since epididymal dysfunctions are related to cases of 
idiopathic male infertility, a focus on the major epididymal proteins related to the 
spermatozoa is important. From a clinical point of view, an increase in our understanding 
of spermatozoa maturation should provide the specific markers that will assist in the 
development of new criteria for both the prediction of male infertility and for improving 
the treatment of male infertility. The implementation of research from the fields of 
genomics and proteomics has assisted in the characterization of some of the already 
identified proteins, as well as in the description of novel epididymal components. We 
anticipate that these great advances will be helpful in the elucidation of the sperm 
maturation process.  
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1. Introduction 
The endometrium is the mucous lining the uterine cavity comprised of a basal and a 
functional layer being the latter the one that sheds during menses and regenerates from the 
basal portion. The main cell populations within the functional stratus are epithelial and 
stromal cells accompanied by a variable number of leukocytes. Epithelial cells are found 
covering the luminal surface and tubular glands in basal and functional layers. Endometrial 
stroma contains reticular connective tissue comprised mainly by uterine fibroblasts that 
rapidly differentiate into decidualized cells when stimulated by an implanting blastocyst. 
The stromal compartment contains also abundant lymphocytes, granulocytes and 
macrophages during luteal phase of the menstrual cycle. These cells along with epithelial 
and stromal fibroblasts are source and target of paracrine signals of proliferation and 
differentiation.  Both components respond to ovarian steroid hormones and depend on each 
other for their structure, function and responsiveness to estrogen (E2) and progesterone (P4) 
(Tabibzadeh, 1998, review). During a normal menstrual cycles, human endometrium display 
unique features for an adult tissue:  undergoes cyclic construction and sloughing. The outer 
layer of the endometrium is loss while the basal layer containing the deep glandular 
epithelium gets preserved. Later on, stem cells located in this layer will originate the various 
endometrial cell types in response to the appropriate hormonal stimulus, regenerating the 
whole endometrium (Padykula, 1991).  
The endometrial cycle is driven by the ovarian steroidal hormones and can be divided in 
three phases: proliferative, secretory and menstrual. Proliferative phase lasts around 10 – 20 
days averaging 14 days. During this phase, glands grow and become winding due to the 
active mitosis of the epithelial cells driven by rising levels of serum E2 resulting in growing 
about 10 times the original thickness of the endometrium. Indeed, extensive DNA synthesis 
in epithelial cells and some in stromal cells is seen during this stage (Padykula, 1991). Once 
ovulation has taken place, the increase of circulating P4 triggers the transition to the 
secretory phase. During this phase, mitotic activity is inhibited and a complex secretory 
activity is induced beginning with glycogen vesicles polarization in glandular epithelial 
cells, locating subnuclearly which is further transported by microfilaments to the apical 
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cells initiate a complex secretory activity along with the establishment of an adequate 
environment for embryo implantation that take place only during a restricted time frame 
called ‘window of implantation’ (Psychoyos, 1986). During this period, morphological and 
molecular changes take place leading to a coordinated expression or repression of key 
molecules that ultimately enable the blastocyst to attach and invade the endometrial tissue. 
Such changes occur independently of the presence of a blastocyst; however the 
endometrium undergoes further biochemical and morphological changes induced by signals 
from the blastocyst and the following trophoblast invasion. With no embryo implantation, 
the endometrium undergoes a series of processes that end toward late secretory phase with 
sloughing and menses. When a successful embryo implantation takes place, luteolysis is 
prevented and the endometrium is not just maintained but differentiates to decidua and 
undergoes dramatic vascular changes at the implantation site. Therefore, gene expression in 
the human endometrium is likely to exhibit neat and distinct changes throughout the 
various stages of the menstrual cycle in accordance with the oscillations in estrogen and 
progesterone serum levels and their tissue receptor levels. Since these ovarian steroid 
hormones drive these processes eliciting an array of cellular and biochemical responses, 
mostly through genomic pathways (O'malley & Tsai, 1992), current thinking suggests that at 
the onset of receptivity, expression of some genes in given cell types of this tissue, is 
temporarily turned on or increased while some others are temporarily turned off or 
decreased (Tabibzadeh, 1998). Some of these changes are essential for establishing and 
maintaining pregnancy. Likewise, when implantation has occurred, another program of 
gene expression takes place in the endometrium, not only maintaining it, but also triggering 
further differentiation to decidua and facilitating and regulating trophoblast invasion and 
placenta development. 
2. Hormonal regulation of the endometrial cycle 
The endometrial cycle depends mainly on the steroidal ovarian hormones, acting though 
cytoplasmic receptors that on its inactive form are found forming a complex with chaperone 
proteins (O'malley & Tsai, 1992). Upon binding of the steroidal hormone with its cognate 
receptor, the chaperone-receptor complex dissociates and the new hormone-receptor complex 
translocates to the nucleus, binding to specific elements of DNA in target genes. As a result 
from this binding and the recruitment of co-activator and co-repressor proteins, the 
transcription rate to mRNA is modified. This process ultimately increases or decreases the 
mRNA transcribed from target genes, which is transported to the cytoplasm where is 
translated to peptides or proteins. Steroid hormones can also elicit rapid actions on target cells 
independently of its genomic regulatory effects. Such actions occur in a time scale from 
seconds to minutes and have been commonly denoted as non-genomic actions so they can be 
distinguished from their direct actions over nuclear gene expression (Gellersen et al., 2009). 
Cytoplasmic expression of receptors for estrogen (ER) and progesterone (PR) in the 
endometrium is mainly regulated by the own steroidal hormones. ER expression increases 
in response to rising levels of E2 during follicular phase of the menstrual cycle, peaking 
during proliferative phase (Bergeron et al., 1988; Lessey et al., 1988). After ovulation, ER 
decrease by P4 influence. The highest expression of PR occur at the time of ovulation driven 
by circulating E2 and are more abundant in glandular epithelium than stroma, disappearing 
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almost completely toward mid secretory phase by effect of the own P4 action. However, 
stromal cells exhibit moderately high PR expression during proliferative and secretory 
phases (Lessey et al., 1988). 
Although E2 and P4 have long been believed to be essential for endometrial development, it 
is now evident that these effects are further mediated and modulated by peptide hormones 
and peptide growth factors secreted by a variety of cell types within the uterine 
endometrium. Cooke et al. (Cooke et al., 1997) using mice model ER deficient showed that 
the proliferative effects of E2 on endometrial epithelium was mediated by stromal ER 
through a paracrine mechanism. The paracrine messenger appears to be insulin growth 
factor (IGF)-1 (Pierro et al., 2001). Several cytokines have bee also described as part of 
endometrial signaling networks such as interleukin (IL)-1, transforming growth factor 
(TGF)-β, vascular-endothelial growth factor (VEGF) and colony stimulating factor (CSF)-1 
(Salamonsen et al., 2000, review). 
The endometrial basal layer which is adjacent to the myometrium, undergoes few changes 
during the menstrual cycle; whereas the functional layer is very sensitive to E2 and P4. 
Estrogens induce proliferation and growth of the endometrial tissue during the proliferative 
phase while post-ovulatory rising levels of circulating P4 from the corpus luteum inhibits 
proliferation and induces the secretory phenotype. This latter hormone has been shown to 
be critical for endometrial receptivity (Baulieu, 1989) regulating the expression of several 
cytokines and growth factors, as well as morphological and molecular changes of the 
endometrial epithelial cells lining the uterine lumen (Giudice, 1999; Lessey, 2003). In 
addition induces the influx of distinct immune cells and subsequently triggers the 
differentiation of the fibroblast from the stromal compartment, a process termed 
decidualization (Irving & Giudice, 1999) characterized by vascular remodeling and 
extensive secretion of prolactin,  insulin-like growth factor binding protein (IGFBP)-1 and 
tissue factor (Tseng & Mazella, 1999; Christian et al., 2001). 
3. Endometrial receptivity and embryo implantation 
Experimental evidence that showed embryo and endometrial development synchronicity as 
a critical factor for successful pregnancy, has underpinned the importance of determinants 
for uterine receptivity to further improve implantation rates in couples under assisted 
reproductive technologies (ART) such as in vitro fertilization. The concept of endometrial 
receptivity is referred to the ability of the endometrium to allow embryo implantation, 
which is the process whereby the blastocyst gets fixed to the uterine epithelium and 
penetrates though it. During this process, complexand synchronized interactions between 
the endometrial and the embryonic cells take place and it has been divided in three 
consecutive stages. The first one is the apposition or the orientation of the blastocyst 
embryonic pole toward the uterine epithelium. During the second stage of implantation or 
adhesion phase, the embryonic throphoectodermal cells attach to the endometrial 
epithelium a firm adhesion is established. Thereafter the invasion phase occurs where 
blastocyst braches the endometrial epithelium and invades the entire endometrium reaching 
the inner third of the myometrium and remodeling the uterine vasculature. 
Endometrial receptivity is not permanent, if fact the uterus does not allow embryo 
implantation during most of the endometrial cycle. This particular feature was first 
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described in the rat and in the mice was described the existence of a ‘window of 
implantation’, which is controlled by the ovarian steroidal hormones: a narrow time frame 
in which the endometrium allows blastocyst implantation (Mclaren, 1956; Psychoyos, 1986). 
These studies showed that depending on the hormonal stimulus used, the endometrium can 
be driven to a neutral, receptive or non-receptive (or refractory) state to embryo 
implantation. Since such window was found to be present in other species (Psychoyos, 1973; 
Psychoyos & Casimiri, 1980) it was postulated this mechanism could be operating also in 
humans. In this regard, Hertig et al. (Hertig et al., 1956) proposed that human embryo 
implantation occurs 5-6 days after ovulation by examination of uterine samples in women 
attempting pregnancy before hysterectomy. They observed free floating embryos within the 
uterine lumen before days 19-20 of the menstrual cycle, whereas from day 21 blastocysts 
were found already implanted. These data have been corroborated in oocyte donation cycles 
in which fertilized oocytes are transferred to the uterus of recipient women during 
spontaneous and induced cycles with exogenous steroids (Navot et al., 1986; Navot et al., 
1991; Bergh & Navot, 1992), leading to the conclusion that the window of implantation in 
humans lasts for 4-6 days during the secretory phase coinciding with peak P4 plasmatic 
levels. It should be noted that unlike the situation in rodents, in humans could not operate 
the switch from the receptive to the non-receptive state. Insufficient release of human 
chorionic gonadotrophin to maternal systemic circulation may lead to failure to rescue the 
corpus luteum. As a consequence, serum P4 will decline leading to menstruation and 
conceptus loss. Embryo-uterine interactions that allow implantation can only occur when 
embryo development is synchronized with the endometrial receptivity period since lack of 
coordination between both events lead to implantation failure (Pope, 1988). 
4. Cellular and molecular changes associated to endometrial receptivity 
Cowel (Cowell, 1969) found that removing the uterine luminal epithelium in the rat, 
blastocyst implants regardless of any hormonal control suggesting that endometrial 
refractoriness lies on the endometrial epithelial cells. Recent data from IVF cycles (Huang et 
al., 2011) seems to support this fact in humans. In animal experiments and in vitro  
models for human implantation have revealed that the endometrial surface undergoes 
significant changes in its adhesive properties. In the pre-receptive state, the endometrium 
displays a structural and functionally polarized epithelium with differentiated basal-lateral 
and apical domains. During the endometrial receptive state, a reduction of the glycocalyx 
thickness and electrostatic charge has been seen in the surface of epithelial cells (Murphy & 
Rogers, 1981; Morris & Potter, 1984). In addition, the long and abundant epithelial microvilli 
retract, creating multiple flat areas in the surface (Schlafke & Enders, 1975; Murphy, 1993). 
This process could be related to the destabilization of the actin cytoskeletal network 
observed in these structures (Luxford & Murphy, 1989; Luxford & Murphy, 1992). On the 
other hand during the receptivity period it has been reported biosynthesis and expression of 
a different repertoire of surface proteins in the apical (Aplin, 1997; Lessey, 1998; Kirn-Safran 
& Carson, 1999) and basal-lateral domains (Rogers & Murphy, 1992; Albers et al., 1995; 
Murphy, 1995; Nikas, 1999). Considering the above mentioned evidence, the acquisition of 
adhesive properties by the epithelium may occur by disruption of the polarized apical-
basolateral phenotype (Denker, 1983; Denker, 1994). Although it is not well understood yet 
the relation between the epithelial polarity loss and the initiation of the adhesion stage of 
implantation, it is speculated that facilitates close apposition between the endometrial 
epithelium and the blastocyst. 
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Several molecules contributing to trophoectoderm adhesion to endometrial epithelium have 
been proposed. During the window of implantation, there is an up-regulation of 
oligosaccharides ligands for selectin in uterine epithelial cells while human trophoectoderm 
express L-selectin, establishing a ligand-receptor system since it promotes binding between 
both cellular types (Genbacev et al., 2003). Other glycoproteins, oligosaccharides chains and 
their receptors found in the endometrial luminal epithelium have been proposed as 
mediators of the blastocyst adhesion. Amongst them is heparan sulphate proteoglycan and 
heparan sulphate binding proteins (Carson et al., 1998; Fukuda & Nozawa, 1999), H type-1 
carbohydrate antigen (Fukuda & Nozawa, 1999). In addition the cell surface mucin with 
antiadhesive properties MUC1 has been involved in endometrial receptivity (Surveyor et al., 
1995). MUC1 is expressed at the luminal endometrial surface in the mid-secretory phase 
(Aplin et al., 1998; Aplin, 1999) and in vitro evidence has shown a local cleavage from 
endometrial epithelial cells at the site of blastocyst attachment (Meseguer et al., 2001). 
Amongst the most studied adhesion molecules is the integrin family, which act as 
extracellular matrix elements receptors mediating adhesion events and signal transduction 
between cells. Some of these glycoproteins display a cycle-dependent endometrial 
expression (Lessey et al., 1992; Tabibzadeh, 1992; Lessey et al., 1994). At least three integrins 
seem to be flanking the opening and closure of human window of implantation, which are 
expressed in glandular epithelium only between days 20-24 of the menstrual cycle (Lessey et 
al., 1992). These integrins are v3, v5 y 51 and recognize the RGD peptide motif. The 
best characterized integrin in endometrial receptivity is integrin v3 (Lessey & Castelbaum, 
2002, review). Intrauterine injection of an antibody against integrin v3 before implantation 
has taken place reduces the number of implantation sites y mice and rabbits (Illera et al., 
2000). However the precise role of integrins in the implantation process is not known yet.  
The transmembrane protein trophinin mediated the hemophilic adhesion between cells 
along with the cytoplasmic proteins tastin and bystin forming a complex with cytoskeletal 
elements (Suzuki et al., 1998). These three proteins have been detected in both trophoblast 
and decidual cells at the embryo-maternal interphase (Suzuki et al., 1999) suggesting a 
potential role in the implantation process.  
Temporal-spatial expression of Epidermal Growth Factor (EGF) family members and their 
receptors (ErbBs) in the embryo and endometrium during the peri-implantation period, 
suggest these growth factors may be mediating the interaction between them (Das et al., 
1997). Members of the EGF family expressed in mice uterus at the moment of implantation 
are the own EGF, the transforming growth factor (TGF)-α, heparin-binding EGF (HB-EGF), 
amphiregulin (Ar), β-cellulin (BTC), epiregulin (Er) and Herregulin (HRG) (Das et al., 1997). 
HB-EGF is expressed in humans during the window of implantation (Leach et al., 1999), and 
also stimulates the development of human embryos generated in IVF cycles (Martin et al., 
1998). The relative importance of the other members from the EGF-family in the 
implantation process has not been determined; however the expression of multiple ligands 
and receptors of such family may assure an adequate embryo development and further, a 
successful implantation. 
The expression of the leukemia inhibitory factor (LIF) cytokine increases in mice 
endometrial glands prior to implantation and this regulation is under maternal control 
(Bhatt et al., 1991). LIF is essential for embryo implantation in mice (Stewart et al., 1992). In 
human endometrium, LIF is expressed in glandular and luminal epithelium (Cullinan et al., 
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Several molecules contributing to trophoectoderm adhesion to endometrial epithelium have 
been proposed. During the window of implantation, there is an up-regulation of 
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express L-selectin, establishing a ligand-receptor system since it promotes binding between 
both cellular types (Genbacev et al., 2003). Other glycoproteins, oligosaccharides chains and 
their receptors found in the endometrial luminal epithelium have been proposed as 
mediators of the blastocyst adhesion. Amongst them is heparan sulphate proteoglycan and 
heparan sulphate binding proteins (Carson et al., 1998; Fukuda & Nozawa, 1999), H type-1 
carbohydrate antigen (Fukuda & Nozawa, 1999). In addition the cell surface mucin with 
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(Aplin et al., 1998; Aplin, 1999) and in vitro evidence has shown a local cleavage from 
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The expression of the leukemia inhibitory factor (LIF) cytokine increases in mice 
endometrial glands prior to implantation and this regulation is under maternal control 
(Bhatt et al., 1991). LIF is essential for embryo implantation in mice (Stewart et al., 1992). In 
human endometrium, LIF is expressed in glandular and luminal epithelium (Cullinan et al., 
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1996; Vogiagis et al., 1996). Although its biological functions are not well understood, the 
intrauterine injection of a monoclonal anti-leukemia inhibitory factor antibody inhibits 
blastocyst implantation in the rhesus monkey (Sengupta et al., 2006), suggesting a potential 
role in human embryo implantation. 
5. Morphological and molecular assessment of the endometrium 
Histomorphological changes of the endometrium throughout the menstrual cycle have 
been described over half a century ago by Noyes (Noyes et al., 1950) where particular 
features of the endometrial histology were correlated to specific days of the menstrual 
cycle allowing the dating of endometrial specimens. Since then, the Noyes criteria 
remained as the gold standard for endometrial evaluation. However the usefulness of 
endometrial dating for couples with infertility has been questioned since histological 
delay in endometrial maturation fails to discriminate between fertile and infertile couples 
(Coutifaris et al., 2004).In addition, other studies (Murray et al., 2004; Dietrich et al., 2007) 
have shown that endometrial histological features failed to reliably distinguish specific 
menstrual cycle days or narrow intervals of days, leading to the conclusion that 
histological dating has neither the accuracy nor the precision to be useful in clinical 
management. Another approach used to assess the endometrial status based on its 
morphological features was the use of scanning electron microscopy. Through the use of 
this technique, it was revealed the cyclic appearance of bulging structures from the  
apical pole of luminal epithelial cells during mid-secretory phase termed pinopodes 
(Nikas et al., 1995) or uterodomes (Murphy, 2000), becoming a candidate for endometrial 
receptivity marker. Although its involvement in embryo implantation has not  
been demonstrated, it is speculated that since they extend beyond cilia, they may be the 
first structure contacting the embryo. The molecular structure of pinopodes  
remains unknown so an adhesive role has yet to be determined. In vitro evidence has 
shown blastocyst attachment to endometrial epithelial cells displaying pinopode-like 
structures (Bentin-Ley et al., 1999). However, recent studies have failed to show a reliable 
pattern for the appearance of these structures in human endometrium (Acosta et al., 2000; 
Usadi et al., 2003; Quinn & Casper, 2009), rising controversy about its usefulness as an 
endometrial receptivity marker. In addition, morphological features seldom provides 
information regarding the molecular mechanisms taking place in the tissue throughout 
the menstrual cycle, which may allow a better understanding of the physiological status 
of the endometrium. 
Molecular changes associated with the acquisition of the endometrial receptive phenotype 
in natural spontaneous cycles and pathological and pharmacological models in which 
endometrial function is compromised rendering it refractory to embryo implantation, have 
been used in search for molecular markers for endometrial receptivity. A number of 
candidate molecules have been proposed including members of the integrin family (Lessey 
et al., 1995; Thomas et al., 2003), glycodelin (Chryssikopoulos et al., 1996), Hb-EGF (Yoo et 
al., 1997), LIF (Ledee-Bataille et al., 2004) and CSF-1 (Kauma et al., 1991). Although much 
effort has been put on identifying endometrial receptivity markers to date no single one has 
been proved to be sensitive and specific enough in predicting pregnancy (Hoozemans et al., 
2004; Strowitzki et al., 2006).  
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6. Wide genomic analysis of human endometrial function 
The search for reliable molecular predictors for embryo implantation in the endometrium 
has been mainly focused on the one-by-one approach. With the development of functional 
genomics analysis tools more than 10 years ago, was possible to identify endometrial gene 
expression profiles under different conditions of receptivity or pregnancy, using DNA 
microarrays technology (Horcajadas et al., 2007). Through this technique it is possible to 
measure the level of expression in a collection of cells for thousands of genes, allows 
discovering genes or pathways likely to be involved in a biological process, even when there 
is no hint regarding their identity (Schena et al., 1995). 
The global gene expression assessment has been used to characterize in a broader way the 
molecular bases of endometrial function in the women, determining the corresponding 
transcript profile to each endometrial phase during the menstrual cycle (Ponnampalam et 
al., 2004; Punyadeera et al., 2005; Talbi et al., 2006). In addition, this approach has been used 
to specifically investigate the particular gene signatures that allow acquisition of 
endometrial receptivity to embryo implantation during spontaneous cycles (Carson et al., 
2002; Kao et al., 2002; Borthwick et al., 2003; Riesewijk et al., 2003; Mirkin et al., 2005). Since 
acquisition of endometrial receptivity is mainly driven by P4 (Conneely et al., 2002; Spencer 
& Bazer, 2002), two strategies based on this feature have been used for gene discovery 
during spontaneous menstrual cycles: comparing gene expression profiles of the 
endometrium under peak P4 circulating levels (days 19-23, window of implantation) and  
under absent (days 8-11, proliferative phase) (Kao et al., 2002; Borthwick et al., 2003) or low 
(days 15-17, early secretory phase) (Carson et al., 2002; Riesewijk et al., 2003; Mirkin et al., 
2005; Haouzi et al., 2009; Haouzi et al., 2009) serum P4. Several other strategies have been 
used to determine the repertoire of genes related to endometrial receptivity using animal, in 
vitro, pharmacological and pathological models which are discussed elsewhere in a 
comprehensive review (Horcajadas et al., 2007).  
We studied the endometrial gene expression signatures from women with implantation 
failure using the oocyte donation model (Tapia et al., 2008). In an oocyte donation cycle, the 
endometrium from the embryo recipient woman is prepared with exogenous hormones in 
order to synchronize conceptus and endometrial development (De Ziegler et al., 1994; 
Younis et al., 1996), providing a better uterine environment than controlled ovarian 
hyperstimulation for embryo implantation to take place. In this sense, oocyte donation 
allows a unique opportunity for investigating endometrial factors involved in human 
blastocyst nidation (Damario et al., 2001). In our study, three groups of subjects were 
recruited: women who had previously participated as recipients in oocyte donation cycles 
and repeatedly exhibited implantation failure (Group A, study group) or had at least one 
successful cycle (Group B, control group); and spontaneously fertile women (Group C, 
normal fertility group). All were treated with exogenous E2 and P4 to induce an oocyte 
donation mock cycle as recipients. An endometrial biopsy was taken during the window of 
implantation (i.e. the seventh day of P4 administration) and RNA from each sample was 
analyzed by cDNA microarrays to identify differentially expressed genes between groups. 
We found sixty three transcripts differentially expressed ( 2-fold) between Groups A and B, 
of which 16 were subjected to real time RT-PCR validation. Eleven of these were 
significantly decreased in Group A with regard to Groups B and C. In addition to those 
genes whose transcript levels was confirmed by real time RT-PCR, we integrated and cross-
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validated a less stringent and larger data set that was constructed with other data sets about 
endometrial gene expression profiles publicly available obtained by other groups. Using this 
strategy we could increase the confidence  in gene discovery for endometrial receptivity for 
many more genes than is tractable with classical validation (Kemmeren et al., 2002; Rhodes 
et al., 2002). For that we constructed a database with the reported transcript level changes 
from non-receptive to receptive endometrial phenotype at the time the study was made  
(Carson et al., 2002; Kao et al., 2002; Borthwick et al., 2003; Riesewijk et al., 2003; Mirkin et 
al., 2005) and 14 coincident genes were identified. Interestingly, five genes out of the 14 
coincident genes were also dysregulated in eutopic endometrium from women with 
endometriosis. These genes are: Complement component 4 binding protein, alpha (C4BPA), 
Glycodelin (PAEP, glycodelin), RAP1 GTPase activating protein 1 (RAP1GA1), Endothelin 
receptor type B (EDNRB) and Ankyrin 3, node of Ranvier [ankyrin G] (ANK3). Interestingly, 
a detailed analysis of the functions associated to the 14 genes whose transcripts were 
significantly decreased in endometria without manifest abnormalities showed that 4 of them 
were related to the regulation of the immune function. This suggest that implantation failure 
in women from group A could be related to molecules from the immune system, whose 
function in the endometrium is to destroy infectious agents and foreign bodies, display an 
exaggerated response in presence of an implanting embryo (Damario et al., 2001). 
Other strategy we have used is the integration and cross-validation of all available data 
sets about endometrial gene expression profiles produced by different groups (Tapia et 
al., 2011)to determine the up- and down-regulated genes that together orchestrate the 
acquisition of the receptive phenotype of the endometrium for embryo implantation. We 
considered studies that had used microarrays technology to determine the gene 
expression profiles that identify different phases of the endometrial cycle in spontaneous 
menstrual cycles (Ponnampalam et al., 2004; Punyadeera et al., 2005; Talbi et al., 2006). In 
addition we included those that also had used this technology during the acquisition of 
endometrial receptivity to embryo implantation (Carson et al., 2002; Kao et al., 2002; 
Borthwick et al., 2003; Riesewijk et al., 2003; Mirkin et al., 2005). In two studies the 
proliferative phase was compared with the ‘window of implantation’ time (Kao et al., 
2002; Borthwick et al., 2003) and in another three studies gene expression differences 
between the early secretory phase (2–4 days after the luteinizing hormone (LH) surge) 
and the receptive phase (7–9 days after the LH surge) were included (Carson et al., 2002; 
Riesewijk et al., 2003; Mirkin et al., 2005). The intersection of lists with regulated genes 
reported in these studies showed a rather small number of coincident transcripts. We 
identified 40 up-regulated genes in at least four of seven reports and 21 down-regulated 
genes present in at least three of six studies considered. We denominated this set of 
coincident genes the consensus endometrial receptivity transcript list (CERTL) (Tapia et 
al., 2011). The most consistent up-regulated genes were C4BPA, SPP1, APOD, CD55, CFD, 
CLDN4, DKK1, ID4, IL15 and MAP3K5; whereas OLFM1, CCNB1, CRABP2, EDN3, 
FGFR1, MSX1 and MSX2 were the most consistently down-regulated in endometrial tissue 
for the acquisition of receptivity to embryo implantation.  
7. Future perspectives in the clinic 
One of the main objectives in reproductive medicine especially in the context of IVF has 
been the search for markers predictive of endometrial receptivity. Even though great efforts 
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have been made to predict embryo implantation for improving live-births, no successful 
endometrial evaluation has been clinically validated so far. Moreover, attempts to improve 
IVF pregnancy rates treating infertile patients with factors thought to be essential for 
implantation process have turned out to achieve the opposite (Brinsden et al., 2009). 
Nevertheless gene expression profiling of endometrial biopsies during the window of 
implantation is one of the most promising strategies for gene discovery related to uterine 
receptivity. In fact, a genomic tool composed of a customized microarray and a 
bioinformatic predictor for endometrial dating and detection of endometrial pathologies has 
been recently described (Diaz-Gimeno et al., 2011). This tool denominated Endometrial 
Receptivity Array (ERA) assesses the transcriptomic signature defined by 134 genes related 
to endometrial receptivity, becoming specific for uterine function evaluation. Other study 
recently published (Tseng et al., 2010), analyzing gene expression profiles of endometrial 
biopsies and using hierarchical cluster analysis described a 123-gene model for endometrial 
function with transcripts up-regulated at mid-secretory phase, moderately expressed at late-
secretary phase, and down-regulated at late-secretory phase. 
The role of the proteins encoded by the transcripts contained in CERTL, ERA and the ‘123-
gene model’  in the acquisition of endometrial receptivity and embryo implantation; as well as 
the prognostic value for each transcript profiling as a marker for endometrial receptivity has 
yet to be determined. Although is highly possible that a combination of these three approaches 
may allow defining the actual transcriptomic signature of human endometrial receptivity. 
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genes present in at least three of six studies considered. We denominated this set of 
coincident genes the consensus endometrial receptivity transcript list (CERTL) (Tapia et 
al., 2011). The most consistent up-regulated genes were C4BPA, SPP1, APOD, CD55, CFD, 
CLDN4, DKK1, ID4, IL15 and MAP3K5; whereas OLFM1, CCNB1, CRABP2, EDN3, 
FGFR1, MSX1 and MSX2 were the most consistently down-regulated in endometrial tissue 
for the acquisition of receptivity to embryo implantation.  
7. Future perspectives in the clinic 
One of the main objectives in reproductive medicine especially in the context of IVF has 
been the search for markers predictive of endometrial receptivity. Even though great efforts 
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have been made to predict embryo implantation for improving live-births, no successful 
endometrial evaluation has been clinically validated so far. Moreover, attempts to improve 
IVF pregnancy rates treating infertile patients with factors thought to be essential for 
implantation process have turned out to achieve the opposite (Brinsden et al., 2009). 
Nevertheless gene expression profiling of endometrial biopsies during the window of 
implantation is one of the most promising strategies for gene discovery related to uterine 
receptivity. In fact, a genomic tool composed of a customized microarray and a 
bioinformatic predictor for endometrial dating and detection of endometrial pathologies has 
been recently described (Diaz-Gimeno et al., 2011). This tool denominated Endometrial 
Receptivity Array (ERA) assesses the transcriptomic signature defined by 134 genes related 
to endometrial receptivity, becoming specific for uterine function evaluation. Other study 
recently published (Tseng et al., 2010), analyzing gene expression profiles of endometrial 
biopsies and using hierarchical cluster analysis described a 123-gene model for endometrial 
function with transcripts up-regulated at mid-secretory phase, moderately expressed at late-
secretary phase, and down-regulated at late-secretory phase. 
The role of the proteins encoded by the transcripts contained in CERTL, ERA and the ‘123-
gene model’  in the acquisition of endometrial receptivity and embryo implantation; as well as 
the prognostic value for each transcript profiling as a marker for endometrial receptivity has 
yet to be determined. Although is highly possible that a combination of these three approaches 
may allow defining the actual transcriptomic signature of human endometrial receptivity. 
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1. Introduction 
The success of pregnancy depends on a receptive endometrium, a normal blastocyst, a 
synchronized cross-talk at the maternal–fetal interface at the time of implantation, and 
finally a successful placentation and remodeling of uterine vasculature. In routine, less than 
5% of oocytes collected in in vitro fertilization (IVF) cycles and only 20 to 25% of embryos 
transferred lead to a birth. Implantation and placentation processes remain the black box of 
fertility, involving following steps: fertilization, endometrial receptivity, embryo 
implantation (apposition-adhesion-invasion), trophoblastic differentiation and invasion 
(Cartwright et al., 2010).  
At the time of fertilization, a cascade of cytokines mediates the oocyte-sperm dialogue long 
time before embryo implantation in the endometrium. At the oocyte side, genomic and 
proteomic profiles of good follicle are under investigation. Markers of oocytes with high 
subsequent embryo implantation potential are one of the main goals of the actual research. 
For example, granulocyte colony stimulating factor (G-CSF or CSF-3) in individual follicular 
fluids (FF) appears to correlate with the birth potential of the corresponding embryo in two 
opposite models of ovarian monitoring, standard ovarian hyperstimulation and modified 
natural IVF/ICSI cycles (Ledee et al., 2008b; Ledee et al., 2011a). To achieve the fertilization 
step, a good quality oocyte must meet a normal sperm with low DNA damages, leading to 
the development of a functionally normal blastocyst able to dialogue with maternal 
endometrium. Sperm DNA damages include fragmentation, trouble of condensation and 
epigenetic modification that could impair implantation process and methylation of 
imprinted genes (Boitrelle et al., 2011; Tavalaee et al., 2009). 
Endometrial receptivity is established during a limited period of time called the implantation 
window. During this 4-days window (d20-d24), endometrium is highly receptive to the 
different signals and ligands produced by embryo throughout apposition, adhesion and 
invasion steps of implantation. The complex signaling networks that regulate this tightly 
coordinated maternal-fetal crosstalk are clearer as studies on endometrial receptivity and 
early pregnancy are performed. Many target molecules have been identified in the receptive 
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endometrium such as specific cytokines equilibrium, growth factors and angiogenic factors 
but also some specific immunological target cells. Despite research and technique 
progresses, despite a lot of publications defining profiles – normal or pathological- at the 
genomic and proteomic level, the molecular fingerprint of the receptive endometrium 
remains unknown (Berlanga et al., 2011; Rashid et al., 2011; Singh et al., 2011).  
The progression of implantation and then pregnancy requires immunological tolerance 
which allows conceptus survival. It has been proposed that uterine natural killer cells (uNK) 
could exert, directly or indirectly, either positive or negative control over these early steps 
(Dosiou and Giudice, 2005). These cells secrete an array of cytokines important for adequate 
local immune regulation, angiogenesis, placental development, and establishment of 
pregnancy. Successful subsequent placentation and remodeling of the uterine vasculature is 
a fundamental step for a healthy pregnancy that requires also a highly orchestrated 
reciprocal signaling process. Deficiencies in this process are implicated in a number of 
dangerous pregnancy complications with excess (percreta/accreta placentation) or defective 
implantation (preeclampsia, intra uterine growth restriction). Implantation failure, recurrent 
miscarriage and preeclampsia have several recognized causes in common, but in most cases, 
the precise etiology remains obscure. 
The most limiting and difficult issue to evaluate during the implantation process is the 
dialogue at the materno-fetal interface. Embryo is able to cross-talk with the endometrium 
through different molecules, cytokines and hormones. It is able to actively participate to its 
own implantation and to influence endometrial gene expression (Kashiwagi et al., 2007). 
Inversely, endometrium is competent to differently answer to the implanting embryo, to 
favor or reject implantation (Bauersachs et al., 2009). Moreover, the cytokine network acting 
in the female reproductive tract around implantation integrates environmental information 
to program the embryo and fine-tune the maternal immune response and endometrial 
remodeling to determine implantation success (Robertson et al., 2011). All these interactions 
are not accessible to the researcher for obvious ethical reasons that let understand why 
implantation remains the black box of reproduction, even in 2012.  
Among the factors produced by the embryo, its specific signal chorionic gonadotropin 
hormone (hCG) and its hyperglycosylated form H-hCG are another example of target 
molecules at this crossroads of immune tolerance, angiogenesis, and invasive process at the 
maternal-fetal interface.  
This chapter will overview the recent literature and personal data concerning impact of 
gametes, endometrium and embryo during implantation process.  
2. The oocyte 
Maternal factors play a predominant role during early embryo development. Oocyte supports 
indeed by itself the early cleavage of the zygote until the 4-8 cells stage. Unfortunately, oocyte 
morphology is poorly discriminative and allow mainly a negative selection (Balaban and 
Urman, 2006; Rienzi et al.) and oocyte quality remains one of the main limiting factors of 
success of Assisted Reproductive Technology (ART) in human. This is due not only to the 
prime impact during early embryo growth but also to the fragility of oocytes along the life 
time. Less than 5% of oocytes collected after ovarian hyperstimulation in IVF program lead to 
birth. The selection of oocytes able to give rise to implanting embryo is crucial to avoid such 
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wastage. Actual research focuses on the oocyte physiology and aim to evidence functional 
markers of good quality oocyte and competence to complete morphological observation of 
embryos which are insufficient to highly predict subsequent successful implantation.  
Throughout the process of folliculogenesis and ovulation, the oocyte maturation from 
resting primary oocyte to secondary oocyte includes a complex sequence of nuclear and 
cytoplasmic events that prepare oocyte to fertilization and initiation of embryo 
development. During all their maturation, oocytes grow and develop in a highly 
coordinated and mutually dependent manner with the cumulus cells surrounding them. 
The formation of meiotic spindles during the two phases of the meiosis is essential for 
accurate chromosome segregation and for the highly asymmetric cell divisions necessary for 
the formation of small polar bodies and a large polarized oocyte (Schatten and Sun, 2011). 
The first polar body is extruded from the oocyte just before fertilization while the second 
one is expelled at the end of the second meiotic division which occurs after the fertilization. 
Chromosomal segregation errors occurs in approximately 15-20% of oocytes (Pellestor et al., 
2005) and 5% of all pregnancies are aneuploidy (Hassold and Hunt, 2001).  
During mostly IVF procedures, high doses of gonadotropins are administered to 
hyperstimulate the development of multiple oocytes to obtain a maximum of matures eggs 
in a single cycle. The aim of such an ovarian stimulation is the production of more than one 
embryo allowing the embryologist to select the best to transfer (while the others are 
cryopreserved for a possible later transfer). The assumption that ovarian stimulation could 
impair oogenesis, embryo quality and endometrial receptivity becomes more and more 
evident. The underlying mechanisms of these detrimental effects are still poorly understood, 
and further knowledge is needed in order to increase the safety of ovarian stimulation and 
to reduce potential effects on embryo development and implantation (Santos et al., 2010). A 
better understanding of oocyte oocyte-cumulus physiology/interactions, as well as, the 
improvement of oocyte selection based on its competence of giving rise to a healthy embryo, 
will ultimately increase the safety of ovarian stimulation and then pregnancy rates in IVF.  
2.1 Oocyte quality and physiology 
A “high quality” oocyte is an oocyte that is able of maturing, being fertilized, realizing a 
good implantation and giving rise to a healthy baby.  
The poor quality of an oocyte seems to be characterized by a range of morphological 
defects or abnormalities, although there is still no precise quantification of the relative 
importance of each different anomaly. There is still not a comprehensive morphological 
oocyte grading scheme able to enough optimize the selection of normal oocytes (Lasiene 
et al., 2009; Patrizio et al., 2007; Rienzi et al., 2011) for fertilization in IVF or for oocyte 
cryopreservation. Criteria usually used to determine the grade of quality of oocytes 
morphology include the evaluation of the structure of oocyte: cumulus complex, oocyte 
cytoplasm, polar body, perivitelline space, zona pellucida and meiotic spindle (Lasiene et 
al., 2009). An oocyte with a large potential to give a competent embryo is describe with 
different characteristics:  
- The oocyte is surrounded by a compact cumulus (at least five layers of cells)(Mayes and 
Sirard, 2001; Nagano et al., 2006; Warriach and Chohan, 2004). 
 
Embryology – Updates and Highlights on Classic Topics 
 
86
endometrium such as specific cytokines equilibrium, growth factors and angiogenic factors 
but also some specific immunological target cells. Despite research and technique 
progresses, despite a lot of publications defining profiles – normal or pathological- at the 
genomic and proteomic level, the molecular fingerprint of the receptive endometrium 
remains unknown (Berlanga et al., 2011; Rashid et al., 2011; Singh et al., 2011).  
The progression of implantation and then pregnancy requires immunological tolerance 
which allows conceptus survival. It has been proposed that uterine natural killer cells (uNK) 
could exert, directly or indirectly, either positive or negative control over these early steps 
(Dosiou and Giudice, 2005). These cells secrete an array of cytokines important for adequate 
local immune regulation, angiogenesis, placental development, and establishment of 
pregnancy. Successful subsequent placentation and remodeling of the uterine vasculature is 
a fundamental step for a healthy pregnancy that requires also a highly orchestrated 
reciprocal signaling process. Deficiencies in this process are implicated in a number of 
dangerous pregnancy complications with excess (percreta/accreta placentation) or defective 
implantation (preeclampsia, intra uterine growth restriction). Implantation failure, recurrent 
miscarriage and preeclampsia have several recognized causes in common, but in most cases, 
the precise etiology remains obscure. 
The most limiting and difficult issue to evaluate during the implantation process is the 
dialogue at the materno-fetal interface. Embryo is able to cross-talk with the endometrium 
through different molecules, cytokines and hormones. It is able to actively participate to its 
own implantation and to influence endometrial gene expression (Kashiwagi et al., 2007). 
Inversely, endometrium is competent to differently answer to the implanting embryo, to 
favor or reject implantation (Bauersachs et al., 2009). Moreover, the cytokine network acting 
in the female reproductive tract around implantation integrates environmental information 
to program the embryo and fine-tune the maternal immune response and endometrial 
remodeling to determine implantation success (Robertson et al., 2011). All these interactions 
are not accessible to the researcher for obvious ethical reasons that let understand why 
implantation remains the black box of reproduction, even in 2012.  
Among the factors produced by the embryo, its specific signal chorionic gonadotropin 
hormone (hCG) and its hyperglycosylated form H-hCG are another example of target 
molecules at this crossroads of immune tolerance, angiogenesis, and invasive process at the 
maternal-fetal interface.  
This chapter will overview the recent literature and personal data concerning impact of 
gametes, endometrium and embryo during implantation process.  
2. The oocyte 
Maternal factors play a predominant role during early embryo development. Oocyte supports 
indeed by itself the early cleavage of the zygote until the 4-8 cells stage. Unfortunately, oocyte 
morphology is poorly discriminative and allow mainly a negative selection (Balaban and 
Urman, 2006; Rienzi et al.) and oocyte quality remains one of the main limiting factors of 
success of Assisted Reproductive Technology (ART) in human. This is due not only to the 
prime impact during early embryo growth but also to the fragility of oocytes along the life 
time. Less than 5% of oocytes collected after ovarian hyperstimulation in IVF program lead to 
birth. The selection of oocytes able to give rise to implanting embryo is crucial to avoid such 
 
The Actors of Human Implantation: Gametes, Embryo, Endometrium 
 
87 
wastage. Actual research focuses on the oocyte physiology and aim to evidence functional 
markers of good quality oocyte and competence to complete morphological observation of 
embryos which are insufficient to highly predict subsequent successful implantation.  
Throughout the process of folliculogenesis and ovulation, the oocyte maturation from 
resting primary oocyte to secondary oocyte includes a complex sequence of nuclear and 
cytoplasmic events that prepare oocyte to fertilization and initiation of embryo 
development. During all their maturation, oocytes grow and develop in a highly 
coordinated and mutually dependent manner with the cumulus cells surrounding them. 
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- Ooplasm is almost transparent and homogeneous or a dark ring is seen around the 
cytoplasm. It is not granular (Balaban et al., 2008).  
- There is none extracytoplasmic abnormalities (like dark zona pellucida, granular, 
vacuoles or cytoplasmic fragments) (Balaban et al., 2008; Rienzi et al., 2008). 
- The perivitelline space is not too large and without grains (Hassan-Ali et al., 1998; Xia, 
1997). 
-  It is estimated that oocytes observed with a polarization light microscope that shown 
birefringent spindle had higher developmental potential after fertilization than oocytes 
without birefringent spindle (Fang et al., 2007; Moon et al., 2003; Rienzi et al., 2004; Shen 
et al., 2006; Wang et al., 2001).  
The morphology of the first polar body expulsed can also be studied to determine oocyte 
quality. Some morphological criteria such as the shape, the size, the surface and the integrity 
of cytoplasm of the polar body can be used to determine oocyte quality (Fancsovits et al., 
2006; Navarro et al., 2009; Rienzi et al., 2008).  
The contribution of each of these characteristics for the selection of a good quality embryo 
are largely discuss in the literature but they are still unclear (Lasiene et al., 2009; Rienzi et al., 
2011; Setti et al., 2011). The selection of good quality oocyte is primordial in order to help 
during the management of ART but also to cryopreserve them to realize a bank of oocytes 
able to support thawing. Recently pregnancies were obtained with oocyte that has been 
cryopreserved or vitrified (Cobo and Diaz, 2011). Cryopreservation of oocytes is a desired 
tool for the possibility of extending the reproductive capability of young women with 
malignant diseases in cases where the treatment may compromise the ovarian reserve 
(Herrero et al., 2011; Saragusty and Arav, 2011). 
Chromosomally abnormal oocyte is morphologically impossible to distinguish with 
traditional observation by the biologist, while it is an important cause of development or 
implantation failure of human embryo produced in vitro. Beside the necessity to optimize 
oocytes observation in order to fertilize them, there is a great need to better characterize a 
good quality oocytes with the purpose of cryopreserve them during fertility saving and egg 
donation programmes.  
The transcriptomic profiling of human oocytes has been studied in normal oocytes and in 
aneuploidy oocyte to find a non-invasive biomarker of aneuploidy (Fragouli et al., 2010). 
Furthermore, the dialogue between the oocyte and its cumulus could be a key factor for the 
development of a competent embryo (Royere et al., 2009). Individual oocytes and their 
associated cumulus cells has been analysed by microarray technologies to provide potential 
viability markers related to oocyte competence. Increasing number of papers have shown 
correlation between cumulus gene expression and oocyte maturation, fertilization rate and 
pregnancy outcome. (Assou et al., 2010; Feuerstein et al., 2007; Hamel et al., 2008; van 
Montfoort et al., 2008; Yerushalmi et al., 2011). The study of Assou et al.(Assou et al., 2010), 
have demonstrated a good correlation between the expression profile of 45 genes from 
cumulus cells analysed by microarray and pregnancy outcome without relationship to the 
morphological grade of the embryo. The transcription of genes of cumulus cells has also 
been studied by Feuerstein et al., the genes were chosen because their expression was 
induced by the LH peak. Expression levels of all genes investigated, except one, were 
increased after resumption of meiosis (Feuerstein et al., 2007). 
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Furthermore, the transcriptome of the first polar body (extruded from the oocyte before 
fertilization) was analysis with the assumption that the polar body transcriptome is 
representative of that of the oocyte. The results show that the transcriptome of the human 
polar body reflect the one of the oocyte. This study could lead at the first molecular 
diagnostic for gene expression in oocyte ready for the fertilization, using mRNA detection 
and quantification (Reich et al., 2011).  
Currently, the selection of the embryo to transfer is based on a morphological base such as 
kinetic of growth, number/size/form of blastomeres, early cleavage, fragmentation rate, 
aspect of ooplasm, aspect of pronuclei, and absence of multinuclear blastomeres. These 
usual morphological criteria are judged not sufficient for selecting the ideal embryo able to 
develop until the blastocyst stage and to transfer and to cryopreserve (Guerif et al., 2007; 
Guerif et al., 2009). Identification of non-invasive test of oocyte competence would 
undoubtedly improve the efficiency of assisted reproductive technology in selecting 
competent embryos.  
The fluid that is in the follicular antrum, accumulated from the early stage of follicle 
development is rich of components and ease of access for studies that may contribute to a 
better understanding of the mechanisms underlying follicular development, oocyte quality 
or even ovarian hyperstimulation (Fahiminiya et al., 2011; Jarkovska et al., 2011). The aim of 
the study realize by Jarkovska et al. (Jarkovska et al., 2011) was to identify candidate 
proteins in follicular fluid (FF) which may help to identify patient at risk of ovarian 
hyperstimulation syndrome of women undergoing in vitro fertilization. Three proteins were 
found as potential markers among which kininogen-1 was highlighted by computer 
modeling as a potential key factor for mediated inflammation and angiogenesis. In the study 
realize Fahiminiya et al. (Fahiminiya et al., 2011), FF were collected from ovaries at three 
different stages of follicle development (early dominant, late dominant and preovulatory) 
and were analyzed by 2D-PAGE, 1D-Page and mass spectrometry to observe the proteomic 
expression in crude, depleted and enriched FF. They demonstrate that the enrichment 
method could be used to visualize and further identify the low-abundance proteins in FF, 
which could reflect the physiological status of the follicle.  
A new marker measurable in FF has been proposed to select embryo with a high potential of 
implantation: the granular colony stimulating factor (G-CSF) (Ledee et al., 2008b). 
2.2 Biomarker of the competence of the oocyte: G-CSF in follicular fluid 
Research performed by Lédée team has extensively explored the follicular Granulocyte –
Colony Stimulating Factor (G-CSF or CSF-3) properties as non-invasive immune biomarker 
of the oocyte competence able to predict subsequent birth (Ledee et al., 2008b). In a first 
study, FF were collected individually and the traceability of each fluid was ensured until 
birth or failure of the attempt was known. Twenty seven cytokines and chemokines were 
simultaneously measured in each FF collected from 132 individual follicles of oocyte 
subsequently fertilized and transferred after conventional ovarian hyperstimulation. The 
conclusion of this study was that the level of G-CSF in individual FF samples correlates with 
the implantation potential of the corresponding embryo. These data were reproduced in a 
cohort of 200 embryos while detailing the adequacy of distinct methods for measuring 
follicular fluid G-CSF (Ledee et al., 2010). 
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- Ooplasm is almost transparent and homogeneous or a dark ring is seen around the 
cytoplasm. It is not granular (Balaban et al., 2008).  
- There is none extracytoplasmic abnormalities (like dark zona pellucida, granular, 
vacuoles or cytoplasmic fragments) (Balaban et al., 2008; Rienzi et al., 2008). 
- The perivitelline space is not too large and without grains (Hassan-Ali et al., 1998; Xia, 
1997). 
-  It is estimated that oocytes observed with a polarization light microscope that shown 
birefringent spindle had higher developmental potential after fertilization than oocytes 
without birefringent spindle (Fang et al., 2007; Moon et al., 2003; Rienzi et al., 2004; Shen 
et al., 2006; Wang et al., 2001).  
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The transcriptomic profiling of human oocytes has been studied in normal oocytes and in 
aneuploidy oocyte to find a non-invasive biomarker of aneuploidy (Fragouli et al., 2010). 
Furthermore, the dialogue between the oocyte and its cumulus could be a key factor for the 
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correlation between cumulus gene expression and oocyte maturation, fertilization rate and 
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Montfoort et al., 2008; Yerushalmi et al., 2011). The study of Assou et al.(Assou et al., 2010), 
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induced by the LH peak. Expression levels of all genes investigated, except one, were 
increased after resumption of meiosis (Feuerstein et al., 2007). 
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Furthermore, the transcriptome of the first polar body (extruded from the oocyte before 
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and quantification (Reich et al., 2011).  
Currently, the selection of the embryo to transfer is based on a morphological base such as 
kinetic of growth, number/size/form of blastomeres, early cleavage, fragmentation rate, 
aspect of ooplasm, aspect of pronuclei, and absence of multinuclear blastomeres. These 
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found as potential markers among which kininogen-1 was highlighted by computer 
modeling as a potential key factor for mediated inflammation and angiogenesis. In the study 
realize Fahiminiya et al. (Fahiminiya et al., 2011), FF were collected from ovaries at three 
different stages of follicle development (early dominant, late dominant and preovulatory) 
and were analyzed by 2D-PAGE, 1D-Page and mass spectrometry to observe the proteomic 
expression in crude, depleted and enriched FF. They demonstrate that the enrichment 
method could be used to visualize and further identify the low-abundance proteins in FF, 
which could reflect the physiological status of the follicle.  
A new marker measurable in FF has been proposed to select embryo with a high potential of 
implantation: the granular colony stimulating factor (G-CSF) (Ledee et al., 2008b). 
2.2 Biomarker of the competence of the oocyte: G-CSF in follicular fluid 
Research performed by Lédée team has extensively explored the follicular Granulocyte –
Colony Stimulating Factor (G-CSF or CSF-3) properties as non-invasive immune biomarker 
of the oocyte competence able to predict subsequent birth (Ledee et al., 2008b). In a first 
study, FF were collected individually and the traceability of each fluid was ensured until 
birth or failure of the attempt was known. Twenty seven cytokines and chemokines were 
simultaneously measured in each FF collected from 132 individual follicles of oocyte 
subsequently fertilized and transferred after conventional ovarian hyperstimulation. The 
conclusion of this study was that the level of G-CSF in individual FF samples correlates with 
the implantation potential of the corresponding embryo. These data were reproduced in a 
cohort of 200 embryos while detailing the adequacy of distinct methods for measuring 
follicular fluid G-CSF (Ledee et al., 2010). 
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A third study was subsequently conducted including 83 patients undergoing a modified 
natural IVF/ICSI cycle to measured 26 soluble factors in the FF of these patients. The aim of 
this study was to provide an experimental model where the traceability was complete: only 
one oocyte was recovered and therefore only one embryo was transferred. Each of the 26 
factors was evaluated as a potential biomarker of subsequent birth and G-CSF was found to 
be the best predictor of birth in this study. The combination of FF G-CSF and morphological 
embryo scoring on day 2 has been suggested as a possible prognostic value before starting 
the embryo transfer (Ledee et al., 2011a). Through these 3 studies, selection of follicular 
fluids over thousand fluids was performed to select the ones corresponding to an embryo 
successfully transferred with the traceability of each sample until birth. Each fluid was 
analysed through multiplex bead based technology. In all experiments, FF G-CSF appears as 
an excellent non-invasive biomarker of oocyte competence in regard to its significant strong 
power of discrimination, independently so adding value, to our daily embryo morphology 
based-selection. 
We postulate that G-CSF factor in individual FF appears to correlate with the birth potential 
of the corresponding embryo in two opposite models of ovarian monitoring: standard 
ovarian hyperstimulation and modified natural IVF/ICSI cycles. Prospective randomized 
studies are needed to confirm the hypothesis and evaluation of adding value when 
correlated with the embryologist morphological choice is currently studied by our team.  
The presence of G-CSF in the female genital tract and its possible role in reproduction have 
already been studied in the past. G-CSF has been shown to be secreted by granulosa cells at 
ovulation (Salmassi et al., 2004), then during the luteal phase within the endometrium and 
finally during gestation in the placenta (Duan, 1990). FF G-CSF may promote local 
maternofetal tolerance (Rutella et al., 2005) or influence the oocyte's own mRNA levels or its 
potential for self-repair (Yannaki et al., 2005). It might also interact with environmental cells 
to produce cytokines and growth factors which are necessary for the embryo's development 
and implantation.  
It has been suggested key interactions within the follicle involving immune cells such as 
dendritic cells and regulatory T (Treg) cells)(Ledee et al., 2011b). Local maternal-foetal 
immunotolerance could potentially be promoted by G-CSF: almost all the miscarriages 
observed in our cohort were found in the group with a low follicular fluid G-CSF level and a 
recent study reported that G-CSF administration significantly increases live-birth rates in 
patients with unexplained recurrent miscarriages (Scarpellini and Sbracia, 2009).  
The measure of the FF G-CSF is a non-invasive method for the assessment of the potentiality of 
the embryo to implant, and is cover by a patent. This method could be quickly implemented 
with a short time response compatible with the selection of the embryo before transfer. FF G-
CSF may also help to promote the single embryo policy by helping to distinguish even before 
the fertilization of the oocyte with a good or a bad potential of implantation. It may also be 
helpful to evaluate individually the oocyte (for women with a low ovarian reserve), to identify 
the best protocol of ovarian stimulation to apply (specific indication of minimal stimulation) 
and to choose in a more powerful way the embryo to cryopreserve.  
2.3 Oocyte influence on embryo development  
First days of embryo development are characterized by a sequence of cells divisions of the 
fertilized oocyte into smaller and smaller cells. These divisions will transform the zygote 
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into an implantation-competent blastocyst. The size of the whole embryo doesn’t change 
until the blastocyst formation, capsuled into the zona pellucida.  
The preimplantation embryo is able to realize a form of autonomous development firstly 
fueled by products provided by the oocyte and then from products coming from the 
activation of its own genome (Schultz, 2005). At the beginning of its life, right after the 
fertilization, the developmental program is initially directed by the maternally inherited 
protein and transcripts. Thereafter the embryonic cells will need to become totipotents. This 
totipotency is acquired by the reset of the epigenetic states of the DNA of the germ cells (the 
oocyte and the spermatozoa) and then by the activation of the embryo’s genome and its own 
epigenetics arrangements. This activation will influence gene expression patterning to 
produce two specific cell types necessary for the survival of the embryo: the trophoblast and 
the internal cellular mass. It will exhibit correct spatiotemporal activity of the sequence of 
events necessary for the embryo development achievement (Corry et al., 2009). The next step 
will be the progressive replacement of maternal derived transcripts located in the cytoplasm 
with the transcripts specifics newly formed from the embryo (Schultz, 2002). A variety of 
epigenetic mechanisms underlies each step of the development to allow the specific identity 
of each cell type. These epigenetic mechanisms may change depending on environmental 
and temporal conditions (Corry et al., 2009).  
Compared to spermatozoa, the DNA methylation status in oocyte prior to fertilization is 
little known. It is difficult to obtain mature, ready-to fertilize oocyte in large enough 
quantities (compared to spermatozoa).  
About the embryo, the organization and the introduction of different epigenetic marks are 
done early during the development of the embryo and are essential for the development of 
the new organism. These epigenetic marks, DNA methylation, histone modifications and 
noncoding RNAs, have a critical role in the cell memory during the development. During 
gametogenesis, spermatozoa and oocyte are produced with distinctive chromatin resulting 
from a epigenetic reprogramming from the original cells (Hales et al., 2011). 
2.4 Environmental influences on oocyte 
- Oocyte aging  
Females who show a progressive decline in fecundity can have oocyte aging. It is known 
that after a certain age the ovarian reserve diminish more quickly. Treatments have been 
proposed to increase the maintenance of the ovarian reserve. Dehydroepiandrosterone 
(DHEA) has been reported to improve pregnancy chances in case of diminished ovarian 
reserve. Currently best available evidence suggests that DHEA improves ovarian function, 
increases pregnancy chances and, by reducing aneuploidy, lowers miscarriage rates. DHEA 
over time also appears to improve ovarian reserve (Gleicher and Barad, 2011; Gleicher et al., 
2010a, b; Sonmezer et al., 2009). Although levels of DHEA produced locally in FF have been 
measured and levels correlate negatively with in vitro fertilization outcomes (Li et al., 2011). 
But age has also an influence on the oocyte itself. When oocyte is getting older, cellular and 
molecular abnormalities have a greater probability to occur. A lot of functional changes 
associated with oocyte aging have been observed, including furthermore: decreased 
fertilization rate, polyspermy, parthenogenesis, chromosomal anomalies, apoptosis and 
abnormal and/or retarded development of embryo (Miao et al., 2009). A study realized by 
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A third study was subsequently conducted including 83 patients undergoing a modified 
natural IVF/ICSI cycle to measured 26 soluble factors in the FF of these patients. The aim of 
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analysed through multiplex bead based technology. In all experiments, FF G-CSF appears as 
an excellent non-invasive biomarker of oocyte competence in regard to its significant strong 
power of discrimination, independently so adding value, to our daily embryo morphology 
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We postulate that G-CSF factor in individual FF appears to correlate with the birth potential 
of the corresponding embryo in two opposite models of ovarian monitoring: standard 
ovarian hyperstimulation and modified natural IVF/ICSI cycles. Prospective randomized 
studies are needed to confirm the hypothesis and evaluation of adding value when 
correlated with the embryologist morphological choice is currently studied by our team.  
The presence of G-CSF in the female genital tract and its possible role in reproduction have 
already been studied in the past. G-CSF has been shown to be secreted by granulosa cells at 
ovulation (Salmassi et al., 2004), then during the luteal phase within the endometrium and 
finally during gestation in the placenta (Duan, 1990). FF G-CSF may promote local 
maternofetal tolerance (Rutella et al., 2005) or influence the oocyte's own mRNA levels or its 
potential for self-repair (Yannaki et al., 2005). It might also interact with environmental cells 
to produce cytokines and growth factors which are necessary for the embryo's development 
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It has been suggested key interactions within the follicle involving immune cells such as 
dendritic cells and regulatory T (Treg) cells)(Ledee et al., 2011b). Local maternal-foetal 
immunotolerance could potentially be promoted by G-CSF: almost all the miscarriages 
observed in our cohort were found in the group with a low follicular fluid G-CSF level and a 
recent study reported that G-CSF administration significantly increases live-birth rates in 
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The measure of the FF G-CSF is a non-invasive method for the assessment of the potentiality of 
the embryo to implant, and is cover by a patent. This method could be quickly implemented 
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CSF may also help to promote the single embryo policy by helping to distinguish even before 
the fertilization of the oocyte with a good or a bad potential of implantation. It may also be 
helpful to evaluate individually the oocyte (for women with a low ovarian reserve), to identify 
the best protocol of ovarian stimulation to apply (specific indication of minimal stimulation) 
and to choose in a more powerful way the embryo to cryopreserve.  
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First days of embryo development are characterized by a sequence of cells divisions of the 
fertilized oocyte into smaller and smaller cells. These divisions will transform the zygote 
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into an implantation-competent blastocyst. The size of the whole embryo doesn’t change 
until the blastocyst formation, capsuled into the zona pellucida.  
The preimplantation embryo is able to realize a form of autonomous development firstly 
fueled by products provided by the oocyte and then from products coming from the 
activation of its own genome (Schultz, 2005). At the beginning of its life, right after the 
fertilization, the developmental program is initially directed by the maternally inherited 
protein and transcripts. Thereafter the embryonic cells will need to become totipotents. This 
totipotency is acquired by the reset of the epigenetic states of the DNA of the germ cells (the 
oocyte and the spermatozoa) and then by the activation of the embryo’s genome and its own 
epigenetics arrangements. This activation will influence gene expression patterning to 
produce two specific cell types necessary for the survival of the embryo: the trophoblast and 
the internal cellular mass. It will exhibit correct spatiotemporal activity of the sequence of 
events necessary for the embryo development achievement (Corry et al., 2009). The next step 
will be the progressive replacement of maternal derived transcripts located in the cytoplasm 
with the transcripts specifics newly formed from the embryo (Schultz, 2002). A variety of 
epigenetic mechanisms underlies each step of the development to allow the specific identity 
of each cell type. These epigenetic mechanisms may change depending on environmental 
and temporal conditions (Corry et al., 2009).  
Compared to spermatozoa, the DNA methylation status in oocyte prior to fertilization is 
little known. It is difficult to obtain mature, ready-to fertilize oocyte in large enough 
quantities (compared to spermatozoa).  
About the embryo, the organization and the introduction of different epigenetic marks are 
done early during the development of the embryo and are essential for the development of 
the new organism. These epigenetic marks, DNA methylation, histone modifications and 
noncoding RNAs, have a critical role in the cell memory during the development. During 
gametogenesis, spermatozoa and oocyte are produced with distinctive chromatin resulting 
from a epigenetic reprogramming from the original cells (Hales et al., 2011). 
2.4 Environmental influences on oocyte 
- Oocyte aging  
Females who show a progressive decline in fecundity can have oocyte aging. It is known 
that after a certain age the ovarian reserve diminish more quickly. Treatments have been 
proposed to increase the maintenance of the ovarian reserve. Dehydroepiandrosterone 
(DHEA) has been reported to improve pregnancy chances in case of diminished ovarian 
reserve. Currently best available evidence suggests that DHEA improves ovarian function, 
increases pregnancy chances and, by reducing aneuploidy, lowers miscarriage rates. DHEA 
over time also appears to improve ovarian reserve (Gleicher and Barad, 2011; Gleicher et al., 
2010a, b; Sonmezer et al., 2009). Although levels of DHEA produced locally in FF have been 
measured and levels correlate negatively with in vitro fertilization outcomes (Li et al., 2011). 
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molecular abnormalities have a greater probability to occur. A lot of functional changes 
associated with oocyte aging have been observed, including furthermore: decreased 
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Wilcox et al., showed that oocyte aging increase significantly the risk of early pregnancy loss 
(Wilcox et al., 1998). It has moreover been showed that embryos resulting from aged oocyte 
fertilized with ICSI showed low implantation rates and low developmental potential after 
transfer (Esfandiari et al., 2005; Javed et al., 2010; Liu et al., 1995; Nagy et al., 1993; Van 
Steirteghem et al., 1993). In a healthy body, reactive oxygen species (ROS) and antioxidants 
remain in balance. When there is an unbalanced towards an overabundance of ROS, 
oxidative stress occurs and can do damages. It has been suggested that oxidative stress 
modulates the age-related decline in fertility (Agarwal et al., 2008; Agarwal et al., 2005) . 
Antioxidants are actually used to enhance female and male fertility, although benefits on 
fertility are still controverted (Ruder et al., 2008; Ruder et al., 2009; Visioli and Hagen, 2011).  
- Obesity  
Obesity is known as a cause of increased risk of infertility, mostly because of ovulatory 
dysfunction, but also because obese women have increased risks for miscarriage and 
stillbirth. In case of ART, implantation and pregnancy rates are lower in obese subjects 
versus subjects with normal weight (Maheshwari et al., 2007). A retrospective study using 
oocyte donation model analyse 97-first cycles recipients of oocyte donation under conditions 
of controlled hormonal stimulation and embryos quality was evaluated. The conclusion of 
this paper said that they found no correlation between the BMI of the women receiving the 
embryo (given by another woman with a high Body Mass Index) in their uterus and the 
implantation rates for the same grade of embryo morphology quality. These results could 
mean that uterine receptivity is not negatively influenced by obesity and that the oocyte or 
the embryo is the cause of decreased pregnancy rate in obese women (Wattanakumtornkul 
et al., 2003). Another retrospective study on 536 first-cycle recipients with  donor oocytes 
had confirmed these results (Styne-Gross et al., 2005). Metabolic syndrome and polycystic 
ovary syndrome are two diseases related to obesity; they can also have a negative impact on 
the women fertility. In mice, it has been recently shown that the negatives effects of obesity 
and insulin resistance persist beyond the pre- and the peri-conception period, affecting 
embryonic development and reproductive outcomes (Cardozo et al., 2011). The mechanisms 
leading to an altered oocyte and embryo quality in obese women could result from an 
altered maternal metabolic environment in FF. A study has explored different molecules 
present in FF from obese women compared to women with a moderate BMI and have found 
that obese women have an increased level of C-reactive protein in FF. This molecule might 
indicate increased oxidative stress in the oocyte’s microenvironment, which impairs its 
development (Robker et al., 2009). 
- Smoking 
In a study realize by Gruber et al., in 2008, smokers presented a higher number of non-
fertilized oocytes than nonsmokers (20.1% vs. 10.8% of fertilization failure)(Gruber et al., 
2008). Another study realize in 2006 in a cohort of twenty-seven patients undergoing IVF 
classified as smokers and 32 as non-smokers showed that smokers had decreased number of 
retrieved oocytes compared with non-smokers (p < 0.05). This study demonstrates that 
active cigarette smoking increases the zona pellucida thickness of oocytes and decreases the 
quality of oocytes (Depa-Martynow et al., 2006). Tobacco compounds exert a deleterious 
effect on the process of ovarian follicle maturation. This effect is expressed by decreased 
pregnancy rate, increased early spontaneous abortions and altered ovarian reserve. 
(Sepaniak et al., 2006; Soares and Melo, 2008). 
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3. The sperm  
The role of the sperm has long been reduced to its progression through the female genital 
tract, and the penetration of the oocyte in order to provide the paternal genetic material. 
However, the quality of this genetic inherited material is of great importance for embryo 
development and early pregnancy. In fact, it has little influence on fertilization and early 
embryo cleavage until the passage of 4 to 8 cells-stage, because the embryo uses almost 
exclusively the maternal RNA and proteins produced and stored during oocyte growth and 
maturation. By the third day of development, the embryonic genome begins to be expressed 
and embryonic RNAs and proteins gradually replace maternal ones. In other words, even if 
ART allows in vitro production of embryos, these embryos can be unable to implant and 
give rise to an ongoing pregnancy and/or a healthy offspring. Their development will 
depend on the activation and quality of its genome, half of which being of paternal origin. 
3.1 The role of spermatozoa and the classical evaluation of semen  
The different roles of the sperm during reproductive process are  classified according to the 
stage at which embryo development fails (Tesarik et al., 2004):  
- Early paternal effects includes inability to go through the female genital tract (problems 
of concentration, mobility, classic morphology), to spontaneously or in an assisted way 
(IVF, ICSI) fertilize the oocyte (inability to fix the zona pellucida glycoproteins ZP 1, 2 
or 3, or to perform the acrosome reaction, …), to activate the oocyte (deficiency in 
phospholipase zeta (Saunders et al., 2002) ...) 
- Late paternal effects will become visible during (or after) the activation of the 
embryonic genome, particularly the paternal genome, resulting in the development of 
apparently normal early embryos (until the third day of development), but which are 
unable to implant or to continue a long-term development after implantation. 
- Very late paternal effects are suspected when faced with recurrent miscarriages or with 
pathologies of imprinted genes (Lucifero et al., 2004; Zini, 2011b) leading potentially to 
inherited diseases.  
Since the beginning of ART, the evaluation of male fertility has often been restricted to a 
conventional semen analysis as recommended by World Health Organization (WHO) 
(World Health Organization., 2010). In the last edition of the WHO manual for the semen 
analysis and processing, limit thresholds have been modified according to the results 
published by Cooper (Cooper et al., 2010). Actually, 1953 men from 5 studies in 8 countries 
have been included in this review. The studies have analyzed semen from men who recently 
become parent with a known TTP (time-to-pregnancy: time between the beginning of 
unprotected intercourse and occurrence of a pregnancy) of maximum 12 months. Percentiles 
95 for the different results were then defined as the new limit thresholds. But in daily ART 
practice, it appears that these tests are not sufficient to permit the diagnostic of possible late 
or very late paternal effects. Some men first judged as infertile succeed to obtain a 
pregnancy with their partner (Haugen et al., 2006), while other men judged above limit 
thresholds as defined by WHO failed to obtain a pregnancy (Bonde et al., 1998) or achieved 
it with miscarriage. Despite these limitations, conventional sperm analysis has permit to 
propose adapted ART treatments in a majority of patients, and the Intracytoplasmic Sperm 
Injection (ICSI) technique (Palermo et al., 1992) used since the early nineties has given the 
chance for a part of these subfertile or infertile men to become parents. 
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Wilcox et al., showed that oocyte aging increase significantly the risk of early pregnancy loss 
(Wilcox et al., 1998). It has moreover been showed that embryos resulting from aged oocyte 
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remain in balance. When there is an unbalanced towards an overabundance of ROS, 
oxidative stress occurs and can do damages. It has been suggested that oxidative stress 
modulates the age-related decline in fertility (Agarwal et al., 2008; Agarwal et al., 2005) . 
Antioxidants are actually used to enhance female and male fertility, although benefits on 
fertility are still controverted (Ruder et al., 2008; Ruder et al., 2009; Visioli and Hagen, 2011).  
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Obesity is known as a cause of increased risk of infertility, mostly because of ovulatory 
dysfunction, but also because obese women have increased risks for miscarriage and 
stillbirth. In case of ART, implantation and pregnancy rates are lower in obese subjects 
versus subjects with normal weight (Maheshwari et al., 2007). A retrospective study using 
oocyte donation model analyse 97-first cycles recipients of oocyte donation under conditions 
of controlled hormonal stimulation and embryos quality was evaluated. The conclusion of 
this paper said that they found no correlation between the BMI of the women receiving the 
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3. The sperm  
The role of the sperm has long been reduced to its progression through the female genital 
tract, and the penetration of the oocyte in order to provide the paternal genetic material. 
However, the quality of this genetic inherited material is of great importance for embryo 
development and early pregnancy. In fact, it has little influence on fertilization and early 
embryo cleavage until the passage of 4 to 8 cells-stage, because the embryo uses almost 
exclusively the maternal RNA and proteins produced and stored during oocyte growth and 
maturation. By the third day of development, the embryonic genome begins to be expressed 
and embryonic RNAs and proteins gradually replace maternal ones. In other words, even if 
ART allows in vitro production of embryos, these embryos can be unable to implant and 
give rise to an ongoing pregnancy and/or a healthy offspring. Their development will 
depend on the activation and quality of its genome, half of which being of paternal origin. 
3.1 The role of spermatozoa and the classical evaluation of semen  
The different roles of the sperm during reproductive process are  classified according to the 
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or 3, or to perform the acrosome reaction, …), to activate the oocyte (deficiency in 
phospholipase zeta (Saunders et al., 2002) ...) 
- Late paternal effects will become visible during (or after) the activation of the 
embryonic genome, particularly the paternal genome, resulting in the development of 
apparently normal early embryos (until the third day of development), but which are 
unable to implant or to continue a long-term development after implantation. 
- Very late paternal effects are suspected when faced with recurrent miscarriages or with 
pathologies of imprinted genes (Lucifero et al., 2004; Zini, 2011b) leading potentially to 
inherited diseases.  
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conventional semen analysis as recommended by World Health Organization (WHO) 
(World Health Organization., 2010). In the last edition of the WHO manual for the semen 
analysis and processing, limit thresholds have been modified according to the results 
published by Cooper (Cooper et al., 2010). Actually, 1953 men from 5 studies in 8 countries 
have been included in this review. The studies have analyzed semen from men who recently 
become parent with a known TTP (time-to-pregnancy: time between the beginning of 
unprotected intercourse and occurrence of a pregnancy) of maximum 12 months. Percentiles 
95 for the different results were then defined as the new limit thresholds. But in daily ART 
practice, it appears that these tests are not sufficient to permit the diagnostic of possible late 
or very late paternal effects. Some men first judged as infertile succeed to obtain a 
pregnancy with their partner (Haugen et al., 2006), while other men judged above limit 
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it with miscarriage. Despite these limitations, conventional sperm analysis has permit to 
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Injection (ICSI) technique (Palermo et al., 1992) used since the early nineties has given the 
chance for a part of these subfertile or infertile men to become parents. 
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3.2 Sperm DNA particular organization  
The first studies on the genetic material carried by sperm have been published at the end of 
the 70s with the establishment of the first human sperm karyotypes by Rudak (Rudak et al., 
1978). In the 90s, the technique of Fluorescent in situ hybridization (FISH) permits to study 
aneuploidy, abnormalities such as translocations, and recombinations during meiosis (Shi et 
al., 2001). Over the past decade, a growing number of papers have been published on the 
organization of sperm chromatin and the integrity of the DNA double helix. It appears that 
different problems in the sperm genetic material - called DNA damages - can affect male 
fertility (Shen et al., 1999; Spano et al., 2000). These DNA damages include abnormalities in 
chromatin condensation and organization, in fragmentation of the double helix (single 
and/or double strand), in DNA bases modifications, in epigenetic damages, etc... (Aitken et 
al., 2009). 
During spermiogenesis, the final phase of spermatogenesis after meiosis, chromatin is 
radically reorganized and undergoes an extreme condensation resulting in a shift from a 
nucleosome-based genome organization to the sperm-specific, highly compacted 
nucleoprotamine structure. The DNA double helix of somatic cells is indeed organized into 
chains of nucleosomes by a family of nuclear proteins, the histones. At spermiogenesis, 
histones are mostly replaced by transition proteins, which are themselves replaced by two 
types of specific nuclear proteins of the male gametes, protamines 1 and 2. These proteins 
are particularly rich in arginines (which help to neutralize negative charges of DNA 
phosphate groups), in cysteines (which allow the formation of disulfide bonds intra and 
inter –protamines), and in histidines (which, in combination with cysteines, permit the 
establishment of zinc bridges). Because of this particular composition, the sperm chromatin 
fibers are strongly compacted, and have almost a crystalline organization (Bjorndahl and 
Kvist, 2010). In human sperm, about 85% of histones are replaced by protamines, while the 
other 15% remain. So sperm chromatin is organized predominantly in toroids (by 
protamines), the rest being organized in nucleosomes (by histones) or attached to the 
nuclear matrix (MARs: Matrix attached regions) (Govin et al., 2011; Jonge and Barratt, 2006; 
Ward, 2010). Recent data support the idea that region-specific programming of the haploid 
male genome is of high importance for the post-fertilization events and for successful 
embryo development. The molecular basis of post-meiotic male genome reorganization and 
compaction constitutes one of the last black boxes in modern biology of reproduction. 
Although the successive transitions in DNA packaging have been well described, the 
molecular factors driving these near genome-wide reorganizations remain obscure 
(Rousseaux et al., 2011). 
This particular organization has several roles. Firstly sperm DNA occupies about 10 times 
less space than somatic cell DNA, which reduces the volume of the head and facilitates the 
movement of sperm. Secondly, this extreme condensation makes the DNA inaccessible to 
molecules such as free radicals ( ROS produced by sperm mitochondria and by leukocytes), 
providing a protection against oxidative attacks. Finally, the distribution of remaining 
nucleosomes is not random but concerns gene regions involved in the early embryonic 
development. Moreover it seems increasingly clear that this organization and the 
inheritance of paternal histones have a very important role in epigenetic control (Miller et 
al., 2010; Tavalaee et al., 2009; Ward, 2010). Firstly remaining histones preferentially bind to 
DNA regions involved in early embryo development. As they are less compacted than if 
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organized by protamines, these regions can be easily decondensed and transcripted. 
Secondly, sperm histones undergo different modifications (methylation, acetylation,...) that 
impact expression of the linked DNA domains (Rousseaux et al., 2008), and that can be 
perturbed in in infertile patients. Similarly, the ratio of protamines 1/2, which should 
normally be close to 1, can have a significant negative impact on fertility when disturbed 
(Hammoud et al., 2011). So it is clear that bad condensation of sperm DNA have an impact 
on male fertility (Venkatesh et al., 2011), and a recent study demonstrates the great 
differences between a fertile control group and a patient group presenting repeated 
spontaneous abortions in terms of chromatin condensation and stability (Talebi et al., 2011).  
3.3 Sperm DNA damages and oxidative stress 
Damages to the DNA double helix are quite varied (Bennetts et al., 2008). The most common 
is the fragmentation of the DNA double helix, which involves the breaking of a bond 
between a phosphate group and the neighboring deoxyribose on one or both strands: this is 
called single- or double-strand fragmentation. Another damage consists of base 
modifications, becoming oxidized or alkylated. Covalent bonds between a strand and 
another molecule or the other strand may also appear. DNA adducts are formed from 
xenobiotics and their metabolites, or from the oxidation of membrane lipids of the sperm, 
such as ethenonucleosides. These adducts can be either stable or result in the loss of a base. 
All these changes interfere with DNA replication or transcription. Similarly, an aberrant 
base repair may cause the appearance of a mutation that can be transmitted to the offspring 
(Aitken and Roman, 2008). 
Another important group of damages to sperm genetic material concerns the epigenetic 
control. One of the most studied epigenetic marks is DNA methylation. Knowing that the 
epigenetic environment of the sperm, especially histones and their modifications, has an 
important role in the establishment and maintenance of epigenetic marks in the embryo, it 
appears that aberrant epigenetic regulation during spermatogenesis has a major impact on 
male fertility and embryonic development (Rajender et al., 2011). For example, poor sperm 
quality has been shown to be associated with hypermethylation of sperm genome 
(Houshdaran et al., 2007). This is probably due to a failure in epigenetic marks erasure that 
normally occurs during spermatogenesis. Promoter methylation aberrations of the gene 
encoding the enzyme methylenetetrahydrofolate reductase (MTHFR, which plays a key role 
in maintaining the bioavailability of methyl groups) are associated with secretory 
azoospermia (Khazamipour et al., 2009). Moreover, abnormal methylation can affect gene 
imprinting, and have an impact on embryonic development. Similarly, methylation 
aberrations were detected in imprinted genes in men with idiopathic infertility (Poplinski et 
al., 2010). Finally, many syndromes (Prader-Willi, Angelman, Silver-Russell and Beckwith-
Wiedemann syndromes) are known to be in a number of cases due to imprinting defects 
(Rajender et al., 2011). All these methylation abnormalities observed in patients are 
fortunately not directly transmitted to the embryo: the question is how far they can be 
hereditary? In the epigenetic reprogramming of sperm DNA, these marks are erased and 
then re-established differentially in men and women. Chromatin organization plays a key 
role in the establishment and maintenance of the methylation profile.  
An important matter about the DNA damages concerns their origin. A theory has been 
proposed by Aitken (Aitken et al., 2009): DNA damages can be considered as a process 
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organized by protamines, these regions can be easily decondensed and transcripted. 
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perturbed in in infertile patients. Similarly, the ratio of protamines 1/2, which should 
normally be close to 1, can have a significant negative impact on fertility when disturbed 
(Hammoud et al., 2011). So it is clear that bad condensation of sperm DNA have an impact 
on male fertility (Venkatesh et al., 2011), and a recent study demonstrates the great 
differences between a fertile control group and a patient group presenting repeated 
spontaneous abortions in terms of chromatin condensation and stability (Talebi et al., 2011).  
3.3 Sperm DNA damages and oxidative stress 
Damages to the DNA double helix are quite varied (Bennetts et al., 2008). The most common 
is the fragmentation of the DNA double helix, which involves the breaking of a bond 
between a phosphate group and the neighboring deoxyribose on one or both strands: this is 
called single- or double-strand fragmentation. Another damage consists of base 
modifications, becoming oxidized or alkylated. Covalent bonds between a strand and 
another molecule or the other strand may also appear. DNA adducts are formed from 
xenobiotics and their metabolites, or from the oxidation of membrane lipids of the sperm, 
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taking place in two stages. First of all, spermatogenesis, especially spermiogenesis, leads to 
inadequate sperm production, with an improperly compacted DNA. In a second step, these 
badly compacted spermatozoa are vulnerable to outside attacks, mainly of oxidative type 
(ROS).  There is indeed a significant correlation between DNA fragmentation and the level 
of 8-hydroxy-2'-deoxyguanosine [8OHdG], a DNA adduct derived from the oxidation of 
DNA (Aitken and De Iuliis, 2010). Apoptosis also appears to play an important role  since 
the sperm cell is unable to perform a complete process of programmed cell death (Aitken 
and De Iuliis, 2010). The compacted DNA, mainly silent, contained in a cytosol-depleted 
cell, and physically separated from mitochondria limit the action of classical apoptosis 
effectors. The problem is that these defective sperm cells, normally silently eliminated in the 
female genital tract, remain capable of fertilization, especially in ARTs (Barratt et al., 2010; 
Kurosaka et al., 2003; Sakkas et al., 2004; Weng et al., 2002). 
In a normal sperm, there is a balance between antioxidant processes and ROS production, 
the latter being normal below a certain level, since it plays a role in sperm capacitation, 
acrosome reaction, and fertilization (Griveau and Le Lannou, 1997). However, oxidative 
stress remains controlled, and the presence of many antioxidants in seminal fluid (taurin, 
vitamin C, vitamin E, glutathione, uric acid, thioredoxin, glutathione peroxidase) limits the 
damaging effects (Tremellen, 2008). However, the balance between ROS and antioxidants 
may be disturbed by various external factors or diseases, which reduce the production of 
antioxidants, increase production of ROS, and / or influence the senescence of spermatozoa. 
All this may lead, especially in cases of inadequate chromatin compaction, to DNA damages 
(Koppers et al., 2008).  
3.4 Impact of sperm DNA damages on fertility and ART 
DNA damages have been studied in different populations of patients or sperm donors. In 
patients with an elevated production of seminal ROS, DNA fragmentation is also increased 
(Mahfouz et al., 2009). Avendano et al. (Avendano et al., 2009) analyzed simultaneously 
sperm morphology and DNA fragmentation, and showed an  increased fragmentation in the 
infertile patient group, despite the selection of morphologically normal spermatozoa for the 
DNA analysis. Correlations exist between fragmentation and classical sperm features, but 
not always those expected: in a population of 1633 patients, an inverse correlation between 
sperm count, fast progressive motility and DNA fragmentation has been found (Cohen-
Bacrie et al., 2009). Altogether, these results allow us to conclude that the study of 
fragmentation gives further additional information about male fertility to those provided by 
conventional analysis of semen.  
In a great part of all the published data concerning fragmentation, authors try to assess the 
predictive value of different tests in terms of chances for achieving pregnancy, spontaneous 
or by different ARTs. Zini showed a strong association between DNA damage and failure to 
obtain a pregnancy naturally or by intrauterine insemination (Zini, 2011a; Zini and Sigman, 
2009). This association, although weaker, exists also with the clinical pregnancy rate in IVF, 
and in a lesser extent for ICSI. On the other hand, fragmentation increases the risk of 
miscarriage for IVF and ICSI. The impact of DNA damages is also more significant for the 
IVF and ICSI in terms of take-home baby rate than clinical pregnancy rate (Avendano et al., 
2010; Benchaib et al., 2007; Boe-Hansen et al., 2006; Borini et al., 2006; Bungum et al., 2007; 
Check et al., 2005; Duran et al., 2002; Evenson et al., 1999; Evenson and Wixon, 2008; 
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Frydman et al., 2008; Gandini et al., 2004; Henkel et al., 2003; Host et al., 2000; Huang et al., 
2005; Lin et al., 2008; Loft et al., 2003; Micinski et al., 2009; Muriel et al., 2006; Simon et al., 
2010; Spano et al., 2000; Speyer et al., 2010; Tarozzi et al., 2009; Zini et al., 2005).  
However, the sensitivity of fragmentation tests remains low. The explanation for this 
observation is that the predictive value of DNA fragmentation tests depends on many 
factors (Sakkas and Alvarez, 2010): the type of DNA damage (single or double strand), the 
method of analysis, the site of injury (introns or exons), the percentage of fragmented cells, 
the extent of damage per cell, or the presence of other damage such as DNA adducts. On the 
other hand, it is clear that the sperm DNA quality is not the only explanation for the failure 
to obtain a pregnancy: oocyte quality and in particular its ability to repair sperm DNA 
(Meseguer et al., 2011), the number of oocytes available in the case of IVF, and the quality of 
the endometrium have a direct impact on the chances of pregnancy. 
Another important point is to avoid a negative impact of ARTs – and in particular of the 
semen processing – on oxidative stress and fragmentation. It is therefore important to 
separate safe sperm from leucocytes and dead cells. Gradient centrifugation or swim-up 
allows the separation of different cell types, while the centrifugation of semen without cell 
separation should be rejected (Jackson et al., 2010; Marchesi et al., 2010; Monqaut et al., 
2011). Anyway, it seems important to limit the number of centrifugations, which stimulate 
the ROS production by spermatozoa (Aitken and Clarkson, 1988; Aitken et al., 2010). The 
elimination of apoptotic sperm by Magnetic Activated Cell Sorting (MACS) could also 
improve pregnancy rates (Dirican et al., 2008; Lee et al., 2010; Polak de Fried and Denaday, 
2010; Rawe et al., 2010). Another issue is to avoid transition metals (which may increase the 
damages caused by ROS) and to add antioxidants to the sperm preparation medium (Aitken 
et al., 2010). Finally, the addition of antioxidants in the cryopreservation medium seems to 
decrease the oxidative stress caused by the cryopreservation itself (Thomson et al., 2009).  
Concerning the technique to fertilize the oocyte when sperm DNA damage is present, it 
seems that ICSI is the least influenced by the DNA fragmentation, although the impact of 
the latter remains significant on the risk of miscarriage (Zini and Sigman, 2009). Several 
techniques derived to improve ICSI aim to add new sperm selection criteria in relation to 
the quality of their genetic material and / or their fertilizing ability.  
The use of polarized light highlights the well-organized structures such as the oocyte 
meiotic spindle, but also the well-organized sperm chromatin which then appears bright, in 
contrast to the improperly condensed one. Used in ICSI, this technique seems to improve 
implantation and clinical pregnancy rates (Gianaroli et al., 2008; Gianaroli et al., 2010). 
Sperm selection based on its ability to recognize and bind hyaluronic acid (HA), a major 
component of cumulus-oocyte complexes extracellular matrix, has been also proposed. 
Using HA-coated Petri dishes, this technique, called PICSI or HA-ICSI, allows the selection 
of sperm with a less fragmented DNA and a better head morphology assessed by high 
magnification (X6500-X10000) living sperm observation (Motile Sperm Morphology 
Examination organelle or MSOME) (Parmegiani et al., 2010a). It also appears to improve 
embryo quality and implantation rate (Parmegiani et al., 2010b).  
Finally, the technique of IMSI (Intracytoplasmic Morphologically Selected Sperm Injection), 
which has been developed 10 years ago, looks promising in particular for the selection of 
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sperm without problems of chromatin organization. In 2001 Bartoov and his team have 
associated their MSOME technique with ICSI to give birth to IMSI. Sperm is then observed 
and selected on a morphology basis at a 10000 times magnification, as compared to a 
conventional ICSI magnification of 200 to 400 times. In IMSI, a Nomarski differential 
interference contrast is used and allows a more precise evaluation of the classical strict 
criteria of sperm morphology (shape of the head, midpiece...), and of the presence at the 
head of surface abnormalities called vacuoles. These vacuoles vary in size and number 
between sperm an also between patients. Several teams have shown a correlation between a 
higher rate of vacuolated sperm and higher DNA damages (Franco et al., 2008; Garolla et al., 
2008; Oliveira et al., 2010), and IMSI was presented as a potential solution for the selection of 
non-fragmented sperm in order to increase the implantation rate and to reduce the 
miscarriage rate (Antinori et al., 2008; Bartoov et al., 2003; Bartoov et al., 2002; Berkovitz et 
al., 2006a; Berkovitz et al., 2006b; Berkovitz et al., 2005). These date are however 
controversial and the question about the origin – fragmentation or decondensation – of the 
vacuoles remain open. Recently, different teams aimed to answer this question. They 
studied a specific population of sperm with large vacuoles (more than 13% of the head 
surface)(Boitrelle et al., 2011; Franco Jr et al., 2011; Perdrix et al., 2011) and came to the 
conclusion that their presence is correlated with abnormal DNA condensation. In this 
particular population, the surface depressions observed in MSOME reflects the presence of a 
nuclear vacuole containing a badly condensed chromatin, as confirmed by aniline blue 
staining (Perdrix et al., 2011). On the other side, no positive correlation was demonstrated 
between these large vacuoles and DNA fragmentation (Boitrelle et al., 2011; Perdrix et al., 
2011). So it seems now clear that the presence of large vacuoles reflects a disruption of 
sperm chromatin condensation. Other types of vacuoles also exist (particularly small 
vacuoles, sometimes numerous, with an area <4% of the surface of the head). Further 
studies are still needed to understand if these vacuoles also reflect DNA damages. 
3.5 Impact of environment on sperm DNA damages 
Numerous factors affect semen oxidative balance, sperm quality and DNA damages. 
Tobacco has an impact on oxidative stress, by increasing the presence of leukocytes in 
semen (Saleh et al., 2002; Soares and Melo, 2008). Pesticides provoke sperm DNA damages, 
especially in cases of occupational exposure, as well as pollutants such as heavy metals or 
polycyclic aromatic hydrocarbons in the air (Delbes et al., 2010; Perry, 2008; Somers and 
Cooper, 2009). Occupational exposure of testicles to heat also has deleterious effects on male 
fertility (Mieusset et al., 1987; Paul et al., 2008) as well as sporadic exposure (Rockett et al., 
2001). The effects of obesity on semen quality are marked not only on the concentration of 
sperm, but also on DNA fragmentation (Kort et al., 2006), probably as a result of a high 
scrotal temperature and of an important hormonal disruption (Du Plessis et al., 2010). 
Mobile phone port to the belt, especially when using a hands-free kit (the emission of 
electromagnetic waves is more important during a call) could have an adverse effect on 
male fertility (Desai et al., 2009). Age has also an effect on sperm quality and in particular on 
the quality of genetic material (Sartorius and Nieschlag, 2010). It has been demonstrated by 
Singh (Singh et al., 2003) that the double-strand fragmentation increases with age. Finally, 
other factors such as high consumption of alcohol, dietary exposure to plasticizers, stress, 
poor diet, are potentially impacting the maintenance of the balance ROS / antioxidants in 
the semen (Tremellen, 2008). 
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Infection of the genitourinary tract is an important medical cause of DNA damages, as the 
influx of activated leukocytes provokes an increased production of free radicals. Systemic 
infections may also increase oxidative stress in sperm through an increase in the concentration 
of leukocytes in semen (HIV) (Umapathy et al., 2001), or via a systemic oxidative stress 
(Tremellen, 2008). Patients who underwent surgery to treat cryptorchidism still have a 
production of ROS and a sperm DNA fragmentation higher than those of fertile men (Smith et 
al., 2007). The presence of varicoceles also increases oxidative stress and DNA damage (Chen 
et al., 2004; Smith et al., 2006). Finally, there is a variety of iatrogenic origins of DNA damages. 
Cancer treatments (chemotherapy, pelvic radiotherapy) are generally detrimental to the 
integrity of sperm DNA (Tremellen, 2008). Concerning ARTs, various semen manipulations 
may affect sperm DNA. Centrifugation and cryopreservation increased oxidative stress, and 
consequently the DNA damage (Aitken et al., 2010; Thomson et al., 2009).  
Several therapeutic strategies have been proposed (Hazout et al., 2008). The most effective is of 
course to treat infections of the urogenital tract. The patient must also be aware of the harmful 
effects of lifestyle (smoking, obesity, exposure to heat ...) on the quality of his sperm. If 
possible, it may be beneficial to limit exposure to pollutants. In the presence of varicoceles, 
embolization or surgery improve sperm quality, not really in term of numeration or 
morphology but clearly in terms of fragmentation of DNA (Smit et al., 2010). Finally there are 
several studies that have examined the effect of antioxidant treatment semen quality and 
sperm DNA. While it is necessary to have new controlled-randomized studies, many 
preliminary publications suggest beneficial effects (Agarwal and Sekhon, 2010). 
In conclusion, the study of sperm DNA has highlighted abnormalities in chromatin 
organization, in DNA double helix and in epigenetic marks that impact male fertility and 
sperm role during reproduction. Sperm DNA analyses enable new diagnosis in infertilities 
previously classified as of idiopathic origin. These problems of DNA damages appear to 
influence fertility in early pregnancy by causing failure of implantation or repeated 
miscarriages. New treatments begin to be developed, but need to be well evaluated in 
prospective controlled-randomized studies. Improved lifestyle, environment and 
antioxidant treatments could improve semen and sperm DNA quality. However the newly 
developed sperm selection techniques remain limited to the quality of semen used: if all the 
sperm have an abnormal DNA, it becomes impossible to make a selection.  
Finally, in accordance with the conclusions of the Position Report published by the Working 
Group of the ESHRE Andrology (Barratt et al., 2010), several recommendations can be 
made. First, it is necessary to continue to develop basic research on the chromatin 
organization to better understand the causes and the nature of DNA damages. It is also 
important to standardize analysis techniques to allow a correct interpretation of results, and 
also to be able to compare the different studies. The development of animal models allowing 
studies on the long-term effects of sperm DNA damages and ARTs, and well conducted 
studies paralleling DNA damages and results in ARTs (with neonatal data) will help the 
clinician in the guidance of patients in treatment options. Finally, the long-term monitoring 
of children from ARTs should be systematized.  
4. Embryo 
Successful implantation requires a competent blastocyst able to cross-talk with the receptive 
endometrium. This process includes dynamic and coordinated changes at the intricate 
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crossroad between endocrinology, immunity and angiogenesis. Implantation process is not 
easily accessible in vivo to the research for obvious ethical and technical reasons. The only 
way to evaluate it is to extend data derived from animal studies, from in vivo studies about 
endometrium and embryo separately or from in vitro endometrium-early blastocyst co-
culture. Despite extensive research in this field, the implantation process remains the black 
box of the reproduction, even in 2012. An important wastage of embryos is observed since 
the majority of blastocysts will perish before or around implantation (Macklon et al., 2002; 
Robertson et al., 2011; Teklenburg et al., 2010a). Implantation failure would come from an 
inadequate gamete/embryo quality, an erroneous cross-talk at the implantation site or an 
inadequate peri-conceptual environment. As recently demonstrated by Robertson et al., the 
peri-conceptual period and environment are critical for pregnancy success: the local 
cytokine network of the reproductive tract integrates environmental information and 
provides a signaling system programming both maternal receptivity and embryo 
development (Robertson et al., 2011). On the other hand, data from Kashiwagi (Kashiwagi et 
al., 2007) and from Bauersachs (Bauersachs et al., 2009) evidence that both embryo and 
endometrium are closely related and are actively influenced by each other, in order to favor 
pregnancy or, at contrary, to reject it. 
Implantation is a 3-steps process including free-floating apposition of the blastocyst then 
adhesion between two epitheliums: endometrium and trophoblast, and finally, the fine-
tuned process of trophoblastic invasion and differentiation. This materno-fetal dialogue is 
mediated through a broad array of molecules released at the implantation site both by 
trophoblast and/or endometrium. During implantation process, embryo and maternal 
tissues talk about immunity and angiogenesis, on an autocrine, paracrine and/or juxtacrine 
mood (Singh et al., 2011). In definitive, implantation process is the best example of a 
successfully tolerated graft and controlled tumor invasion.  
4.1 Trophoblast differentiation 
Placentation in Humans is characterized by the formation of a highly invasive 
hemochorial placenta accompanied with dramatical changes in the vasculature of the 
uterus. Differentiation of cytotrophoblast includes villous trophoblast ensuring exchanges 
at the maternal-fetal interface, and extravillous cytotrophoblast (EVCT) anchoring the 
placenta and participating to the vascular remodeling of the wall of spiral arteries. This 
deep trophoblastic invasion through the entire depth of the endometrium and the inner 
third of the myometrium is considered the hallmark of human pregnancy. Trophoblast 
deriving from trophectoderm, clothes the terminal villi (the outermost branches of the 
villous trees) that descend from the chorionic plate and fix to the basal plate by anchoring 
villi (Carter, 2011). The chorionic villi are then the structural and functional unit of the 
placenta, floating within the maternal blood present in the intervillous chambers. Villous 
cytotrophoblast that mantles the chorionic villi, aggregates and fuses to form the 
syncytiotrophoblast (ST), allowing efficient communication and signal exchanges. It 
ensures the endocrine function of placenta, releasing hormones involved in the 
homeostasis of pregnancy such as chorionic gonadotropin and placental lactogen. In the 
other hand, EVCT refers to the invading trophoblast that exits the villi and colonizes the 
uterine wall and spiral arteries, the lumen of which is plugged by trophoblastic cells 
during the first 8 weeks of gestation (Fournier et al., 2011).  
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Subsequent transformation of spiral arteries is a 2-steps process: the first seems to be 
mediated to factors secreted by uNK and covers endothelial swelling and vascular smooth 
muscle cells (VSMC) loss of coherence (Harris, 2011); the second is linked to the loss of 
endothelium, the beak down of VSMC/elastic fibers and finally the incorporation into the 
vessel wall of extravillous trophoblast cells, embed in a fibrinoid-rich matrix (Carter and 
Pijnenborg, 2011). The consequences of these changes are the widening of the vessel lumen, 
highly increasing the supplying blood to the intervillous space. In the placenta formation as 
during implantation process, immunity and angiogenesis are closely related.  
Successful invasion is mediated through both maternal and embryo factors. Differentiation 
of cytotrophoblast to ST or EVCT is accurately controlled by transcription factors, hormones, 
growth factors, cytokines, and O2 level. Implantation, early embryo development and 
placentation processes take indeed place under a low oxygen environment during the first 
trimester of gestation. Many pregnancy disorders such as fetal growth restriction or pre-
eclampsia are associated to the loss of invasiveness, with the extravillous trophoblast that 
does not reach the myometrium and the corresponding arterial segments retaining therefore 
their endothelium; whereas an excessive trophoblast invasion is associated with invasive 
mola, placenta accrete or choriocarcinoma (Lunghi et al., 2007). Pre-eclampsia is a 
pregnancy-specific syndrome characterized by hypertension, proteinuria and edema. It 
resolves on placenta delivery. Placental hypoxia is likely to be responsible for the maternal 
vascular dysfunction, through the increased placental release of anti-angiogenic factors such 
as soluble receptors flt1 and endoglin, both binding vascular endothelium growth factor 
(VEGF), placental growth factor (PLGF) and transforming growth factor (TGF)beta1/3 in the 
maternal circulation and causing endothelial dysfunctions (Lorquet et al., 2010).  
4.2 Embryonic signals: Example of the embryo-specific hCG 
The first known human embryo specific signal is hCG which is produced by the embryo 
before implantation, since it has been detected in embryo supernatants as soon as day 2 post-
fertilization (Ramu et al., 2011). Human chorionic gonadotropin is the major pregnancy 
glycoprotein hormone, from the cystine knot cytokines superfamily, and is specifically 
secreted by trophoblast. It is classically well known from it action as corpus luteum 
progesterone production rescuer but many recent studies has evidenced more and more extra-
gonadal actions. HCG is a non-covalently linked heterodimer composed of 2 subunits α 
(produced by cytotrophoblast) and β (produced by syncytium). Maternal concentration and 
glycosylation of hCG change throughout the pregnancy since 3 majors isoforms are described, 
all of which sharing the hCG β amino acide sequence (Banerjee and Fazleabas, 2011):  
- native hCG: produced by syncytium, its concentration reach a peak around week 10 
then drops. Its main gonadal action is to rescue corpus luteum and support 
progesterone production but many extragonadal actions on uterine receptivity, 
trophoblast functions, immunity and angiogenesis are described (see below). It signals 
through the LH/hCG receptor (LHR), which has been described on different extra-
gonadal human tissues (Berndt et al., 2006; Rao, 2006). Recent data concerning impact of 
hCG on uNK cells suggest that hCG may also bind to the mannose receptor (Kane et al., 
2009). 
- hyperglycosylated hCG (H-hCG): produced by EVCT, it accounts for 90% of total hCG 
production with a peak in the week following implantation. It is an autocrine factor 
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modulating its own production and highly promoting invasiveness of trophoblast. H-
hCG 2D structure is different from native hCG, appears to be independent in numerous 
biological functions, overall promoting placental implantation/invasiveness and is 
likely to signal through a different receptor than LHR (TGF-beta Receptor?). H-hCG is 
also critical for choriocarcinoma growth and malignancy (Cole, 2010; Fournier et al., 
2011; Guibourdenche et al., 2010). 
- free beta subunit of H-hCG (hCG free β): produced by all non-trophoblastic 
malignancies, it inhibits apoptosis and promotes malignant transformation of cancer 
cells.  
Data from literature and from our own work show that through native hCG (and H-hCG 
concerning invasiveness of EVCT), embryo profoundly intervenes in its own implantation 
and favors immunological tolerance and active angiogenesis that are crucial for successful 
implantation (Banerjee and Fazleabas, 2011; Tsampalas et al., 2010).  
At the first steps of implantation, hCG is able to prolong the WOI, by inhibiting decidual 
Insulin like Growth Factor (IGF)-Binding Protein and IGFI (both markers of complete 
decidualization) (Fluhr et al., 2008b), and in association with interleukin 1 (IL-1), to favor 
adhesion via the increase in trophinin expression on endometrial epithelium (Sugihara et al., 
2008). Concerning trophoblast functions hCG (and its hyperglycosylated variant) has been 
demonstrated to promote trophoblastic cells migration, and to reduce endometrial barrier, 
through its action on matrix metalloprotease protein 9 (MMP9, increased), TIMP-1, -2, -3 
(reduced), GM-CSF, IL-11 (Chen et al., 2011; Fluhr et al., 2008a; Paiva et al., 2011). We also 
observed that hCG is able to increase leukemia inhibitory factor (LIF) production by 
endometrial epithelial cells in vitro, a cytokine known to be crucial for implantation in mice 
(Perrier d'Hauterive et al., 2004; Stewart, 1994). These data has been confirmed by different 
teams (Licht et al., 2002; Sherwin et al., 2007).  
HCG levels coincide with the development of trophoblast tolerance. Indeed, it offers many 
immunological properties. For example, hCG increases the number of uterine natural killer 
cells that play a key role in the establishment of pregnancy (Kane et al., 2009). HCG also 
intervenes in the development of local immune tolerance through apoptosis via Fas/Fas-
Ligand (Kayisli et al., 2003). It also modulates the Th1/Th2 balance toward the Th2 pathway 
(Koldehoff et al., 2011). During pregnancy, the balance of Th1 (cell-mediated immunity) and 
Th2 (humoral immunity) cytokines is characterized by an initial prevalence (but not an 
exclusivity) of Th2 cytokines, followed by a progressive shift towards Th1 predominance 
late in gestation, that when is abnormal, may initiate and intensify the cascade of 
inflammatory cytokine production involved in adverse pregnancy outcomes (Challis et al., 
2009). In a more general way, Khan et al. showed that the administration of hCG to 
nonobese diabetic mice (NOD) before the beginning of the clinical symptoms reduced the 
increase in glycaemia, reversed establishment of insulitis, and inhibited the development of 
Th1 autoimmune diabetes (Khan et al., 2001). A recent large proteomic study demonstrated 
the influence of several molecules produced by the trophoblast that regulate the mother’s 
immune tolerance. Among these molecules, hCG inhibits T lymphocytes (Dong et al., 2008). 
The transient tolerance, evident during gestation is at least partially achieved via the 
presence of regulatory T cells that are expended during pregnancy (Dimova et al., 2011; 
Ernerudh et al., 2011; Fainboim and Arruvito, 2011; Nevers et al., 2011; Xiong et al., 2010) at 
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the maternal-fetal interface, showing a suppressive phenotype, whereas Treg cells are not 
increase in the circulation of pregnant women. In part, they are attracted by hCG at the 
fetal–maternal interface during early pregnancy, via a LHR signalling (Leber et al., 2010; 
Schumacher et al., 2009). Finally, hCG treatment of activated dendritic cells results in an up-
regulation of MHC class II, IL-10 and IDO expression, reducing the ability to stimulate T cell 
proliferation. Impact of dendritic cells during implantation has recently been review by 
Blois (Blois et al., 2011).  
Interestingly, immunologic properties of hCG are likely to differ as far as urinary versus 
recombinant molecules are concerned. These data are particularly important to keep in 
mind if immunomodulation of hCG would apply in clinical practice (Carbone et al., 2010; 
Kajihara et al., 2011). 
Beside immune tolerance, a successful implantation requires also an extensive vascular 
remodeling of maternal arteries at the placental bed. Recent data demonstrate angiogenic 
effects of hCG via its interaction with endometrial epithelial cells which are able to produce 
angiogenic VEGF under hCG-LHR binding. Moreover, hCG highly increases angiogenesis 
of new mature vessels, via the stimulation endothelial cells proliferation as well as the 
migration of smooth muscle cells leading to the maturation of vessels, an important step for 
placentation (Berndt et al., 2009; Berndt et al., 2006). 
Taken together the immune and vascular roles of hCG during early pregnancy, it is not 
surprising that this hormone has been studied during pregnancy disorders such as pre-
eclampsia (Kalinderis et al., 2011; Norris et al., 2011).   
5. The endometrium 
Implantation of the embryo into the maternal endometrium represents a unique biological 
process example of an immunological (tolerance of an allograft) and biological (adhesion of 
two epithelia) paradox (Perrier D'hauterive et al., 2002). The success of implantation depends 
on a receptive endometrium, a functionally normal blastocyst and a synchronized cross-talk 
between embryonic and maternal tissues. Though sexual steroids control the process (Paulson, 
2011), a cascade of cytokines, growth factors and adhesion molecules are the private paracrine 
mediators of the uterine receptivity. Particularly, progesterone is crucial to establishment of 
endometrial receptivity, modulating subsequently the appearance or disappearance of a wide 
network of molecules responsible of the uterine receptivity.  
5.1 The window of implantation and the decidua 
Endometrium undergoes cyclic morphological and functional changes, including growth, 
differentiation and desquamation. Altogether, these cyclic physiological modifications lead 
to the preparation of a receptive endometrium able to tolerate the foetal allograft and to 
control invasiveness of trophoblastic cells, allowing implantation process during the mid-
secretory phase. Control of gene expression is crucial to this process, and inappropriate 
epigenetic modifications occasioning an altered chromatin structure and transcriptional 
activity may result in aberrant expression of receptive endometrial pattern. Epigenetics is 
likely to be associated with the initial regeneration and then proliferation of endometrium, 
angiogenesis, decidual reaction and angiogenesis (Munro et al., 2010).  
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Whereas the implantation can occur in any human tissue, the endometrium is one of rare in 
which the embryo cannot implant, except during one limited period called the window of 
implantation (WOI), at the time when progesterone reaches peak serum concentrations (day 
20-day24), allowing embryo to implant only under optimal circumstances. During this 
period, it offers a high receptivity to the embryo, resulting in a successful pregnancy 
(Lessey, 2011). This physiological state of the endometrium at the mid-secretory phase 
allows blastocyst 3-steps implantation process: apposition, then adhesion followed by 
trophoblast invasion and then induction of localized changes in the stroma called 
decidualization (Rashid et al., 2011).  
WOI ends with the decidual transformation, where endometrium becomes a well 
vascularized tissue and stromal cell differentiate into specialized decidual cells (Teklenburg 
et al., 2010b). Factors secreted by decidual cells (such as LEFTY-A) compromise endometrial 
receptivity, ending the WOI. Oedema, increased vascular permeability, proliferation and 
transformation of fibroblast into cuboid secreting cells, invasion of leucocytes and 
angiogenesis are the principal mechanisms enabling decidua to resist to oxidative stress, to 
allow interaction within immune cells and to restrain the invasiveness of trophoblasts.  
Apprehending molecular mechanisms of endometrial receptivity and then decidual 
transformation would provide a better understanding implantation process and its 
pathological implications. Failure to express adequate decidualization pattern is likely to 
induce early pregnancy lost or predispose to obstetrical complications such as implantation 
failure, recurrent miscarriages, pre-eclampsia, fetal growth restriction... (Blois et al., 2011; 
Brosens, 2011; Plaisier, 2011).  
Actual research aims to dissect the molecular basis for the changes occurring during the 
WOI at the genomic and proteomic level (Berlanga et al., 2011; Diaz-Gimeno et al., 2011; 
Horcajadas et al., 2007). Despite a lot of experiments aiming to evidence relevant and 
selective biomarkers of uterine receptivity, there is to date no molecular fingerprint of the 
WOI. This is due partly to the discovery of an increasingly higher number of potential new 
markers according to the evolution of research, partly to the structural composition of 
endometrium, where the specialized epithelial cells that encounter the embryo are distinct 
from the glandular part. Finally, it is important to note the absence of consensus to which 
biomarkers to use for endometrial receptivity, and none of studied mediators (Mucine 1, L-
selectin ligand, integrins, heparin-binding epidermal growth factor-like growth factor) has 
been explored in sufficient detail to validate its usefulness in clinical practice (Lessey, 2011).  
The modification occurring in the endometrium during the WOI is closely related to 
angiogenesis and to immune system, allowing the tolerance of the fetal allograft and an 
adequate vascular remodelling during plancentation for a successful pregnancy until birth. 
Angiogenesis refers to the formation of new vessels from existing ones, by elongation, 
intussusception or sprouting of endothelial cells. One of the key local adaptations to 
pregnancy is the stimulation of maternal vessel network at the embryo implantation site. 
Normal fetal development requires extensive angiogenesis and important vascular 
remodelings allowing adequate supply of nutrients as well as gas and metabolite exchanges. 
Abnormal uterine blood supply is associated with higher perinatal morbidity and mortality 
caused by preterm delivery, preeclampsia, or intrauterine growth restriction. Stimulation of 
angiogenesis in many organs (including uterus) is mediated through enhanced expression 
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of VEGF, an angiogenic cytokine produced by epithelial endometrial and stromal cells 
(Berndt et al., 2006). As demonstrated at the next section, some other molecules from a 
trophoblastic origin, are able to actively stimulate maternal vascular remodelling as well.  
In parallel, immune cells increasingly infiltrate endometrium from post-ovulation to 
menstruation in absence of pregnancy. In case of pregnancy, an higher increased number is 
observed after fertilisation up to mid gestation, since 30% of decidual cells are leukocytes, 
including 75% of uterine natural killers (uNK) (Plaisier, 2011; Zhang et al., 2011). It has been 
proposed that uNK could exert, directly or indirectly, either positive or negative control 
over implantation process. These cells secrete an array of cytokines important for adequate 
local immune regulation, angiogenesis, placental development, and establishment of 
pregnancy. Other immune cells or systems such as dendritic cells, T regulatory cells, 
macrophages, Th1/Th2 equilibrium orchestrate immune tolerance, trophoblast invasion and 
angiogenesis associated with embryo implantation (Blois et al., 2011; Denney et al., 2011). 
ART programs, and particularly egg/embryo donation protocols, has clearly contributed to 
our knowledge of endometrial physiology. They gave us the opportunity to separately 
evaluate oocyte and endometrium, and to discover that endometrial receptivity can be 
controlled artificially with exogenous estrogen and progesterone, with a certain success 
(Paulson, 2011). Although it ensures obtaining a sufficient number of oocytes and thus 
embryos, ovarian hyper stimulation with exogenous gonadotropins is likely to be associated 
with modified endometrial development that may impact endometrial receptivity and 
success of implantation. These phenomenons would result from the inducing of an embryo-
endometrium asynchrony (histologic endometrial advancement), the up-regulation of P-
receptor expression, and a negative correlation between implantation and premature 
progesterone elevation, impacting fresh implantation rates in normal and high responders 
(Shapiro et al., 2011a, b), despite some other controversial results (Levi et al., 2001). 
5.2 Clinical relevance of endometrial immunity  
A better understanding of the uterine–embryo interaction and of the “seed and soil” 
regulations during embryo implantation is mandatory to increase the efficacy of ART. 
Implantation failure, recurrent miscarriage and preeclampsia have several recognized 
causes in common, but in most cases, the precise etiology remains obscure. Recent data in 
reproductive immunology identify the importance of the local immune environment and 
suggest to the clinician the need to develop tools to explore these endometrial perturbations 
(Tuckerman et al., 2010).  
Indeed the semantic distinction between implantation failure, abortion and preeclampsia 
might in fact be more quantitative than qualitative (Chaouat, 2008). An important subset of 
implantation defects is the consequence of a deregulation of the interleukin systems, tumor 
necrosis factor (TNFα), interferon system as well as the uNK cell-mediated networks. Both 
deficient and excess expression of cytokines and immune cells number and activation play 
indeed detrimental key roles in implantation, since these actors can have both positive and 
negative effects. 
For example, in human reproduction, a proper balance in the IL-12, IL-18, IL-15 and a 
correct uNK activation stat result in successful implantation and pregnancy. Conversely, 
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imbalances in these parameters correlate with implantation failure or early pregnancy loss 
(Ledee, 2005). Their expression controls the local uNK recruitment and subendometrial 
angiogenesis as reflected by the vascular flow index (VFI) determined by three-dimensional 
ultrasound (Ledee et al., 2008a; Ledee et al., 2011b).  
The excellent correlation between IL-15 mRNA expression and the sub endometrial vascular 
flow index (VFI) suggests that this cytokine and the uNK cells that produce it participate to 
the local control of angiogenesis. Patients with a low sub-endometrial VFI and low IL-15 
mRNA are patients with insufficient uNK recruitment and/or inadequate uNK-derived 
angiogenic-related proteins. In contrast, some patients with implantation failure exhibit very 
high VFI and, at the same time, high IL-15 and IL-18 mRNAs and CD56+ cell count. A Th-1 
excess could possibly be involved in implantation failure (Kwak-Kim et al., 2005). 
Abnormal subendometrial vascularization assessed by ultrasound may be the consequence 
of distinct cytokine dysregulation patterns. These may cause implantation failure, abortion 
or preeclampsia, through abnormal (insufficient or excessive) recruitment of uNK cells or 
through inadequate endothelial vascular remodeling before implantation. 3-D 
ultrasonography with vocal analysis may inform on the uterine preparation to a 
constructive dialogue with the conceptus through an adequate trophicity and angiogenesis. 
This point on echographic evaluation of endometrium opens up new horizons for the 
evaluation of the endometrium, well beyond the simple measurement of thickness that 
improperly correlate with the outcome of IVF, since without absolute cutoff (Noyes et al., 
1995; Paulson, 2011). Nevertheless, focusing on vascularization at the time of implantation is 
absolutely mandatory from a physiological point of view (Ledee, 2005). In daily clinical 
practice, echographic evaluation of subendometrial VFI and measurement of the IL-15 and 
IL-18 mRNAs together with CD56+ counts may be useful to identify those women at risk of 
implantation failure (Ledee et al., 2011b).  
Moreover, Tumor necrosis factor like WEAK inducer of apoptosis (TWEAK) is a 
transmembrane protein which, when cleaved, functions as a soluble cytokine. It is highly 
expressed by different immune cells and triggers multiple roles, including control of 
angiogenesis. TWEAK and IL-18 mRNA expression are correlated in patients with 
implantation failures. Basic TWEAK expression influences the IL-18 related uNK 
recruitment and local cytotoxicity. Actually, as demonstrated by Petitbarat et al., TWEAK 
doesn’t act on IL-18 expression but is likely to control IL-18 related cytotoxicity on uNK cells 
when IL-18 is over-expressed (Petitbarat et al., 2010).  
Using large-scale microarray analysis, endometrial gene expression at the time of the 
implantation window was compared in fertile control patients (FC) and women displaying 
previous IVF/ICSI repeated implantation failure (IF) or recurrent unexplained miscarriages 
(RM). Biological functions and gene networks were explored using the Ingenuity Pathways 
Analysis software. The number of differentially expressed genes revealed the extent of 
changes within the preconceptional endometrium as a function of either fertility or 
infertility. The main similarities of differentially expressed genes between IF and RM relate 
to immune and hematological system development abnormalities, especially deregulation of 
the differentiation and development of T lymphocytes and blood cells. As the endometrium 
is now thought to be a biosensor for the quality of the embryo, such differential expression 
may have direct consequences on the initial embryo-uterus dialogue (Chaouat et al., 2011; 
Ledee et al., 2011c). 
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6. Conclusion: Implantation process 
Implantation process and placenta formation are closely associated to angiogenesis and 
immune tolerance, at the crossroad of endocrinology. Whereas embryo could implant in 
every human tissues and particularly in Fallopian tubes with sometimes a very huge 
morbidity (Shaw and Horne, 2011), uterus is tailored to tolerate the fetal allograft and to 
allow controlled invasiveness of trophoblast only during the WOI, ensuring the success of 
the intricate cascade of implantation. Blastocyst implantation requires a competent embryo- 
supported by the fertilization of a good quality oocyte by a top spermatozoa – able to cross-
talk with a receptive endometrium, and the dialogue must talk about immunity and 
angiogenesis. Implantation failure and some pathologies of pregnancy are associated to 
defect of this close dialogue at one or many steps of the cascade.  
Implantation rate in IVF treatment certainly benefits from research about all these fields in 
reproductive medicine, able to increase selection, diagnostic and treatment of the different 
actors of implantation: gametes, endometrium, embryo and the most difficult issue: the 
dialogue between each other.  
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imbalances in these parameters correlate with implantation failure or early pregnancy loss 
(Ledee, 2005). Their expression controls the local uNK recruitment and subendometrial 
angiogenesis as reflected by the vascular flow index (VFI) determined by three-dimensional 
ultrasound (Ledee et al., 2008a; Ledee et al., 2011b).  
The excellent correlation between IL-15 mRNA expression and the sub endometrial vascular 
flow index (VFI) suggests that this cytokine and the uNK cells that produce it participate to 
the local control of angiogenesis. Patients with a low sub-endometrial VFI and low IL-15 
mRNA are patients with insufficient uNK recruitment and/or inadequate uNK-derived 
angiogenic-related proteins. In contrast, some patients with implantation failure exhibit very 
high VFI and, at the same time, high IL-15 and IL-18 mRNAs and CD56+ cell count. A Th-1 
excess could possibly be involved in implantation failure (Kwak-Kim et al., 2005). 
Abnormal subendometrial vascularization assessed by ultrasound may be the consequence 
of distinct cytokine dysregulation patterns. These may cause implantation failure, abortion 
or preeclampsia, through abnormal (insufficient or excessive) recruitment of uNK cells or 
through inadequate endothelial vascular remodeling before implantation. 3-D 
ultrasonography with vocal analysis may inform on the uterine preparation to a 
constructive dialogue with the conceptus through an adequate trophicity and angiogenesis. 
This point on echographic evaluation of endometrium opens up new horizons for the 
evaluation of the endometrium, well beyond the simple measurement of thickness that 
improperly correlate with the outcome of IVF, since without absolute cutoff (Noyes et al., 
1995; Paulson, 2011). Nevertheless, focusing on vascularization at the time of implantation is 
absolutely mandatory from a physiological point of view (Ledee, 2005). In daily clinical 
practice, echographic evaluation of subendometrial VFI and measurement of the IL-15 and 
IL-18 mRNAs together with CD56+ counts may be useful to identify those women at risk of 
implantation failure (Ledee et al., 2011b).  
Moreover, Tumor necrosis factor like WEAK inducer of apoptosis (TWEAK) is a 
transmembrane protein which, when cleaved, functions as a soluble cytokine. It is highly 
expressed by different immune cells and triggers multiple roles, including control of 
angiogenesis. TWEAK and IL-18 mRNA expression are correlated in patients with 
implantation failures. Basic TWEAK expression influences the IL-18 related uNK 
recruitment and local cytotoxicity. Actually, as demonstrated by Petitbarat et al., TWEAK 
doesn’t act on IL-18 expression but is likely to control IL-18 related cytotoxicity on uNK cells 
when IL-18 is over-expressed (Petitbarat et al., 2010).  
Using large-scale microarray analysis, endometrial gene expression at the time of the 
implantation window was compared in fertile control patients (FC) and women displaying 
previous IVF/ICSI repeated implantation failure (IF) or recurrent unexplained miscarriages 
(RM). Biological functions and gene networks were explored using the Ingenuity Pathways 
Analysis software. The number of differentially expressed genes revealed the extent of 
changes within the preconceptional endometrium as a function of either fertility or 
infertility. The main similarities of differentially expressed genes between IF and RM relate 
to immune and hematological system development abnormalities, especially deregulation of 
the differentiation and development of T lymphocytes and blood cells. As the endometrium 
is now thought to be a biosensor for the quality of the embryo, such differential expression 
may have direct consequences on the initial embryo-uterus dialogue (Chaouat et al., 2011; 
Ledee et al., 2011c). 
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6. Conclusion: Implantation process 
Implantation process and placenta formation are closely associated to angiogenesis and 
immune tolerance, at the crossroad of endocrinology. Whereas embryo could implant in 
every human tissues and particularly in Fallopian tubes with sometimes a very huge 
morbidity (Shaw and Horne, 2011), uterus is tailored to tolerate the fetal allograft and to 
allow controlled invasiveness of trophoblast only during the WOI, ensuring the success of 
the intricate cascade of implantation. Blastocyst implantation requires a competent embryo- 
supported by the fertilization of a good quality oocyte by a top spermatozoa – able to cross-
talk with a receptive endometrium, and the dialogue must talk about immunity and 
angiogenesis. Implantation failure and some pathologies of pregnancy are associated to 
defect of this close dialogue at one or many steps of the cascade.  
Implantation rate in IVF treatment certainly benefits from research about all these fields in 
reproductive medicine, able to increase selection, diagnostic and treatment of the different 
actors of implantation: gametes, endometrium, embryo and the most difficult issue: the 
dialogue between each other.  
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1. Introduction 
Placenta formation occurs through a complex and coordinated effort between the fetus’s 
extraembryonic tissues and the gravid  endometrial tissues. Many macrophages are 
present in the placenta throughout pregnancy and have been detected as early as day 10 
of pregnancy (Chang et al., 1993). Placental macrophages include Hofbauer cells of the 
fetal chorionic villi and decidual macrophages of the maternal decidua basalis (Figure 1) 
(Bulmer & Johnson, 1984). Functions of placental macrophages include the production of 
substances that regulate local immune reactions (such as factors that regulate maternal 
immunological tolerance and fetal protection) and that promote angiogenesis in the 
placenta during its development (Mues et al., 1989; Sevala et al., 2007). Although they 
represent a significant presence on both the maternal and fetal sides of the placenta, 
placental macrophage functions have not been completely elucidated and still remain a 
significantly studied area of investigation. 
 
Fig. 1. The mesenchymal core of this fetal tertiary chorionic villus contains a Hofbauer cell, 
seen as a large, pale-staining placental macrophage with an eccentric nucleus.  
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2. General placenta function 
The placenta provides an interface for communication between the maternal blood and the 
developing fetus. Substances are selectively transported between the separate but closely 
approximated maternal and fetal vascular systems. Substances exchanged between the fetal 
blood (contained within fetal vessels of chorionic villi) and maternal blood (located within 
sinusoids surrounding villi) include nutrients, waste products, oxygen, carbon dioxide, 
hormones, cytokines, immunoglobulins, drugs, and microbes.  
Signaling molecules found in the placenta, such as hormones and cytokines, are important 
for the maintenance of pregnancy, maternal-fetal tolerance, parturition, lactation, and 
barrier to infection. Placental cells that produce these mediators include fetal trophoblasts 
and placental macrophages. This article is not intended to describe the placenta and all of its 
components in detail, but to discuss one facet of this complex, transient, vital organ of 
pregnancy, the placental macrophage.  
3. Macrophage phenotypes overview 
Human monocytes and macrophages are players in the innate immune system. Macrophages 
are bone marrow/hematopoietic-derived cells that migrate through the blood circulation to 
home to and take up residence within various tissues, where they play a pivotal role in 
coordinating processes such as development and host defense by secretion of cytokines, 
chemokines and growth factors and by phagocytosis. Furthermore, macrophages link the 
innate and adaptive immune systems through phagocytosis, digestion, and antigen 
presentation (macrophage expression of Human Leukocyte Antigen (HLA) class II 
molecules and co-stimulatory receptors such as CD80/CD86) to T lymphocytes. The role of 
macrophages in the orchestration of inflammation, immune responses, and wound 
healing/tissue remodeling has been a field of intensive study.  
Macrophages exhibit great plasticity in their ability to transform between phenotypes. While 
unstimulated, resting macrophages are relatively quiescent and express low levels of 
cytokines and growth factors, activation by agents in the surrounding micro-environmental 
milieu polarizes macrophages to yield a broad spectrum of macrophage phenotypes based 
on location and micro-environmental influences. Environmental stimuli that influence the 
expression of inducible genes and polarization of macrophages may include activating 
agents, pathogens, cytokines, hypoxia, and ischemia (Pinhal-Enfield et al., 2003; 
Ramanathan et al., 2007). 
Based on exposure to surrounding micro-environmental cues, macrophages are induced to 
alter their expression profiles. Two major classifications have been used in the past to 
describe activated macrophages as polarized towards pro-inflammatory or anti-
inflammatory phenotypes. Although categorization of macrophage phenotypes can be 
muddled by assorted combinations of activating agents, macrophages respond to micro-
environmental stimuli and are typically described as “classically”-activated (M1) pro-
inflammatory macrophages or “alternatively”-activated (M2) wound healing macrophages. 
Based on exposure time and the types of activating stimuli, macrophages may switch 
activation state to other phenotypes (Martinez et al., 2009; Daley et al., 2010; Porcheray et al., 
2005; Classen et al., 2009). M1 macrophages induce processes during injury and infection 
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that promote inflammatory processes and promote Th1- type immune responses leading to 
enhanced killing of microbes and tumor cells. M2 macrophages on the other hand, display 
immunosuppressive effects, resolve inflammation through production of anti-inflammatory 
cytokines, enhance phagocytosis and elimination of debris, secrete growth and angiogenic 
factors that stimulate tissue remodeling and repair, and stimulate Th2-type immune 
responses. M2 macrophages are characterized by a distinctive molecular repertoire and have 
been implicated in the down-regulation of inflammation, tissue remodeling, repair, parasite 
killing, allergic reactions, tumor promotion, and placenta formation (Pinhal-Enfield & 
Leibovich, 2011; Leibovich et al., 2010). These descriptions of polarized M1 macrophages or 
M2 macrophages only represent macrophages at the far ends of the spectrum. Macrophage 
phenotypes might be better described as a series of gradations and nuances within a broad 
spectrum between the pro-inflammatory macrophage at one far end and the anti-
inflammatory macrophage at the other end. 
3.1 Induction of macrophage phenotypes 
Heterogenous macrophage populations are found within tissues. These differentiated 
macrophages are plastic and retain the capacity to transform their phenotype in response to 
micro-environmental cues and immune-specific influences. Activated macrophages switch 
phenotypes to develop phagocytic and secretory profiles directed for specific functional 
activities that are in alignment with the original stimuli (Daley et al., 2010).  
Unstimulated macrophages express low levels of inflammatory cytokines and growth 
factors such as tumor necrosis factor-(TNF-), interleukin (IL)-12, and vascular endothelial 
growth factor (VEGF). Stimulation of macrophages with products of pathogenic agents such 
as Toll-like Receptor (TLR) agonists (e.g., lipopolysaccharide (LPS), flagellins, or 
lipoproteins), either with or without interferon-(IFN-) nduces “classical“ M1 activation, 
characterized by production of TNF- and IL-12.  
M2 “alternatively activated“ macrophages are commonly characterized as being induced in 
response to IL-4 and IL-13 through the IL-4 receptor- (IL-4R, and up-regulating 
expression of IL-10, TGF-, and VEGF while down-regulating expression of TNF- and IL-
12 (Martinez et al., 2009; Classen et al., 2009). M2 macrophages also display a series of cell 
surface and intracellular markers (Table 1). Further investigation, however, has revealed 
that IL-4 and IL-13 are not necessary for induction of the M2-like phenotype and mouse 
wounds lacking IL-4/IL-13 still contain M1 and M2-like macrophages (Daley et al., 2010). 
The IL-4/IL-13-independent pathways of alternative macrophage activation that induce 
phenotypes resembling M2 macrophages represent an intense field of study as the 
functional traits of these M2 macrophages and the different activating agents that induce 
them are characterized.  
3.1.1 M1 macrophages 
M1 macrophages promote and coordinate inflammatory processes during injury and 
infection that are essential for intracellular pathogen removal. These macrophages are 
induced by pathogen associated molecular patterns (PAMPs), such as the TLR4 agonist, 
LPS, damage associated molecular patterns (DAMPs), such as those derived from 
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factors that stimulate tissue remodeling and repair, and stimulate Th2-type immune 
responses. M2 macrophages are characterized by a distinctive molecular repertoire and have 
been implicated in the down-regulation of inflammation, tissue remodeling, repair, parasite 
killing, allergic reactions, tumor promotion, and placenta formation (Pinhal-Enfield & 
Leibovich, 2011; Leibovich et al., 2010). These descriptions of polarized M1 macrophages or 
M2 macrophages only represent macrophages at the far ends of the spectrum. Macrophage 
phenotypes might be better described as a series of gradations and nuances within a broad 
spectrum between the pro-inflammatory macrophage at one far end and the anti-
inflammatory macrophage at the other end. 
3.1 Induction of macrophage phenotypes 
Heterogenous macrophage populations are found within tissues. These differentiated 
macrophages are plastic and retain the capacity to transform their phenotype in response to 
micro-environmental cues and immune-specific influences. Activated macrophages switch 
phenotypes to develop phagocytic and secretory profiles directed for specific functional 
activities that are in alignment with the original stimuli (Daley et al., 2010).  
Unstimulated macrophages express low levels of inflammatory cytokines and growth 
factors such as tumor necrosis factor-(TNF-), interleukin (IL)-12, and vascular endothelial 
growth factor (VEGF). Stimulation of macrophages with products of pathogenic agents such 
as Toll-like Receptor (TLR) agonists (e.g., lipopolysaccharide (LPS), flagellins, or 
lipoproteins), either with or without interferon-(IFN-) nduces “classical“ M1 activation, 
characterized by production of TNF- and IL-12.  
M2 “alternatively activated“ macrophages are commonly characterized as being induced in 
response to IL-4 and IL-13 through the IL-4 receptor- (IL-4R, and up-regulating 
expression of IL-10, TGF-, and VEGF while down-regulating expression of TNF- and IL-
12 (Martinez et al., 2009; Classen et al., 2009). M2 macrophages also display a series of cell 
surface and intracellular markers (Table 1). Further investigation, however, has revealed 
that IL-4 and IL-13 are not necessary for induction of the M2-like phenotype and mouse 
wounds lacking IL-4/IL-13 still contain M1 and M2-like macrophages (Daley et al., 2010). 
The IL-4/IL-13-independent pathways of alternative macrophage activation that induce 
phenotypes resembling M2 macrophages represent an intense field of study as the 
functional traits of these M2 macrophages and the different activating agents that induce 
them are characterized.  
3.1.1 M1 macrophages 
M1 macrophages promote and coordinate inflammatory processes during injury and 
infection that are essential for intracellular pathogen removal. These macrophages are 
induced by pathogen associated molecular patterns (PAMPs), such as the TLR4 agonist, 
LPS, damage associated molecular patterns (DAMPs), such as those derived from 
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mitochondria of apoptotic neutrophils, and IFN- (produced by activated Th1, Tc1, NK 
cells). Pro-inflammatory and cytotoxic responses against intracellular pathogens and 
transformed cells (such as cancer cells) are directedthrough induction of cytokines (e.g., IL-1, 
IL-6, IL-12, TNF-) and inflammatory mediators (e.g., nitric oxide (NO) through inducible 
NO synthase (iNOS)), and increases in leukocyte recruitment and phagocytic and antigen 
presenting activity. These initial, pro-inflammatory M1 macrophages predominate in the 
early wound, which becomes a dynamic cauldron of mediators that are in constant flux as 
interactions, inductions, and adaptations take place (Martinez et al., 2009; Classen et al., 
2009; VanGinderarchter et al., 2006). In contrast, M2 macrophages are critical for the 
resolution of inflammation and the induction of angiogenesis, tissue remodeling, and repair 
through production of anti-inflammatory cytokines, growth and angiogenic factors, and by 
phagocytosis and elimination of debris (Martinez et al., 2009; Daley et al., 2010; Classen et 
al., 2009; Taylor et al., 2005; Rubartelli et al., 2007; VanGinderarchter et al., 2006). M2 
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 and wound healing 
Table 1. Inducing agents involved in the regulation of gene expression contribute to the 
development of M1 and M2 macrophage phenotypes. (Martines et al., 2009; Leibovich et al., 
2011). 
3.1.2 M2 macrophages 
Macrophage phenotypes can vary and switch based on temporal and environmental cues, 
making their investigation and classification complex. Wound macrophages in the early 
stages of healing have a more M1-like profile with elevated expression of TNF- and IL-6 
and less TGF-while those in later stages of healing have a more M2-like profile, with less 
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pro-inflammatory cytokine expression, no induction of iNOS, and elevated markers of 
alternative activation, including CD206, dectin-1, arginase-1 (Arg-1), and chitinase 3-like 3 
(Ym1) (Daley et al., 2010; Black et al., 2008)  It is worth noting that the complexity of 
studying alternatively-activated M2 macrophage phenotypes is also attributed to divergent 
profiles in different animal models. While Arg-1 has become a reliable marker of murine M2 
macrophages, it is not a good marker for human M2 macrophages.  
The M2 macrophage phenotype describes a broad category of anti-inflammatory, wound 
healing macrophages that down-regulate effects of pro-inflammatory M1 macrophages and 
have often been described as IL-4/IL-13-dependent. However, both M1 and M2-like 
macrophage phenotypes were also observed in wounds in mice where IL-4 and IL-13 
signaling is absent. Stimulation of macrophages with IL-4 and IL-13 (cytokines produced by 
induced CD4+ Th2 and CD8+ Tc2 cells, NK cells, basophils, mast cells, eosinophils) results 
in “alternative activation“ of macrophages . These “alternatively activated“ macrophages 
were first termed  M2 macrophages, have anti-inflammatory and wound healing properties, 
and are associated with allergic and anti-parasitic responses (Martinez et al., 2009). M2 
macrophages express low levels of pro-inflammatory mediators (such as TNF-, IL-12, IL-
1, IL-8, and oxygen radicals) and express elevated levels of anti-inflammatory cytokines, 
growth factors, and phagocytic receptors such as IL-10, VEGF, TGF-, CD206 mannose 
receptor, and CD204 scavenger receptor (Martinez et al., 2009; Classen et al., 2009;  Stein et 
al., 1992; Abramson and Gallin, 1990). M2 macrophages tailor immune responses by 
chemokine secretion patterns that attract specific sets of leukocytes (monocytes, basophils, 
memory T cells, Th2 cells, and eosinophils). See Table 1 for a list of some M2 macrophage 
markers (Martinez et al., 2009; Classen et al., 2009; Mantovani et al., 2006). In addition to 
their key role in resolving inflammation and mediating repair, M2 macrophages also play a 
role in some pathological processes. Up-regulation of alternative macrophage gene 
expression leads to stifling of Th1 responses and consequent vulnerability to infection, 
allergic responses in asthma, tumor progression assisted by tumor-associated M2-like 
macrophages (TAMs), and fibroproliferative complications of infection and inflammation 
(VanGinderarchter et al., 2006; Mantovani et al., 2006; Luo et al., 2006; Yang et al., 2009; 
Porta et al., 2009; Macedo et al., 2007).  
Further characterization of macrophages has lead to the exploration of other types of 
alternatively activated M2-like macrophages involved in wound healing that are IL-4/IL-13-
independent. The broad category of M2 macrophages has been subdivided based on 
inducing agents and subsequent expression patterns. M2 macrophage subtypes include the 
more commonly investigated M2a macrophage (activated by IL-4 or IL-13), M2b 
macrophage (induced by immune complexes (ICs) and IL-1 or TLR agonists), M2c 
macrophage (stimulated by IL-10, transforming growth factor- (TGF- or glucocorticoids), 
and M2d macrophage (a new subtype induced by switching M1 macrophages into M2-like 
macrophages through initial TLR activation followed by adenosine A2A receptor (A2AR) 
activation) (Figure 2) (Martinez et al., 2009; Leibovich et al., 2011).  
In contrast to the relatively well-characterized M2a macrophage subtype, many M2 
macrophages (M2b, M2c, M2d) are not associated with a Th2 immune response or IL-
4/IL-13 activation. Evidence of this is seen with M2 macrophage activation in IL-4R KO 
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mitochondria of apoptotic neutrophils, and IFN- (produced by activated Th1, Tc1, NK 
cells). Pro-inflammatory and cytotoxic responses against intracellular pathogens and 
transformed cells (such as cancer cells) are directedthrough induction of cytokines (e.g., IL-1, 
IL-6, IL-12, TNF-) and inflammatory mediators (e.g., nitric oxide (NO) through inducible 
NO synthase (iNOS)), and increases in leukocyte recruitment and phagocytic and antigen 
presenting activity. These initial, pro-inflammatory M1 macrophages predominate in the 
early wound, which becomes a dynamic cauldron of mediators that are in constant flux as 
interactions, inductions, and adaptations take place (Martinez et al., 2009; Classen et al., 
2009; VanGinderarchter et al., 2006). In contrast, M2 macrophages are critical for the 
resolution of inflammation and the induction of angiogenesis, tissue remodeling, and repair 
through production of anti-inflammatory cytokines, growth and angiogenic factors, and by 
phagocytosis and elimination of debris (Martinez et al., 2009; Daley et al., 2010; Classen et 
al., 2009; Taylor et al., 2005; Rubartelli et al., 2007; VanGinderarchter et al., 2006). M2 
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Table 1. Inducing agents involved in the regulation of gene expression contribute to the 
development of M1 and M2 macrophage phenotypes. (Martines et al., 2009; Leibovich et al., 
2011). 
3.1.2 M2 macrophages 
Macrophage phenotypes can vary and switch based on temporal and environmental cues, 
making their investigation and classification complex. Wound macrophages in the early 
stages of healing have a more M1-like profile with elevated expression of TNF- and IL-6 
and less TGF-while those in later stages of healing have a more M2-like profile, with less 
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pro-inflammatory cytokine expression, no induction of iNOS, and elevated markers of 
alternative activation, including CD206, dectin-1, arginase-1 (Arg-1), and chitinase 3-like 3 
(Ym1) (Daley et al., 2010; Black et al., 2008)  It is worth noting that the complexity of 
studying alternatively-activated M2 macrophage phenotypes is also attributed to divergent 
profiles in different animal models. While Arg-1 has become a reliable marker of murine M2 
macrophages, it is not a good marker for human M2 macrophages.  
The M2 macrophage phenotype describes a broad category of anti-inflammatory, wound 
healing macrophages that down-regulate effects of pro-inflammatory M1 macrophages and 
have often been described as IL-4/IL-13-dependent. However, both M1 and M2-like 
macrophage phenotypes were also observed in wounds in mice where IL-4 and IL-13 
signaling is absent. Stimulation of macrophages with IL-4 and IL-13 (cytokines produced by 
induced CD4+ Th2 and CD8+ Tc2 cells, NK cells, basophils, mast cells, eosinophils) results 
in “alternative activation“ of macrophages . These “alternatively activated“ macrophages 
were first termed  M2 macrophages, have anti-inflammatory and wound healing properties, 
and are associated with allergic and anti-parasitic responses (Martinez et al., 2009). M2 
macrophages express low levels of pro-inflammatory mediators (such as TNF-, IL-12, IL-
1, IL-8, and oxygen radicals) and express elevated levels of anti-inflammatory cytokines, 
growth factors, and phagocytic receptors such as IL-10, VEGF, TGF-, CD206 mannose 
receptor, and CD204 scavenger receptor (Martinez et al., 2009; Classen et al., 2009;  Stein et 
al., 1992; Abramson and Gallin, 1990). M2 macrophages tailor immune responses by 
chemokine secretion patterns that attract specific sets of leukocytes (monocytes, basophils, 
memory T cells, Th2 cells, and eosinophils). See Table 1 for a list of some M2 macrophage 
markers (Martinez et al., 2009; Classen et al., 2009; Mantovani et al., 2006). In addition to 
their key role in resolving inflammation and mediating repair, M2 macrophages also play a 
role in some pathological processes. Up-regulation of alternative macrophage gene 
expression leads to stifling of Th1 responses and consequent vulnerability to infection, 
allergic responses in asthma, tumor progression assisted by tumor-associated M2-like 
macrophages (TAMs), and fibroproliferative complications of infection and inflammation 
(VanGinderarchter et al., 2006; Mantovani et al., 2006; Luo et al., 2006; Yang et al., 2009; 
Porta et al., 2009; Macedo et al., 2007).  
Further characterization of macrophages has lead to the exploration of other types of 
alternatively activated M2-like macrophages involved in wound healing that are IL-4/IL-13-
independent. The broad category of M2 macrophages has been subdivided based on 
inducing agents and subsequent expression patterns. M2 macrophage subtypes include the 
more commonly investigated M2a macrophage (activated by IL-4 or IL-13), M2b 
macrophage (induced by immune complexes (ICs) and IL-1 or TLR agonists), M2c 
macrophage (stimulated by IL-10, transforming growth factor- (TGF- or glucocorticoids), 
and M2d macrophage (a new subtype induced by switching M1 macrophages into M2-like 
macrophages through initial TLR activation followed by adenosine A2A receptor (A2AR) 
activation) (Figure 2) (Martinez et al., 2009; Leibovich et al., 2011).  
In contrast to the relatively well-characterized M2a macrophage subtype, many M2 
macrophages (M2b, M2c, M2d) are not associated with a Th2 immune response or IL-
4/IL-13 activation. Evidence of this is seen with M2 macrophage activation in IL-4R KO 
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mice and in the presence of the IL-13R2 decoy receptor in spite of inhibition of IL-13-
dependent phosphorylation of downstream STAT6 and the absence of IL-4 or IL-13 in the 
wound environment. These IL-4/IL-13-deficient mice exhibit macrophages with both M1 
and M2 overlapping and non-overlapping expression patterns (Daley et al., 2010; 
Leibovich et al., 2011).  
 
 
Fig. 2. The broad spectrum of macrophage phenotypes induced by various agents show 
overlapping and non-overlapping patterns of gene expression.  
Investigation of the influence of multiple co-stimulators on macrophages allows for some 
insight on downstream signaling pathways and the resulting phenotypic macrophage 
profiles. For example, in the inflammatory environment, the retaliatory metabolite 
adenosine rapidly accumulates extracellularly as an ATP breakdown product and TLRs and 
A2ARs are both expressed on macrophages as important regulators of inflammation and 
repair. Understanding the downstream effects from simultaneous activation of these 
receptors may provide insight on how to enhance or block M2 macrophage effects by 
regulating signaling mediators or using receptor agonists or antagonists. Characterization of 
M2 macrophages by simultaneous induction with multiple agents may more accurately 
mimic true micro-environmental conditions. Co-stimulation of TLRs and A2ARs may be a 
more relevant reflection of macrophage surroundings, where adenosine accumulation 
occurs in inflammatory, ischemic, and hypoxic settings, leading to phenotype switching 
from TLR agonist-induced pro-inflammatory M1 macrophages (secrete TNF- and IL-12) to 
adenosine-induced wound healing and anti-inflammatory M2d macrophages (down-
regulation of TNF- and IL-12 and secretion of IL-10 and VEGF) in a temporally defined 
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manner. This induction of A2ARs plays a key role in switching pro-inflammatory M1 to an 
angiogenic M2-like phenotype. Solitary activation of these receptors may not show 
expression patterns seen in co-stimulation models. This example of receptor co-stimulation 
on macrophages shows that macrophage activation and its role in wound healing is a 
complex event involving multiple micro-environmental stimuli (Leibovich et al., 2011; 
Macedo et al., 2007). Knowledge of the processes leading to the phenotypic switches 
occurring in macrophages may yield potential therapeutic targets for promoting wound 
healing or for dampeningabnormal wound healing. Although macrophages have varying 
and dynamic roles that adapt to activating agents in the surrounding milieu, a clear 
understanding of how to manipulate and switch these phenotypic profiles may provide 
potential benefits.  
4. Placental macrophages 
In adult tissues, macrophages coordinate tissue homeostasis and orchestrate host defense 
and wound healing. During fetal development, macrophages are abundantly present in the 
pregnant uterus and placenta. These placental macrophages play a key role in synthesis of 
vital mediators involved in the establishment and maintenance of pregnancy, parturition, 
lactation, local immune reactions, and maternal-fetal tolerance.  
Although they exhibit their own, unique phenotypic profile, placental macrophages display 
key features of many other tissue macrophages. These characteristics include growth with 
stimulation by colony-stimulating factor-1, expression of Fc receptors and phagocytosis, and 
expression of macrophage markers (CD14, CD11b/Cd18, and F4/80) (Chang et al., 1993).  
4.1 Origins of placental macrophages 
In the human placenta, macrophages have been detected as early as day 10 of pregnancy 
and many of these macrophages are present throughout pregnancy (Chang et al., 1993)  
Placental macrophages reside within fetal chorionic villi and uterine decidua during 
pregnancy, where they assist placental development, manage host defense, and maintain 
pregnancy.  
Fetal placental macrophages and maternal placental macrophages reach the placenta by 
different routes. During prenatal development, monocyte progenitors originate in the 
hypoblast-derived fetal yolk sac and migrate to the mesenchymal core of fetal chorionic villi 
in the placenta. These placental macrophages on the fetal side are called Hofbauer cells. 
Placental macrophages on the maternal side of the placenta are derived from hematopoietic 
pluripotent stem cells that differentiate into monocyte progenitors, which will mature and 
leave the bone marrow to enter the blood. After an approximate  8 hour migration through 
the circulatory system, the maturing monocyte will enter various organs and tissues, such as 
the uterine endometrial stroma, where tissue-specific factors will further induce 
differentiation to form a tissue macrophage (Figure 3) (McIntire et al., 2006). 
4.2 General functions of placental macrophages 
Macrophages are present in many tissues, including the placenta, and make up a dynamic 
and heterogenous population of cells. Macrophage phenotypes and functions, which are 
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mice and in the presence of the IL-13R2 decoy receptor in spite of inhibition of IL-13-
dependent phosphorylation of downstream STAT6 and the absence of IL-4 or IL-13 in the 
wound environment. These IL-4/IL-13-deficient mice exhibit macrophages with both M1 
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regulating signaling mediators or using receptor agonists or antagonists. Characterization of 
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manner. This induction of A2ARs plays a key role in switching pro-inflammatory M1 to an 
angiogenic M2-like phenotype. Solitary activation of these receptors may not show 
expression patterns seen in co-stimulation models. This example of receptor co-stimulation 
on macrophages shows that macrophage activation and its role in wound healing is a 
complex event involving multiple micro-environmental stimuli (Leibovich et al., 2011; 
Macedo et al., 2007). Knowledge of the processes leading to the phenotypic switches 
occurring in macrophages may yield potential therapeutic targets for promoting wound 
healing or for dampeningabnormal wound healing. Although macrophages have varying 
and dynamic roles that adapt to activating agents in the surrounding milieu, a clear 
understanding of how to manipulate and switch these phenotypic profiles may provide 
potential benefits.  
4. Placental macrophages 
In adult tissues, macrophages coordinate tissue homeostasis and orchestrate host defense 
and wound healing. During fetal development, macrophages are abundantly present in the 
pregnant uterus and placenta. These placental macrophages play a key role in synthesis of 
vital mediators involved in the establishment and maintenance of pregnancy, parturition, 
lactation, local immune reactions, and maternal-fetal tolerance.  
Although they exhibit their own, unique phenotypic profile, placental macrophages display 
key features of many other tissue macrophages. These characteristics include growth with 
stimulation by colony-stimulating factor-1, expression of Fc receptors and phagocytosis, and 
expression of macrophage markers (CD14, CD11b/Cd18, and F4/80) (Chang et al., 1993).  
4.1 Origins of placental macrophages 
In the human placenta, macrophages have been detected as early as day 10 of pregnancy 
and many of these macrophages are present throughout pregnancy (Chang et al., 1993)  
Placental macrophages reside within fetal chorionic villi and uterine decidua during 
pregnancy, where they assist placental development, manage host defense, and maintain 
pregnancy.  
Fetal placental macrophages and maternal placental macrophages reach the placenta by 
different routes. During prenatal development, monocyte progenitors originate in the 
hypoblast-derived fetal yolk sac and migrate to the mesenchymal core of fetal chorionic villi 
in the placenta. These placental macrophages on the fetal side are called Hofbauer cells. 
Placental macrophages on the maternal side of the placenta are derived from hematopoietic 
pluripotent stem cells that differentiate into monocyte progenitors, which will mature and 
leave the bone marrow to enter the blood. After an approximate  8 hour migration through 
the circulatory system, the maturing monocyte will enter various organs and tissues, such as 
the uterine endometrial stroma, where tissue-specific factors will further induce 
differentiation to form a tissue macrophage (Figure 3) (McIntire et al., 2006). 
4.2 General functions of placental macrophages 
Macrophages are present in many tissues, including the placenta, and make up a dynamic 
and heterogenous population of cells. Macrophage phenotypes and functions, which are 
 
Embryology – Updates and Highlights on Classic Topics 
 
134 
induced at least in part by the surrounding micro-environmental milieu, are crucial in 
inflammation, immunity, and wound healing. Macrophages are induced by environmental 
cues to regulate expression of growth factors, chemokines, cytokines, proteolytic enzymes, 
adhesion molecules, and phagocytic receptors (Martinez et al., 2009).  
 
 
Fig. 3. Placental macrophages originate from two different sources. Hofbauer cells originate 
from yolk sac cells that migrate to ultimately take up residence in the fetal chorionic villi of 
the placenta. Decidual macrophages are bone marrow-derived and take up residence in the 
uterine endometrial stroma of the placenta’s decidua basalis.  
Macrophages are abundant in the placenta and play a large role through regulation of 
immune cells and tissue growth. Placental macrophages are influential in many processes, 
including implantation, trophoblast function, placenta construction (via induction of 
angiogenesis), maternal-fetal tolerance, fetal defense/protection from infection, and 
parturition (Bulmer & Johnson, 1984; Mues et al., 1989; Sevala et al., 2007; Kzhyshkowska et 
al., 2008; Nagamatsu & Schust, 2010; Garcia et al., 1993). Placental macrophages are pivotal 
to many of these processes because of their plasticity and ability to switch phenotypes 
based on surrounding micro-environmental cues. For example, decidual placental 
macrophages respond to placental stimuli that control maternal immune reponses to the 
fetus (maternal-fetal tolerance) as well as to pathogenic stimuli during infections (host 
defense). During pregnancy, placental macrophages are exposed to local stimuli that induce 
an array of macrophage phenotypes with M1 and M2 characteristics. Placental macrophages 
express surface markers and secrete mediators such as cytokines, prostaglandins, proteolytic 
enzymes, and chemokines (McIntire et al., 2006). It should be noted that while 
microenvironmental modulation of placental macrophages plays an important role in 
regulating macrophage phenotype, it is also possible that selective recruitment of distinct 
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monocyte sub-populations might also play role. The nature of the monocyte precursor 
subpopulations that give rise to resident placental macrophages has not been studied in 
detail, and the role of local proliferation of macrophages in the placenta versus recruitment 
of new macrophages from the circulation in the maintenance of macrophage homeostasis is 
not yet clear. 
4.2.1 Placental macrophages in placenta construction 
Macrophages are abundant in fetal tissue and these macrophages play a role in placental 
development. Angiogenesis is critical for vascular development in the fetal chorionic villi of 
the placenta and is induced by secretion of VEGF from nearby Hofbauer cells located in the 
chorionic villus mesenchyme. VEGF binds the fms-like tyrosine kinase 1 receptor (Flt-1), 
which is expressed on trophoblast and endothelial cells during early pregnancy (Clark et al., 
1986). Interestingly, the placenta produces elevated levels of soluble Flt-1 receptor (sFlt-1) in 
women with pre-eclampsia. This sFlt-1 sequesters VEGF and results in dysfunctional 
angiogenesis in the placenta (Luttun and Carmeliet, 2003)  Placental development 
progresses (apoptosis, phagocytosis, matrix degradation, remodeling) via continued 
interactions between maternal decidual placental macrophages and fetal-derived 
trophoblasts (Nagamatsu & Schust, 2010).  
In addition to secretion of angiogenic factors by fetal Hofbauer cells that  promote 
angiogenesis during placental development, maternal decidual placental macrophages also 
contribute to angiogenesis in the placenta by the abundant expression of the stabilin-1 
scavenger receptor. Stabilin-1 is a receptor for placental lactogen (PL), a prolactin growth 
hormone secreted by trophoblasts. PL is important for placental angiogenesis, as seen by 
the correlation between low PL concentrations and aberrant placental angiogenesis leading 
to intrauterine growth restriction. PL is also involved in post-natal growth and 
mammogenesis/lactogenesis (Kzhyshkowska et al., 2008). Stabilin-1 binds and endocytoses 
PL. Internalized PL within the decidual macrophage can then proceed through a 
degradation pathway in which PL within lysosomes is enzymatically digested or through a 
storage pathway in which PL migrates to the trans-Golgi network for processing to be stored 
within secretory vesicles until called upon for release by low extracellular PL concentrations. 
Therefore, stabilin-1 expression on decidual M2 macrophages may serve as a sensor to 
regulate extracellular PL (through endocytosis and intracellular sorting of PL) and result in 
further regulation of factors involved in angiogenesis during placental growth 
(Kzhyshkowska et al., 2008). 
4.2.2 Placental macrophages in maternal-fetal tolerance 
There are multiple factors involved in maternal-fetal tolerance. Decidual placental 
macrophages are an integral component for suppression of the maternal immunologic 
response to the allogenic placenta and fetus. Macrophages are antigen presenting cells 
(APCs) that often activate T cells to initiate an adaptive immune response. However, 
although decidual placental macrophages constitutively express major histocompatibility 
complex class II molecules, they have a decreased ability to present antigens to T cells. As a 
result, T lymphocyte activation does not occur and the allogenic fetus is protected from 
rejection by the maternal immune system. Another result of placental macrophage inability 
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induced at least in part by the surrounding micro-environmental milieu, are crucial in 
inflammation, immunity, and wound healing. Macrophages are induced by environmental 
cues to regulate expression of growth factors, chemokines, cytokines, proteolytic enzymes, 
adhesion molecules, and phagocytic receptors (Martinez et al., 2009).  
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defense). During pregnancy, placental macrophages are exposed to local stimuli that induce 
an array of macrophage phenotypes with M1 and M2 characteristics. Placental macrophages 
express surface markers and secrete mediators such as cytokines, prostaglandins, proteolytic 
enzymes, and chemokines (McIntire et al., 2006). It should be noted that while 
microenvironmental modulation of placental macrophages plays an important role in 
regulating macrophage phenotype, it is also possible that selective recruitment of distinct 
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monocyte sub-populations might also play role. The nature of the monocyte precursor 
subpopulations that give rise to resident placental macrophages has not been studied in 
detail, and the role of local proliferation of macrophages in the placenta versus recruitment 
of new macrophages from the circulation in the maintenance of macrophage homeostasis is 
not yet clear. 
4.2.1 Placental macrophages in placenta construction 
Macrophages are abundant in fetal tissue and these macrophages play a role in placental 
development. Angiogenesis is critical for vascular development in the fetal chorionic villi of 
the placenta and is induced by secretion of VEGF from nearby Hofbauer cells located in the 
chorionic villus mesenchyme. VEGF binds the fms-like tyrosine kinase 1 receptor (Flt-1), 
which is expressed on trophoblast and endothelial cells during early pregnancy (Clark et al., 
1986). Interestingly, the placenta produces elevated levels of soluble Flt-1 receptor (sFlt-1) in 
women with pre-eclampsia. This sFlt-1 sequesters VEGF and results in dysfunctional 
angiogenesis in the placenta (Luttun and Carmeliet, 2003)  Placental development 
progresses (apoptosis, phagocytosis, matrix degradation, remodeling) via continued 
interactions between maternal decidual placental macrophages and fetal-derived 
trophoblasts (Nagamatsu & Schust, 2010).  
In addition to secretion of angiogenic factors by fetal Hofbauer cells that  promote 
angiogenesis during placental development, maternal decidual placental macrophages also 
contribute to angiogenesis in the placenta by the abundant expression of the stabilin-1 
scavenger receptor. Stabilin-1 is a receptor for placental lactogen (PL), a prolactin growth 
hormone secreted by trophoblasts. PL is important for placental angiogenesis, as seen by 
the correlation between low PL concentrations and aberrant placental angiogenesis leading 
to intrauterine growth restriction. PL is also involved in post-natal growth and 
mammogenesis/lactogenesis (Kzhyshkowska et al., 2008). Stabilin-1 binds and endocytoses 
PL. Internalized PL within the decidual macrophage can then proceed through a 
degradation pathway in which PL within lysosomes is enzymatically digested or through a 
storage pathway in which PL migrates to the trans-Golgi network for processing to be stored 
within secretory vesicles until called upon for release by low extracellular PL concentrations. 
Therefore, stabilin-1 expression on decidual M2 macrophages may serve as a sensor to 
regulate extracellular PL (through endocytosis and intracellular sorting of PL) and result in 
further regulation of factors involved in angiogenesis during placental growth 
(Kzhyshkowska et al., 2008). 
4.2.2 Placental macrophages in maternal-fetal tolerance 
There are multiple factors involved in maternal-fetal tolerance. Decidual placental 
macrophages are an integral component for suppression of the maternal immunologic 
response to the allogenic placenta and fetus. Macrophages are antigen presenting cells 
(APCs) that often activate T cells to initiate an adaptive immune response. However, 
although decidual placental macrophages constitutively express major histocompatibility 
complex class II molecules, they have a decreased ability to present antigens to T cells. As a 
result, T lymphocyte activation does not occur and the allogenic fetus is protected from 
rejection by the maternal immune system. Another result of placental macrophage inability 
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to present antigen to T cells is the inability of placental macrophages to induce an efficient 
immune response against Listeria monocytogene despite expressing MHC class II molecules 
(Chang et al., 1993; Nagamatsu & Schust, 2010) Furthermore, placental macrophages express 
higher levels of indole 2,3 dioxygenase (IDO), which catabolizes L-tryptophan. L-
tryptophan is required for T-cell activation and inhibition of IDO correlated to rejection of 
the fetus by the mother (Gordon et al., 2003).  
4.2.3 Placental macrophages as a barrier to infection 
The main defenders against infection of the placenta are placental macrophages. Among 
many other functions, macrophages play a vital role in removal of nonself as well as 
unwanted self-ligands through expression of scavenger receptors and other receptors that 
are targeted for pathogen binding, such as Toll-like receptors (e.g., TLR4 bind LPS) and 
chemokine-CC motif-receptor 5 (CCR5) (HIV-1 infection requires surface expression of 
CCR5 and CD4). While sometimes displaying a weak barrier to some pathogens like 
Listeria monocytogenes, placental macrophages often show a strong barrier to numerous 
bacterial and viral infections (Garcia-Crespo et al., 2009; Kzhyshkowska et al., 2008).   
Although macrophages are primary targets for viral infection, placental macrophages are 
less susceptible to HIV-1 infection (and other viral infections) than other macrophages. The 
placenta is often a barrier to viral replication, and viral transmission from mother to infant 
often occurs during the birth. Placental macrophages show lower levels of susceptibility to 
HIV-1 infection than monocyte-derived macrophages and this may be attributed to differing 
phenotypes. Although there are lower levels of CD4 and CCR5 expression in placental 
macrophages, it has been suggested that the mode of HIV-1 restriction in the placenta occurs 
at the transcriptional level. HIV-1-infected placental macrophages and monocyte-derived 
macrophages show different protein secretion profiles. Peroxiredoxins are antioxidant 
molecules that are more abundantly associated with placental macrophages compared to 
monocyte-derived macrophages. Also, some peroxiredoxins (1,2, and 4) have been shown to 
have anti-viral activity against HIV-1. Compared to monocyte-derived macrophages, 
placental macrophages show abundant secretion of peroxiredoxin 5. The up-regulated 
secretion of peroxiredoxin and its protective role against HIV-1 in the placenta may be 
through suppression of TNF--induced transcriptional activity of nuclear factor-kappa light 
chain enhancer of activated B cells (NF-B). In fact, although there appears to be no 
difference in viral integration for placental macrophages versus other monocyte-derived 
macrophages, there is reduced viral protein expression in placental macrophages. Therefore, 
HIV-1 restriction appears to be occuring in placental macrophages at the transcriptional 
level. NF-B is required for viral transcription of HIV-1 and suppression may lead to 
inefficient HIV-1 replication in placental macrophages. TNF--induced transcriptional 
activity of NF-B may also be thwarted in placental macrophages by down-regulation of 
cystatin B. Cystatin B induces NO production in macrophages, which up-regulates TNF-. 
Reduced HIV-1 replication has been correlated with cystatin B down-regulation and 
increased HIV-1 replication is enhanced by NO synthesis in macrophages. These factors 
(among others) distinguish placental macrophages from other macrophages and are 
influential in the restriction of HIV-1 (and perhaps other viruses) in the placenta (Garcia et 
al, 2009; Garcia-Crespo et al., 2010). 
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4.2.4 Placental macrophages as a mediator in parturition and other signaling/hormone 
Placental macrophages exhibit varying phenotypes throughout pregnancy. Placental 
macrophages are stimulated by changes in the micro-environment to switch phenotypes at 
varying stages of pregnancy as well as during aberrant activity. During late pregnancy, 
placental macrophage activity is switched to play a role in parturition through production of 
pro-inflammatory cytokines and prostaglandin E2. Altered placental macrophage 
phenotypes are also linked to the pathologic disease such as preeclampsia (Nagamatsu & 
Schust, 2010; Wetzka et al., 1997). 
During most of pregnancy placental macrophages have an M2-like immunosuppressive 
gene expression profile (such as IL-10 secretion). However, decidual placental macrophages 
may expess pro-inflammatory characteristics. For example, CD11cHI decidual placental 
macrophages may express pro-inflammatory and antigen-presenting genes while CD11cLO 
decidual placental macrophages express anti-inflammatory and tissue repair genes (Houser 
et al., 2011). It is important to recognize that classification of placental macrophages is 
complex and dependent on multiple factors, such as location within the placenta, stage of 
pregnancy, and factors (e.g., hormones and hypoxia) that change the surrounding micro-
environment. Differential recruitment of distinct monocyte sub-populations may also play 
a role, as mentioned earlier. 
4.3 M2-type placental macrophages 
Placental macrophages display polarization towards an alternatively-activated, M2 
phenotype. Hofbauer cells (fetal placental macrophages within chorionic villi) and decidual 
macrophages (maternal placental macrophages within the endometrial decidual stroma) are 
both classified as M2/alternatively-activated macrophages (Joerink et al., 2011; Gustafsson 
et al., 2011). The role of IL-4 in polarization of placental macrophages is blurred by variable 
placental macrophage phenotypic profiles. Although IL-4 is involved in endocytosis of 
stabilin-1-bound PL by placental macrophages, decidual macrophages induced via IL-4-
independent means display different expression profiles than those seen with IL-4 
stimulation, indicating that a Th2 environment is not required for decidual macrophage 
development (Svensson et al., 2011; Kzhyshkowska et al., 2008).  
As M2 macrophages, the placental macrophage profile typically shows down-regulation 
of pro-inflammatory mediators and up-regulation of mediators that are 
immunosuppressive and anti-inflammatory. However, as with many other tissue 
macrophages, a placental macrophage does not exhibit a phenotype extreme that solely 
expresses M2 markers. Placental macrophages may express M1 markers, but the 
representative expression pattern emphasizes many M2 markers. The placental 
macrophage M2 marker expression is regulated by activating agents (such as cytokines, 
hormones, and adenosine) in the surrounding micro-environment in a manner that yields 
an M2 phenotype profile that is distinct from other M2 macrophages. The exact nature 
and combinations of activating agents to achieve this unique profile has yet to be 
completely elucidated. Analyses of M2 placental macrophages from normal pregnancies 
and pregnancies with complications have shed some light on dysregulation. In fact, a 
correlation between dysregulation of some placental macrophage markers and 
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to present antigen to T cells is the inability of placental macrophages to induce an efficient 
immune response against Listeria monocytogene despite expressing MHC class II molecules 
(Chang et al., 1993; Nagamatsu & Schust, 2010) Furthermore, placental macrophages express 
higher levels of indole 2,3 dioxygenase (IDO), which catabolizes L-tryptophan. L-
tryptophan is required for T-cell activation and inhibition of IDO correlated to rejection of 
the fetus by the mother (Gordon et al., 2003).  
4.2.3 Placental macrophages as a barrier to infection 
The main defenders against infection of the placenta are placental macrophages. Among 
many other functions, macrophages play a vital role in removal of nonself as well as 
unwanted self-ligands through expression of scavenger receptors and other receptors that 
are targeted for pathogen binding, such as Toll-like receptors (e.g., TLR4 bind LPS) and 
chemokine-CC motif-receptor 5 (CCR5) (HIV-1 infection requires surface expression of 
CCR5 and CD4). While sometimes displaying a weak barrier to some pathogens like 
Listeria monocytogenes, placental macrophages often show a strong barrier to numerous 
bacterial and viral infections (Garcia-Crespo et al., 2009; Kzhyshkowska et al., 2008).   
Although macrophages are primary targets for viral infection, placental macrophages are 
less susceptible to HIV-1 infection (and other viral infections) than other macrophages. The 
placenta is often a barrier to viral replication, and viral transmission from mother to infant 
often occurs during the birth. Placental macrophages show lower levels of susceptibility to 
HIV-1 infection than monocyte-derived macrophages and this may be attributed to differing 
phenotypes. Although there are lower levels of CD4 and CCR5 expression in placental 
macrophages, it has been suggested that the mode of HIV-1 restriction in the placenta occurs 
at the transcriptional level. HIV-1-infected placental macrophages and monocyte-derived 
macrophages show different protein secretion profiles. Peroxiredoxins are antioxidant 
molecules that are more abundantly associated with placental macrophages compared to 
monocyte-derived macrophages. Also, some peroxiredoxins (1,2, and 4) have been shown to 
have anti-viral activity against HIV-1. Compared to monocyte-derived macrophages, 
placental macrophages show abundant secretion of peroxiredoxin 5. The up-regulated 
secretion of peroxiredoxin and its protective role against HIV-1 in the placenta may be 
through suppression of TNF--induced transcriptional activity of nuclear factor-kappa light 
chain enhancer of activated B cells (NF-B). In fact, although there appears to be no 
difference in viral integration for placental macrophages versus other monocyte-derived 
macrophages, there is reduced viral protein expression in placental macrophages. Therefore, 
HIV-1 restriction appears to be occuring in placental macrophages at the transcriptional 
level. NF-B is required for viral transcription of HIV-1 and suppression may lead to 
inefficient HIV-1 replication in placental macrophages. TNF--induced transcriptional 
activity of NF-B may also be thwarted in placental macrophages by down-regulation of 
cystatin B. Cystatin B induces NO production in macrophages, which up-regulates TNF-. 
Reduced HIV-1 replication has been correlated with cystatin B down-regulation and 
increased HIV-1 replication is enhanced by NO synthesis in macrophages. These factors 
(among others) distinguish placental macrophages from other macrophages and are 
influential in the restriction of HIV-1 (and perhaps other viruses) in the placenta (Garcia et 
al, 2009; Garcia-Crespo et al., 2010). 
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4.2.4 Placental macrophages as a mediator in parturition and other signaling/hormone 
Placental macrophages exhibit varying phenotypes throughout pregnancy. Placental 
macrophages are stimulated by changes in the micro-environment to switch phenotypes at 
varying stages of pregnancy as well as during aberrant activity. During late pregnancy, 
placental macrophage activity is switched to play a role in parturition through production of 
pro-inflammatory cytokines and prostaglandin E2. Altered placental macrophage 
phenotypes are also linked to the pathologic disease such as preeclampsia (Nagamatsu & 
Schust, 2010; Wetzka et al., 1997). 
During most of pregnancy placental macrophages have an M2-like immunosuppressive 
gene expression profile (such as IL-10 secretion). However, decidual placental macrophages 
may expess pro-inflammatory characteristics. For example, CD11cHI decidual placental 
macrophages may express pro-inflammatory and antigen-presenting genes while CD11cLO 
decidual placental macrophages express anti-inflammatory and tissue repair genes (Houser 
et al., 2011). It is important to recognize that classification of placental macrophages is 
complex and dependent on multiple factors, such as location within the placenta, stage of 
pregnancy, and factors (e.g., hormones and hypoxia) that change the surrounding micro-
environment. Differential recruitment of distinct monocyte sub-populations may also play 
a role, as mentioned earlier. 
4.3 M2-type placental macrophages 
Placental macrophages display polarization towards an alternatively-activated, M2 
phenotype. Hofbauer cells (fetal placental macrophages within chorionic villi) and decidual 
macrophages (maternal placental macrophages within the endometrial decidual stroma) are 
both classified as M2/alternatively-activated macrophages (Joerink et al., 2011; Gustafsson 
et al., 2011). The role of IL-4 in polarization of placental macrophages is blurred by variable 
placental macrophage phenotypic profiles. Although IL-4 is involved in endocytosis of 
stabilin-1-bound PL by placental macrophages, decidual macrophages induced via IL-4-
independent means display different expression profiles than those seen with IL-4 
stimulation, indicating that a Th2 environment is not required for decidual macrophage 
development (Svensson et al., 2011; Kzhyshkowska et al., 2008).  
As M2 macrophages, the placental macrophage profile typically shows down-regulation 
of pro-inflammatory mediators and up-regulation of mediators that are 
immunosuppressive and anti-inflammatory. However, as with many other tissue 
macrophages, a placental macrophage does not exhibit a phenotype extreme that solely 
expresses M2 markers. Placental macrophages may express M1 markers, but the 
representative expression pattern emphasizes many M2 markers. The placental 
macrophage M2 marker expression is regulated by activating agents (such as cytokines, 
hormones, and adenosine) in the surrounding micro-environment in a manner that yields 
an M2 phenotype profile that is distinct from other M2 macrophages. The exact nature 
and combinations of activating agents to achieve this unique profile has yet to be 
completely elucidated. Analyses of M2 placental macrophages from normal pregnancies 
and pregnancies with complications have shed some light on dysregulation. In fact, a 
correlation between dysregulation of some placental macrophage markers and 
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preeclampsia (MR, CCL2, IGF-1, MMP9), pre-term labor (CCL18) and intrauterine growth 
restriction (IGF-1) has been shown (Gustafsson et al., 2011).  
Placental macrophages typically lack or exhibit low expression of pro-inflammatory M1 
markers (such as CX3CR1, IL-7R and CCR7), as described in Hofbauer cells by Joerink et al. 
(2011). Many placental macrophage M2 markers have been investigated. A number of M2 
markers have been identified in placental macrophages such as DC-SIGN (attachment factor 
for HIV-1 entry), CD163 and mannose receptor/CD206, stabilin-1, CCL18 (involved in 
tolerance of T lymphocytes with reduced expression after the onset of labor), CD209, 
fibronectin-1 and insulin-like growth factor-1 (IGF-1), TREM-2, alpha 2 macroglobulin 
(A2M), prostaglandin D2 synthase (PGDS), and IL-10 (Kzhyshkowska et al., 2008; 
Gustafsson et al., 2011; Svensson et al., 2011; Joerink et al., 2011). Recall that placental 
macrophages are not at the extreme end of the M2 spectrum of macrophages and that M1-
type markers can also be seen in placental macrophage populations. For example, placental 
macrophages express IL-6 and CCL2 (aka monocyte-chemoattractant protein-1, MCP-1), 
which are typically pro-inflammatory M1 markers. It has been suggested that CCL2 
expression by placental macrophages may be important for monocyte recruitment to 
decidua and that macrophage phenotypes may then be altered by other environmental 
factors upon arrival (Svensson et al., 2011; Gustafsson et al., 2011). Furthermore, Houser et 
al. (2011) have characterized decidual placental macrophages as having profiles associated 
with M1 and M2 macrophages. As mentioned previously,  CD11cHI decidual macrophages 
are pro-inflammatory while CD11cLO decidual macrophages are anti-inflammatory. Thus, 
decidual macrophages have varying phenotypes that help to coordinate maternal-fetal 
interactions at the placenta (Houser et al., 2011).  
5. Research and clinical implications  
5.1 Advantages and limitations of experimental models/materials 
It should be emphasized that some limitations to consider in the characterization of 
alternatively-activated macrophages include species-species variation in gene expression 
patterns and variable effects of the micro-environment surrounding macrophages. 
Investigation of M1 and M2 marker expression has been focused more predominantly using 
murine macrophages and human homologs for some murine markers have not been found  
(Martinez et al., 2009).  
Furthermore, agents in the environment surrounding macrophages influence macrophage 
activation, and while in vitro models are useful, analyses obtained from them are limited. 
Macrophages in culture enable investigators to highlight activation factors and gene 
expression patterns; however, absence of in vivo models may overlook interactions with 
other cell types and the mediators that they may elaborate. It is crucial to investigate 
interactions of expressed proteins that may be different in an in vivo  context in which there 
may be interaction with other cells or mediators. Macrophage activation is a complex and 
dynamic enterprise with characteristics that vary with time to result in early and late 
markers. For example, expression of CCL18 in decidual macrophages declines with onset of 
labor (Gustaffson et al., 2011). Macrophage phenotype switching is driven in a temporally-
orchestrated manner that depends upon alterations in the micro-environment, such as that 
seen in the changing placenta.  
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5.2 Clinical implications and future research 
M1 and M2 macrophages are pivotal players in host defense, wound repair, and 
pregnancy and further investigation into these polarized activated macrophage 
phenotypes may elucidate normal and variant processes. Knowledge of processes 
associated with placental macrophages may shed light on pathological mechanisms and 
may present attractive potential pharmaceutical targets to regulate disease. For example, 
decidual macrophages with overexpression of M1 markers have been implicated in 
parturition and early embryo loss (Gustaffson et al., 2011). Thus, manipulation of 
placental macrophage phenotypes by modulating signaling pathways in macrophages or 
by altering the surrounding environment may provide therapeutic benefits. For example, 
because of their angiogenic effects, induction of M2 macrophages phenotypes may 
enhance placental growth.  
6. Conclusion 
Macrophages are found throughout the body and exhibit a broad spectrum of phenotypes 
based in large part  on the surrounding microenvironment. Placental macrophages exhibit a 
phenotypic profile more characterisitic of M2 macrophages that are immunomodulatory 
and promote angiogenesis for placental development. Investigation of placental 
macrophages may provide insight into normal development as well as possible causes of 
embryo loss. 
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by altering the surrounding environment may provide therapeutic benefits. For example, 
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1. Introduction 
Early embryonic development is a very precise and complicated process. When a sperm 
meets an egg, a series of well-orchestrated changes take place, which end up with distinct 
types of cells that make up an organism. Cells start from a pluripotent state and differentiate 
without changes in DNA sequence. A differentiated cell shares the same DNA sequence 
with the zygote from which it is descended (mammalian B and T cells being an exception). 
The diverse functions of different cells are due to tissue-specific patterns of gene expression, 
which are established during development; once the fates of the cells are decided, they will 
be maintained faithfully through cell divisions. Hence it is reasonable to assert that 
development is, by definition, an epigenetic process (Reik, 2007). The specific gene 
expression programs in differentiated cells are regulated by a more flexible system, which 
dynamically switches on and off the genes for maintaining homeostasis or responding to 
environmental changes. 
Epigenetics is defined as “the study of heritable changes in genome function that occur 
without alterations to the DNA sequence” (Probst, et al., 2009). Epigenetics has been 
suggested as the key regulatory system in early development. Mechanistically, epigenetic 
regulation involves the covalent modification of chromatin components such as DNA 
methylation and histone modifications (acetylation, methylation and phosphorylation are 
the best characterized).  Short and long non-coding RNAs are also part of the epigenetic 
regulatory system because of their role in targeting the chromatin modifications within the 
genome (Hawkins & Morris, 2008; Morris, 2009a). DNA methylation at the cytosine residue 
of CpG dinucleotides is the most studied epigenetic modification in mammals. Its effects on 
genome function underlie a number of physiological phenomena such as genomic 
imprinting and X chromosome inactivation, and it also contributes to the genesis of human 
cancers and to aging. CpG methylation was the only known chemical modification of 
mammalian genomic DNA with an epigenetic role before the discovery of 5-
hydroxymethylcytosine that will be discussed later (Haluskova, 2010; Ohgane, et al., 2008). 
CpG methylation is stable, heritable and reversible, which fulfils the requirement for a 
dynamic regulation system for development. 
DNA methylation is most vulnerable to the environment during early development, because 
the genome methylation pattern is established during this stage and the DNA synthetic rate 
is very high in the early embryo. In mammals, proper DNA methylation is essential for 
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normal development. Aberrant methylation patterns are involved in various developmental 
pathological phenomena and even diseases in adult life that are known under the rubric:  
the Developmental Origin of Health and Disease (DOHaD) (Waterland & Michels, 2007).  
In this chapter, we will discuss the biochemistry of DNA CpG methylation including the 
enzymes catalyzing the process and the controversial pathways of DNA demethylation. The 
dynamics of DNA methylation in early development will be covered as well as the role of 
methylation in cell-lineage determination, imprinting and the genesis of germ cells. We will 
also review the evidence supporting the importance of DNA methylation in DOHaD. 
2. The biochemical mechanism of DNA methylation 
DNA methylation occurs via covalent modification of cytosine by adding a methyl group to 
the carbon-5 of the pyrimidine ring mainly in a 5’-CG-3’ dinucleotide pattern (CpG: C 
phosphodiester G). It is performed by the DNA methyltranferase (Dnmt) enzyme family. All 
identified Dnmts use S-Adenosylmethionine (SAM) as the methyl group (CH3) donor. SAM, 
a biological sulfonium compound, is a major methyl donor involved in a number of 
essential reactions, including DNA, RNA and protein methylation (Lin, 2011).  
The mechanism of DNA cytosine 5-methylation was analyzed for the prokaryotic Dnmt 
M.HhaI, which recognizes the specific sequence of 5’-GCGC-3’ and methylates the first 
cytosine (J. C. Wu & Santi, 1985, 1987). Prokaryotic and eukaryotic Dnmts share a number 
of conserved primary amino acid motifs that are believed to be important both 
structurally and functionally.  
 
Fig. 1. Catalytic mechanism of cytosine methylation by Dnmt.  
The Dnmt performs a nucleophilic attack on the C6, which leads to the formation of a 
covalent intermediate and activation of the C5. The activated C5 performs a nucleophilic 
attack on the methyl donor S-Adenosylmethionine (SAM) to acquire a methyl group from 
SAM. Following the methyl transfer, the C5 proton is eliminated and the intermediate  
is released, yielding the ultimate product: cytosine methylated on C5. Adapted from 
Kumar et al (1994). 
The key features of the catalytic mechanism involve the nucleophilic attack on the carbon-
6 of the target cytosine by a conserved cysteine residue of the enzyme and formation of a 
covalent intermediate (Kumar, et al., 1994) (Fig 1). The process is induced by binding of 
the enzyme to DNA, which turns the target cytosine 180° away from the DNA double 
helix and positions it in the active site with little disturbance to the rest of the DNA 
duplex. The details of this process, termed base flipping, are poorly understood 
(Gerasimaite, et al., 2011; Klimasauskas, et al., 1994; Matje, et al., 2011). The base flipping 
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pulls the target base into closer contact with the enzyme, allowing for the accurate 
recognition of the extrahelical base and the subsequent chemical reactions. The catalytic 
loop of the enzyme, which contains six highly conserved residues, including the catalytic 
nucleophile cysteine residue, moves towards the DNA and stabilizes the extrahelical base 
for methylation (Hermann, Gowher, et al., 2004; Matje, et al., 2011). The nucleophilic 
attack on carbon-6 is performed by the thiol group of the cysteine residue, whereas the 
carbon-5 is relatively unreactive. The positively charged sulfonium ion in SAM makes the 
methyl group that is bonded to the sulfur atom chemically reactive to nucleophilic attack 
(Hermann, Gowher, et al., 2004). The attack leads to the formation of a covalent 
intermediate between the enzyme and the carbon-6 atom of the flipped out target 
cytosine, which results in activation of the carbon-5 atom. The activated carbon-5 
performs a nucleophilic attack on SAM to acquire a methyl group from SAM. Following 
the methyl transfer, the carbon-5 proton is eliminated and the intermediate is released, 
yielding the ultimate product: cytosine methylated on carbon-5 (Hermann, Gowher, et al., 
2004; Klimasauskas, et al., 1994; Kumar, et al., 1994; Yoo & Medina-Franco, 2011). 
3. DNA methyltranferases (Dnmts) 
In mammals, the DNA methylation pattern is set up by three active members of the Dnmt 
family: Dnmt1, Dnmt3a and Dnmt3b. Dnmt3a and Dnmt3b are responsible for the de novo 
methylation that establishes the initial CpG methylation pattern during embryonic 
development, while Dnmt1 is required for maintenance of this pattern, copying the 
information to newly synthesized DNA during replication (Hermann, Goyal, et al., 2004). 
Although structurally similar to other Dnmts, the fourth member, Dnmt2, acts more as an 
RNA methyltransferase (Goll, et al., 2006). Dnmt3-Like protein (Dnmt3L) is a Dnmt-related 
protein that is catalytically inactive, but physically associates with Dnmt3a and Dnmt3b and 
modulates their catalytic activity (Hata, et al., 2002).  
3.1 Dnmt1 
Dnmt1 was the first discovered mammalian DNA methyltransferase (Gruenbaum, et al., 
1982). It is highly conserved among eukaryotes. Dnmt1 is a large single polypeptide that 
comprises 1620 amino acid residues. It contains a large N-terminal domain and a smaller 
C-terminal part, which are connected by a linker of glycine-lysine repeats (Frauer, et al., 
2011).  The N-terminal domain comprises several motifs and is responsible for 
intracellular targeting and regulation of catalytic activity. The C-terminal part harbours all 
ten catalytic motifs that have been identified in bacterial Dnmts (Goll & Bestor, 2005). 
However, studies have shown Dnmt1 exhibited no enzyme activity without the presence 
of its N-terminal domain (Fatemi, et al., 2001; Margot, et al., 2000; Zimmermann, et al., 
1997). In agreement with this, direct interactions between the C-terminal and N-terminal 
parts have been observed and found necessary for Dnmt1 enzyme activity (Fatemi, et al., 
2001; Margot, et al., 2003).   
Dnmt1 is responsible predominantly for the maintenance of DNA methylation information 
through cell divisions. Targeted mutation of the Dnmt1 gene in mice was lethal with 
significantly reduced levels of DNA methylation (E. Li, et al., 1992). The preference of 
Dnmt1 for hemimethylated CpG sites that appear after DNA replication is the key property 
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for this function. After DNA replication, methylated and unmethylated CpG sites are 
transformed into hemimethylated and unmethylated sites, respectively. Dnmt1 shows a 15- 
to 50- fold preference for methylation at hemimethylated sites compared with unmethylated 
sites (Fatemi, et al., 2001; Pradhan, et al., 1999; Zucker, et al., 1985). Dnmt1 acts on 
hemimethylated sites to ensure maintenance of DNA methylation patterns from parental to 
daughter genomes, which also makes it a major target of current pharmaceutical interest. 5-
aza-cytidine, which is an inhibitor of Dnmt1, has been approved by US Food and Drug 
Administration (FDA) for the treatment of all subtypes of myelodysplatic syndromes (MDS) 
(Kaminskas, et al., 2005). 
Dnmt1 was also found to have de novo methylation activity in mouse embryo lysates (Yoder, 
et al., 1997) and CpG island de novo methylation is related to Dnmt1 (Feltus, et al., 2003; Jair, 
et al., 2006). Additionally, Dnmt1 is required for maintenance of methylation in non-CpG 
DNA methylation (Grandjean, et al., 2007). Dnmt1 also interacts with a number of proteins, 
such as methyl-CpG binding proteins, histone deacetylases and histone methyltransferases, 
forming a complicated network regulating chromatin organization and gene expression 
(Kimura & Shiota, 2003).  
3.2 Dnmt2 
Dnmt2 was identified through the analysis of expressed sequence tags (EST) databases 
during a search for de novo DNA methyltransferases in 1998 (Van den Wyngaert, et al., 1998; 
Yoder & Bestor, 1998). Although the existence of all the consensus catalytic motifs strongly 
suggests DNA methyltranferase activity, no catalytic enzyme activity could be detected in 
initial assays. Dnmt2-deficient mouse embryonic stem cells were viable and no obvious 
DNA methylation changes were observed (Okano, et al., 1998b). The function of Dnmt2 
remained enigmatic until a comparatively weak DNA methyltransferase activity was 
demonstrated both in vitro and in vivo (Hermann, et al., 2003; Kunert, et al., 2003; Liu, et al., 
2003; Tang, et al., 2003). 
The weak enzyme activity, however, is not sufficient explanation for the surprisingly 
extensive conservation of Dnmt2 among different species ranging from Schizosaccharomyces 
pombe to Homo sapiens, which indicates an important biological role. Moreover, the 
presence of Dnmt2 is not always accompanied by the presence of DNA methylation, which 
suggests Dnmt2 has additional functions (Schaefer & Lyko, 2009). Studies have uncovered a 
robust transfer RNA (tRNA) methyltransferase activity of Dnmt2 through a DNA 
methyltransferase-like catalytic mechanism (Goll, et al., 2006; Jurkowski, et al., 2008). The 
functional significance of the dual DNA and RNA methyltransferase activity is still 
undiscovered. More work needs to be done to force the closed door of Dnmt2 open.  
3.3 Dnmt3 family 
The Dnmt3 family involves two active enzymes (Dnmt3a and Dnmt3b) and another Dnmt-
like protein (Dnmt3L). Dnmt3a and Dnmt3b were identified in the human and the mouse 
through a search of EST databases using full-length bacterial type II cytosine-5 
methyltransferase sequences. They share similar domain arrangements, including a variable 
region at the N-terminal, which is involved in enzyme targeting, and a C-terminal catalytic 
domain (Chen, et al., 2004).  
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Dnmt3a and Dnmt3b are highly expressed in undifferentiated embryonic stem (ES) cells. 
Though Dnmt3a expression can be readily detected in most adult tissues, Dnmt3b is 
expressed at very low levels in most tissues except testis, thyroid and bone marrow (Okano, 
et al., 1998a; Xie, et al., 1999). The methylation activities of Dnmt3a and Dnmt3b for 
unmethylated DNA and hemimethylated DNA are comparable (Okano, et al., 1998a). 
Inactivation of Dnmt3a and Dnmt3b in mouse ES cells impairs de novo methylation and 
causes postnatal and embryonic lethality respectively. Consequently, they were assigned to 
be responsible for the establishment of DNA methylation pattern during embryogenesis 
(Okano, et al., 1999).  
Encoded by different genes, Dnmt3a and Dnmt3b are functionally overlapping. The 
embryonic defects in mouse ES cells deficient in both Dnmt3a and Dnmt3b are more severe 
than in single mutant mice (Okano, et al., 1999). The two enzymes, however, possesses 
different functions during embryogenesis. Dnmt3b is the major de novo DNA 
methyltransferase detected at embryonic day 4.5-7.0 (E4.5–7.0) in mouse embryonic cells, 
whereas Dnmt3a is significantly and ubiquitously detectable after E10.5 when Dnmt3b is 
below the detection level (Watanabe, et al., 2002). Mutation of Dnmt3b is identified to be 
responsible for a rare autosomal recessive disorder, which is termed as ICF syndrome, 
characterized by immunodeficiency, facial anomalies and centromere instability (Hansen, et 
al., 1999). Dnmt3b also participates in maintaining aberrant hypermethylation in colorectal 
cancer cells, acting cooperatively with Dnmt1 (Rhee, et al., 2002). Lately, high recurrence of 
Dnmt3a mutations has been reported in acute myeloid leukemia (Ley, et al., 2010; Shah & 
Licht, 2011). In addition, certain CpG sites within the Fgf-1 gene locus have been proved to 
be selectively methylated by Dnmt3a in vivo but not by Dnmt3b (Oka, et al., 2006). The 
mechanism and significance of this activity are still undiscovered.  
Although the third member of Dnmt3 family, Dnmt3L, shows a high degree of structural 
similarities of its N-terminal PHD-like zinc finger domain to Dnmt3a and Dnmt3b, it has 
been shown to have no catalytic activity. Key catalytic residues in C-terminal that are 
necessary for DNA methyltransferase activity are missing in Dnmt3L (Aapola, et al., 2000; 
Cheng & Blumenthal, 2008). However, Dnmt3L was reported to play an important role in 
establishment of DNA methylation in maternally imprinted genes in mice (Hata, et al., 
2002). Deletion of the Dnmt3L gene results in aberrant de novo methylation of dispersed 
repeated DNA sequences in male germ cells (Bourc'his & Bestor, 2004). Besides, Dnmt3L has 
been shown to bind and colocalize with Dnmt3a and Dnmt3b in the nuclei of mammalian 
cells. It also stimulates de novo methylation by Dnmt3a in human cell lines (Chedin, et al., 
2002; Hata, et al., 2002).  
4. CpG content and methylation pattern in the DNA of mammalian cells and 
relationship to gene activity 
In mammalian genomes, the abundance of CpG dinucleotides is less than expected on the 
basis of GC content. In human DNA, CpG incidence is only about 25% of what is expected 
considering the base composition (Saxonov, et al., 2006). Moreover, the CpG dinucleotides 
are unevenly distributed in the genome, forming clusters called CpG islands. According to 
the complete genomic sequence of human chromosomes 21 and 22, the CpG islands are 
characterized as DNA regions >500 bp with a GC content >55% and observed 
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CpG/expected CpG of 0.65 (Takai & Jones, 2002). CpG islands occur at or near about 40% of 
mammalian promoters, and play crucial roles in the regulation of gene expression (Fatemi, 
et al., 2005). In accordance with this, bioinformatic evaluation showed a bimodal 
distribution of promoters segregating them into high CpG content and low CpG content 
classes (HCP and LCP, respectively) (Nagae, et al., 2011; Saxonov, et al., 2006). The two 
distributions overlap, and promoters in the overlapping region form a class of intermediate 
CpG content promoters (ICP, or “weak” CpG-promoters) (Weber, et al., 2007).   
The majority of CpG sites are cytosine-methylated in genomic DNA with percentages 
between 60%~90% depending on the source reports (Gruenbaum, et al., 1981; Razin, et al., 
1984). The exceptions are CpG islands, where CpG sites are usually unmethylated. It follows 
that HCPs are usually undermethylated while LCPs are highly methylated at a level not 
different from the rest of genomic DNA. According to a genome-wide study (Weber, et al., 
2007), 65% of established human promoters belong to the HCP class, but only 25% of the 
hypermethylated promoters are from this category. On the other hand, only 25% of 
promoters classify as LCP, but 42% of hypermethylated promoters belong to the LCP group. 
Notably, matching the promoter CpG density and methylation data with gene expression 
information in public databases has revealed that the undermethylated HCP-controlled 
genes often perform general “housekeeping” functions and are expressed in many tissues, 
while the highly methylated LCPs are frequently associated with tissue–specific functions 
and exhibit more restricted expression (Nagae, et al., 2011; Saxonov, et al., 2006; Weber, et 
al., 2007). Genome-scale analyses have also demonstrated that a small percentage of HCPs 
(3-4%) is hypermethylated in somatic cells (Meissner, et al., 2008; Shen, et al., 2007; Weber, et 
al., 2007). More detailed examination of this subgroup has shown that it is enriched in 
germline-specific genes and in germline-derived cells, where the genes function, these HCPs 
are undermethylated. Collectively the above relationships between CpG density, 
methylation level and expression suggest that hypermethylation of HCPs is incompatible 
with gene activity and controls the tissue specific expression of a small group of genes in 
differentiated cells. The experimentally determined genome-wide relationship between CpG 
rich (HCP and ICP) promoter activity and methylation level supports this possibility 
(Weber, et al., 2007). The role of CpG methylation in controlling LCP-associated gene 
activity may be similar, but has been demonstrated only recently as discussed below.  
Illingworth et al. (Illingworth, et al., 2008) devised a method to detect CpG islands 
experimentally and determine their methylation levels. They have found that about half of 
the islands overlap with annotated transcription start sites, the rest being intragenic and 
intergenic. Interestingly, these non-promoter CpG islands were methylated at a much higher 
frequency than annotated HCPs, and tissue-specific methylation was also more frequent. In 
another genome-wide study, methylation of intragenic CpG islands was found to correlate 
positively with the level of expression of the host gene (Straussman, et al., 2009). Therefore 
the possibility exists that many “non-promoter” CpG islands actually span unannotated 
transcription start sites and function as HCPs controlling the production of regulatory 
(suppressive) non-coding RNAs (Morris, 2009a, 2009b)  in a tissue-specific and methylation-
sensitive fashion. Thus, some or most of the unmethylated HCPs may be regulated 
indirectly by methylation-sensitive CpG island promoters in a manner analogous to 
imprinted genes (Latos & Barlow, 2009).  
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Immunoprecipitation-based genome-wide analysis of promoters showed relatively high 
methylation levels of LCPs without significant relationship to promoter activity (Weber, et 
al., 2007). Since LCPs control many genes with tissue specific expression and function, this 
issue required further study. Nagae et al. used a sensitive beadarray technique 
(HumanMethylation27 BeadChip, Illumina) to determine the methylation level of 27 587 
individual CpG sites in 14 475 promoters in 21 normal human tissue samples (Nagae, et al., 
2011). As expected, HCPs were generally hypomethylated in all tissues. The CpG poor LCPs 
were methylated more extensively; however, the methylation level of individual LCPs 
varied widely between tissues. Gene ontology (GO) analysis showed that the 
hypomethylated, but not hypermethylated, LCPs in each tissue belonged to genes closely 
related to tissue specific functions. Furthermore, the expression of representative sets of 
tissue specific hypomethylated genes was increased in the corresponding tissue, while 
hypermethylation (relative to the average) had no relationship to expression. These 
methylation-sensitive LCPs were particularly enriched in transcription factor recognition 
motifs. Thus, LCPs are also regulated negatively by methylation, possibly by blocking 
transcription factor binding/activity at critical CpG sites. These results, together with the 
additional observation that many tissue-specific hypomethylated LCPs were fully 
methylated in embryonic stem cells and induced pluripotent cells (Nagae, et al., 2011), raise 
the possibility that terminal differentiation is associated with the demethylation of tissue-
specific LCP-driven genes.  
Genomic imprinting, which suppresses either the paternal or the maternal alleles of defined 
gene clusters, and X chromosome inactivation in females are the best characterised examples 
of gene silencing by CpG methylation (Heard, et al., 1997; Illingworth, et al., 2008; Latos & 
Barlow, 2009). Both of these processes are integrated with development and will be 
discussed further below. 
Finally, small, but detectable, non-CpG (notably CpA and CpT) methylation has been 
reported in mammalian genomes (Kouidou, et al., 2006; Ramsahoye, et al., 2000; White, et 
al., 2002). Bernard H. et al (Ramsahoye, et al., 2000) reported that 15~20% of total cytosine 
methylation in ESCs (embryonic stem cells) is at non-CpG sites, mostly at CpA and, to a less 
extent, at CpT. However, the establishment and maintenance of non-CpG methylation is 
unclear. It is reported that similar to CpG site methylation, non-CpG site methylation is also 
mediated by Dnmt3 and maintained by Dnmt1 (Grandjean, et al., 2007; Ramsahoye, et al., 
2000; White, et al., 2002).  
5. Mechanisms of DNA methylation-mediated transcriptional repression  
As described in the previous section, DNA methylation is strongly associated with the 
suppression of gene expression. Two main mechanisms are involved in the repression and 
they are biologically relevant. First, DNA methylation has been shown to directly interfere 
with the binding of some transcription factors to the CpG sites. It is known that many 
factors bind CpG-containing regions to stimulate gene expression, and a number of these 
consensus binding motifs (CRE, ETS, NRF-1, E-Box, AP2, etc, see ref. (Rozenberg, et al., 
2008) and references therein) fail to bind or function if the CpG sites are methylated 
(Campanero, et al., 2000; Pierard, et al.; Sunahori, et al., 2009).  
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The second mechanism involves recruitment of methyl-CpG-binding domain (MBD) 
proteins, which selectively recognize methylated CpG sites and silence associated genes by 
recruiting transcriptional corepressor complexes involving histone deacetylases (HDACs) 
and histone methyltransferases (P. A. Jones & Laird, 1999; Munro, et al.; Prendergast & Ziff, 
1991). A family of MBD proteins has been identified that include MeCP2, MBD1, MBD2, 
MBD3 and MBD4 (Hendrich & Bird, 1998). The MBD domains show homology among these 
proteins, whereas the transcription repression domains (TRD) identified in MeCP2, MBD1 
and MBD2 are non-conserved.  
MeCP2 is the founder of the MBD protein family, which represses gene expression by 
recruiting the corepressor mSin3A that interacts with HDAC1 (P. L. Jones, et al., 1998; Nan, 
et al., 1998). Mutation in the MeCP2 gene in the X-chromosome accounts for the vast 
majority of RTT (Rett) syndrome cases, which is a postnatal neurodevelopment disorder 
characterized by mental retardation, ataxia, hand stereotypes, seizures, and breathing 
irregularities (Amir, et al., 1999). MeCP2 represses gene expression by recruiting mSin3A, 
which interacts with HDAC1 (P. L. Jones, et al., 1998; Nan, et al., 1998).  Mammalian MBD3 
does not directly bind to CpG sites because of a mutation of the MBD (Saito & Ishikawa, 
2002). However, it is essential for embryogenesis, since targeted deletion of MBD3 results in 
mouse embryo lethality (Hendrich, et al., 2001). There is little evidence of MBD4 acting as a 
transcription repressor, instead, it is an important thymine DNA glycosylase involved in 
DNA repair (Hendrich, et al., 1999).  
6. 5-hydroxymethylcytosine (5hmC), the sixth base of mammalian DNA  
Besides 5-methylcytosine (5mC), mammalian genomic DNA also contains 5-
hydroxymethylcytosine (5hmC), which is the oxidative modification of 5mC and is 
recognized as the sixth base of DNA. The first report of 5hmC in mammals was in 1972 
(Penn, et al., 1972). Little attention, however, was attracted because of the lack of 
consistently reproducible data (Kothari & Shankar, 1976). Two recent reports, however, 
brought 5hmC back into the limelight (Kriaucionis & Heintz, 2009; Tahiliani, et al., 2009). 
Kriaucionis and Heintz detected 5hmC in mouse Purkinje cells and granule cells as 0.6% and 
0.2% of total nucleotides, respectively. Tahiliani et al detected an even lower percentage of 
5hmC in mouse ES cells, only 0.03% of all bases. After these discoveries, a number of 
methods were developed to distinguish 5hmC from 5mC, since traditional bisulfite 
sequencing or methylation-sensitive restriction digestion do not differentiate between the 
two modified bases (Huang, et al., 2010; Jin, et al., 2010).  
Munzel et al (Munzel, et al., 2010) have found that 5hmC is widely distributed in mouse 
brain. Relatively high levels of 5hmC were found in areas responsible for higher cognitive 
functions, such as in hippocampus and cortex. The level of 5hmC in mouse hippocampus  
increased by approximately 75% in 90-day-old mice compared to in one-day-old mice, 
which was unrelated to oxidative DNA damage due to aging. Coincidentally, Song et al 
(Song, et al., 2010) reported an increase of 5hmc level from 0.1% of total nucleotides in post-
natal day 7 to 0.4% in adult age in mouse cerebellum tissue. 5hmC is speculated to play an 
important role in central nervous system development.  
The generation of 5hmC is based on the pre-existence of 5mC (Ficz, et al., 2011; 
Szwagierczak, et al., 2010; Williams, et al., 2011). The conversion of 5mC to 5hmC is 
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achieved by the ten-eleven translocation (TET) enzyme family that has been identified in a 
homology search using the sequences of JBP1 and JPB2, which are responsible for 
hydroxylation and glucosylation of the 5-methyl group of thymine (Tahiliani, et al., 2009; 
Yu, et al., 2007). Three members of TET family have been uncovered, TET1, TET2 and TET3. 
Lately, the TET protein has been reported to catalyse the generation of 5-carboxylcytosine 
(5caC) and 5-formylcytosine (5fC), which might be involved in the active demethylation of 
DNA (He, et al., 2011; Ito, et al., 2011).   
The functional consequences of the 5hmC modification are still unclear. Like other 
modifications, it may alter chromatin organization by recruiting or excluding factors that 
influence transcription (S. C. Wu & Zhang, 2010). Importantly, it is proposed to be involved 
in the enigmatic process of DNA demethylation. First, 5hmC cannot be recognised by 
Dnmt1. Therefore, it interferes with the Dnmt1-mediated maintenance of DNA methylation, 
which results in passive demethylation during replication (Valinluck & Sowers, 2007). 
Second, it may be a key intermediate in the controversial process of active demethylation. 
We discuss this in detail in the section on DNA demethylation below. Additionally, it was 
reported that the MBD family, including MeCP2, MBD1, MBD2 and MBD4, have 
significantly reduced affinity for CpG sites that are hydroxymethylated (Jin, et al., 2010; 
Valinluck, et al., 2004). Given the repressive transcriptional role of MBD proteins and their 
interactions with histone modifying enzymes, the conversion from 5mC to 5hmC could 
reduce MDB activity at the affected sites and change epigenetic patterns to promote 
transcriptional activity.  
7. DNA demethylation in the zygote 
DNA methylation is a stable but not irreversible epigenetic mark. The reverse process, DNA 
demethylation, has been observed in specific contexts. Genome-wide DNA demethylation 
occurs after fertilization, when the existing DNA methylation pattern of the paternal and 
maternal genomes is erased and the epigenetic state of the early embryo is reset (Hajkova, et 
al., 2002; Mayer, et al., 2000).  
The loss of DNA methylation is achieved in two distinct ways, passive demethylation and 
active demethylation. Passive demethylation occurs due to replication-dependent inhibition 
or absence of Dnmt1, which results in lack of DNA methylation in the newly synthesized 
DNA. Active demethylation refers to actively removing the methyl group, the methylated 
cytosine or the whole nucleotide; the mechanisms in mammals are still poorly understood 
and controversial. 
Various mechanisms of active demethylation in mammals have been proposed, including 
direct enzymatic removal of the methyl group from 5mC, nucleotide-replacement reaction 
and further modifications of 5mC followed by a base excision repair (BER) pathway.  
Direct removal of the methyl group from 5mC seems to be the most direct way to achieve 
demethylation, however, a robust enzyme activity of a “demethylase”is needed to break the 
strong carbon-carbon bond. One of the MBD proteins, MBD2, is the first to be identified to 
serve as a DNA demethylase. MBD2 was shown in vitro to remove the methyl group and 
release in the form of methanol (Bhattacharya, et al., 1999). However, this mechanism was 
strongly contested because several groups failed to reproduce the enzyme activity in 
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The second mechanism involves recruitment of methyl-CpG-binding domain (MBD) 
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and histone methyltransferases (P. A. Jones & Laird, 1999; Munro, et al.; Prendergast & Ziff, 
1991). A family of MBD proteins has been identified that include MeCP2, MBD1, MBD2, 
MBD3 and MBD4 (Hendrich & Bird, 1998). The MBD domains show homology among these 
proteins, whereas the transcription repression domains (TRD) identified in MeCP2, MBD1 
and MBD2 are non-conserved.  
MeCP2 is the founder of the MBD protein family, which represses gene expression by 
recruiting the corepressor mSin3A that interacts with HDAC1 (P. L. Jones, et al., 1998; Nan, 
et al., 1998). Mutation in the MeCP2 gene in the X-chromosome accounts for the vast 
majority of RTT (Rett) syndrome cases, which is a postnatal neurodevelopment disorder 
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recognized as the sixth base of DNA. The first report of 5hmC in mammals was in 1972 
(Penn, et al., 1972). Little attention, however, was attracted because of the lack of 
consistently reproducible data (Kothari & Shankar, 1976). Two recent reports, however, 
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Kriaucionis and Heintz detected 5hmC in mouse Purkinje cells and granule cells as 0.6% and 
0.2% of total nucleotides, respectively. Tahiliani et al detected an even lower percentage of 
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increased by approximately 75% in 90-day-old mice compared to in one-day-old mice, 
which was unrelated to oxidative DNA damage due to aging. Coincidentally, Song et al 
(Song, et al., 2010) reported an increase of 5hmc level from 0.1% of total nucleotides in post-
natal day 7 to 0.4% in adult age in mouse cerebellum tissue. 5hmC is speculated to play an 
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The generation of 5hmC is based on the pre-existence of 5mC (Ficz, et al., 2011; 
Szwagierczak, et al., 2010; Williams, et al., 2011). The conversion of 5mC to 5hmC is 
 
DNA Methylation in Development 
 
151 
achieved by the ten-eleven translocation (TET) enzyme family that has been identified in a 
homology search using the sequences of JBP1 and JPB2, which are responsible for 
hydroxylation and glucosylation of the 5-methyl group of thymine (Tahiliani, et al., 2009; 
Yu, et al., 2007). Three members of TET family have been uncovered, TET1, TET2 and TET3. 
Lately, the TET protein has been reported to catalyse the generation of 5-carboxylcytosine 
(5caC) and 5-formylcytosine (5fC), which might be involved in the active demethylation of 
DNA (He, et al., 2011; Ito, et al., 2011).   
The functional consequences of the 5hmC modification are still unclear. Like other 
modifications, it may alter chromatin organization by recruiting or excluding factors that 
influence transcription (S. C. Wu & Zhang, 2010). Importantly, it is proposed to be involved 
in the enigmatic process of DNA demethylation. First, 5hmC cannot be recognised by 
Dnmt1. Therefore, it interferes with the Dnmt1-mediated maintenance of DNA methylation, 
which results in passive demethylation during replication (Valinluck & Sowers, 2007). 
Second, it may be a key intermediate in the controversial process of active demethylation. 
We discuss this in detail in the section on DNA demethylation below. Additionally, it was 
reported that the MBD family, including MeCP2, MBD1, MBD2 and MBD4, have 
significantly reduced affinity for CpG sites that are hydroxymethylated (Jin, et al., 2010; 
Valinluck, et al., 2004). Given the repressive transcriptional role of MBD proteins and their 
interactions with histone modifying enzymes, the conversion from 5mC to 5hmC could 
reduce MDB activity at the affected sites and change epigenetic patterns to promote 
transcriptional activity.  
7. DNA demethylation in the zygote 
DNA methylation is a stable but not irreversible epigenetic mark. The reverse process, DNA 
demethylation, has been observed in specific contexts. Genome-wide DNA demethylation 
occurs after fertilization, when the existing DNA methylation pattern of the paternal and 
maternal genomes is erased and the epigenetic state of the early embryo is reset (Hajkova, et 
al., 2002; Mayer, et al., 2000).  
The loss of DNA methylation is achieved in two distinct ways, passive demethylation and 
active demethylation. Passive demethylation occurs due to replication-dependent inhibition 
or absence of Dnmt1, which results in lack of DNA methylation in the newly synthesized 
DNA. Active demethylation refers to actively removing the methyl group, the methylated 
cytosine or the whole nucleotide; the mechanisms in mammals are still poorly understood 
and controversial. 
Various mechanisms of active demethylation in mammals have been proposed, including 
direct enzymatic removal of the methyl group from 5mC, nucleotide-replacement reaction 
and further modifications of 5mC followed by a base excision repair (BER) pathway.  
Direct removal of the methyl group from 5mC seems to be the most direct way to achieve 
demethylation, however, a robust enzyme activity of a “demethylase”is needed to break the 
strong carbon-carbon bond. One of the MBD proteins, MBD2, is the first to be identified to 
serve as a DNA demethylase. MBD2 was shown in vitro to remove the methyl group and 
release in the form of methanol (Bhattacharya, et al., 1999). However, this mechanism was 
strongly contested because several groups failed to reproduce the enzyme activity in 
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different genes (Boeke, et al., 2000; H. H. Ng, et al., 1999). Moreover, it has been revealed 
that MBD2-null mice still exhibit normal pattern of DNA methylation (Hendrich, et al., 
2001), and the active demethylation of the paternal genome still occurs normally in zygote 
deficient in MBD2 (Santos, et al., 2002), which suggests that the major demethylation 
mechanisms do not involve MBD2. 
The nucleotide-replacement reaction is commonly involved in substantial DNA repair 
following damage due to exposure to radiation or chemicals. The basic steps include dual 
incisions flanking the lesion, release of a 24~32 nucleotide oligomer and replacement with 
new synthesized nucleotides followed by ligation (Sancar, et al., 2004).  A DNA repair 
protein, growth arrest and DNA-damage-inducible 45a (Gadd45a), was reported to 
participate in active demethylation. Knockdown of Gadd45a leads to hypermethylation and 
gene silencing, whereas overexpression results in activation of loci-specific gene and global 
demethylation (Barreto, et al., 2007). Again, other studies failed to confirm the role of 
Gadd45a in active DNA demethylation, which raises doubts on this pathway (Engel, et al., 
2009; Jin, et al., 2008).  
The DNA glycosylase and base excision repair (BER) system mediated active demethylation 
is the main mechanism utilized by plants. The key steps involve a group of 5mC 
glycosylases (including ROS1, DME, DML2 and DML3) removing the methylated cytosine, 
followed by a BER pathway to fill in the gap with an unmethylated cytosine (J. K. Zhu, 
2009). However, evidence supporting this mechanism in mammals seems less convincing 
due to the lack of 5mC glycosylase in mammalian cells. Although MBD4 and thymine DNA 
glycosylase (TDG), two confirmed TG mismatch glycosylases, have been reported to have 
weak activity against 5mC: G in vitro, this activity is 30~40 fold lower compared to the T: G 
mismatch (B. Zhu, Zheng, Angliker, et al., 2000; B. Zhu, Zheng, Hess, et al., 2000). In 
addition, deletion of MBD4 does not affect the active demethylation of the paternal genome 
in zygotes, which challenges the possibility that MBD4 is the principal DNA demethylase 
operating after fertilization (Santos & Dean, 2004). 
It has also been proposed that active demethylation can be achieved by the deamination of 
5mC to generate T followed by the BER pathway to replace the T with an unmethylated 
cytosine.  The activation-induced deaminase (AID) and apolipoprotein B mRNA-editing 
catalytic polypeptides (Apobec) family are able to deaminate 5mC (Morgan, et al., 2004). 
Recent work has also shown that AID is necessary for promoter demethylation of the OCT4 
and NANOG genes in the reprogramming of human somatic cells to pluripotent stem cells 
(Bhutani, et al., 2010). However, AID is active on single-stranded, but not on double-
stranded DNA and its affinity to 5mC is 10-fold lower than to unmethylated cytosine 
(Bransteitter, et al., 2003). Surprisingly, Dnmt3a and Dnmt3b have also been shown to 
possess 5mC deaminase activity in vitro, which may be involved in the CpG 
methylation/demethylation cycling observed at the pS2/TFF1 gene promoter after estrogen 
stimulation (Metivier, et al., 2008). More work needs to be done to uncover the mechanism 
and significance of these dual functions.  
Recently, an oxidative-deamination-BER pathway (Fig.2) of active demethylation has been 
described with 5hmC as the key intermediate. The TET proteins have been shown to oxidize 
5mC to generate 5hmC that is acted upon by the AID and Apobec family deaminases to 
generate 5hmU for subsequent processing by BER (Guo, et al., 2011). TDG exhibits robust 
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glycosylase activity on the 5hmU•G mismatch to remove 5hmU and the gap is filled by an 
unmethylated cytosine. Both knockout and inactive point mutations of TDG result in mice 
embryo lethality and developmental defect (Cortellino, et al., 2011). In addition, it has been 
demonstrated that 5mC and 5hmC can be further modified to 5-formylcytosine (5fC) and 5-
carboxylcytosine (5caC) by TET proteins. The existence of 5fC and 5caC has been identified 
in mice ES cells (Ito, et al., 2011). TDG is able to recognize and cleave 5caC and 5fC to initiate 
the BER pathway (He, et al., 2011; Maiti & Drohat, 2011). It is also proposed that an 
unknown decarboxylase enzyme is involved in the conversion from 5caC to C, without the 
participation of BER (Ito, et al., 2011). 
 
Fig. 2. Pathways of active DNA demethylation. 
5mC can be hydroxylated by TET to generate 5hmC, which can be further oxidized to 5fC 
and 5caC. Alternatively, 5hmC can be deaminased by AID and Apobec family members to 
generate 5hmU. Base excision repair (BER) will be initiated by modified bases, eventually 
replacing them with cytosine. 
8. Dynamic of DNA methylation in development 
Extensive reprogramming of epigenomes occurs during early development, allowing  
cells to attain a totipotent developmental potential. Remodeling of DNA methylation 
patterns, including a genome-wide demethylation with imprinted genes as exceptions, is 
observed in mammalian zygotes, primordial germ cells and early embryos. This process is 
essential for erasure of the previous germ line DNA methylation pattern and 
establishment of new marks.  
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different genes (Boeke, et al., 2000; H. H. Ng, et al., 1999). Moreover, it has been revealed 
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2009). However, evidence supporting this mechanism in mammals seems less convincing 
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in zygotes, which challenges the possibility that MBD4 is the principal DNA demethylase 
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5mC to generate T followed by the BER pathway to replace the T with an unmethylated 
cytosine.  The activation-induced deaminase (AID) and apolipoprotein B mRNA-editing 
catalytic polypeptides (Apobec) family are able to deaminate 5mC (Morgan, et al., 2004). 
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(Bransteitter, et al., 2003). Surprisingly, Dnmt3a and Dnmt3b have also been shown to 
possess 5mC deaminase activity in vitro, which may be involved in the CpG 
methylation/demethylation cycling observed at the pS2/TFF1 gene promoter after estrogen 
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described with 5hmC as the key intermediate. The TET proteins have been shown to oxidize 
5mC to generate 5hmC that is acted upon by the AID and Apobec family deaminases to 
generate 5hmU for subsequent processing by BER (Guo, et al., 2011). TDG exhibits robust 
 
DNA Methylation in Development 
 
153 
glycosylase activity on the 5hmU•G mismatch to remove 5hmU and the gap is filled by an 
unmethylated cytosine. Both knockout and inactive point mutations of TDG result in mice 
embryo lethality and developmental defect (Cortellino, et al., 2011). In addition, it has been 
demonstrated that 5mC and 5hmC can be further modified to 5-formylcytosine (5fC) and 5-
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and 5caC. Alternatively, 5hmC can be deaminased by AID and Apobec family members to 
generate 5hmU. Base excision repair (BER) will be initiated by modified bases, eventually 
replacing them with cytosine. 
8. Dynamic of DNA methylation in development 
Extensive reprogramming of epigenomes occurs during early development, allowing  
cells to attain a totipotent developmental potential. Remodeling of DNA methylation 
patterns, including a genome-wide demethylation with imprinted genes as exceptions, is 
observed in mammalian zygotes, primordial germ cells and early embryos. This process is 
essential for erasure of the previous germ line DNA methylation pattern and 
establishment of new marks.  
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8.1 Asymmetric genome-wide demethylation  
The genomes of sperm and oocytes are organised differently. The genome of sperm is 
packaged with protamines, while oocytes are packaged with histones. At fertilization, a 
rapid exchange from protamine to histone occurs in the paternal genome. As early as a few 
hours after fertilization, a remarkable asymmetric DNA demethylation occurs in the two 
parental genomes, although they are exposed to the same oocyte cytoplasm. The paternal 
genome undergoes a genome-wide demethylation before the first cell division cycle, which 
is therefore considered active demethylation, while the maternal genome is protected from 
this reprogramming (Oswald, et al., 2000). Notably, some regions of the paternal genome are 
still resistant to demethylation, including imprinted genes. 
Recent work from two laboratories has linked this loss of 5mC to its conversion to 5hmC 
(Iqbal, et al., 2011; Wossidlo, et al., 2011). Analysis of mouse, rabbit and bovine embryos 
showed a strong presence of 5hmC in the paternal pronucleus, while the amount of 5mC 
decreased. On the other hand, 5hmC in the maternal pronucleus was nearly undetectable, 
compared to the abundance of 5mC. This suggests that 5mC in the paternal, but not in the 
maternal, pronuclei is converted to 5hmC possibly as part of the active demethylation 
pathway outlined above. The distribution differences of 5hmC in the two parental 
pronucleus were maintained towards the two-cell stage. It was also shown that TET3 
contributed significantly to this conversion. Tet3 exhibits extremely high expression levels in 
oocytes and zygotes compared to the very low levels of TET1 and TET2. Levels of TET3 
decrease dramatically at the two-cell stage, which stops the further increase of 5hmC levels. 
Knockdown of TET3 results in substantial reduction of 5hmC and a strong increase of 5mC 
in the paternal pronucleus. Consistent with the lack of active demethylation, the maternal 
pronucleus is inaccessible to this TET3-mediated conversion from 5mC to 5hmC. 
Knockdown of TET3 has little effect on the 5mC signal in the maternal pronucleus.  
An intriguing question is how the maternal pronucleus is protected from active 
demethylation. It has been proposed that the PGC7/Stella gene is important for this 
protection, since the maternal genome of the PGC7/Stella-null zygote undergoes significant 
demethylation (Coward, et al., 2009). It has also been reported that the absence of 
PGC7/Stella leads to the increase of 5hmC in the maternal pronucleus, which suggests 
PGC7/Stella as a protector of 5mC against oxidation (Wossidlo, et al., 2011). The mechanism 
of the protection, however, remains unclear. A further question is why the presence of 
PGC7/Stella does not protect the paternal pronucleus from demethylation. Structural 
differences may be the answer.  
The maternal genome undergoes gradual passive demethylation during the several cell 
divisions leading towards blastocyst formation due to a lack of maintenance of methylation 
in the zygote. Imprinted genes are resistant to this process, as well as to the active 
demethylation in the paternal genome. 
8.2 Genomic imprinting 
Although extensive DNA methylation reprogramming occurs in early development, a 
number of genes are resistant to this change including imprinted genes. Gene imprinting is 
an enigmatic phenomenon that causes genes to be expressed in a parental-origin-specific 
way, wherein either the paternally or the maternally inherited allele is silenced. 
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Approximately 60 imprinted genes have been identified in the human (R. K. Yuen, et al., 
2011). Genomic imprinting plays a significant role in normal development through 
regulating embryo growth, placental function and neurobehavioral processes (McGrath & 
Solter, 1984; Surani, et al., 1984). Abnormal expression of imprinted genes has been 
demonstrated to be associated with a few human diseases, including the Prader-Willi 
syndrome (PWS), the Angelman syndrome (AS), the Silver-Russell syndrome (SRS) and the 
Beckwith-Wiedemann syndrome (BWS) (Paulsen & Ferguson-Smith, 2001). 
DNA methylation is the key feature of imprinted gene clusters. The regions at imprinted 
loci marked by DNA methylation (DMRs) are methylated only on one allele. The product 
of one gene in an imprinted cluster is often a non-coding RNA, which regulates the 
expression of the other members of the cluster in cis. The DMRs established through the 
germ line often coincide with crucial imprinting control regions (ICRs), which if 
methylated, suppress the expression of the regulatory non-coding RNA. During 
development of primordial germ cells, DNA methylation is erased and then re-established 
in the process of oogenesis and spermatogenesis to generate gender specific germline 
imprinting patterns. Once established, the imprinted status will be stably maintained in 
all somatic lineages. Other DMRs acquire this methylation status after fertilization and are 
often tissue-specific (J. R. Mann, 2001). The mechanisms of the resistance of imprinted 
genes to epigenetic reprogramming post-fertilization are complex and still not fully 
characterised (see ref. (Weaver, et al., 2009)for review). A few factors have been suggested 
to be involved, including the DNMT1 isoforms DNMT1o and DNMT1s, MDB3 and 
PGC7/Stella, which also participates in the protection of the maternal genome from post-
fertilization active demethylation (Nakamura, et al., 2007). ZFP57, which is a KRAB zinc 
finger protein, has been demonstrated to be required for maintenance of maternal 
methylation imprints at the Snrpn imprinted region. It is also important for maintenance 
of genomic imprinting at multiple DMRs (X. Li, et al., 2008).  
Dysregulation of imprinted genes are associated with a number of human syndromes that 
will be discussed in the following sections.  
8.3 DNA methylation in germ cell development 
After implantation of the blastocyst, a subset of pluripotent cells in the epiblast generate 
primordial germ cells (PGCs), the origin of both oocytes and spermatozoa, in responding to 
signals from extraembryonic ectoderm and visceral endoderm. Two critical transcription 
factors, B-lymphocyte maturation-induced protein1 (BLIMP1, also known as PR domain 
zinc finger protein1)) and PRDM14 are essential for specification of PGCs and suppression 
of somatic gene expression (Ohinata, et al., 2005; Saitou, 2009).  
When the germ cell fate is established, the level of global DNA methylation is similar to that 
observed in surrounding epiblast cells (Seki, et al., 2005). The cells then gradually migrate to 
the genital ridge accompanied by significant reprogramming of epigenetic marks. A 
substantial reduction of genome-wide DNA methylation has been observed after 
specification of germ cells. However, it is not until arriving at genital ridge that DNA 
methylation including parental imprinting marks is extensively erased (Hajkova, et al., 
2002). Due to the presence of Dnmt1 for most of the period, this widespread demethylation 
is considered to be active, replication-independent. BER pathway has been reported to be 
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involved in the process. Interestingly, significant expression of TET1 gene has been detected 
in mouse PGCs, indicating a role of 5hmC as an intermediate in this active demethylation 
(Hajkova, et al., 2010). 
In female mammals, one of the two copies of X chromosomes is inactivated to balance the X-
linked gene dosage between females and males. The process is termed X chromosome 
inactivation and is stably maintained in female somatic cells by the DNA methylation mark 
at the silenced genes. In female germ cell development, the inactivated X chromosome is 
reactivated. This reactivation occurs during migration and gonadal colonization, which 
coincides with genome-wide DNA demethylation.  
In the global demethylation of PGCs, parental imprinting marks are erased and reset in a 
gender specific fashion. In male germ cells, the new imprints are progressively established 
during late fetal development and are not completed until the mature sperm stage (J. Y. Li, 
et al., 2004). In contrast, the initiation of methylation imprints occurs postnatally during the 
oocyte growth phase (Lucifero, et al., 2004). The Dnmt3 family is responsible for the de novo 
methylation of imprinted DMRs. Knockout of Dnmt3a and Dnmt3b in mouse germ cell line 
revealed that although they are both involved, Dnmt3a plays the major role in establishment 
of imprinting with Dnmt3L as a critical co-factor (Kaneda, et al., 2004; Kato, et al., 2007). 
8.4 DNA methylation in cellular differentiation during development 
The evidence summarized above demonstrates that DNA (CpG) methylation is a critically 
important component of all aspects of cellular differentiation from fertilization to 
senescence. At the molecular level, CpG methylation of DNA results in gene silencing. X-
chromosome inactivation and genomic imprinting are well characterised, specific examples 
of this phenomenon. In the developmental time line, the paternally and maternally inherited 
DNA methylation patterns are quickly erased in the zygote after fertilization by active and 
passive demethylation, respectively. DNA methylation levels in the genome reach a nadir at 
the morula stage (Abdalla, et al., 2009; Weaver, et al., 2009). In the subsequent phase of 
blastocyst formation, a primary differentiation event occurs, giving rise to two distinct cell 
lineages, the inner cell mass (ICM) and the trophectoderm.  The ICM will generate the 
embryo proper as well as extraembryonic endoderm and mesoderm, while the 
trophectoderm will form the chorion and the placenta (Fleming, 1987). During blastocyst 
differentiation, a wave of de novo methylation is carried out by Dnmt3 family members, 
which leads to different methylation patterns between the ICM and trophectoderm. This 
occurs around the time of implantation. The main de novo Dnmt at the blastocyst stage, 
Dnmt3b, has been specifically localized in the ICM of mouse blastocysts (Watanabe, et al., 
2002). Thus the pluripotent stem cells of the ICM show much higher levels of DNA 
methylation compared to the trophectoderm; and this lineage-based methylation difference 
persists into the later stage of development, placenta and embryo proper (Santos, et al., 
2002). The embryonic stem cells lose cell lineage restriction and differentiate into trophoblast 
cells after the deletion of Dnmt1, which implicates DNA methylation as the key factor to 
achieve cell lineage stability. At the gene expression level, the robust difference in 
methylation of a transcription factor encoding gene, Elf5, has been shown to be critical in cell 
lineage fate. It is hypermethylated and repressed in the embryonic cell lineage but 
hypomethylated and expressed in the trophoblast compartment (R. K. Ng, et al., 2008).  
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The general genomic pattern of CpG methylation is established during ICM differentiation 
in the blastocyst at the time of implantation. Thus, CpG-rich promoters (HCPs and ICPs) 
remain unmethylated, probably due to the protective effect of cis-acting sequence motifs 
(Straussman, et al., 2009). On the other hand, CpG-poor promoters (LCPs), often controlling 
genes with tissue-specific expression are highly methylated possibly to prevent untimely 
expression in the pluripotent embryonic stem cells (ESCs) (Nagae, et al., 2011). The 
exceptions include the pluripotency and ESC-self renewal-associated genes, which often 
belong to the LCP class but are unmethylated in ESCs (e.g. Nanog, Pou5f1, Gdf3 (Straussman, 
et al., 2009)). Recent work suggests that the demethylation of Nanog is a TET1-dependent 
active process maintaining Nanog expression in mouse ESCs (Ito, et al., 2010). This example 
raises the possibility that other LCP class promoters also undergo targeted active 
demethylation in ESCs. 
Differentiation of ESCs to various somatic cell types is also associated with changing DNA 
methylation of functionally relevant promoters. A small proportion of HCPs, controlling 
germline-specific genes, becomes methylated de novo in all cell types except for germline-
derived cells (Shen, et al., 2007; Weber, et al., 2007), where they are expressed. Similarly, 
ESC-specific HCP-controlled genes are shut down in differentiated cells by de novo 
methylation of the promoter (Straussman, et al., 2009). CpG-island sequences at gene loci 
controlling development, such as OSR1, PAX6 and HOXC are frequently methylated in 
normal tissues; however, these methylations do not appear to correlate closely with gene 
expression levels (Illingworth, et al., 2008). The mechanisms that select these HCPs for 
methylation are unclear, but may involve other epigenetic marks such as histone 
modifications (Meissner, 2010). CpG-poor promoters (LCPs) undergo tissue-specific 
demethylation during differentiation, which correlates with the increased activity of 
functionally relevant genes (Nagae, et al., 2011). The mechanism of this gene and tissue 
selective process is unclear; it may involve the newly discovered TET-dependent active 
demethylation, or it may be passive demethylation driven by transcription factor binding to 
the promoter, which may prevent maintenance  methylation after cell division.  
The pattern of DNA methylation is considered stable after differentiation as long as cellular 
identity is maintained. Recent studies, however, have shown that the CpG methylation 
pattern changes during life. Christensen et al., (Christensen, et al., 2009) analysed 1413 CpG 
sites at 773 genes in 217 healthy individuals, and observed that CpG island methylation 
levels increased, while non-CpG island methylation levels decreased with age. 
Environmental factors, such as tobacco smoking, also affected CpG methylation levels in 
individuals. Yuen et al. (R. K. C. Yuen, et al., 2011) compared the methylation status of 1315 
CpG loci in 752 genes from five somatic tissues between normal second trimester fetuses 
and adults. They found tissue-specific differentially methylated regions in 195 loci in the 
fetuses, but only 17% of these were maintained in adults. Further, the methylation status of 
about 10% of the examined sites changed more than 40% between the fetus and the adult. 
These data indicate the plasticity of the tissue-specific DNA methylation patterns and their 
susceptibility to environmental conditions.  
9. DNA methylation and human diseases 
Age and the environment have key importance in many disease processes; therefore it is not 
surprising that aberrant DNA methylation contributes to a variety of pathologies. Epigenetic 
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involved in the process. Interestingly, significant expression of TET1 gene has been detected 
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of this phenomenon. In the developmental time line, the paternally and maternally inherited 
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passive demethylation, respectively. DNA methylation levels in the genome reach a nadir at 
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blastocyst formation, a primary differentiation event occurs, giving rise to two distinct cell 
lineages, the inner cell mass (ICM) and the trophectoderm.  The ICM will generate the 
embryo proper as well as extraembryonic endoderm and mesoderm, while the 
trophectoderm will form the chorion and the placenta (Fleming, 1987). During blastocyst 
differentiation, a wave of de novo methylation is carried out by Dnmt3 family members, 
which leads to different methylation patterns between the ICM and trophectoderm. This 
occurs around the time of implantation. The main de novo Dnmt at the blastocyst stage, 
Dnmt3b, has been specifically localized in the ICM of mouse blastocysts (Watanabe, et al., 
2002). Thus the pluripotent stem cells of the ICM show much higher levels of DNA 
methylation compared to the trophectoderm; and this lineage-based methylation difference 
persists into the later stage of development, placenta and embryo proper (Santos, et al., 
2002). The embryonic stem cells lose cell lineage restriction and differentiate into trophoblast 
cells after the deletion of Dnmt1, which implicates DNA methylation as the key factor to 
achieve cell lineage stability. At the gene expression level, the robust difference in 
methylation of a transcription factor encoding gene, Elf5, has been shown to be critical in cell 
lineage fate. It is hypermethylated and repressed in the embryonic cell lineage but 
hypomethylated and expressed in the trophoblast compartment (R. K. Ng, et al., 2008).  
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changes have been firmly established as components of malignant transformation; however, 
this large area of investigation has been recently reviewed (Brait & Sidransky, 2011) and is 
beyond the scope of this chapter (Esteller, 2011). In recent years, the relationship between 
adverse intrauterine conditions at early development and increased risk of post-natal 
diseases has been recognized.  
Chronic diseases including cardiovascular disease, type 2 diabetes and obesity are 
associated with abnormal intrauterine growth and development (Hales & Barker, 1992; 
Osmond, et al., 1993; Rich-Edwards, et al., 2005). This relationship has been termed as the 
Developmental Origins of Health and Disease (DOHaD). The hypothesis of DOHaD 
indicates a high degree of phenotypic plasticity during development. Epigenetic regulation 
have been suggested to be the most attractive mediator between transient environmental 
exposures and sustained changes at gene, cell or tissues levels. Especially, aberrant DNA 
methylation of key disease-associated genes has been suggested to be involved in DOHaD.  
9.1 Role of maternal diet 
Maternal malnutrition is a comparatively well characterized factor influencing DNA 
methylation of genes in the context of DOHaD (See ref.  (Burdge & Lillycrop, 2010) for 
review). Further, several studies have reported that altered maternal intake of folate is 
linked to change of DNA methylation in the offspring (Kim, et al., 2009; Waterland, et al., 
2006; Waterland & Jirtle, 2003). Folate deficiency has been strongly associated with 
incomplete closure of the neural tube. Suppression of methylation cycles, which can be 
the consequence of insufficient maternal intake of folate, causes a high risk of neural tube 
defect in mice (Dunlevy, et al., 2006). Recently, it has been reported that reduced maternal 
folate status may contribute to the development of colorectal cancer in adult offspring 
(McKay, et al., 2011). Maternal folate depletion is associated with a locus-specific drop of 
DNA methylation in the Slc39a4 gene in fetal gut. The Slc39a4 gene has been shown to be 
hypomethylated in colorectal cancer. Thus the deficiency of folate in pregnancy might 
have consequence for colorectal cancer development if the altered methylation is 
sustained into adulthood.  
Folate supplementation during pregnancy has been widely used to reduce the incidence of 
neural tube defects. It has been suspected, however, that folate may have adverse effects 
inducing allergic diseases such as asthma and eczema by altering the methylation status of 
DNA in the offspring (Dunstan, et al., 2011; Hollingsworth, et al., 2008).  
Apart from nutrition, maternal behaviour (level of care, depression) has also been shown to 
alter the methylation of steroid receptor gene promoters in the offspring and influence 
steroid hormone sensitivity later in life (Champagne, et al., 2006; Oberlander, et al., 2008). 
9.2 Infection and inflammation 
Maternal infections such as urinary tract and periodontal infection have been correlated 
with pregnancy complications (reviewed in ref. (Conde-Agudelo, et al., 2008)). Treatment of 
periodontal disease during pregnancy was reported to reduce the rate of preterm birth and 
lower incidence of low birth weight (Polyzos, et al., 2009). The mechanisms underlying this 
relationship has been linked to abnormal DNA methylation patterns (Bobetsis, et al., 2007). 
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Specifically, it has been shown in murine placenta tissues that maternal oral infection caused 
by C. rectus can induce hypermethylation in the promoter of imprinted insulin-like growth 
factor 2 (Igf2) gene. Deficiency of Igf2 gene expression leads to reduction of placental growth 
and restricted fetal growth (Constancia, et al., 2002). This suggests that DNA altered 
methylation (and expression) of key genes can contribute to infection-associated adverse 
pregnancy outcomes such as intrauterine growth restriction (IUGR).  
Loss of DNA methylation in T cells has been shown in systemic lupus erythematosus (SLE), 
an autoimmune disease affecting multiple organs. A significant decrease of genomic DNA 
methylation with reduced Dnmt1 levels has been reported (Richardson, et al., 1990).  
Specific genes relevant to the SLE phenotype are also hypomethylated in T cells of SLE 
patients compared to their normal counterparts (Lu, et al., 2002; Oelke, et al., 2004). The 
DNA methylation inhibitor 5-aza-2’-deoxycytidine causes autoreactivity of T cells in vitro as 
well as an SLE-like disease in vivo, suggesting that T cell DNA hypomethylation is involved 
in the autoantibody response in SLE (Quddus, et al., 1993).   
9.3 Endometriosis 
Dysregulation of DNA methylation in several genes has been reported in endometriosis, a 
common gynecological condition affecting women of reproductive age. The promoter  
of progesterone receptor B (PR-B) has been shown to be hypermethylated in 
endometriosis, which may be responsible for PR-B down-regulation and the notable 
progesterone resistance (Y. Wu, et al., 2006). The promoter of estrogen receptor 2 (ESR2)  
is hypomethylated in endometriosis, which may result in the significantly increased  
level of estrogen receptor expression compared to the stromal cells in  endometrium (Y. 
Wu, et al., 2006).  
9.4 Disruptions of imprinting 
The human chromosome 11p15.5 harbours a cluster of imprinted genes including paternally 
expressed insulin-like growth factor 2 (IGF2) and maternally expressed H19 and KCNQ1 
(KVLQT1) genes (Paulsen, et al., 1998). DNA methylation abnormalities at 11p15.5 can cause 
two distinct growth disorders, the Beckwith–Wiedemann (BWS) and the Silver–Russell 
(SRS) syndromes. BWS is characterized by fetal and postnatal overgrowth, macroglossia, 
neonatal hypoglycaemia and an increased incidence of childhood tumors. SRS is 
characterized by severe intrauterine and postnatal growth retardation, dysmorphic facial 
features, feeding difficulties, and body and limb asymmetry. DNA methylation defects 
account for approximately 60–70% of BWS and SRS patients (Demars, et al., 2011). Two 
imprinting control regions, ICR1 and ICR2, control the differential expression of imprinted 
genes at 11p15.5. Both the paternal and maternal alleles of ICR1 and ICR2 are methylated in 
normal cells. The DNA methylation defects at ICR1 is usually the hypermethylation of the 
maternal allele, leading to both BWS and SRS, whereas DNA methylation defects at ICR2 
usually involve loss of maternal-allele-specific DNA methylation, which results in only BWS 
(Robertson, 2005).  
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are two distinct neurogenetic 
disorders in which the same domain on chromosome 15 is affected. AS is caused by the loss 
of the maternally expressed gene, UBE3A, which is only imprinted in the brain. Loss of 
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changes have been firmly established as components of malignant transformation; however, 
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DNA methylation in the Slc39a4 gene in fetal gut. The Slc39a4 gene has been shown to be 
hypomethylated in colorectal cancer. Thus the deficiency of folate in pregnancy might 
have consequence for colorectal cancer development if the altered methylation is 
sustained into adulthood.  
Folate supplementation during pregnancy has been widely used to reduce the incidence of 
neural tube defects. It has been suspected, however, that folate may have adverse effects 
inducing allergic diseases such as asthma and eczema by altering the methylation status of 
DNA in the offspring (Dunstan, et al., 2011; Hollingsworth, et al., 2008).  
Apart from nutrition, maternal behaviour (level of care, depression) has also been shown to 
alter the methylation of steroid receptor gene promoters in the offspring and influence 
steroid hormone sensitivity later in life (Champagne, et al., 2006; Oberlander, et al., 2008). 
9.2 Infection and inflammation 
Maternal infections such as urinary tract and periodontal infection have been correlated 
with pregnancy complications (reviewed in ref. (Conde-Agudelo, et al., 2008)). Treatment of 
periodontal disease during pregnancy was reported to reduce the rate of preterm birth and 
lower incidence of low birth weight (Polyzos, et al., 2009). The mechanisms underlying this 
relationship has been linked to abnormal DNA methylation patterns (Bobetsis, et al., 2007). 
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Specifically, it has been shown in murine placenta tissues that maternal oral infection caused 
by C. rectus can induce hypermethylation in the promoter of imprinted insulin-like growth 
factor 2 (Igf2) gene. Deficiency of Igf2 gene expression leads to reduction of placental growth 
and restricted fetal growth (Constancia, et al., 2002). This suggests that DNA altered 
methylation (and expression) of key genes can contribute to infection-associated adverse 
pregnancy outcomes such as intrauterine growth restriction (IUGR).  
Loss of DNA methylation in T cells has been shown in systemic lupus erythematosus (SLE), 
an autoimmune disease affecting multiple organs. A significant decrease of genomic DNA 
methylation with reduced Dnmt1 levels has been reported (Richardson, et al., 1990).  
Specific genes relevant to the SLE phenotype are also hypomethylated in T cells of SLE 
patients compared to their normal counterparts (Lu, et al., 2002; Oelke, et al., 2004). The 
DNA methylation inhibitor 5-aza-2’-deoxycytidine causes autoreactivity of T cells in vitro as 
well as an SLE-like disease in vivo, suggesting that T cell DNA hypomethylation is involved 
in the autoantibody response in SLE (Quddus, et al., 1993).   
9.3 Endometriosis 
Dysregulation of DNA methylation in several genes has been reported in endometriosis, a 
common gynecological condition affecting women of reproductive age. The promoter  
of progesterone receptor B (PR-B) has been shown to be hypermethylated in 
endometriosis, which may be responsible for PR-B down-regulation and the notable 
progesterone resistance (Y. Wu, et al., 2006). The promoter of estrogen receptor 2 (ESR2)  
is hypomethylated in endometriosis, which may result in the significantly increased  
level of estrogen receptor expression compared to the stromal cells in  endometrium (Y. 
Wu, et al., 2006).  
9.4 Disruptions of imprinting 
The human chromosome 11p15.5 harbours a cluster of imprinted genes including paternally 
expressed insulin-like growth factor 2 (IGF2) and maternally expressed H19 and KCNQ1 
(KVLQT1) genes (Paulsen, et al., 1998). DNA methylation abnormalities at 11p15.5 can cause 
two distinct growth disorders, the Beckwith–Wiedemann (BWS) and the Silver–Russell 
(SRS) syndromes. BWS is characterized by fetal and postnatal overgrowth, macroglossia, 
neonatal hypoglycaemia and an increased incidence of childhood tumors. SRS is 
characterized by severe intrauterine and postnatal growth retardation, dysmorphic facial 
features, feeding difficulties, and body and limb asymmetry. DNA methylation defects 
account for approximately 60–70% of BWS and SRS patients (Demars, et al., 2011). Two 
imprinting control regions, ICR1 and ICR2, control the differential expression of imprinted 
genes at 11p15.5. Both the paternal and maternal alleles of ICR1 and ICR2 are methylated in 
normal cells. The DNA methylation defects at ICR1 is usually the hypermethylation of the 
maternal allele, leading to both BWS and SRS, whereas DNA methylation defects at ICR2 
usually involve loss of maternal-allele-specific DNA methylation, which results in only BWS 
(Robertson, 2005).  
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are two distinct neurogenetic 
disorders in which the same domain on chromosome 15 is affected. AS is caused by the loss 
of the maternally expressed gene, UBE3A, which is only imprinted in the brain. Loss of 
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maternal DNA methylation or maternal ICR deletion is involved in the imprinting defects, 
which account for ~5% of AS.  
9.5 ARTs and imprinting defects 
In the setting of infertility, the use of assisted reproductive technologies (ARTs) has been 
growing. Although the majorities of the children conceived with ARTs develop normally, 
recent studies have suggested a possible link between ARTs and genomic imprinting 
disorders.  Cox et al. (2002) have reported that two children who were conceived by 
intracytoplasmic sperm injection (ICSI) develop AS and a third case has been reported by 
Orstavik et al. (2003). A loss of methylation on the maternal allele at SNRPN locus have been 
shown in all three children, while the paternal allele has normal methylation pattern, 
suggesting a relationship between AS and an ICSI associated imprinting defect. A few 
studies have also pointed to the association between the occurrence of BWS and in vitro 
fertilization (IVF) and ICSI. Hypomethylation of KCNQ1OT1 due to a chromosome 11p15.5 
ICR2 defect as well as an abnormal methylation pattern of H19 have been observed in 
children conceived via ARTs (DeBaun, et al., 2003).  
It has been proposed that in vitro manipulations of several steps involved in conception 
contribute to alteration of the normal imprinting processes. In current ARTs protocols, in 
vitro culturing of embryos is extended until the blastocyst stage before embryo transfer to 
allow high pregnancy rate and reduce the risk of multiple pregnancy. It has been 
demonstrated that culture of preimplantation embryos influences genomic imprinting 
marks (Khosla, et al., 2001; M. R. Mann, et al., 2004). ARTs also involve induced ovulation 
via hormonal stimulation and in vitro maturation of oocytes, which might interrupt the 
natural development of oocytes and the genomic imprinting marks of the maturing oocytes 
(Iliadou, et al., 2011).  
The number of pathological conditions where aberrant DNA methylation is a contributor 
will likely increase as more refined technologies become available for the sensitive, accurate 
and high-throughput determination of CpG methylation at affordable prices. It is reasonable 
to expect that the complex mechanisms underlying CpG methylation, demethylation, 
methylation targeting and methylation protection will offer new therapeutic targets to 
alleviate the consequences of aberrant methylation in disease. 
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1. Introduction 
Both development and adult homeostatic maintenance of different tissues and organs are 
dependent on the activity of a specific cell type named stem cell (SC). In recent years, SCs 
has been tested for clinical therapies against complex diseases. For many of these diseases, 
SC treatments offer a glimmer of hope. Fortunately, in some other instances, these therapies 
are an interesting reality. 
In this chapter, we aim to introduce the readers to the nature and diversity of SC. We will 
describe their origin and location in the human body and the main SC therapies used in 
clinical practice. Finally, we will propose a standard goal of current applications to convince 
readers about future avenues in these treatments. 
2. Stem cells 
2.1 Concept and types 
A stem cell is an undifferentiated cell that is able to proliferate, giving rise to various types 
of differentiating cell lineages. Through unequal divisions, SCs may predominantly give rise 
to two different cells: one SC and one progenitor cell which continues cell division to finally 
initiate cell differentiation. These are the two inherent features of the lineages of these cells, 
self-renewal and differentiation. Depending on their location and un-differentiation state, 
these cells are able to generate/restitute specific tissues, organs or complete embryos  
(Figure 1). This capacity is named potency. A stem cell shows a high potency when many 
different cell lines can be obtained in vitro or in vivo. SCs show reduced potency when very 
few cell lines can be obtained. 
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Totipotent stem cells: Cells able to differentiate into any embryonic or extra-embryonic cell 
line. Blastomeres from zygote to morula are totipotent cells. 
Pluripotent stem cells: Cells able to differentiate into any cell line derived from any of the 
three embryonic sheets. Cells of the Inner Cell Mass, the embryoblast, and cells of the 
germinal ridges are pluripotent SCs. 
Multipotent stem cells: Cells able to differentiate into any cell type derived from only one 
embryonic sheet. Ectoderm, endoderm or mesoderm stem cells are multipotent. 
 
Fig. 1. Cell potency varies during human embryogenesis and organogenesis.  
The zygote (1) and blastomeres at two cell stage (2) and morula (3) are totipotent cells. Cells 
in the inner mass of the blastocyst (4) are pluripotent. Trilaminar disc (5) cells are 
multipotent. Stem cells at heart or large bones (6) are either multipotent or unipotent. Green 
and yellow cells in the blastocyst respectively are trophoblast and inner cell mass. 
Under this classification, the embryo appears as a very important source of many different 
types of stem cells. Cells of the Inner Cell Mass are named Embryonic stem cells (ESCs, 
Thomson et al., 1998) and show a high potency. Besides, Adult (or Somatic) Stem Cells 
(ASCs) are resident cells in adult tissues all along the complete life span. These cells show a 
smaller potency than ESCs but lesser risks and bioethical problems (see below) during their 
clinical use. 
ASCs are responsible of adult tissue homeostasis. This homeostasis is established as a 
balance between cell death and cell proliferation. A clear example can be found in the skin. 
Superficial cell layers in the epidermis are continuously dying and being lost. In order to 
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maintain epidermis stability, basal cell layer continuously proliferate. This proliferation is 
carried out by a population of epidermal stem cells. 
In order to maintain tissue homeostasis, ASC show specific cell cycle properties. These cells 
are in a quiescent state. Under a wound stimulus, they proliferate and give rise to 
differentiated cell lineages. Cell proliferation and differentiation are compensated in such a 
way that new differentiated cells are proportionate to the original induction by wound 
signals.  Following a tissue injury and under new inducing signals released from the wound, 
ASC leave the quiescent state, proliferate and differentiate to replace damaged or dead cells. 
This natural process can restore absent or wounded tissues in few days. 
Modern Cell Biology technologies have also been able to induce potency in adult 
differentiated cells. By specific in vitro culturing conditions, differentiated cells can 
dedifferentiate and proliferate to initiate several newly-differentiating cell lines. These cells 
are named induced pluripotent stem cells (iPS, Takahashi et al., 2007). All above-
mentioned stem cells can be used in a potential cell therapy. 
2.2 Locations and functions 
Since the earliest stages of embryogenesis, stem cells can be inferred to occur. Blastomeres in 
all pre-morula stages are able to generate a complete organism when isolated from the rest. 
Thus, these blastomeres are the source of totipotent embryonic stem cells. A well-known 
example of this is both groups of blastomeres isolated to form two monozygotic twins 
during early development. Both resulting individuals are genetically identical and generate 
independent chorion, placenta and amniotic cavities. Thus, these monozygotic twins are 
also diamniotic, dichorionic and diplacental.  
Just before implantation, blastocysts form pluripotent stem cells in the Inner Cell mass or 
embryoblast. At this stage, a first cell commitment can be observed during human 
embryogenesis, the embryoblast is able to generate a complete organism but not the 
extraembryonic tissues. During embryoblast formation, the isolation of two inner cell 
masses also generates two monozygotic and diamniotic twins, but they are monochorionic 
and monoplacental. These unique structures are generated from a different embryonic tissue 
named trophoblast. 
Following this stage, the inner cell mass further specifies and moves their cells to form the 
embryonic sheets in two consecutive structures, the bilaminar and the trilaminar discs (see 
Figure 1). These three embryonic sheets, the ectoderm, the endoderm and the mesoderm, are 
formed by multipotent stem cells, committed to generate specific cell fates. Stem cells from 
any of these sheets are unable to differentiate into the typical fates of cells from other sheets 
(Thomson et al., 1998). 
The ectoderm forms the nervous system and the integument. In the adult, a group of 
ectoderm-derived stem cells can be found in the basal layer of the epidermis, the epidermal 
stem cells, and in sub-ventricular positions within the central nervous system, the neural 
stem cells. The former regulate a continuous epidermal renewal, whereas the latter maintain 
the cellular structure of the nervous tissue against a classical paradigm of nervous 
proliferative quiescence. Also associated to ectoderm, a derived embryonic source of stem 
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cells is found in the neural crest. During neural crest fusion, a group of ectodermal cells 
trans-differentiate into migratory derived cells and generate different cell types all along the 
body. These cell fates are skin melanocytes, facial bones and sensory neurons among others. 
This large migratory pathway can provide ectoderm-derived stem cells in peculiar locations 
such as carotid body, from which stem cells can be obtained to use them in therapies for 
Parkinson's disease.  
On the other hand, the endoderm gives rise to the respiratory and digestive systems. 
Endoderm-derived stem cells are multipotent and can be found in mucosae basal layer in 
both systems. These cells show a high cell proliferation rate and are continuously in risk to 
be affected by carcinogenic reagents. These reasons may have led these systems to show the 
highest neoplasia frequency of all human organs. In the human liver, another endoderm-
derived stem cell type can be found, the oval cells. These cells have been recently shown to 
be involved in hepatic-regeneration. A number of cell types can be differentiated from these 
oval cells, such as the hepatocytes or biliary duct cells.  
Finally, mesoderm is involved in the formation of many different apparatus or systems: the 
skeletal apparatus (bones, cartilage, tendons), the vascular system (blood, blood vessels and 
heart), excretory (nephric systems and kidney) and reproductive (gonads) systems and the 
whole connective tissue in the organism. Thus, many mesoderm-derived stem cells are also 
located in many locations in the body to form all these tissues. From a clinical point of view, 
optimal stem cells are those forming the blood, the haematopietic stem cells in the bone 
marrow, and mesenchymal stem cells which differentiate into muscle (myoblast), bone 
(osteoblast), cartilage (chondroblast), fat tissue (adipoblast) or fibroblast progenitor cells. 
These cell types can be found in any mesoderm-derived tissue. A special type of 
mesenchymal stem cells is umbilical cord stem cells that can be differentiated into blood or 
mesenchymal cells.  These stem cells from umbilical cord are a handy and bloodless source 
of highly proliferative stem cells useful for clinical purposes. 
2.2.1 Stem cell genetic program 
The knowledge of a genetic program for stem cells was initiated by two German 
embryologists, Theodor Boveri and Hans Driesch. In the late XIXs, both scientists 
respectively showed that the program was both located inside the nucleus and dependent 
on cell-to-cell interactions. Hans Driesch also proposed that the early embryo is a harmonic 
system in which all, or many, cells show the same potency which is dependent on cell-to-cell 
interactions. Modern Molecular and Developmental Biology are providing important 
information on the nuclear location of the genetic program and the cell-to-cell interaction-
dependence of animal embryogenesis.  
Any animal or human cell is also under the control of a genetic program. This genetic 
program is regulated by a hierarchy of transcription factors that either enhance or silence 
the activity of a single enzyme named the RNA polymerase II (Figure 2). This enzyme 
generates a heterogeneous RNA using as a substrate a DNA template in the open reading 
frame of the gene. This heterogeneous RNA is processed by RNA splicing and editing to 
generate the messenger RNA. In the ribosome, this messenger RNA is translated into 
protein. Protein synthesis requires a complete set of other specific proteins and RNAs to 
either form the ribosome or regulate its activity.  
 




Fig. 2. A gene transcriptional hierarchy controls cell specification.  
At each stage, blue proteins to the right are RNA polymerase II enzymes. Protein complex in 
various colors is the general transcription complex. At each stage, isolated color boxes to the 
left (1 to 3) are specific transcription factors. Longer blue narrow rectangles are DNA strands 
and shorter yellow and dark blue narrow rectangles are messenger RNAs codifying for 
transcription factors in the same color. Explanations can be found in the text. 
The activity of the RNA polymerase II depends upon two different regulatory protein-
complexes, the general and the specific transcription complexes. The latter complexes are 
formed by the transcription factors (Figure 2) and co-factors. These proteins are able to bind 
DNA and step-by-step activate new downstream genes. Some of these new genes may 
codify for other transcription factors that activate further new downstream genes. Some of 
these transcription factors which act during animal embryogenesis are codified by genes 
named Hox, achaete, scute, engrailed, myoD, Dorsal, cubitus interruptus, apterous, Pannier or 
Iroquois. These animal proteins are ordered in a transcriptional hierarchy, the so-called 
genetic program (Figure 2). This hierarchy is so complex that almost all embryonic cells can 
be supposed to be different at the transcription level (See Alberts et al., 2007). Finally, this 
genetic program also transcribes mRNAs codifying for other protein types. These new 
proteins may be structural or collaborate in the regulation of many cell properties, such as 
cell division, apoptosis or differentiation. This completes the genetic control of 
embryogenesis or tissue maintenance.  
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Two additional features can be observed in animal development, cell-to-cell interaction 
dependence and pleiotropism. In animals, transcription regulation is balanced among all cells. 
This balanced regulation is able to generate cell diversity, organ size or pattern formation 
during embryogenesis. By this process, the transcription regulation of a given cell depends 
upon the transcription in surrounding cells. In order to balance these transcription activities, a 
number of different signal transduction pathways have been found (see Figure 3). Wnt, Sonic 
hedgehog, FGFs and BMPs are ligands that activate some of these transduction pathways.  
This balanced transcription can be traced back to the genome from the mother to regulate 
follicle cells signaling. Moreover, these proteins can interact with many other proteins in other 
cells to regulate many cell processes. Thus, the same ligands may pleiotropically regulate cell 
differentiation in ectoderm, endoderm and mesoderm-derived stem cells. The embryonic-
sheet specificity is provided by the genetic program of each cell. 
 
Fig. 3. Cell-to-cell interactions regulate gene transcription within each human cell.  
Signals can travel along varying distances. The upper left cell is a stem cell. The lower left 
and right cells respectively are a differentiating cell and a new stem cell. Details are 
described in text. 
These studies in animal species provide a good tool to now find human genes candidate to 
be regulating any cell process. By sequence similarity between any animal and human gene, 
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an orthologous human gene can be found. When compared with the animal gene, this 
human gene may also show similar functions in the human organism. 
When studying human stem cells, all these regulatory features can also be found. Notch or 
Wnt signaling pathways have  been shown to control the cell-to-cell-interaction-dependent 
decision between cell proliferation and cell differentiation.In humans, additional functions 
have been shown for these signaling pathways. The same can be found when other 
signaling pathways are studied. Transcription factors acting in stem cells are Bmi1, Oct4, 
SOX2, Klf-4, cMyc, FoxD3, or EGR1. An interesting effort might completely relate SC gene 
transcription to embryonic genetic program. 
In summary, the differentiation of any stem cell type depends on a hierarchy of 
transcription, traced back to maternal information. This hierarchical regulation also 
influences, in a balanced way, the differentiation of other surrounding cell types. These 
neighboring influences, such as the so-called stem cell niche, are under profound analysis.  
2.2.2 Stem cell niches 
Stem cells require a very specific chemical and physical environment for a correct function. 
This environment is provided by the Niche, a group of cells providing signals to stem cells 
for a balanced activity within the tissue (see Becerra et al., 2011).  
SC niche is defined as the microenvironment formed by SC, non-SC niche resident cells and 
specific signaling and ECM molecules surrounding them. The niche controls SC divisions. 
This SC proliferation can be regulated to fulfill the homeostatic needs (Becerra et al., 2011). 
Although the information on niche structure is still scarce, a recent increase in scientific 
publication on this topic is being issued. Drosophila testis or germarium, hair follicle, 
intestine crypts, bone marrow and brain sub-ventricular zone are niches under intense 
study (Fig. 4). 
Thus, the molecular/cellular paradigm is providing a new solution to one of the oldest 
unsolved questions in current developmental biology. Potency is now being understood 
under the concepts of genetic program and cell-to-cell interactions, and this may also help 
clinical practices. 
3. Cell therapies 
3.1 Introduction and concept 
An ancestral question, traced back much before ancient Greece, is to understand why 
human body does not regenerate. A Greek example is Prometheus legend. Prometheus was 
immortal but stole fire from Zeus and was condemned to be devoured by an eagle. The 
eagle ate his liver every day, but Prometheus continuously regenerated his organ back and 
back again. The ancient observation of living beings led to the idea of animal regeneration. 
Indeed, sea urchin, triton or fishes are able to regenerate their limbs to restitute previous 
amputations. This probably inspired the legend. 
The discovery and study of human stem cells brought about new hopes of recovering absent 
or injured organs. This was the birth of Cell therapy. Cell therapy is the treatment of 
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Fig. 3. Cell-to-cell interactions regulate gene transcription within each human cell.  
Signals can travel along varying distances. The upper left cell is a stem cell. The lower left 
and right cells respectively are a differentiating cell and a new stem cell. Details are 
described in text. 
These studies in animal species provide a good tool to now find human genes candidate to 
be regulating any cell process. By sequence similarity between any animal and human gene, 
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an orthologous human gene can be found. When compared with the animal gene, this 
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human diseases by application of cells. Although this discipline is at its beginnings, many 
current therapies aim to use stem cells to treat an important variety of human diseases. 
 
Fig. 4. Simplified schematic representation of the niche of stem cells in the bone marrow.  
MSC and HSC interact in the endosteal niche, around the bone, and the vascular niche, close 
to the blood vessels. A lot of factors have been identified related to the regulation of 
hematopoiesis and the fate of the MSC. (1) spicules of bone, (2) osteoblasts, (3) 
hematopoietic stem cells (HSC), (4)Hematopoietic progenitor cells, (5) mesenchymal stem 
cells (MSC), (6) fenestrated capillaries, (7) progenitors inside capillaries, and (8) is an 
osteoclast.  
The above-mentioned cells, neural, respiratory or digestive mucosae stem cells, 
haematopoietic, epidermal, mesenchymal or umbilical cord stem cells are currently used to 
treat diseases. However, the methods for obtaining these cells and treatment effectiveness 
vary depending upon cell type or potency. 
In 1998, embryonic stem cells were first discovered (Thomson et al., 1998). Inner cell mass 
cells from a blastocyst were cultured in vitro. An empirical device was used to succeed in 
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this task. This empirical device was being used since 1960s for in vitro culture of animal 
cells. Fibroblasts were killed by irradiation inducing extensive mutations in their nuclei 
DNA. A lawn of irradiated fibroblasts was deposited in a Petri dish, the feeder layer, in 
order to feed the non-irradiated embryonic cells. During culturing, these cells spontaneously 
dissociated from one another. These living cells were sub-cultured in another feeder layer to 
obtain embryonic stem cell colonies. These cells showed an important pluripotency when 
induced to differentiate in vitro under a variety of different stimuli and eventually produced 
teratomas when grafted into a mouse. 
More modern techniques have been used to culture stem cells by in vitro amplification. 
Some of these cells can be obtained by egg enucleation and subsequent nuclear implantation 
from a differentiated somatic cell. If a pre-treatment of nutrient deprivation is carried out, 
nuclear re-programming may occur. This re-programming is able to de-differentiate the 
somatic cell nucleus and re-induce early embryogenesis in vitro. Under these conditions, a 
population of cultured cells from the patient can be obtained. Following these techniques, 
Asexually Produced Totipotent (APT) Cells were obtained. This technique shows a great 
advantage as these cells are not immunologically rejected when clinically used. 
Two experimental trials are used to verify the quality of embryonic stem cells: 
i. Teratome formation  
If ESCs are experimentally implanted in animals, they generate tumors. These tumors may 
differentiate structures such as gastric glands, teeth or hairs. The nature of these structures 
suggests that these tumors may be originated from any embryonic sheet. 
ii. Chimera induction  
If embryonic stem cells are implanted into a genetically different inner cell mass, a chimeric 
organism is formed. Although classical terminology states that chimeric organism are 
mixture of different species,ESC-derived chimerism only implies genetic differences within 
a given species. In these mammalian organisms, the cells show two different genomes. This 
may be useful to trace the location of cells by simple histological observations, but it can also 
be used as a cellular treatment of diseases. 
All these manipulations of human embryos or genes have precluded a direct application of 
these techniques due to bioethics reasons. Due to continuous argumentations in the society, 
an alternative to ESC use in cell therapies have arisen since the beginning. This technique 
use multipotent stem cells obtained from the adult, the above-mentioned ASC. Cell 
therapies using ASC has been widely expanded in clinical use around the world. However, 
although ASC are safe and very useful in many therapies, they show several practical 
problems that have to be considered. 
A first problem is related to methods to obtain ASCs. Almost any stem cell type has to be 
obtained by a different experimental protocol. Thus, there are simple ways and very difficult 
protocols of obtaining stem cells. The easiest protocol is bone marrow aspiration to obtain 
mesenchymal and haematopoietic stem cells. This is clinically used in everyday treatment of 
leukemia or blood cell diseases. The most difficult protocol is to obtain neural stem cells 
from sub-ependymal layers. The clinical protocols using this latter technique are far away 
from being regularly used at hospitals due to its low benefit/risk level. 
 
Embryology – Updates and Highlights on Classic Topics 
 
180 
human diseases by application of cells. Although this discipline is at its beginnings, many 
current therapies aim to use stem cells to treat an important variety of human diseases. 
 
Fig. 4. Simplified schematic representation of the niche of stem cells in the bone marrow.  
MSC and HSC interact in the endosteal niche, around the bone, and the vascular niche, close 
to the blood vessels. A lot of factors have been identified related to the regulation of 
hematopoiesis and the fate of the MSC. (1) spicules of bone, (2) osteoblasts, (3) 
hematopoietic stem cells (HSC), (4)Hematopoietic progenitor cells, (5) mesenchymal stem 
cells (MSC), (6) fenestrated capillaries, (7) progenitors inside capillaries, and (8) is an 
osteoclast.  
The above-mentioned cells, neural, respiratory or digestive mucosae stem cells, 
haematopoietic, epidermal, mesenchymal or umbilical cord stem cells are currently used to 
treat diseases. However, the methods for obtaining these cells and treatment effectiveness 
vary depending upon cell type or potency. 
In 1998, embryonic stem cells were first discovered (Thomson et al., 1998). Inner cell mass 
cells from a blastocyst were cultured in vitro. An empirical device was used to succeed in 
 
Stem Cell Therapies 
 
181 
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advantage as these cells are not immunologically rejected when clinically used. 
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a given species. In these mammalian organisms, the cells show two different genomes. This 
may be useful to trace the location of cells by simple histological observations, but it can also 
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All these manipulations of human embryos or genes have precluded a direct application of 
these techniques due to bioethics reasons. Due to continuous argumentations in the society, 
an alternative to ESC use in cell therapies have arisen since the beginning. This technique 
use multipotent stem cells obtained from the adult, the above-mentioned ASC. Cell 
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although ASC are safe and very useful in many therapies, they show several practical 
problems that have to be considered. 
A first problem is related to methods to obtain ASCs. Almost any stem cell type has to be 
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mesenchymal and haematopoietic stem cells. This is clinically used in everyday treatment of 
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from being regularly used at hospitals due to its low benefit/risk level. 
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Beside stem cells, these techniques normally require further auxiliary material. Among 
them, bioactive molecules and artificial scaffold are currently necessary for growth and cell 
differentiation to obtain tissue integration. All these auxiliary techniques are included in the 
so-called Tissue Engineering.  
3.2 Current applications 
Many different cell therapy techniques are currently under legalization process to be 
applied to treat modern diseases. Some of these diseases affect bone, cartilage, central 
nervous and immune systems, skin, heart or blood. Bone Marrow therapies to treat blood or 
skeletal diseases are widely spread treatments used all around the world. However, other 
cell therapies are still under intense research. These stem cell techniques are treating self-
immune or neurological diseases, such as Parkinson, ELA or medullar traumas. 
The most important factor boosting improvement of these treatments is the close-knit 
collaboration between basic and applied research. From basic research, model systems must 
be proposed to evaluate the effectiveness of cell therapy. These model systems require the 
definition of precise model species, organ, tissues and/or cell type to verify responses to 
treatments. Experimental conditions, such as transgenic mice, implanted animals or in vitro 
culturing, may also be necessary for this model system definition. In some instances, some 
of these techniques may also be applied to hospitals, where material useful for the definite 
cell treatment is necessary. During this process, biological research grants are substituted 
with pre-clinical trials, always under medical rigorousness and refereeing. Since most 
applications require ex vivo manipulation of cells collected from the donor, the European 
Union has regulated its use as a drug. 
In order to provide examples of this tortuous journey, we will discuss three examples. These 
three cell treatment examples use the same stem cell type, the mesoderm-derived 
mesenchymal stem cells (MSC). We will show that these three cases are elements in a single 
routing process that can be used as stepping stones to be followed when similar strategies 
are expected to be applied (Figure 5). 
The first therapy is widely used around the world. Every hospital has enough experience 
and tradition in its application. Moreover, citizens in modern societies have a clear 
knowledge of its existence and utility. This technique is Haematopietic stem cells 
implantation, or the well-known bone marrow transplantation. The second therapy is also 
well implanted in hospitals but it is rarer than previous ones. Although it has roots in 
ancient Egypt, there is not such a consensual application as HSC implantation. This is the 
use of mesenchymal stem cells in treatments of bone diseases. The third case is at pre-
clinical trials stage in some hospitals but it is widely unknown in clinical environments. This 
is the use of MSC to treat psoriasis or other angiogenic diseases. The three cases can be 
understood as a gradual process of accepting a unique clinical success. At this stage, the 
reconstruction of the original environment of stem cells in the body is reproduced and then 
these cells are able to restitute homeostasis in the organism. 
3.2.1 Cell therapy and haematopoiesis 
The tissue that generates blood cells is the Bone Marrow.  In the bone marrow, millions of 
HSC and MSC can be found. If after an accident, an important quantity of blood is lost,  
 




Fig. 5. Bone marrow aspiration and liposuction provide mesenchymal stem cells.  
(A) bone marrow aspiration or liposuction, (B)  direct grafting of mesenchymal stem cells 
(mononuclear cell fraction), (C) in vitro amplification of progenitor cells, (D) grafting of 
amplified stem cells,  adsorbed on pieces of biomaterial (E)  and (F) potential treatment of a 
diabetic foot. 
signals are released at bone marrow to activate HSC. This activation induces cell 
proliferation and differentiation of the haematopoietic lineage to restore all blood cells. The 
restoring of blood cells is mandatory for reconstitution of blood in the injured patient. 
Following experiments with irradiated dogs, bone marrow transplantation was shown to be 
useful to restitute blood homeostasis. The physiological knowledge of the process has 
directed a clear improvement of treatments against hematological diseases. This treatment 
obtains bone marrow from healthy donors and implants them in compatible patients. Even 
though blood transfusions are commonly used due to mobilization of marrow progenitors 
to peripheral blood, bone marrow sources are iliac crests, sternum, femur and humerus. 
Bone marrow is the residence of millions of HSCs able to restitute these cells.  
Effectiveness of bone marrow transplantation can be easily studied in hematological 
diseases, such as congenital aplastic anemia, thalassemia, platelet defects or coagulopathy. 
In these instances, HSC at transplanted bone marrow restitute absent or defective blood cells 
in the patient (Figure 5). However, leukemia treatments provide additional information on 
this clinical strategy. This disease mostly affects white blood cells. In these diseases, white 
blood cells are present in the patient but they are in variable quantities suggesting loss of 
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regulation by uncontrolled proliferation. Bone marrow transplantation has also been 
important to treat leukemia. This cell therapy restores red blood cells and platelets 
previously reduced by chemical treatments. But this therapy also regulates abnormal HSC 
by substituting them with healthy HSC from donors. These healthy HSCs regulate patient 
haematopoiesis to homeostatic conditions. 
Millions of MSC, adipocytes or pericytes are still present in the irradiated host bone 
marrow. Some of these auxiliary cells may also help to generate a correct signaling ambient 
for the proliferation of cells to be up-regulated (Figure 4). Indeed, some of these cell types 
have been proposed to act as HSC Niche to provide a fine regulation of the restituting 
process. In the end, this fine regulation is crucial for homeostatic renewal and health 
restitution. This fine regulation of stem cells is the real standard goal of this technique. A 
tentative hypothesis would extend this standard goal to any other cell therapy method. 
Since this type of cell therapy does not perform ex vivo manipulation, they do not impose 
regulatory standards of drug quality. 
3.2.2 Cell therapy and chondrogenesis/osteogenesis 
In modern societies, a number of diseases have appeared associated to the new life style. The 
increase in life span brings about additional degenerative diseases, such as osteoporosis or 
arthritis, which affect bones and joints of an increasingly number of citizens. Moreover, traffic 
accidents or the massive play of sports also generates an important number of bone and joint 
diseases. These ostearticular patients are thus widely these ostearticular patients are widely 
distributed in the population and very different age groups can be affected by similar diseases. 
Although some evidence of limited digit regeneration has been reported in children, 
treatments for these diseases must be adapted to the special conditions of the patient.  
Cell therapy of partial bone or cartilage-defects, requires the in situ administration of 
osteoblast and chondroblast progenitor cells. These cells can also be obtained from bone 
marrow or other origins, amplified and induced in vitro into a osteo- or chondrogenic 
lineage. Then, these cells can easily be applied to the injured tissue (Figure 5). But, when 
surgeons transplanted these cells, they did not obtained proper results. Scaffolds to support 
cells and appropriate signals were not present and the skeletal tissue was not completely 
restored. A classical clinical practice was to obtain bone powder or small bone fragments 
and apply them to the operation field. Following this technique, a very important increase in 
bone regeneration was obtained. Then, surgeons transplanted a mixture of this powder and 
osteoblast progenitor cells to significantly improve bone regeneration. Even in these 
treatments, small or even larger pieces of bones were also transplanted in the mixture to 
gradually obtain better results. At this stage, a clear conclusion can also be obtained. Stem 
cells cannot fulfill a correct treatment by themselves, and a potential stem cell niche, either 
natural or artificial, to provide a necessary cell induction, must be present. 
Indeed, artificial biocompatible materials have also been extensively developed in this task. 
These biomaterials show superficial properties of special adherence to progenitor cells. 
Moreover, a number of different proteins, many in the TGF-beta super-family, can also be 
applied. These molecular treatments aim to reproduce the natural regulation of progenitor 
cells in the body and are combined with the cell therapy. This type of Tissue Engineering is 
one of the most promising techniques in this area. Pre-clinical and clinical trials are well 
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advanced and are showing significant results. As expected, these "artificial" treatments will 
be compared with "natural" ones after bone fragments transplantation, where cells, signals 
and extracellular matrix components are present. As the latter cannot always be applied due 
to the type of bone lesion, artificial scaffold treatments could be a candidate cell therapy in 
most hospitals in a short future. 
In general, these therapies take advantage of easy methods to obtain MSC. Bone Marrow 
aspiration is a well-founded medical technique. This technique can be applied to the 
patient and an important number of MSC obtained in vitro. These cells and the 
appropriate natural or artificial scaffold can hopefully collaborate in the regeneration of 
osteocartilage injuries. Recent alternatives to bone marrow aspiration can be found in 
liposuction techniques. Vasculo-stromal fraction from fat tissue obtained by this 
technique can be use as an in vitro source of MSCs. Potency and quality of these cells are 
enough to obtain osteoblasts or chondroblasts under the appropriate stimuli. But 
liposuction is less invasive than bone marrow aspiration and can further help the cosmetic 
surgery of the patient. In any case, cell therapy for skeletal repair is one of the most 
promising applications of regenerative medicine. 
3.2.3 Cell therapy and angiogenesis 
Angiogenesis is the generation of new capillaries by a process of sprouting of pre-existing 
microvessels. In health, vessel proliferation is under stringent control and occurs only 
during embryonic development, endometrial regulation, reproductive cycle and wound 
repair. On the contrary, a persistent and deregulated angiogenesis is related to diseases such 
as proliferative retinopathies, psoriasis and rheumatoid arthritis, and seems to be essential 
for tumor growth and metastasis (Carmeliet, 2005). On the other hand, the concept of 
therapeutic angiogenesis has emerged as an approach to ischemic diseases in which 
stimulation of new vessels growth is intended to restore blood supply to ischemic tissue 
(Carmeliet, 2005; Tirziu and Simons, 2005).  
Promising results in pre-clinical studies prompted the initiation of a number of clinical trials 
in patients with advanced coronary and peripheral arterial disease who had no other 
treatment option (Lachmann and Nikol, 2007; Tse et al., 2007). In spite of the recent 
advances in medical therapy, coronary artery disease remains the major cause of morbidity 
and mortality in the developing countries. In patients with severe coronary artery disease, 
persistent myocardial ischemia in hibernated myocardium can result in progressive loss of 
cardiomyocytes with development of heart failure. On the other hand, peripheral arterial 
disease is a common manifestation of systemic atherosclerosis that is associated with a 
significant limitation in limb function due to ischemia and high risk of cardiovascular 
mortality. The lower limb manifestations of peripheral arterial disease are classified into the 
categories of chronic stable claudication, critical leg ischemia, and acute limb ischemia. 
Lower limb ischemia is a major health problem since, in the absence of effective 
pharmacological, interventional or surgical treatment, amputation becomes the only 
solution to unbearable symptoms at the end-stage. 
A part of therapeutic angiogenesis approaches to treat coronary and peripheral artery 
diseases is based on cell therapy. Bone marrow consists of multiple cell populations, 
including endothelial progenitor cells, which have been shown to differentiate into 
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advanced and are showing significant results. As expected, these "artificial" treatments will 
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endothelial cells and release several angiogenic factors and thereby enhance 
neovascularisation in animal models of hind limb ischemia. The promising results from 
various preclinical studies provide the basis for clinical trials using bone marrow-derived 
cells or non-bone marrow cells, like cells from the peripheral blood or other tissues 
(Figure 5). However, the mechanisms by which these cells exert their positive effects are 
poorly understood (Lachmann and Nikol, 2007). Furthermore, although the initial pilot 
clinical trials showed potential clinical benefit of bone marrow derived cell therapy for 
therapeutic angiogenesis, the long-term safety, the optimal timing and treatment strategy 
remains unclear (Tse et al., 2007). This might explain why, up to the moment, some 
controversial results have been obtained. While a meta-analysis of randomized, controlled 
clinical trials of therapeutic angiogenesis published in 2009 concluded that patients with 
peripheral arterial disease -and in particular those with critical ischemia- improved their 
symptoms when treated with cell therapy with acceptable tolerability, a more recently 
published article concluded that stem cell or progenitor cell therapy did not reveal clinical 
benefit in patients with peripheral artery disease (De Haro et al., 2009; Nikol, 2011). 
Additional controlled clinical trials are in progress. When data from large randomized 
placebo-controlled trials will be available, it will be possible to evaluate properly the 
actual impact of this therapeutic approach. 
4. Risks and bioethics problems 
As any other medical treatment, cell therapy techniques may show intrinsic risks or lead to 
unexpected damages. First, to obtain adult MSC is bloody. Although it varies with the used 
technique, all methods show morbidity. Improvement can be found from Bone marrow 
aspiration to liposuction. The first technique is painful and shows potential surgical risks, 
whereas the second operation shows lesser morbidity although certain potential surgical 
complications can still arise. In any case, other alternatives show even worse side effects. 
Neural stem cells or liver oval cells can be obtained from an adult, but a complete 
neurosurgical or hepatic operation is necessary with many additional drawbacks. 
Obtaining the ASCs is not the whole problem. Stem cell implantation is another risky part of 
the protocol. When manipulating biological material during the surgical operation, the 
infection risk is very high. In order to reduce this risk, the surgeon and auxiliary 
manipulators has to follow strict conditions and actuations. All these risk does not preclude 
the application of these techniques. However, all implicated manipulators have to strictly 
follow many security protocols at each stage. Good Manufactured Practices (GMP) must be 
observed at all times. 
Moreover, postsurgical risks must also be considered. When heterologous grafts (donor and 
host are different persons) are carried out, immunological rejection is always important. 
Indeed, very severe diseases can appear such as Graft-against-Host disease or Systemic 
Inflammatory Response Syndrome which can drive to death to the patient. A continuous 
risk of cell treatments is to produce an uncontrolled growth in grafted cells to generate 
neoplasia. Statistically, the risk to suffer neoplasia is much lower when treated with ASC 
than using ESC. In ASC treatments, this probability is similar to that observed in untreated 
patients due to other carcinogenic factors. Recent findings indicate the MSCs produce 
recovery by trophic and immunomodulatory effects (Caplan, 2009). This has boosted 
numerous clinical trials that may hopefully lead to new healing therapies. 
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Another limiting question is posed by bioethics commissions. A big controversy arose with 
embryonic stem cells. To obtain these cells, embryos must be destroyed or their genetic 
material manipulated. This leads to moral problems which involves both the scientific 
community and the non-scientific society. Some countries approved these protocols whereas 
others did not. So, besides the moral questions, other economical-political reasons also 
influenced the natural development of these protocols. All this has led scientists and 
physicians to avoid the use of these cells in favor of ASCs.  
5. Future perspectives 
Besides all these improvements, Cell therapy has a long journey ahead. Among all obvious 
perspectives, to obtain Stem Cells through a lesser bloody operation, to find the appropriate 
stem cell source and to investigate the best signaling cocktail for any tissue differentiation, 
are clear options. In order to reach this, a continuous interaction between scientists and 
physicians must occur. If these therapies are approved for use in every hospital, GMP labs 
would be installed near the operating room. On the contrary, if marketing criteria are 
imposed, “therapeutic cells are drugs”, the situation will be very different.  
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1. Introduction 
This chapter may look strange for a text-book. While the usual text-books expose firmly 
established facts and theories, the main aim of this essay is to tell about what we do not 
know and do not understand and to show that this “dark area” is probably greater than the 
elucidated one. No less strange may look that our arguments are based to a great extent 
upon the data obtained long ago and for many times described but, as we try to argue, up to 
now adequately non-interpreted. On the other hand, the main pathway which we suggest to 
move along, that is the application of a self-organization theory to developmental events, is 
missed in conventional text-books. Taking into consideration a strange genre of this essay, 
the author have to apologize the potential readers for its inevitable shortages: some points 
may be discussed too briefly, while others too much emphasized. Nevertheless, my goal will 
be achieved if just single readers will realize that in the science about organic development 
much more than some small details are unknown and unexplained; and that the young 
generation of researchers has ahead a fascinating field for further studies.  
2. Do we understand development? 
Being an aged Professor of Moscow State University, within several decades I am reading 
Embryology lectures for a large class of Biology students. I was a witness of an exciting 
transformation of this science (which, in the hope to look more modern changed its 
traditional name to “Developmental Biology”) from a minor and poorly known affiliation of 
zoology or histology to a powerful and highly respectable branch of life sciences, closely 
linked with genetics and molecular biology and becoming an indispensable part of stem cell 
research, regenerative medicine, and so on. At the first glance, everybody even to a small 
extent related to this science should be proud of its achievements. But nevertheless, several 
times during my lecture course I feel myself uneasy with my students, as if I do not tell 
them the whole truth. And the truth is that, in spite of all the technological achievements, 
we the specialists do not understand the development of organisms not so much in details, 
as in its main outlines. Yes, we can produce by our willing in artificial conditions some types 
of cells and multicellular structures, but we have to take these and other results as given, 
without really explaining them. Actually, we cannot answer a question which looks naïve, 
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but is actually very deep: why in the course of normal development a given stage (that is, a given 
set of embryonic structures) is exchanged by another one, no less definite; or why,  what looks even 
more miraculous, a variable set of structures comes towards quite a definite end-result (Fig. 1). 
 
Fig. 1. Two examples of developmental successions. A-M: succesive stages of sea-urchin 
development.In this case the structure of each next stage is strictly determined. N-Q: 
development of a hydroid polyp from a cleaving egg to larva stage.The early and 
intermediate stages (N-P) have quite a variable structure, but the end-stage Q is the same in 
all the cases (From Beloussov, 2008). 
True, a response to a question “why” which can satisfy us is itself in no way definite and 
unambiguous, especially in biology. If you ask, why a given embryonic structure  
is appeared at this time and location, at least three different kinds of “explanation” can  
be given.  
First, some people will be satisfied by claiming that a given structure is arisen here and at 
that time moment because this is required for fulfilling its subsequent physiological 
functions, and/or obtaining some selective advantages, and so on. All such statements, 
which exchange the question “why” by “for what purpose” belong to so called teleology – a 
view which is looking into future for finding the reasons for what has happened just now or 
in the past. Teleology cannot be completely withdrawn from life sciences –for a biologist to 
look for goals is a respectable business. However, if we want to follow the main way taken 
by other natural sciences, we have to search the answers to the “why” questions in the 
immediate past of a given event, rather than in its future. 
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Just this idea became a basis for a classical causality, which is often called Laplacian, because 
it was formalized by the great French mathematician Pierre Simon Laplace at the beginning 
of XIX century and was considered for a long time to be the only one compatible with a real 
science. By this approach, the main aim of a science is to analyze the observed world to such 
an extent that it could be presented as (being split to) a chain of one-to-one cause-effects 
links, a single cause being able to produce no more than one event. The main task of 
investigator is to compile a complete list of the causes. If fulfilling this task, the surrounding 
world will become completely predictable: nothing new (unexpected) can happen in it.  
Paradoxically, the Laplacian approach became, in the course of time, much more deeply 
rooted in biology, than in physical sciences, which Laplace had into mind. In particular, it 
has been introduced in embryology by the German embryologist Wilhelm Roux already at 
the end of XIX century. Up to now it remains to be the leading ideology of this science 
(although most of experimenters do not even suspect this). 
Meanwhile, in physics since Galileo and Newton times another approach, which may be 
called law-centered one, took the leading positions. In a certain sense, it is opposite to the 
causal one, although the both developed hand by hand. While classical causality is directed 
towards detalization (by splitting a world into a set of as detailed as possible cause-effects 
relations), the law-centered approach tends to generalize, by establishing invariable relations 
between as much as possible events. For example, if two physical bodies are moving along 
different trajectories, this approach invites us to formulate a common law describing the 
both movements, while if following the classical causality we should search the specific 
causes for each of the movements, and even for the small parts of the trajectories. It was the 
law-centered approach who gave to the physical sciences a predictive power, that is, any 
power at all. Our main question will be - should we use this approach in developmental 
biology, or we are completely satisfied by a classical causality? The answer will depend 
mainly upon whether the successions of developmental events are underlain by perfect 
causal chains, determined in all their links. Let us look, whether this is the case. In doing 
this, we shall explore the possibilities of two mostly used versions of a causal approach. The 
first one claims, that the main causes of the developmental events are genes, while another 
ascribes a leading role to the influences of the earlier arisen embryonic structures upon the 
subsequent ones.  
A genocentric approach seems, at the first glance, firmly substantiated, because the genes, 
or, if speaking more precisely, so called signaling pathways, that is the relays of protein-
protein interactions, triggered by so called ligands (in most cases, products of genes activity) 
and switching on other genes are indispensable participants of virtually all the biological 
processes, including developmental ones. If blocking (knockouting) certain genes and/or 
signaling pathways, many developmental events will be abolished and distorted. Does it 
mean however that there exists one-to-one relation between a gene/signaling pathway on 
one hand and a given embryonic structure on the other?   
Many years ago the biologists believed, that this was just the case. One of the milestones of a 
first half of XX century biology was a claim: “One gene – one character” (a character was 
taken at that time as something static, related to an adult state). More recently, however, 
when the amazing technical progress permitted to trace the expression of single genes in the 
course of development, quite unexpected results have been obtained: it turned out that the 
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products of activity of the same or closely homologous genes and/or the same signaling 
pathways were involved in quite different developmental events and vice versa. Text-books 
in developmental and cell biology are full of such examples. Here are just few of them: 
- “The interactions betweeen msx-1 and msx-2 homeodomain proteins characterize the 
formation of teeth in the jaw field, the progress zone in the limb field, and the neural 
retina in the eye” (Gilbert, 2010).   
- The transcription factor Pax-6 is expressed at different times and at different levels in 
the telencephalon, hindbrain and spinal cord of the central nervous system; in the lens, 
cornea, neural and pigmented retina, lacrimal gland and conjunctiva of the eye; and in 
the pancreas (Alberts et al., 2003). 
- In Drosophila embryos a gene Engrailed is involved in segmentation of a germ band, 
development of intestine, nervous system and wings. In mouse same gene participates 
in brain and somites development. In Echinodermata it takes part in skeleton and 
nervous system development (Alberts et al., 2003). 
- Delta-Notch signaling pathway regulates: neuro-epithelial differentiation in insects, 
feather formation in birds,fates of blastomeres in Nematodes, differentiation of T-
lymphocytes etc (Alberts et al., 2003). 
- Hunchback gene is involved at the early stage of Drosophila development as one of so-
called gap genes and at the later stages participates in development of neural system. 
By summarizing: if we know everything about the genes/signaling pathways being in work 
in the given space/time location, we can tell nothing about what embryonic process is going 
on, and vice versa. This is enough for concluding that the genes/signaling pathways in spite 
of all their importance cannot be considered as “causes” of development; much better to say 
that they are tools, which can be utilized by a developing organism for quite different 
purposes. Certainly, the tools deserve to be studied, and such studies can be very important 
and useful, but they do not help us to answer our main question. Accordingly, the results of 
our studies will have no predictable power – we are doomed to investigate each next 
experimental point separately.  
Let us pass to the second version of the causal approach, ascribing the main role to the 
interactions between embryonic rudiments. Just this version was used by Roux and his 
followers.  
The first task which Roux decided to solve by his approach was a long standing controversy 
between two general views upon development. The first of them, called preformism, 
claimed that each structure of an adult has its own material representative from the very 
beginning of development, the latter being localized somewhere inside an egg or 
spermatozoon. By this view, from the very beginning of development an embryo is no less 
spatially complicated than the adult organism. The alternative view, called epigenesis, 
negated this idea, suggesting that an early embryo is less complicated than the advanced 
one, and may be even homogeneous. Roux attempted to resolve this alternative by dividing 
an embryo into parts: if the preformism were true, an isolated part of embryo will produce, 
under subsequent development, nothing else than that set of organs, which will be normally 
produced from this very part; if, meanwhile, a part, after its isolation, will produce another 
or, moreover, the larger set of organs, preformism should be rejected. Roux himself 
performed this procedure by killing one of two first cells (blastomeres) of a frog egg with a 
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heated needle. As a result, the remaining blastomere produced roughly a half of embryo. It 
looked, as if preformism was true. However, such a situation lasted less than for a decade. 
Several years later another German embryologist, Hans Driesch, separated the blastomeres 
of another animal, sea urchin, by more delicate technique: by using sea water lacking 
calcium ions he separated the blasstomeres, but kept all of them alive. The result was quite 
another: each of two first blastomeres, and even each of the first four ones gave rise to entire, 
almost normal embryos (although of a correspondingly diminished sizes), rather than to the 
parts which had to be normally developed from the isolated blastomeres (Fig. 2). This effect 
was called embryonic regulations. 
  
Fig. 2. A scheme of Driesch’s experiment demonstrating embryonic regulations: so-called 
plutei larvae developed from the single blastomeres separated at 4-cell stage have roughly 
the same structure (at the diminished size) as the normal larva (from Gilbert, 2010, 
modified).  
A similar result was obtained in another set of Driesch experiments, in which the 
blastomeres were rearranged (changed their neighbors). In spite of rearrangement, the 
subsequent development was going in a normal way. Since Driesch times, hundreds of such 
experiments have been performed at the different animal species and stages of 
development, obtaining in general (if omitting details, unnecessary in out context) quite 
similar results. 
What should we derive from these experiments as related to the concept of one-to-one 
causal chains? 
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If we continue to assume that each structure of an adult or of an advanced embryo possesses 
its own causal chain traceable from the very beginning of development, embryonic 
regulations enforce us to conclude that each one of say four blastomeres contains at the 
same time ¼, ½ or a full set of the causal chains and, moreover, the portions of these sets 
contained in the same blastomere may be different in the different experiments. Taking into 
mind, that a blastomere “do not know” in advance, whether he will be isolated or not, and 
what neighbors will he have, we have to accept that embryonic regulations make the idea of 
one-to-one causal chains contradictory and absurd: at least during the developmental period 
when the regulations are taking place, any causal chains should be smoothed and lost.  
Besides embryonic regulations, there are also other arguments against the existence of 
one-to one causal chains. One of the main ones is a so-called equifinality, illustrated by 
Fig. 1N-Q. It is the attainment of the same end-result of development by quite various, 
sometimes purely stochastic developmental pathways. A stochasticity of embryonic 
processes firstly emphasized already a century ago by the Russian biologist Alexander 
Gurwitsch, looks to be a background of many morphogenetic events, first of all those 
associated with branched rudiments (blood vessels, lungs, leaf veins). These structures are 
of a fractal nature and are hence generated in chaotic regimes, to which the notion of 
specific causes is completely inapplicable.  
Now let us look, what conclusions from his experiments made Driesch himself.  
He expressed them in a laconic statement, known as Driesch law: “A fate of a part of 
embryo depends upon its position within a whole” [let us add: rather than upon its 
internal properties].  
By this formulation Driesch wanted to interpret embryonic regulations in the following way. 
At the first step, the shape of a normal early embryo is in rough outlines and in diminished 
size restored. Next, each cell of a regulated embryo “recalculates” its position according to 
its coordinates within a new “whole” and develops according to this recalculated position, 
rather than follows its normal destiny. Formally such interpretation may be true, but several 
important questions remain unanswered. First of them is: by what means a roughly normal 
shape of an early embryo is restored? This process is not explained by Driesch law. 
Moreover, well after Driesch it was shown that a normal shape can be restored from the 
cells arranged in a completely chaotic manner (Fig. 3). The second question is: what are the  
 
Fig. 3. Normal sea-urchin larvae can arise from completely random aggregations of 
embryonic cells. 
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reference points for the recalculation procedure? Driesch formulation – “according to a 
whole”-  is too vague, although, as we’ll see later, such a vagueness has its own justifications. 
Meanwhile, in a new and a most popular version of Driesch law – a concept of  “positional 
information” (PI) (Wolpert, 1996) - the answer was another: cell positions are referred to 
certain special predetermined points, often defined as “sources” and “sinks” of some 
diffusible substances, the morphogenes. But it is easy to demonstrate that the existence of 
such predetermined points is incompatible with embryonic regulations. The matter is that 
under either partial removal or rearrangement of embryonic material all of its elements 
(including those which are suggested to be the reference points) take the positions, 
geometrically non-homologous to those occupied by the same points in normally 
developing embryos (Fig. 4). Moreover, so far as the early embryos are capable to  
  
Fig. 4. Embryonic regulations are incompatible with the assumption of any prelocalized 
specific material elements (say, P andQ), regarded as the sources of a positional information 
(PI). After the dissection of an embryo part upper from a dotted line shown in A and closure 
of the wound (B) the positions of the elements P and Q (as well as all the others) will become 
geometrically non-homologous to the same elements’ positions in A. As a result, any points 
of an embryo which occupy in A and B homologous positions (say, a and a1, b and b1, c and 
c1) will perceive quite different PI signals which is incompatible with embryonic regulations 
(from Beloussov, 1998).  
regulations after the removals and rearrangements of quite different embryonic areas, any 
predetermined elements will take in different experiments quite different (but each time 
geometrically non-homologous) positions. Consequently, we have only two formal 
possibilities to “save” a concept of predetermined reference points: either to suggest that 
such a role is passed each time to the elements, occupying geometrically homologous 
positions, or to assume that all the elements of a partial or normal embryo play a role of the 
reference points. However, the both versions (out of which the second one looks more 
consistent) imply that either only the reference points or even all the embryonic elements 
should somehow “feel” the shape of a whole. Here we see that a vagueness of the Driesch 
formulation had its reasons: intuitively he felt that the regulations which he discovered 
cannot be explained without implying the action of something related to irreducible whole 
to the minor elements. In his time, when the Laplacian determinism still was in full power, 
such a claim looked as something inappropriate for a real science. Today it is impossible to 
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negate such things; moreover, the verbal expressions like “top-down causation”, “emergent 
behavior” and “context-dependency” have been coined for describing them. However, mere 
words are not enough; what we need is a coherent law-centered theory explaining the 
arising of complexity, holistic regulations and so on. Remarkably, such a theory has been 
emerged already several decades ago quite outside of biology as a result of convergence of 
several branches of mathematics and physics. This is a self-organization theory (SOT). 
Before addressing to SOT directly, we must however get some knowledge of another  
topics – a symmetry theory (even irrespective to SOT it is very useful for any biologist).  
3. Elements of a symmetry theory as related to development 
In short, a symmetry theory is dealing with invariable transformations of geometric 
bodies, that is, with those kinds of movements which superpose a body with itself. The 
emphasis upon invariability makes this theory closely related to the very essence of law-
centered approach.  
We’ll restrict ourselves to the elementary part of a symmetry theory, which is dealing with 
three kinds of movements: rotations, reflections and translations and explore some simple 
examples. It is easy to see, for example, that a rectangle superposes with itself under 
rotations around its center to 900, 1800, 2700 and 3600 (that is, in four positions), a regular 
triangle do the same under rotations to 1200, 2400 and 3600 (3 positions), while a disc 
superposes with itself under rotation to an infinite (∞) numbers of angles. A number of 
positions superposing a body with itself is defined as an order of symmetry (in the above 
cases it is a rotational symmetry). If, as in the case of a disc, the number of such rotations is 
infinite, one speaks about a power of a symmetry order. Passing from 2-dimensional disc to 
3-dimensional sphere, we obtain a rotational symmetry power ∞/∞, what means that the 
rotations may go around an infinite number of central axes intersected at any angles.  
The bodies possessing any order of a rotational symmetry may have or not have reflection 
(mirror) symmetry, its plane denoted as m. Thus, a combined rotation/reflection symmetry 
of a sphere is ∞/∞· m. The bodies having no mirror symmetry at all can exist in two mutually 
reflected modifications, which can be arbitrarily defined as left and right.  
The translational symmetry is that of linear repeated patterns. Its order is characterized by 
a smaller linear shift n, which superposes a shifted pattern with non-shifted one. If a 
pattern is homogeneous along the shift direction (n is infinitesimal), the translational 
symmetry order is ∞.  
After learning these definitions, we can easily see that the development of an egg towards 
the adult state is associated with a stepwise reduction of symmetry order (or a series of 
symmetry breaks, as is often told). Thus, an egg before the establishment of its polar axis has 
a symmetry order of a sphere (∞ / ∞ · m), after the axis establishment it is reduced up to ∞ · 
m, while after determination of a saggital plane (into which the antero-posterior axis of a 
future organism is located) it becomes 1 · m (we ignore a right-left asymmetry, which is of a 
molecular origin and seems to persist throughout the entire life cycles without any 
fundamental perturbations). The development of advanced embryos is mostly associated 
with reduction of a translational symmetry order, that is, with establishment of the finite 
(rather than infinitesimal) n values. Most obvious examples are the formation of 
mesodermal somites out of a roughly homogeneous cell mass, or a subdivision of an 
initially smooth neural tube into brain vesicles.  
 
Self-Organization, Symmetry and Morphomechanics in Development of Organisms 
 
197 
We pay so much attention to symmetry breaks, because they are closely associated with the 
entire problem of causation. This linkage has been formulated by a classical principle 
claimed by the French physicist Pierre Curie exactly at the time when Driesch made his 
regulations experiments (although the both scientists did not know anything about each 
other). In his principle, Curie gave for the first time a strict definition of an effect and its 
cause. By his idea, any observable event is associated with the reduction of a symmetry 
order (by his words, “This is a dissymmetry, which creates an event”). Next, by Curie 
principle, no symmetry break can take place spontaneously, that is, without a somewhere 
located “dissymmetrizer”, an object with the already reduced symmetry order. It is a 
dissymmetrizer, which fits a notion of a “cause”.  
By applying this concept to developmental events, we have to conclude that any step of the 
above mentioned symmetry breaks, according to Curie principle, demands a 
dissymmetrizer, located either outside or inside of an entire egg/embryo. Let us start from 
the earliest developmental events. At the first glance, they require external dissymmetrizers. 
For example, an egg polarity in the eggs of brown algae can be established by a directed 
illumination of an egg and the polarity of many animal eggs by the surrounding structures 
of an ovary. The position of a saggital plane in amphibian eggs is determined by the point of 
a sperm entrance, and so on. However, very accurate observations have shown, that the 
external agents are not necessary: the algae eggs acquire polarity under absolutely isotropic 
illumination and amphibian eggs can select a plane of saggital symmetry out of an infinite 
bunch of planes even in the absence of a spermatozoon (parthenogenesis), or if it was 
inserted accurately into the egg pole (where it cannot act as a dissymmetrizer).  
Even less are the chances to find any dissymmetrizers for the events taking place in more 
advanced embryos. Here, as known from embryology text-books, in very many cases one 
rudiment plays a role of a so called inductor which triggers the development of another one, 
and in most cases this process is directly or indirectly mediated by chemical agents, emitted 
by inductor. Usually the inductors are regarded as the “causes” of the induced organs 
formation, but is it so in the terms of Curie principle? It is easy to show, that virtually in all 
these cases the symmetry order (as a rule, translational) of an induced morphological 
structure is considerably reduced in relation to that of an inductor; for the cases of purely 
chemical induction this is obvious without any comments. In the terms more customary for 
biologists this means that the morphological structure of an induced rudiment cannot be 
derived in one-to-one manner from that of  an inductor: certain factors, increasing the 
complexity of the induced organ and non related to inductor itself should be involved.  
In general, both embryonic regulations and symmetry breaks without dissymmetrizers 
leads us to conclude, that in the course of development more complicated (less symmetric), 
although if perfectly ordered entities are emerged from less complicated (more symmetric) 
ones. This is incompatible with a classical causal approach, but perfectly fits to what is 
called self-organization. Is such a process unique for the living beings?   
4. Self-organization in inanimate matter 
Already more than century ago the first examples of the similar events proceeding in non-
biological systems has been described by the French physicist Benard. This was the 
formation of cell-like structures (Benard cells) from a homogeneous viscous liquid, 
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molecular origin and seems to persist throughout the entire life cycles without any 
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(rather than infinitesimal) n values. Most obvious examples are the formation of 
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We pay so much attention to symmetry breaks, because they are closely associated with the 
entire problem of causation. This linkage has been formulated by a classical principle 
claimed by the French physicist Pierre Curie exactly at the time when Driesch made his 
regulations experiments (although the both scientists did not know anything about each 
other). In his principle, Curie gave for the first time a strict definition of an effect and its 
cause. By his idea, any observable event is associated with the reduction of a symmetry 
order (by his words, “This is a dissymmetry, which creates an event”). Next, by Curie 
principle, no symmetry break can take place spontaneously, that is, without a somewhere 
located “dissymmetrizer”, an object with the already reduced symmetry order. It is a 
dissymmetrizer, which fits a notion of a “cause”.  
By applying this concept to developmental events, we have to conclude that any step of the 
above mentioned symmetry breaks, according to Curie principle, demands a 
dissymmetrizer, located either outside or inside of an entire egg/embryo. Let us start from 
the earliest developmental events. At the first glance, they require external dissymmetrizers. 
For example, an egg polarity in the eggs of brown algae can be established by a directed 
illumination of an egg and the polarity of many animal eggs by the surrounding structures 
of an ovary. The position of a saggital plane in amphibian eggs is determined by the point of 
a sperm entrance, and so on. However, very accurate observations have shown, that the 
external agents are not necessary: the algae eggs acquire polarity under absolutely isotropic 
illumination and amphibian eggs can select a plane of saggital symmetry out of an infinite 
bunch of planes even in the absence of a spermatozoon (parthenogenesis), or if it was 
inserted accurately into the egg pole (where it cannot act as a dissymmetrizer).  
Even less are the chances to find any dissymmetrizers for the events taking place in more 
advanced embryos. Here, as known from embryology text-books, in very many cases one 
rudiment plays a role of a so called inductor which triggers the development of another one, 
and in most cases this process is directly or indirectly mediated by chemical agents, emitted 
by inductor. Usually the inductors are regarded as the “causes” of the induced organs 
formation, but is it so in the terms of Curie principle? It is easy to show, that virtually in all 
these cases the symmetry order (as a rule, translational) of an induced morphological 
structure is considerably reduced in relation to that of an inductor; for the cases of purely 
chemical induction this is obvious without any comments. In the terms more customary for 
biologists this means that the morphological structure of an induced rudiment cannot be 
derived in one-to-one manner from that of  an inductor: certain factors, increasing the 
complexity of the induced organ and non related to inductor itself should be involved.  
In general, both embryonic regulations and symmetry breaks without dissymmetrizers 
leads us to conclude, that in the course of development more complicated (less symmetric), 
although if perfectly ordered entities are emerged from less complicated (more symmetric) 
ones. This is incompatible with a classical causal approach, but perfectly fits to what is 
called self-organization. Is such a process unique for the living beings?   
4. Self-organization in inanimate matter 
Already more than century ago the first examples of the similar events proceeding in non-
biological systems has been described by the French physicist Benard. This was the 
formation of cell-like structures (Benard cells) from a homogeneous viscous liquid, 
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intensively heated from below (Fig. 5A, D). These structures immediately disappeared after 
heating was stopped, or became less pronounced. As proved later by one of SOT founders, 
Ilya Prigogine, these structures appeared because under enough intense flow of energy the 
convection streams (upward shifts of heated liquid particles and downward shifts of the 
cooled ones) pass from a random to so-called coherent regime, characterized by collective 
movements along some common  trajectories which became now energetically more 
advantageous than the random movements along individual tracks (Fig. 5B, C). What we 
see here is a real emergence of an ordered complexity from a homogeneous state or, in other 
words, a spontaneous (non-embedded from outside) reduction of a symmetry order: the 
initial infinite order of a translational symmetry is reduced up to that of n order, where n is a 
Benard cell diameter. 
 
Fig. 5. Benard cells. A: general view from the top. B, C: schemes Of coherent convection 
streams. D: evolution of Benard cells patterns under constant heating (from left to right) 
While the phenomenon of Benard cells formation did not pay much interest and was not 
considered as a breakthrough event, quite another was a public reaction to the occasional 
discovery of a fluctuating chemical reaction by the Russian chemist Boris Belousov in 
1950ieth. Although firstly it was rejected by the editorial board of a scientific journal (the 
referee wrote that it violates the second law of thermodynamics and hence should not exist) 
very soon an entire research team from the Institute of Biophysics, Russian Acad. Sci. 
extensively elaborated this reaction, transformed it into space-unfolded “autowaves” and 
gave its complete theory. Because of its vividness, the reaction became very popular 
throughout the world: everybody could see that within a couple of minutes a series of ever 
complicated spiral waves appear from “nowhere”, that is from a completely homogeneous 
state (Fig. 6). 
 




Fig. 6. Successive structures (1-8) arisen during Belousov-Zhabotinsky chemical reaction. 
5. A theory of something emerged from nothing 
Now we’ll give a very brief and elementary review of SOT principles (for much more 
complete, but still popular SOT account see Capra, 1996; for a developmentally related 
account see Beloussov, 1998).  Let the readers only slightly familiar with math be not afraid: 
the math will be minimal. As other great specialist in this field, Rene Thom said – “this is not 
the math, this is a mere drawing”. Our drawings will be also minimal – most will be 
expressed by words. 
The first point to be noticed is that contrary to classical mathematics, SOT is about a real 
world, which is full of so called unexpected perturbations, or a noise. Without noise none of 
the effects, predicted and described by SOT, will take place. For us biologists this is quite 
obvious: all the organisms are living in a very noisy world, which they have to resist and/or 
assimilate, preserving their individual, or a species-specific way of living. Such a property of 
a dynamic, or functional (not static!) resistance is also one of the main components of a self-
organization. It is called robustness. All the natural systems are to a certain extent robust – 
otherwise they would not exist at all. However, robustness always has its limits, and when 
they are exceeded, a system abruptly passes into another state, which is as a rule also robust.  
Let us express the above said by mathematical symbols. We shall see that such a 
transformation will very much clarify what was told before. Our main tool will be 
differential equations, firstly one variable linear, and then two variables nonlinear ones. 
Why is it necessary? The matter is, that even the simplest differential equation like  
 dx/dt = kx (1) 
has the following properties, lacking, say, in algebraic equations: 
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1. It describes a process, rather than a static state; 
2. It contains a feedback loop: not just the right part variables affect the left part ones, but 
vice versa as well. The feedback may be either positive, or negative, or, in the case of 
two variables equations, positive-negative (±). The latter is mostly useful for self-
organization. 
3. Most important in our context: differential equations combine the values of quite a 
different order - dx/dt is an infinitely small part of x. Thus, x represents a whole, while 
dx/dt its small part. Correspondingly, the action of x upon dx/dt is the action of a whole 
upon its parts. Just formally, differential equations imply a holistic causation, which we 
beforehand derived from experiments. . 
Let us now add a free member “-A” to eq. (1), obtaining 
  dx/dt = kx – A (1a) 
and make a graph (Fig. 7A), depicting by arrows the directions of dx/dt . We’ll get what is 
called the vector field (in this case 1-dimensional). Owing the presence of a free member, we 
have a stationary point dx/dt = 0 at x = A/k, from which the vectors dx/dt are diverged. 
Correspondingly, if we reverse the signs of the right part members, getting 
  dx/dt = -  kx + A (1b) 
the vectors will be converged towards the point with the same coordinates (Fig. 7B). This is 
enough for coming to the main notions of SOT: those of a dynamic (or Lyapunov) 
stability/instability. The solution (stationary point) in eq (1a) is unstable, because any 
infinitesimal shift from this point will bring us away without any chance to return back. On 
the contrary, in the framework of (1b) equation after any shift we’ll come back to the 
stationary point, which is unlimitedly stable. We call this kind of stability/instability 
dynamic because it relates to the variable x, which dynamics is just traced in the equations. 
Besides these dynamic variable(s), in all the equations another kind of values is always 
present and plays a leading role: those are so called parameters, which either do not change 
at all their values, or change them in an order more slowly than the dynamic variables. A 
distinction between dynamic variables and parameters is very important, because it relates 
to the fundamental concept of the structural-dynamic levels. This concept, belonging to so 
called systems theory, claims that a surrounding world (both animate and non-animate) is 
stratified into a number of more or less discrete levels distinguishing from each other by 
characteristic times (Tch) and characteristic dimensions (Lch) of the related events; the both 
hierarchies are, as a rule, roughly parallel to each other. In this language, the parameters, at 
least by Tch criteria, should be attributed to a much higher level than the dynamic variables. 
As concerning Lch it is crucial that in the developing organisms the dynamic variables are 
always the collective entities: all the developmental events are based upon the action of 
many cells, or many molecules, occupying different positions. As a rule, all the members of 
this collective share the same parameters values (otherwise this would not be a common 
system). Correspondingly, the area of the parameters action (the parameters Lch) is also 
greater than Lch for each one dynamic variable.  
In eq (1a, 1b) the parameters are represented by k and A values. Even in these simplest 
equations they are playing the main role and, remarkably, do it in quite a robust manner. 
Namely, there are the signs (+ or -) rather than the absolute values of the both parameters 
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which decide whether the solution will be stable or unstable: it is easy to see, for example, 
that only eq (1b) rather than (1a) has stable solutions. At the same time, in the immediate 
vicinity of k = 0 just very small shifts of k values are enough for switching a solution from 
stable to unstable, and vice versa. In other words, in relation to the shift of, say, parameter k 
eq (1) is unstable at k≈0 and stable in all the other areas. This is another kind of 
stability/instability, which is called parametric, or structural. A notion of a structural stability 
very adequately represents such biological realities as, for example, a morphology of a 
taxon, because it reflects at the same time a preservation of a general “Bauplan” and some 
considerable, but nevertheless limited fluctuations. 
The notions of stability/instability (both dynamic and parametric) and their regulation are 
of a primary importance for understanding the developmental transformations and their 
relations to causality. When we notice, as mentioned above, that at least some of the 
symmetry breaks look to be proceeded “spontaneously”, this actually means that the 
preceded symmetry order has lost its dynamical stability and hence can be broken by 
negligibly small perturbations (of a noise intensity), to which a developing organism is 
insensible during stable periods. By the way, this means that Curie principle formally keeps 
its validity during instability periods as well, but at that time the “causes” are so small that 
cannot be distinguished from the ever presented noise.  
 
Fig. 7. Vector fields and solutions of some simple differential equations. A, B: linear 
equations. In A the solution is unstable (empty circle, vectors diverging), while in B it is 
stable (filled circle, vectors converging). C: under k < 0 there is only one stable solution x = 
0, while under    k > 0 this solution becomes unstable while two stable solutions appear in 
exchange. A transition from negative to positive k values corresponds to that from a single 
non-differentiated to a differentiated state (colored scheme to the right). For more details 
see text. 
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Under these conditions, it is meaningless to look for the “causes” in their classical sense. 
What we need to know instead is why at the given moment an embryonic structure has lost 
its previous stability. Meanwhile, we know already, that the loss (or acquiring) of stability is 
provided by the changes of the parameters values. This conclusion is of a direct 
methodological usage: instead of  splitting the studied systems into ever smaller parts in 
pursuit of ever escaping causes, we should concentrate our interest onto macroscopic levels, 
to which the parameters belong.  
For illustrating the role of parametric regulation in more details, we have to go from linear 
to non-linear equations. This shift is not just formal: it means that we pass from 
independently acting elements to interacting ones (those which either enhance, or inhibit 
each other, or make the both things together). In other words, non-linearity means 
cooperative interactions, most of all important for developmental events. A simple example: 
suggest that N identical elements affect the event A. If these elements are independent of 
each other, their action upon A is proportional to N, while if N elements enhance each other, 
it is proportional to N(N-1) ≈ kN2.  
We miss a quadratic non-linearity and come directly to the 3-rd order one, as providing one 
of the best illustrations of developmental processes. Consider the equation 
 dx/dt =kx – k1x3( k1 > 0) (2) 
which describes a first order positive feedback between kx  and dx/dt  and 3-rd order 
negative feedback between k1x3  and dx/dt . It can be easily tested, that under k < 0 eq (2) has 
only one rational solution x1 = 0 which is stable, while under k > 0 this solution becomes 
unstable, while two new stable symmetric solutions appear: 
 x2, x3 = ± √ k/k1 
(Fig. 7C). The main property of this model is that when k parameter in his rightwards 
movement reaches positive values, a number of stable solutions increases from one to two. 
Accordingly, it is a simplest model of the complexity increase, or of the reduction of a 
symmetry order (under    k < 0 the sole stable solution x1 = 0 is the axis of a rotational and 
reflection symmetry, while under positive k none of the stable solutions x2, x3 can play this 
role). In biological language this is just what we define as differentiation. The most 
important lesson from this model is that such a crucial step is under a full parametric 
control. That does not mean that the dynamic variables play no role at all, but this role is 
parametrically dependent. Namely, only under k > 0 the dynamic variables can select one of 
two vacant stable solutions. But they do it in quite a robust manner, without being obliged 
to take precise values: under any  x > 0 the positive solution is selected, while under any x < 
0 the negative one. Therefore:  
(1) there are the parameters which determine the number and the values of stable solutions, 
that is, stable states, potentially achievable by a system; (2) among these, the actual states are 
selected by the dynamic variables in quite a robust manner: each stable state is a “basin of 
attraction” of infinitesimal number of the dynamic variables values. 
By the way, these conclusions undermine a myth of an extremely precise organization of the 
living beings: the main condition for surviving and keeping their individuality is a small 
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number of potentially achievable and highly robust stable states, rather than a precise 
arrangement of the dynamic variables, which never exists.  
Remarkably, most of the above said can be easily translated into embryological language. 
One of the most important notions of embryology is indeed that of a competence: briefly 
speaking, this is a capability of a given embryo region at a given stage to develop into more 
than one direction. Now we may see that in SOT language it corresponds to that region of 
the parameters values, which has more than one stable solution. Therefore, the existence or 
the absence of a competence should be regulated parametrically. The next step after 
reaching the region of competence will be to come into the “attraction basin” of a definite 
solution. This event corresponds to what is defined in embryology as determination, and we 
can conclude that it is a matter of dynamic regulation. Same will be true for the final 
reaching of a stable state; in embryological language this is differentiation. 
At the end of this section, let us briefly describe, even missing formulae, some more 
complicated self-organizing systems. Biologically very important class of systems is 
described by 2-variables (X and Y) non-linear differential equations, where Tch for Y are in 
an order smaller than for X: therefore, if including the parameters, these systems are at least 
three-leveled. In addition, the variables are interconnected by (+, -) feedbacks: a slower 
variable X inhibits a fast variable Y, while the latter enhances the first one. As a result, in a 
wide range of the values of a single controlling parameter we get so called autooscillations, 
that is, non-damped regular fluctuations of the both variables values. Complementing this 
system by a linear dependence between Y and dx/dt, we transform ever persisting 
autooscillations into a so-called trigger regime with two stable states, exchanging each other 
after finite perturbations of one of the variables. The arisen structures may be either only 
time-dependent, or in addition space-unfolded. In the latter case one has to assume that at 
least one of the variables is diffusing through space (it may exemplify not only a chemical 
substance, but also a certain physical state). In any case, all of these either purely temporal, 
or spatial-temporal structures are able to create, under a proper range of controlling 
parameters, quite stable patterns out a completely homogeneous state; note however that 
the patterns are stable until the supply of dynamic variables will continue.  
6. Application of SOT to embryonic development 
The first person to be mentioned here is Conrad Waddington, a British scientist who, even 
before SOT emerged in its present form, suggested a very stimulating allegory of 
development, that of a mountain landscape, consisting of valleys (which symbolize stable 
developmental trajectories) and crusts (imaging unstable states between valleys) (for recent 
account see Goldberg et al., 2007). There is also a tale that it was Waddington who asked a 
famous mathematician Alan Turing whether it is possible to construct a model generating a 
macroscopic order out of a completely homogeneous state. Turing did so postulating 
feedback interactions and diffusion of two reagents (Turing, 1952). His model became quite 
famous, even if it had no relations to any real biological process. An entire series of models, 
aiming to imitate biological realities have been constructed later on by Gierer and Meinhardt 
(Meinhardt, 1980). In general, the models postulated feedback interactions between two 
chemical substances, one of them (the activator) stimulating the development of a certain 
structure, while another (the inhibitor) suppressing the activator. Necessary was also the 
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number of potentially achievable and highly robust stable states, rather than a precise 
arrangement of the dynamic variables, which never exists.  
Remarkably, most of the above said can be easily translated into embryological language. 
One of the most important notions of embryology is indeed that of a competence: briefly 
speaking, this is a capability of a given embryo region at a given stage to develop into more 
than one direction. Now we may see that in SOT language it corresponds to that region of 
the parameters values, which has more than one stable solution. Therefore, the existence or 
the absence of a competence should be regulated parametrically. The next step after 
reaching the region of competence will be to come into the “attraction basin” of a definite 
solution. This event corresponds to what is defined in embryology as determination, and we 
can conclude that it is a matter of dynamic regulation. Same will be true for the final 
reaching of a stable state; in embryological language this is differentiation. 
At the end of this section, let us briefly describe, even missing formulae, some more 
complicated self-organizing systems. Biologically very important class of systems is 
described by 2-variables (X and Y) non-linear differential equations, where Tch for Y are in 
an order smaller than for X: therefore, if including the parameters, these systems are at least 
three-leveled. In addition, the variables are interconnected by (+, -) feedbacks: a slower 
variable X inhibits a fast variable Y, while the latter enhances the first one. As a result, in a 
wide range of the values of a single controlling parameter we get so called autooscillations, 
that is, non-damped regular fluctuations of the both variables values. Complementing this 
system by a linear dependence between Y and dx/dt, we transform ever persisting 
autooscillations into a so-called trigger regime with two stable states, exchanging each other 
after finite perturbations of one of the variables. The arisen structures may be either only 
time-dependent, or in addition space-unfolded. In the latter case one has to assume that at 
least one of the variables is diffusing through space (it may exemplify not only a chemical 
substance, but also a certain physical state). In any case, all of these either purely temporal, 
or spatial-temporal structures are able to create, under a proper range of controlling 
parameters, quite stable patterns out a completely homogeneous state; note however that 
the patterns are stable until the supply of dynamic variables will continue.  
6. Application of SOT to embryonic development 
The first person to be mentioned here is Conrad Waddington, a British scientist who, even 
before SOT emerged in its present form, suggested a very stimulating allegory of 
development, that of a mountain landscape, consisting of valleys (which symbolize stable 
developmental trajectories) and crusts (imaging unstable states between valleys) (for recent 
account see Goldberg et al., 2007). There is also a tale that it was Waddington who asked a 
famous mathematician Alan Turing whether it is possible to construct a model generating a 
macroscopic order out of a completely homogeneous state. Turing did so postulating 
feedback interactions and diffusion of two reagents (Turing, 1952). His model became quite 
famous, even if it had no relations to any real biological process. An entire series of models, 
aiming to imitate biological realities have been constructed later on by Gierer and Meinhardt 
(Meinhardt, 1980). In general, the models postulated feedback interactions between two 
chemical substances, one of them (the activator) stimulating the development of a certain 
structure, while another (the inhibitor) suppressing the activator. Necessary was also the 
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inequality of the both components diffusion rates: the inhibitor should diffuse much more 
rapidly than the activator.  
These models permitted to reproduce a number of biomorphic patterns, mostly periodic 
ones and in particular those related to surface designs. Also, they introduced an important 
principle: “short-range activation – long range inhibition” - which seems to be a wide-
spread tool for pattern formation, although not necessarily connected with diffusible 
chemical substances. Meanwhile, the authors were fully satisfied by reproducing some 
single steps of development, without expressing any interest to model more or less 
prolonged chains of events. As a result, the initial conditions and the relations between 
postulated chemical substances and morphological structures which they assume to 
“activate” or “inhibit” had to be taken each time in quite an arbitrary way.  
7. Mechanically-based self-organization (morphomechanics) 
Much closer to biological realities and less connected with arbitrary assumptions became 
another class of models, emerged since 1980ieth. The main acting agents in these models 
were mechanical stresses (MS), generated by embryonic cells. Even a priori MS looked to be 
good candidates for being involved into regulatory circuits by the following reasons at least: 
- they belong to universal (largely non-specific) natural agents; 
- they are acting at the same time on quite different structural levels, from molecular to 
that of whole organisms; 
- MS create very effective feedbacks with geometry of stressed bodies: any changes in MS 
pattern affect geometry in a well-predicted way, and vice versa. As D’Arcy Thompson 
told in his classical book “On Growth and Form” (last edition: Thompson, 1961) “Form 
is a diagram of forces”.  
As discovered during several last decades, embryonic tissues of all the studied animals, 
from lower invertebrates to human beings are mechanically stressed (same, even to a greater 
extent is true for plants). Embryonic MS are of different origin. In early development the 
main stressing force is turgor pressure in embryonic cavities (blastocoel, subgerminal 
cavity), which is born due to ion pumping and which stretches the surrounding cell layers. 
At the advanced stages most of stresses are caused by collective movements of many dozens 
of cells. Cell proliferation also contributes to MS. It is of a particular importance, that MS are 
arranged along ordered patterns, remaining topologically invariable during successive 
developmental periods and drastically changing in between. They never are uniformly 
spread throughout the developing embryos, but are generated in a certain part and 
transmitted by rigid structures to others. 
Already several decades ago the German anatomist Bleschmidt described a large set of MS 
patterns emerging in human development, and claimed that “the general rules… that are 
applicable to man … have much in common with the rules of the developmental 
movements that take place in animals and even in plants” (Bleschmidt and Gasser, 1978). In 
advanced embryos he distinguished 8 different kinds of MS fields which participate in 
development of practically all the organs. Some of them are depicted in Fig.8A-C. 
Modulations of MS patterns (relaxation, reorientation, changes in MS values) in amphibian 
and chicken embryos lead to grave developmental anomalies. A number of fetus 
pathologies are also mechano-dependent. 
 




Fig. 8. Some examples of “biokinetic” schemes of human embryos anlagen by Blechschmidt 
and Hasser (1978). A: a rudiment of a finger; B: heel pad of 5 months fetus; C: a somite with 
surrounding tissues. Diverging and converging arrows depict stretching areas and those 
resisting to stretch, correspondingly. The main idea is that all the anlagen have their own 
patterns of mechanical stresses.  
Most important, self-generated MS affect each other, creating feedbacks. Harris and 
coworkers (1984) evidenced the presence of such feedbacks by observing cell cultures 
seeded onto highly elastic substrates which the cells were able to stretch by their own 
contractile forces (Fig. 9A, B). As a result, homogeneously seeded cells became rearranged 
into regular clusters (Fig. 9C). This is a real self-organization (reduction of symmetry order) 
created by a feedback between short range adhesive interactions, tending to clump cells 
together into a tight cluster and long range stretching forces which extend the substrate and 
hence decrease cell density. Within the model framework, the adhesive forces correspond to 
short range activation, while the stretching forces to the long range inhibition of Gierer-
Meinhardt models. Therefore, mathematics is roughly the same, but physics quite another – 
mechanics instead of chemistry! Quite similar, although if independently developed 
approach has been used in Belintzev et al. (1987) model, aiming to reproduce a segregation 
of initially homogeneous epithelial layers into the domains of columnar and flattened cells. 
In this model a role of short range activation was played by so called contact cell 
polarization (CCP) – cell-cell transmission of a tendency to become columnar. At the same 
time, long range inhibition, similarly to Harris et al. model, was provided by mechanical 
tension, arisen in the epithelial layer with fixed ends just because of CCP. Hence, again we 
have here a mechanically based (+, -) feedback. This model is of a special interest, because 
(unexpectedly to the authors) it became able to reproduce some main properties of 
embryonic regulations, namely preservation of proportions under different absolute 
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dimensions of a layer. This became possible, because the model equation contains a 
member, referring to holistic (independent from individual elements) property of a layer: 
this is the average cell polarization throughout the entire layer. Thus, the model can be 
considered as a mathematical expression of the Driesch law.  
 
Fig. 9. Formation of regular cell clusters onto an elastic substrate. A: a single crawling cell 
shrinks the underlain substrate and hence stretches that located outside. B: a large cluster of 
adhered cells (to the left) stretches the cells located outside (to the right). C: a regular cell 
pattern arisen in the dermal layer of chicken embryo under the similar mechanical 
conditions (from Harris et al., 1984, with the authors’ permission). 
The described models made the first steps away from a purely static view upon development: 
we began to understand, why a given stage is exchanged by the next one. However, the 
modeled chains were too short and very soon abrupt. Is it possible to use a mechanically-based 
approach for reproducing much more prolonged developmental successions, including the 
above models as particular cases? Such an attempt has been performed by our research group 
about two decades ago (at the initial stage of this enterprise very important contribution was 
made by Dr. Jay Mittenthal from Illinois University, USA). 
Our main idea was very simple. It is well known that any organism, deviated by any 
external perturbation (including certainly mechanical forces) from its normal functioning, 
tries to diminish the results of perturbation up to their complete annihilation. We modify 
this almost trivial statement by adding that any part of a developing organism affected by a 
mechanical force (coming normally from another part of the same embryo) not only tends to 
restore its initial stress value, but do it with a certain overshoot. This assumption, called the 
hypothesis of MS hyper-restoration (HR), permitted to make several predictions, opened for 
experimental and model testing (Beloussov and Grabovsky, 2006; Beloussov, 2008). 
For example, according to this model, a stretching of a tissue piece by an external force 
should produce the active reaction which firstly diminishes stretching and then, as a part of 
HR response, generates the internal pressure force, directed along a previous stretching (Fig. 
10A). As a rule, this is done by so called cell intercalation, that is, cells insertion between 
each other in the direction, perpendicular to stretching (Fig. 10C). Accordingly, if a tissue 
piece is relaxed or, the more, compressed, its cells should actively contract in the direction of 
relaxation/compression, tending to produce tension is this very direction (Fig. 10B, D). If 
applying these predictions to a cell sheet bent by external force, we should expect that its 
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concave (compressed) side will be actively contracted, while the convex (stretched) one 
extended. As a result, their cooperative action will actively increase the folding, just 
triggered by external force.  
Importantly, these reactions are connected by feedbacks with each other. Among them, one 
of the main can be called “contraction-extension” (CE) feedback. As any other self-
organizing event, it starts from a fluctuation – in this case, of a stretching/compression 
stress along cell layer. For example, if a part A of a layer  is stretched slightly more than a 
neighboring part B and the layers edges are firmly fixed, at the next time period part A will 
be actively extended and hence compresses the part B. The latter will respond to this by 
active contraction, even more stretching A, and vice versa. The modeling showed 
(Beloussov & Grabovsky, 2006), that the results of these interactions crucially depend upon 
one of the parameters, a so called threshold stretching stress (TSS), that is the minimal 
stretching stress required for generating the internal pressure. If TSS is taken large enough, a 
layer will be segregated into single alternated domains of columnar and flattened cells. Just 
this situation corresponds to Belintzev et al. model. Under TSS decrease the number of 
alternative cell domains is increased while under very small TSS no stationary structures are 
produced: instead, a series of running waves is generated. This exemplifies a parametric 
dependence of morphogenesis. 
 
Fig. 10. Model of hyperrestoration of mechanical stresses. A, B: schemes of the responses to 
stretching and to relaxation/compression, correspondingly. Horizontal axis: mechanical 
stress (compression to the left, tension to the right). Vertical axis: time. C: a typical way for a 
response to stretching (cell intercalation). D: response to relaxation by tangential contraction 
(columnarization) of some neighboring cells. Vertical bars: firmly fixed edges. 
Now let us reproduce in very broad outlines a more or less prolonged (but still uncomplete) 
chain of morphogenetic events. We start from so called “idealized blastula” stage, a 
spherically symmetric body with the walls of equal thickness which surround a concentric 
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cavity and are stretched by the turgor pressure within the latter. Why during normal 
development a blastula stage embryo will not stop at this stage but passes instead towards a 
more complicated (less symmetric) form? By our suggestion, this is because, according to 
CE-feedback, a spherical symmetry of blastula is unstable: even small local variations in its 
wall thickness will produce the corresponding differences of tensile stresses: thinner parts 
will be stretched to a greater extent and hence produce the greatest internal pressure, 
actively extending themselves and compressing the resting part(s) of the cavity wall. At the 
next step the mostly compressed part will generate, according to above said, the active 
contraction force. This delimits the start of the next stage, called gastrulation. In general, 
such a contraction can be achieved by different ways. The first of them is emigration of some 
cells from the compressed part inside the blastula cavity. This is typical for some lower 
Invertebrates (Cnidaria). Another one is the folding of a compressed part of a cell sheet; it is 
more elaborated type of gastrulation, called invagination. However, the folding itself may 
go in different geometric ways: the extreme ones are exemplified by a creation of a straight 
slit (Fig. 11A), and a circular fold (Fig. 11E). Take a sheet of paper and try to reproduce each 
of them. You will see how easy is to make a slit-like fold, while to make a circular one is 
virtually impossible – so much radial folds are arisen around! In order to smooth out the 
folds, the excessive cells should be removed (emigrated) from the folded area. In principle, 
CE-feedback can provide such a mechanism, but it is to be well tuned. On the contrary, a 
slit-like folding does not demand so refined regulation.  
Nature employed the both ways: the first one is typical, for example, to Annelides and 
Arthropoda (belonging to a large group called Protostomia), while the second one for  
Echinodermata and Chordata (belonging to so called Deuterostomia). Interestingly, some 
lower Invertebrates, belonging to the type Cnidaria, took a variable intermediate way (Fig. 
11B). In any case, the geometry of gastrulation very much affects subsequent development. 
The laterally compressed slit-like Protostomia blastopores should actively elongate themselves 
along the slit axis, compresses their polar regions (which later on transform to the oral and 
anal openings) but to a very small extent affects mechanically the rest of embryo (Fig. 11C, D). 
On the contrary, a gradually contracted hoop-like blastopore of Deuterostomia embryos 
creates around it a diverged radial tensile field, being extended over the entire embryonic 
surface and thus involving it into a coordinated morphogenesis (Fig. 11F).  
Meanwhile, a uniform mode of a circular blastopore contraction is also unstable: similarly to 
what took place at the blastula stage, even small local irregularities in contraction rate along 
the blastopore periphery should subdivide it into the compression and extension zones. As a 
result, an ideal circular symmetry will be sooner or later broken and the blastopore together 
with its surroundings will acquire either a radial symmetry of n order, depicted by a symbol 
n·m, or a mirror symmetry 1·m. The latter mode of symmetry means formation of dorso-
ventrality, still rudimentary in Echinodermata but fully expressed in Chordata. The dorsal line 
is that of a maximal active extension of embryonic body. Along this line another CE-feedback 
is created: its posterior part becomes extended, while the anterior one relaxed/compressed. 
This latter region transforms into a transversely extended head (Fig. 11H, h).  
Later on the body of Vertebrate embryos becomes segregated into more or less 
independently developing territories (“fields of organs”) into which the similar events are 
taking place in diminished scales. It will be a fascinating and as yet almost untouched field 
of studies to construct self-organizing models for all of them.  
 




Fig. 11. Formation and mechanical role of slit-like and circular blastopores. A: typical 
blastopore of Protostomia. B: irregular blastopores of Cnidarian embryos. C, D: tensile fields 
in the vicinity of slit-like blastopores. E: circular blastopore of amphibian embryo. F-H: 
transformation of a radially symmetric tensile field around a circular blastopore (F) into 1·m 
symmetry field with a dominating dorsal axis (G, H). H is a view from the left. d: dorsal 
side, h: head region. 
8. Few words in conclusion 
The main message of this essay is that the classical causal approach, continued to be used 
(even if unconsciously) by overwhelming majority of investigators cannot explain the main 
properties of development – the arising of more complex entities from less complex and even 
homogeneous ones and the associated “top-down causation” – influence of an irreducible 
whole upon its parts. As a result, a present-day developmental biology looks, even in the best 
cases, as a list of separate “instructions” of how to make this or that structure rather than a 
science with its own laws and predictive power. On the other hand, SOT, one of the leading 
branches of the modern knowledge, turned out to be quite suitable for promoting 
developmental biology to perform a desired transformation. To the present time, however, 
only the first steps on this way have been made. What we need now, is not so much a 
construction of specific models, but a general understanding of the nature of feedbacks, 
parameters and dynamic variables mostly involved in development. To a great extent this is 
related to a widely used notion of “genetic information”. We have already seen, that it is far 
from being specific (an old concept “one gene – one morphological structure” is fully 
incompatible with modern data). Meanwhile, SOT opens a much more rational way for qualify 
it more properly: so far as genomes belong to the most constant components of the life cycles 
and the genetic factors are dealing, first of all, with the rates of molecular processes, it looks 
reasonable to attribute to genetic factors the role of the highest order parameters (those having 
the largest Tch and Lch). Within such a framework, the role of “genetic information” is quite 
powerful, but non-addressed: knowing the parameters’ values but being non-informed about 
the structure of the feedback loops into which they are involved, we cannot tell anything about 
the role which is played by the first ones (as a rule, these roles should be quite multiple). The 
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cavity and are stretched by the turgor pressure within the latter. Why during normal 
development a blastula stage embryo will not stop at this stage but passes instead towards a 
more complicated (less symmetric) form? By our suggestion, this is because, according to 
CE-feedback, a spherical symmetry of blastula is unstable: even small local variations in its 
wall thickness will produce the corresponding differences of tensile stresses: thinner parts 
will be stretched to a greater extent and hence produce the greatest internal pressure, 
actively extending themselves and compressing the resting part(s) of the cavity wall. At the 
next step the mostly compressed part will generate, according to above said, the active 
contraction force. This delimits the start of the next stage, called gastrulation. In general, 
such a contraction can be achieved by different ways. The first of them is emigration of some 
cells from the compressed part inside the blastula cavity. This is typical for some lower 
Invertebrates (Cnidaria). Another one is the folding of a compressed part of a cell sheet; it is 
more elaborated type of gastrulation, called invagination. However, the folding itself may 
go in different geometric ways: the extreme ones are exemplified by a creation of a straight 
slit (Fig. 11A), and a circular fold (Fig. 11E). Take a sheet of paper and try to reproduce each 
of them. You will see how easy is to make a slit-like fold, while to make a circular one is 
virtually impossible – so much radial folds are arisen around! In order to smooth out the 
folds, the excessive cells should be removed (emigrated) from the folded area. In principle, 
CE-feedback can provide such a mechanism, but it is to be well tuned. On the contrary, a 
slit-like folding does not demand so refined regulation.  
Nature employed the both ways: the first one is typical, for example, to Annelides and 
Arthropoda (belonging to a large group called Protostomia), while the second one for  
Echinodermata and Chordata (belonging to so called Deuterostomia). Interestingly, some 
lower Invertebrates, belonging to the type Cnidaria, took a variable intermediate way (Fig. 
11B). In any case, the geometry of gastrulation very much affects subsequent development. 
The laterally compressed slit-like Protostomia blastopores should actively elongate themselves 
along the slit axis, compresses their polar regions (which later on transform to the oral and 
anal openings) but to a very small extent affects mechanically the rest of embryo (Fig. 11C, D). 
On the contrary, a gradually contracted hoop-like blastopore of Deuterostomia embryos 
creates around it a diverged radial tensile field, being extended over the entire embryonic 
surface and thus involving it into a coordinated morphogenesis (Fig. 11F).  
Meanwhile, a uniform mode of a circular blastopore contraction is also unstable: similarly to 
what took place at the blastula stage, even small local irregularities in contraction rate along 
the blastopore periphery should subdivide it into the compression and extension zones. As a 
result, an ideal circular symmetry will be sooner or later broken and the blastopore together 
with its surroundings will acquire either a radial symmetry of n order, depicted by a symbol 
n·m, or a mirror symmetry 1·m. The latter mode of symmetry means formation of dorso-
ventrality, still rudimentary in Echinodermata but fully expressed in Chordata. The dorsal line 
is that of a maximal active extension of embryonic body. Along this line another CE-feedback 
is created: its posterior part becomes extended, while the anterior one relaxed/compressed. 
This latter region transforms into a transversely extended head (Fig. 11H, h).  
Later on the body of Vertebrate embryos becomes segregated into more or less 
independently developing territories (“fields of organs”) into which the similar events are 
taking place in diminished scales. It will be a fascinating and as yet almost untouched field 
of studies to construct self-organizing models for all of them.  
 




Fig. 11. Formation and mechanical role of slit-like and circular blastopores. A: typical 
blastopore of Protostomia. B: irregular blastopores of Cnidarian embryos. C, D: tensile fields 
in the vicinity of slit-like blastopores. E: circular blastopore of amphibian embryo. F-H: 
transformation of a radially symmetric tensile field around a circular blastopore (F) into 1·m 
symmetry field with a dominating dorsal axis (G, H). H is a view from the left. d: dorsal 
side, h: head region. 
8. Few words in conclusion 
The main message of this essay is that the classical causal approach, continued to be used 
(even if unconsciously) by overwhelming majority of investigators cannot explain the main 
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homogeneous ones and the associated “top-down causation” – influence of an irreducible 
whole upon its parts. As a result, a present-day developmental biology looks, even in the best 
cases, as a list of separate “instructions” of how to make this or that structure rather than a 
science with its own laws and predictive power. On the other hand, SOT, one of the leading 
branches of the modern knowledge, turned out to be quite suitable for promoting 
developmental biology to perform a desired transformation. To the present time, however, 
only the first steps on this way have been made. What we need now, is not so much a 
construction of specific models, but a general understanding of the nature of feedbacks, 
parameters and dynamic variables mostly involved in development. To a great extent this is 
related to a widely used notion of “genetic information”. We have already seen, that it is far 
from being specific (an old concept “one gene – one morphological structure” is fully 
incompatible with modern data). Meanwhile, SOT opens a much more rational way for qualify 
it more properly: so far as genomes belong to the most constant components of the life cycles 
and the genetic factors are dealing, first of all, with the rates of molecular processes, it looks 
reasonable to attribute to genetic factors the role of the highest order parameters (those having 
the largest Tch and Lch). Within such a framework, the role of “genetic information” is quite 
powerful, but non-addressed: knowing the parameters’ values but being non-informed about 
the structure of the feedback loops into which they are involved, we cannot tell anything about 
the role which is played by the first ones (as a rule, these roles should be quite multiple). The 
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parameters themselves, if taken out of the context of an associated equation or, at least, of a 
feedback contour are, so to say, blind – they have no definite meaning at all. If continuing to 
apply the notion of information to developmental events (although this never can be done 
with a desired degree of  precision), we have to conclude, that it is smoothed between several 
structural levels: not only DNA and proteins, but also morphological structures and embryo 
geometry bear an essential amount of “information”, irreducible to other levels events. Or, in 
other words, the biological information is embedded in wide contexts, rather than in single 
elements. By believing that the solution of all the developmental mysteries can be reached by 
splitting embryos in ever diminished parts, we may miss the very essence, which is resided 
onto meso- and macroscopic, rather than microscopic level. 
Our last question will be of a utilitarian nature: why do we need to pay any efforts by 
transforming biology into a law-centered science, if already in its present-day state it gives so 
many results, useful for medicine and biotechnology? True, as a great physicist Boltzman told, 
nothing is more practical than a good theory. But is this citation applicable to biology? Nobody 
can be sure of it, but the attempt is worth to be performed. In any case, one can hardly be 
content to see the science about the most complicated, ordered and aesthetically perfect 
natural processes using a methodology not very different from that of a medieval alchemy. 
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